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Summary 
The rapid increase in myopia prevalence has escalated a wealth of research interest in the 
prevention mechanisms of myopia. Orthokeratology (ortho-k) is among the most promising 
approaches. A reluctance to employ this modality has been observed, owing to the selective 
treatment outcome and the long-term effects to the corneal tissue.  
This thesis investigates the attitudes of clinicians towards various myopia control 
interventions, including ortho-k within a cross-sectional internet-based survey; long-term 
effects of ortho-k lens wear on corneal biomechanical properties in myopic school-children 
over a two year period; short-term corneal biomechanical changes over the first 7 nights of 
lens wear; and the influence of factors (age, ethnicity, eye/body size and nutrition) on 
corneal biomechanical properties in healthy adults. The aim of this thesis is to aid a deeper 
understanding of the role of corneal biomechanical properties in ortho-k lens wear, 
specifically for myopia control. 
The findings within the thesis demonstrate that surveyed eye-care practitioners are aware 
of the scientific findings within the field of myopia control; two thirds would still prescribe 
single vision glasses to their patients, owing to a lack of clear guidelines and the selective 
treatment outcome. Results of the ortho-k studies suggest that the corneal biomechanical 
characteristics are affected by long term ortho-k wear, having a stabilising effect to the 
components of the anterior eye in progressing myopia. Short term ortho- k lens wear study 
reveals marked changes in corneal biomechanical parameters within the first seven nights 
of lens wear. Ortho-k itself and the anterior segment changes observed cannot explain all 
the variation in treatment response. The final study demonstrates the relationship between 
corneal biomechanical parameters and nutrition, ocular biometry and body size, suggesting 
that individual factors, although non-substantially, contribute towards the treatment 
outcome. 
It, is therefore, suggested to establish an internationally acknowledged guideline for myopia 
control. Further studies should be designed to understand the complex mechanisms 
underlying ortho-k in myopia control. 
 
 
 
Keywords: orthokeratology, myopia control, corneal biomechanics, short and long-term 
changes, factors.  
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Chapter 1. Introduction 
1.1 General overview 
The rapid increase in myopia prevalence has escalated an amplified interest in this research 
area (Pan et el. 2012). The multifactorial nature of this condition has set challenges for the 
researchers and clinicians on how to manage this condition more effectively (Flitcroft 2012). 
Orthokeratology (ortho-k) is among the most promising methods for slowing down myopia 
progression (Holden et al. 2014). However, a reluctance towards this intervention has been 
seen over the years owing to the individually selective treatment outcome, which frequently 
has been linked to the corneal response to the treatment (Swarbrick et al. 1998; Swarbrick 
2006). This chapter introduces the findings on myopia development, progression, myopia 
control (MC) and, in detail, one of the MC interventions, ortho-k, currently available in the 
scientific literature. Ortho-k is reviewed particularly in relation to the corneal structure and 
biomechanical properties. Subsequently this chapter outlines the research rationale and 
aims for the experimental chapters included in the thesis. 
1.2 Myopia 
1.2.1 Definition of myopia 
Myopia is an ametropic condition in which a mismatch exists between the optical power of 
the eye and its axial length. The parallel light entering the myopic eye forms a sharp image 
in front of the retinal plane, resulting in the perception of a blurred visual image.The 
imbalance may arise from an eye either having a relatively long axial length or increased 
optical power of one or more of its refractive elements (Rosenfield 2006). Studies indicate 
that myopia is mostly axial in nature, resulting from the increase in vitreous chamber depth 
and that the contribution of the cornea is relatively small (Wallman and Adams 1987; 
Grosvenor and Scott 1994; Grosvenor and Goss 1998; Strang et al. 1998; Logan et al. 
2004). As a result, the far point of an eye, a point conjugating to the fovea when 
accommodation is fully relaxed, is located in front of the eye. Therefore, it is difficult for one 
to see distant objects clearly. Visual acuity (VA) in myopia can be restored with the use of 
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corrective lenses. Normal vision is restored by the introduction of a divergent optical 
element in front of the eye matching the degree of myopic refractive error (Rabbetts 2007; 
Sankaridurg and Holden 2014).  
1.2.2 Prevalence of myopia 
The prevalence of myopia has increased globally in the last few decades reaching epidemic 
levels in some parts of the world. For example, a study conducted by Vitale et al. (2009), 
comparing the incidence of myopia in 12-54 year old population in the United States of 
America between 1971-1972 and 1999-2004, showed that the levels of myopia increased 
from 25% to 46.1% respectively. In a population of Taiwanese school-children (aged 16 to 
18 years) an increase in myopia from 74% to 84% between 1983 and 2000 was reported 
(Lin et al. 2004). In a recent study McCullough et al. (2016) reported a doubled rate of 
myopia prevalence amongst white British school children when compared to last 50 years. 
 
Regional differences exist in prevalence of myopia (Pan et al. 2012). High myopia 
prevalence has been associated with the region of South-East Asia. In a study conducted 
by Lam et al. (2004), 87.2% of children between 13 to 15 years of age, attending local 
schools in Hong Kong, were found to be myopic. Correspondingly, 81% of Taiwanese 
school children aged 15 years were found to be myopic (Lin et al. 2004). In other parts of 
the world, myopia prevalence is much lower, for example, in teenage children it was found 
to be 27.4% in Europe (Williams et al. 2015) and 29.4% in Australia (French et al. 2013); 
however a clear trend of increase can be seen (Williams et al. 2015; Mccullough et al. 2016). 
In the United States of America prevalence of 20% in a group of 13 year old children was 
reported (Zadnik 1997), whilst in the UK it was reported to be 14.6% of the same age 
(McCullough et al. 2016). 
Myopia prevalence varies with age (Grosvenor 1987; Mutti and Zadnik 2000; Pan et al. 
2012), reaching its peak in the second or third decade of life and decreasing gradually 
afterwards (Vitale et al. 2008; Vitale et al. 2009; Williams et al. 2015). For example, Williams 
et al. (2015) reported that the prevalence of myopia was 47.2% and 27.5% amongst adults 
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aged 25 to 29 years and 55-59 years respectively. This may reflect the the increasing 
prevelance of myopia among younger generations (Williams et al. 2015) but, most likely, 
the well documented hyperopic shift associated with normal aging (Mutti and Zadnik 2000a; 
Lee et al. 2002; Vitale et al. 2009). Studies of refractive error in childhood are indicating that 
myopia is an increasingly prevalent condition thoughrout the school years and is reaching 
into early adulthood more frequently (Goh and Lam 1994; Kinge et al. 2000; Saw et al. 
2002; Jorge et al. 2007) 
A systematic review and meta-analysis conducted by Holden and colleagues suggested 
that half of the world’s population (~5 billion people) will be myopic by 2050 (Holden et al. 
2015; Holden et al. 2016). It is estimated that one fifth of these myopic individuals will be 
highly myopic (≥ -5.00 D) (Holden et al. 2015). Currently the rates of high myopia vary 
grately across the globe. Population based surveys, comparing the rates of high myopia 
among Australin, American and Wester European adults (≤ 40 years), have reported 
relatilively low prevelance of 2% to 4% (Kempen et al. 2004). The rate is slighty higher in 
the region of South East Asia. Prevelence of 7% of high myopia amoung adults (40 to 79 
years) has been reported (Wong et al. 2000). Contrary the prevalence of high myopia within 
the cohort of Singeporean schoolchildren (age 7-9 years) was found to fall within a rage of 
15% to 18% (Saw et al. 2005a). The information regarding the rates of high myopia 
prevalence within American and Europian children is scarce, however trends of increasing 
rate in myopia have been reported (McCullough et al. 2016). Myopia and especially high 
myopia have been negatively associated with various medical, social and financial factors 
(Flitcroft, 2012; Foster and Jiang, 2014). The increased risk between high myopia and 
ocular pathology not only amplifies the menace of vision loss but also has demonstrated a 
measurable decrease in the quality of life that was comparable with that of patients with 
keratoconus (Rose et al. 2000; Takashima et al. 2001). Moreover, the financial implications 
and the burden on the healthcare system by uncorrected distance vision, mostly caused by 
myopia, have been estimated to be over 200 billion US dollars per annum (Smith et al. 
2009). These factors have affected the overall attitude towards myopia as not a simple 
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refractive inconvenience that can be easly corrected with spectacle lenses (Flitcroft, 2012; 
Holden et. al 2014).  
1.2.3 Emmetropisation 
Emmetropsation is described as the diminishment of neonatal refractive error (Troilo 1992). 
It is postulated that both active and passive processes drive the process of emmetropisation 
and subsequently preserve it (Troilo 1992; Brown et al. 1999). Passive emmetropisation is 
associated with a normal eye growth (eye enlargement) whilst active emmetropisation is 
dependent on a visual feedback (Troilo 1992; Brown et al. 1999). 
At birth, refractive error is typically hyperopic (Banks 1980; Wood et al. 1995; Kuo et al. 
2003; Varughese et al. 2005) and generally falls within a range of +2.00 ± 2.00 D (Banks 
1980) or +2.40 ± 2.62 D (Varughese et al. 2005). Approximately 50% of the new-born 
population have a spherical refractive error (>2.50 D) (Cook and Glasscock 1951). During 
the first year of life rapid eye growth occurs and a decline in hyperopia to a mean level of 
+1.50 D is observed (Saunders et al. 1995; Wood et al. 1995). This phase is associated 
with significant changes in axial length (Mutti et al. 2005) and corneal (Inagaki 1986; Mutti 
et al. 2005) and crystalline lens (Mutti et al. 2005) power. The axial elongination is is mostly 
associated with the the enlargement of the vitreous chamber and to a lesser exten with the 
growth in the anterior chamber (Mutti et al. 2005). Crystalline lens thins significantly during 
this period and flattening is observed in both anterior and posterior lens radii (Mutti et al. 
2005). Simultaneously an increase in the equivalent crystalline lens refractive index can be 
seen, which in turn results in a large decrease in the power of the crystalline lens (Mutti et 
al. 2005). It is estimated that at this stage crystalline lens decreseases in power three times 
as much the cornea does (Mutti et al. 2005). The lens streching in the equatorial plane 
during the rapid phase of emmetropisation has been suggested to be a vital factor for 
maintaining emmetropia in a growing eye (Mutti 2010). Mutti et al. (2013) demonstrated that 
around one year before myopia onset crystalline lens lost its compensatory mechanism for 
maintainnig emmetropisation – changing it power in tandem with axial elongination. 
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Crystalline lens ceased thinning, flattening and loosing power in a cohort of 732 ethnically 
diverse schoolchildren (6-14 years of age) (Mutti et al. 2013). 
The process of emmetropisation continues at slower rate until six years of age, when 
emmetropia is commonly achieved (Flitcroft 2014). Morgan et al. (2010), however, suggests 
that mild hyperopia instead of emmetropia is the preferred end point of emmetropisation. In 
the study, gathering data from children (n=38811; age 5 to 15 years) in eight study sites 
around the globe to provide a representative population-based sample, Morgan and 
colleagues (2010) demonstrated that cohorts with a low rate of myopia prevalence, tend to 
remain mildly hypermetropoc even at age of fifteen. In a recent study Zadnik et al. (2015) 
proposed a model for prediction of juvenile-onset myopia and identified cycloplegic 
spherical equivalent (SE) refractive error as the best single predictor for future myopia 
development. Refractive error of <+0.75 D of hyperopia at age of 6 years is associated with 
an increased risk of myopia development (Zadnik et al. 2015). 
After six years of age a divergent pattern in the distribution of human refractive error can be 
seen (Flitcroft 2014). A mean refraction of -0.50 ± 0.67 D was observed in a group of 7 to 
9-year-old Chinese children (n=1043) (Saw et al. 2004a) and +0.17 ± 1.00 D in 7 year old 
Taiwanese children (Lin et al. 2004), whilst by the age of 11 it was observed to be –1.20 ± 
1.93 D in Taiwanese school-children (Lin et al. 2004). Whereas in the United Kingdom it 
was +1.23 D (lying in the range of +0.97 to +1.49 D) amongst 6 to 7 years children and 
+0.45 (laying in the range of +0.21 to +0.69 D) amongst 12 to 13 year old children of 
European ethnicity (Logan et al. 2011).  
1.2.4 Mechanisms of myopia development 
The complex multifactorial nature of myopia has been widely discussed (Mutti et al. 2002; 
Morgan and Rose 2005; Rose, Morgan, Smith, et al. 2008a; Flitcroft 2014; Goldschmidt and 
Jacobsen 2014). However, the exact mechanisms driving the disproportional relationship 
between the axial length and dioptric power of the eye, are not yet fully understood.  
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1.2.4.1 Genetic factors 
As emphasised in the reviews by Saw et al. (2000) and Goldschmidt and Jacobsen (2014), 
genetics play a role in myopia development. Twin studies have revealed a high heritability 
of refractive error (Lyhne et al. 2001) with greater prevalence among monozygotic twins 
than dizygotic twins (Hammond et al. 2001; Dirani et al. 2006) 
The role of parental myopia has been established. Pacella et al. (1999) reported that the 
risk of myopia development in a child with two myopic parents is 5.09 times higher than it 
would be for a child with non-myopic parents. Mutti et al. (2002) reported odds ratios of 3.31 
and 7.29 for a child to develop myopia in cases where one or both parents were myopic 
respectively. Jones-Jordan et al. (2010) conducted a discrete-time survival model analysis 
in a cohort of 1854 non-myopic first graders and followed them until the eighth grade. The 
risk of a child becoming myopic based on parental myopia and cycloplegic autorefraction 
was evaluated. Authors concluded that refractive error at first grade level and the number 
of myopic parents can be used as a predictor for myopia development. However, sensitivity 
of these factors was reported to be low and other factors, which might be more reliable, 
should be taken into an account. In another study Jones-Jordan and colleagues (2014) 
reported results of the effect of near work, outdoor activity and myopia in a cohort of 700 
families. Heredity was the strongest contributor to the similarities in refractive error between 
siblings.  
More than 40 genetic loci linked to myopia have been identified (Paluru et al. 2003; 
Hammond et al. 2004; Zhang et al. 2006; Zadnik et al. 2015). Autosomal dominant (AD) 
high myopia, for example, has been associated with 18p, 12q and 17q, with MYP3 locus on 
12q accounting for approximately 25% of cases in the United Kingdom (Farbrother et al. 
2004). Furthermore, 9 loci affecting the axial length of an eye solely, as well as overall 
refractive error of an eye have been identified, emphasising the complex genetic nature of 
myopia (Cheng et al. 2013). 
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1.2.4.2 Educational level and near work 
An association between parental educational level/occupation and myopia prevalence was 
reported by the COMET study group: higher levels of education were associated with higher 
myopia prevalence (Gwiazda et al. 2011a).  
Mutti et al. (2002) investigated various factors associated with myopia development. Myopic 
children demonstrated a higher ability in reading tests. Similarly, correlations between 
intelligence and myopia development have been drawn by Ashton (1985) and Saw and co-
workers (Saw et al. 2001; Saw et al. 2004a).  
Mutti et al. (2002) reported an association between near work and myopia, however, 
heredity was found to be more pronounced risk factor. The link between near work and 
myopia has also been investigated by Ip et al. (2008) and, similar to the findings of Mutti et 
al. (2002), a vague correlation was drawn between time children spent engaged in near 
work related activities and myopia. Nevertheless, the intensity of the near work was 
proposed as a relevant factor, especially when comparing children of Caucasian and Asian 
ethnicity. This difference in ethnicity has suggested that the diverse mode of education 
encountered among different countries is a possible triggering factor for myopia 
development (Ip et al. 2008). A study conducted by Lam et al. (2004) compared the 
prevalence of myopia among two groups of schoolchildren in Hong Kong: one attending 
local schools, where academic activities are more demanding and near work intensive, and 
the other attending international schools, which are less demanding and near work 
intensive. The age of schoolchildren (13 to 15 years) was selected so that children would 
have been enrolled in the educational system long enough for the influence of each mode 
of education to be evaluated. Higher prevalence of myopia was observed amongst local 
schoolchildren rather than international schoolchildren (87.2% and 62% respectively). 
However, when ethnicity was taken into an account, higher rates of myopia were observed 
amongst Chinese schoolchildren regardless of the type of school they attended. When the 
lifestyle and academic demands of Australian and Singaporean schoolchildren of Chinese 
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ethnicity (age 6 to 7 years) were compared, higher rates of myopia were found in 
Singaporean than Australian children (29.1% compared to 3.3%) (Rose et al. 2008a). 
Interestingly, the Australian schoolchildren spent more time engaged in near work-related 
activities outside the school, but more time outdoors, compared to the other group. 
However, Singaporean children are enrolled in the educational system at a younger age, 
hence, being exposed to close-up work for a longer period in total (Rose et al. 2008a). An 
association between near work and myopia was also found in a recent study conducted by 
Li et al. (2015). Authors reported that a close reading distance and prolonged periods of 
reading were correlated with myopia in a large cohort (n=1770) of children (age 10 to 15 
years) of Chinese ethnicity (Li et al. 2015). 
Jones-Jordan et al. (2012) also studied the impact of near work on refractive error 
development and annual myopia progression in a large cohort of ethnically diverse myopic 
children as a part of CLEERE Study and found a small clinical effect on annual myopia 
progression related to the near work. Moreover, when the effect of near work on myopia 
progression was investigated amongst siblings from 700 families (n=1522), no significant 
effect was found and heritability was the main contributor (Jones-Jordan et al. 2014). 
However, overall a recen meta-analysis by Huang et al. (2015) suggests that near work 
activity is a relevant factor in myopia development and progression and, based on the 
evidence available, should be considered a moderately important to outcome (level B) – 
risk factor for myopia development. Meta-analysis demonstrated that schoolchildren who 
engage in near work activities significantly more, had an 80% higher risk of developimg 
myopia at some point of their lives (Huang et al. 2015). Moreover, the association between 
near work and myopia indicated a 2% increased odds of myopia per additional dioptre-hour 
of time spent engaging in near work related activities per week (Huang et al. 2015). 
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1.2.4.3 Accommodative factors: lag of accommodation, AC/A ratio and the role of 
esophoria 
Reduction in accommodative response to various stimuli have been noted in myopic 
individuals, inducing blur during near work stimulating axial growth (McBrien and Millodot 
1986; Gwiazda et al. 1993; Gwiazda et al. 1999; Mutti et al. 2000a). Woodman et al. (2010) 
demonstrated that prolonged accommodative tasks induce transient changes in axial length 
(AL) in young myopes and emmetropes, causing a temporary shift towards a more myopic 
refraction. Mallen et al. (2006) reported an increase of 0.058 ± 0.037 mm and 0.037 ± 0.027 
mm in AL in young early-onset myopes and emmetropes matched for age and amplitude of 
accommodation for a 6.00 D accommodative demand, respectively. Later studies supported 
findings by Mallen et al. (2006). In a similar study set-up Read et al. (2010) demonstrated 
mean axial elongation of 0.023 ± 0.023 mm in a group of young myopes and 0.025 ± 0.015 
mm in emmetropes. Results published by Woodman et al. (2010) also sustained the 
magnitude of axial elongation reported previously with a mean increase in AL of 0.027 ± 
0.021 mm amongst early-onset myopes and 0.010 ± 0.015 mm amongst emmetropes, 
respectively. The slight variations between the results might have arisen from the 
differences in study populations (myopia onset and age range of the cohort), 
instrumentation used and corrections applied for the changes in crystalline lens thickness 
(Read et al. 2010; Woodman et al. 2010). 
Ciuffreda and Wallis (1998) introduced the term ‘near work induced transient myopia’ 
(NITM) and showed that myopes exhibit an accommodative inaccuracy (0.35 D), when 
shifting focus to distant object after a prolonged period of near work. NITM has also been 
observed in other studies (Ferree et al. 1931; Vera-Diaz et al. 2002; Wolffsohn et al. 2003; 
Vasudevan and Ciuffreda 2008). In addition, the response of the vergence system is altered 
in both myopic children (Gwiazda et al. 1999) and myopic adults (Jiang 1995), when 
compared to emmetropes. Gwiazda et al. (1999), for example, reported a higher 
accommodative convergence to accommodation ratio (AC/A ratio) and an increased 
amount of accommodative convergence in myopic children, supporting the assumption that 
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myopic children accommodate excessively during prolonged near vision tasks. This 
subsequently triggers an elevated accommodative convergence response. High AC/A 
ratios have been associated with early stages of myopia development, however these tend 
to stabilise and reach similar values to those of emmetropic individuals in later stages of 
myopia onset (Gwiazda et al. 1993; Gwiazda et al. 1995; Gwiazda et al. 1999). Furthermore, 
a shift towards a more esophoric state at near has been reported among myopic children, 
as well as the tendency to under-accommodate if esophoria is present (Gwiazda et al. 1993; 
Gwiazda et al. 1995; Gwiazda et al. 1999). Therefore, it is speculated that esophoric 
myopes must relax their accommodation to reduce excessive accommodative convergence 
in order to maintain single binocular vision (Gwiazda et al. 1999). Alterations in 
accommodation and vergence response can be observed as early as 2 years before the 
onset of myopia (Gwiazda et al. 2005).  
1.2.4.4 Outdoor activity and lighting levels 
Studies reviewing the influence of lifestyle on myopia development have highlighted the 
importance of outdoor activities (Jones et al. 2007; Rose, et al. 2008a; Rose et al. 2008b). 
Jones et al. (2007) investigated outdoor activity, in tandem with the history of parental 
myopia, in 514 schoolchildren and concluded that lower amounts of outdoor activity 
increased the risk of child becoming myopic in the eighth grade (the mean estimated age 
of the commencement of myopia onset was 11.4 ± 1.5 years), if a child had two myopic 
parents rather than none or one myopic parent. Moreover, the chances of developing 
myopia decreased in children who were highly engaged in outdoor activities and had no 
history of parental myopia in comparison to those with both parents being myopic (Jones et 
al. 2007).  
Subsequently Rose et al. (2008a) compared the influence of time spent outdoors between 
Australian and Singaporean schoolchildren of Chinese ethnicity (n=124 and n=628 
respectively). On average, Singaporean schoolchildren were four times less engaged in 
outdoor and sports activities than Australian schoolchildren of Chinese ethnicity (3.05 hours 
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per week compared to 13.75 hours per week respectively), with the myopia prevalence 
being almost ten times higher in the Singaporean schoolchildren. It was speculated that the 
higher levels of educational pressure in Singapore leads to prolonged near work and, in 
combination with a reduction in time spent outdoors, could trigger myopia development 
(Rose et al. 2008a).  
Furthermore, Rose et al. (2008b) investigated the influence of outdoor activity in groups of 
6 and 12-year-old Australian schoolchildren (n=1765 and n=2367 respectively) over a 
period of 2 years, as a part of Sydney Myopia study. Rose et al. (2008b) reported lower 
rates of myopia in children, who were more engaged in outdoor activities and did less near 
work, than in children, who spent more time indoors engaged in near work-related activities. 
Authors speculated that the higher luminance levels of outdoors compared to those of 
indoors, trigger biochemical processes, which might contribute to more hyperopic refraction 
(Rose et. al 2008b). Also, in higher luminance pupil diameter is smaller and, hence, ensures 
a greater depth of focus (Rose et. al 2008b).  
The findings of Rose and colleagues (2008a, 2008b) are supported by a similar study 
investigating the associations between outdoor activity and myopia development in a 
population of Singaporean children and adolescents (11 to 20 years of age) (Dirani et al. 
2009). Guggenheim et al. (2012) investigated the influence of time spent outdoors and 
physical activity in 13,988 English school-children living in the former Avon health authority 
over a period of 7 years. The results supported the hypothesis that increased time spent 
outdoors has a protective effect on myopia development. The amount of time spent 
outdoors was found to be independent of the level of physical activity. A study following a 
cohort of Chinese schoolchildren (n=382, mean age 6.3 ± 0.4 years) further supported the 
hypothesis of the protective effects of increased outdoor activity (Guo et al. 2017). 
Urbanisation, although not directly, has been linked to myopia development and, when 
studied in an association with outdoor activities, has been shown to be a risk factor as 
children in urban areas spend significantly less time outdoors and more time engaged in 
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near work-related indoor activities compared to children in the rural areas who spend more 
time outdoors (Wu et al. 2010; Guo et al. 2013). 
Jones-Jordan and colleagues from the CLEERE Study Group on several occasions have 
demonstrated that the protective effectt of outdoor activities after the onset of myopia is 
negligible. In 2012 Jones-Jordan et al. studied the association between myopia progression 
and time spent outdoors and in various visual activities in a cohort of 835 ethnicaly diverse 
myopic children (6 to 14 years of age at baseline). The clinical effect on myopia progression 
was found to be small and did not reduce annual myopia progression. Furthermore Jones-
Jordan et al. (2014) investigated the contribution of near work and outdoor activity towards 
refrective development in a cohort of 700 families and 1522 children (mean age 13.3 ± 0.90 
years at the last visit) of different ethnical over a period of 20 years (1989-2009). Although 
outdoor activity and other shared environmental factors did have an impact on the myopia 
progression among the siblings, it was slight and major effect was attributed to genetic 
factors (Jones-Jordan et al. 2014). This may suggest that time spent outdoors may not exert 
a general inhibitory effect on ocular growth and the protective mechanisms before and after 
the myopia onset could be driven by different underlaying processes (Jones-Jordan et al. 
2012). 
A recent meta-analysis conducted by Xiong et al. (2017) also after systematically analysing 
the available information on time spent outdoors and its association with myopia, supported 
the hypothesis proposed by Jones-Jordan and colleagues (2012). The protective effect of 
outdoor activities could be observed before/at onset of myopia but not for myopia 
progression. Likewise, increased time spent outdoors had a positive effect towards incident 
myopia but not myopia progression (Xiong et al. 2017). Nevertheless, the pooled data 
demonstrated that time spent outdoors prevents a shift towards myopic shift in refraction in 
the entire study population (Xiong et al. 2017). 
The exact mechanism behind the protective effect of outdoor activities is still uncertain, 
however, animal studies support the assumptions drawn by Rose et al. (2008b) discussed 
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previously. Moreover, myopia progression is shown to be slower during the summer months 
compared to with winter months, emphasising the importance of lighting levels (Fulk et al. 
2002; Donovan et al. 2012; Gwiazda et al. 2014). A study conducted by Ashby et al. (2009) 
using chicks as an experimental model suggests that natural daylight conditions 
(approximately 30 000 lx) are correlated with shorter axial lengths and more hyperopic 
refractions than, for example, exposure to normal laboratory lightning (approximately 500 
lx). Cohen et al. (2011) and Smith et al. (2012) have also demonstrated the protective nature 
of high luminance levels on myopia development, using chick and rhesus monkey models 
respectively. Moreover, Ashby and Schaeffel (2010) demonstrated the possible 
involvement of dopamine, a light-dependant retinal neuro-modulator in the retardation of 
myopia development, by exposing chicks with induced myopia to different ambient lightning 
levels and then injecting them with spiperone, a dopamine antagonist, which overcomes the 
protective nature of higher ambient light levels and, once again, enhances the progression 
of deprivation myopia. 
Zadnik et al. (2000) investigated the effects of night-time nursery light effects on myopia 
progression in a CLEERE study cohort of ethnically diverse 1200 schoolchildren. Authors 
concluded that night-time lighting is not a risk factor for myopia development (Zadnik et al. 
2000). Simiilar findings were reported by Gwiazda et al. (2000) and no influene of light 
cycles were found to influence myopia development and ocular growth. 
Lower levels of vitamin D have been associated with myopia development (Mutti et al. 
2011a; Mutti and Marks 2011; Yazar et al. 2014; Gardner et al. 2015). Myopic individuals 
have notably significantly lower concentrations of 25(OH)D3 in their blood compared to non-
myopes. Contrary Williams et al. (2016) did not find lower levels of serum vitamin D3 in a 
cohort of 3168 myopic individuals (age 72.4 ± 5.0 years) of Southern and Northen European 
background. Nevertheless, study findings supported the protective effect of UVB exposure 
during lifetime, especially between 14 to 29 years of age, and myopia development 
(Williams et al. 2016). Therefore, more studies are required to investigate the relationship 
between vitamin D levels and sun exposure as the two factors are closely linked and could 
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potentially aid in designing a more effectibve intervention for slowing down myopia 
progression (Yazar et al. 2014; Williams et al. 2016). 
1.2.4.5 The role of the retinal periphery in myopia development 
The aforementioned genetic and environmental factors highlight the multifaceted nature of 
myopia; however, they do not fully address the issue of its unknown underlying mechanism. 
Studies using animal models have demonstrated the influence of optical blur on the 
refractive development of the eye and the importance of visual feedback and stimulated a 
vast interest in human ocular development (Smith et al. 1994; Smith 1998; Smith and Hung 
1999; Smith et al. 1999; Stone and Flitcroft 2004). Deprivation of form vision (form 
deprivation), which is achieved, for example, by eyelid suture or rearing vision with 
translucent occluders, in early stages of life, stimulates rapid axial eye growth and, hence, 
myopia progression (Wiesel and Raviola 1977; Wallman et al. 1978; Smith et al. 1987). 
Once the form deprivation is ceased, the eye experiences myopic defocus, which is then 
overcome by slowing the growth of vitreous chamber (Wallman and Adams 1987). 
Optical defocus in animal models most commonly is induced by spectacle or contact lenses 
(Wildsoet and Wallman 1995; Smith et al. 1994; Smith et al. 1999; Benavent-Perez et al. 
2012). For example myopic defocus, imposed by positive spectacle lenses in chicks, is 
eliminated by the thickening of the choroid which moves the retina closer to the image plane, 
as demonstrated by Wildsoet and Wallman (1995). Whereas hyperopic defocus, induced 
by negative lenses, is compensated for by axial elongation (Wildsoet and Wallman 1995). 
Subsequent recovery, following the removal of the spectacle lens, includes changes in chick 
choroidal thickness and normalisation of their eye’s axial length (Wildsoet and Wallman 
1995). Most of the animal studies and also human studies conducted until recently have 
been focused on the central part of retina and fovea, neglecting most of the retina, the 
periphery (Stone and Flitcroft 2004; Wallman and Winawer 2004). 
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1.2.4.5.1 Animal studies  
A series of animal studies have been conducted to investigate the possible involvement of 
the peripheral retina in the development of myopic refractive error (Smith et al. 2005; Smith 
et al. 2007; Huang et al. 2009; Smith et al. 2009a; Smith et al. 2009b). Smith et al. (2005) 
restricted peripheral vision using specially designed binocular goggles with a small central 
aperture in 12 infant monkeys for a year. It was observed that the absence of peripheral 
vision disrupted the emmetropisation process. A myopic shift in refraction was noted in the 
experimental group when compared to the control group (which did not undergo treatment; 
+0.03 ± 2.39 D vs +2.39 ± 0.92 D respectively). The vitreous chamber was elongated in the 
treatment group compared to the control group; therefore, it was assumed that the 
deprivation of peripheral vision accelerates the rate of axial growth. When unrestricted 
vision was re-introduced after the goggle rearing period, a recovery and shift towards a 
refractive state laying within the normal range was observed, even if the fovea was ablated 
(Smith et al. 2005). However, Schippert and Schaeffel (2006) contradicted these findings 
by demonstrating that the restriction of peripheral vision does not necessarily result in axial 
growth in chicks. The authors hypothesised that the field of restricted vision could be linked 
to the myopisation and that they restricted too little of the peripheral vision. Schippert and 
Schaeffel speculated that, if only 2 to 3 mm of central vision had been left unrestricted, a 
shift towards myopic refraction could have resulted (Schippert and Schaeffel 2006). 
In a landmark study, Smith and colleagues demonstrated that the fovea is not required for 
normal eye growth (Smith et al. 2007). Monocular foveal ablation in 13 young rhesus 
monkeys was induced by photocoagulation. Subsequently, 3 monkeys were chosen as 
control animals and were allowed an unrestricted vision, whilst the remaining monkeys were 
fitted with form-deprivation goggles. Monocular foveal ablation had no effect on the process 
of emmetropisation in the control monkeys as the refractive error was within the normal 
range in both eyes. Whereas in the treatment group, where ablation was combined with 
form deprivation, intraocular differences between the refractive status of eyes were 
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observed, and foveal ablation did not prevent the development of form deprivation myopia 
(Smith et al. 2007).  
More recently, Smith et al. (2009a) demonstrated that the retinal mechanisms contributing 
towards myopia development are regionally selective, using a monkey model. When 
monocular form deprivation of the nasal visual field of 9 infant monkeys was introduced, 
axial growth in the treated portion of the visual field was observed in 6 monkeys (Smith, 
Huang, et al. 2009). This selective involvement of local retinal regions has also been 
observed in chicks (Wallman et al. 1987; Diether and Schaeffel 1997). Wallman et al. (1987) 
reported a selective development of form deprivation myopia in chicks, when part or all of 
the retina was restricted with white translucent occluders. The position of the myopia 
induced corresponded to the retinal region deprived, i.e. temporal, nasal or the whole retina, 
whilst the unrestricted area remained emmetropic or nearly emmetropic (Wallman et al. 
1987). 
Smith and colleagues (2009b), supported their previous findings (2007) pertaining to 
peripheral retinal involvement in the process of myopia development, using a monkey model 
(Smith, et al. 2009b). Peripheral hyperopic defocus was induced in 8 monkeys, using -3.00 
D lenses with 6.00 mm central apertures, allowing binocular vision. Simultaneously, 6 
monkeys underwent monocular foveal ablation with photocoagulation and were 
subsequently fitted with -3.00 D lenses that induced hyperopic defocus across the entire 
visual field. Twenty-four monkeys were used as controls and were allowed unrestricted 
vision, whilst 4 monkeys wore plano lenses binocularly from 3 weeks till approximately 5 
months of age. At the end of the rearing period, the control monkeys were hyperopic (mean 
refraction +2.57 ± 1.07 D), whilst monkeys in both experimental groups developed myopia. 
The mean refraction in the -3.00 D aperture group was +0.36 ± 2.69 D compared to +0.46 
± 2.49 D in the foveal ablation/-3.00 D full-field hyperopic defocus group. Although he 
standard deviation are large and refractive error is scattered in both groups and, therefore, 
should be viewed cautiously, Smith et al. (2009b) concluded that peripheral hyperopic 
defocus can trigger myopia development, either in the presence or absence of clear central 
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vision. The authors also proposed the possibility of spatial distribution across all the retina 
and the mechanisms underlying form deprivation are alike, because two different rearing 
strategies (deprivation with -3.00 D aperture lenses and combination of -3.00 D lenses and 
foveal ablation with photocoagulation respectively) gave similar results (Smith, et al. 2009b).  
Huang et al. (2009) reported that monkeys undergoing form deprivation demonstrated a 
relatively hyperopic peripheral refraction. Ten rhesus monkeys were fitted with diffuser 
lenses to impose monocular form deprivation. The fellow eye of the form deprived monkeys 
was used as a control. An additional 6 monkeys were allowed unrestricted vision and were 
also used as controls. After the rearing period 7 monkeys in experimental group developed 
myopia in the form deprived eye. Six of form deprived monkeys developed a relative 
hyperopic refraction in the treated eye, whilst in the control eye it was similar to the central 
refraction. Two of the form deprived monkeys developed relative hyperopia in the treated 
eye and peripheral refraction tended to become less hyperopic with the increasing 
eccentricity. 
Study conducted by Benavente-Perez and colleagues (2012) using a marmoset model to 
investigate the effect of multizone contact lenses, which imposed a hyperopic and myopic 
defocus simultaneously, demonstrated the possible benefit of such intervention for myopia 
control and possible regulatory effect of myopia development. Authors fitted 10 marmosets 
with specifically designed multifzone contact lenses, consisting of six concentring rings of 
opposite power (+5.00 D and -5.00 D), in one eye and plano contact lens in the 
contralateralr eye, using it as a control. The simultaneous imposal of myopic and hyperopic 
defocus resulted in more hyperopic refraction and ocular growth in treated eyes compared 
to the control ones. The mean hyperopic shift (MSE of treated eyes – MSE of control eyes) 
was + 1.44 ± 0.45 D (Benavent-Perez et al. 2012). Three of six treated animals, one of 
which were myopic at baseline, and that had myopia in both eyes at the end of the study 
period, were less myopic in their treated eye compared to the control one (Benavent-Perez 
et al. 2012). These results were in agreement with a previous study by Trolio et al. (2009) 
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and another study conducted in 2014 by Benavent-Perez et al, in which marmosets were 
also used as the experimental model. 
In response to the aforementioned findings, in a retrospective review describing peripheral 
management strategies for myopia, Smith (2011) and Wallman and Winawer (2004) 
speculated that signals from the periphery can dominate those generated by fovea, owing 
to the large summation area available across peripheral retina when compared to the 
centrally located fovea. 
1.2.4.5.2 Peripheral refraction in humans  
The involvement of the retinal periphery cannot be assessed in the same manner in human 
studies, however, certain observations can be made by evaluating peripheral refractive 
error. Hoogerheide et al. (1971) evaluated refractive error across the horizontal visual field 
(± 60o from the centre of fixation) in young adults (18-20 years old) undergoing training to 
become pilots. They found that emmetropic or mildly hyperopic pilots, who developed 
myopia over a course of unspecified time, had at least one hyperopic semi-field meridian 
when compared to the axial refraction. Mutti and colleagues (2000b) studied central 
refractive error and peripheral refractive error in nasal visual field (30o form the primary gaze 
in nasal meridian only) in a group of 5 to 14 year old children under cycloplegia, using an 
auto refractor (Mutti et al. 2000b). Myopic children were found to have a slightly hyperopic 
peripheral refraction (+0.80 ± 1.29 D) compared to emmetropes and hyperopes (-0.41 ± 
0.75 D and -1.09 ± 1.02 D respectively). Subsequently Mutti et al. (2007) measured the 
peripheral refractive error before and after the onset of myopia in a cohort of 605 children 
(6 to 14 years) and observed changes in peripheral refraction with an accelerated shift 
towards a more hyperopic refraction (30o from the primary gaze) a year before onset of 
myopia. Interestingly, Atchison et al. (2006) found meridional differences in peripheral 
refraction with hyperopia being more pronounced across horizontal rather than vertical 
meridian in adult myopes.  
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Other studies investigated peripheral refraction in various individual groups, for example in 
emmetropic, hyperopic and myopic individuals between the age of 18 and 57 years (n=32) 
(Millodot 1981), emmetropic, hyperopic and myopic individuals between the age of 21 to 33 
years (n=31) (Seidemann et al. 2002), myopic individuals between the age of 14 to 26 years 
old (n=56) (Logan et al. 2004) and found a link between hyperopic peripheral refraction and 
myopia (Ferree et al. 1931; Rempt et al. 1971; Millodot 1981; Seidemann et al. 2002; 
Schmid 2003; Logan et al. 2004; Kang et al. 2010; Mutti et al. 2011b).  
Contrary to the findings listed beforehand, Sng (2011) did not observe a correlation between 
hyperopic peripheral refraction and the development or progression of myopia, in a cohort 
of 187 Singaporean children of Chinese ethnicity (7.2 ± 3.0 years of age), questioning the 
hypothesis of hyperopic peripheral refraction being a predictive factor for myopia 
development. Atchinson et al. (2015) also did not support the hypothesis of relative 
peripheral hyperopia as a predictor factor for myopia development or progression in a cohort 
of >1700 children of Chinese ethnicity (7 years of age at baseline) and >1000 children of 
Chinese ethnicity (14 years of age at baseline) over a two year period along the horizontal 
visual field. If this hypothesis would be ideally describe myopia development and 
progression, the central refractive error should become more myopic, whilst the relative 
peripheral refraction become more hyperopic. Study data, however, show, an opposite 
relationship – the larger the myopic shift in the central refraction in developing/progressive 
myopes, the more myopic (negative) the relative peripheral refraction was (Atchinson et al. 
2015). However, authors did not present their findings as absolute and suggested that 
retinal periphery might have role in myopia development/progression and central refractive 
error owing to other factors, such as retinal/ocular shape (Atchinson et al. 2015). 
Sng and colleagues proposed that a hyperopic peripheral refraction is a characteristic of an 
eye with developed refractive error (Sng et al. 2011). This view has been supported by 
Huang et al (2009) in primates. Moreover, observations of individuals with ocular conditions 
such as congenital cataracts and ptosis supports the theory of the involvement of both 
central and peripheral retina in the formation of eye’s refractive status (Weiss 2003). 
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1.2.4.5.3 Peripheral refraction and ocular shape  
Human peripheral refraction studies have shown relative peripheral hyperopia in myopes, 
relative peripheral myopia in hyperopes and relative peripheral myopia or near-emmetropia 
in emmetropes (Mutti et al. 2000; Seidemann et al. 2002; Calver et al. 2007), suggesting a 
more prolate eye shape in myopes, a more oblate shape in hyperopes and a spherical or 
slightly oblate shape in emmetropes, which is a classic characterisation of the shape of an 
eyeball in relation to refractive error (Ferree et al. 1931; Deller et al. 1947; Rempt et al. 
1971; Mutti et al. 2000b). These hypotheses, however, must be approached with caution 
(Cheng et al. 1992; Stone and Flitcroft 2004). When form deprivation myopia is induced in 
animal models and ocular shape is assessed, a more prolate ocular shape owing to axial 
elongation and, hence, posterior globe dimensions are found, nevertheless, individual 
variations exist (Wallman et al. 1987; Huang et al. 2009). The results obtained from human 
studies highlight the individual variations (Cheng et al. 1992; Singh et al. 2006).  
Cheng et al. (1992) measured ocular shape in 6 emmetropic, 8 hyperopic and 7 myopic 
eyes, using magnetic resonance imaging (MRI) and did not find a correlation between 
refractive error and eye shape. They concluded that emmetropic, hyperopic and myopic 
eyes vary in overall size, but not in the shape, describing vast majority of eyes as being 
sphero-elliptical (Cheng et al. 1992). Only two myopic eyes (-5.50 D and -8.00 D) were 
observed to be asymmetrical and distorted in shape (authors did not discuss shape changes 
in detail). MRI measurements showed that mean ocular dimensions of emmetropic eyes 
were slightly longer than those of hyperopic eyes, but shorter than those of myopic eyes 
(Cheng et al. 1992). Singh et al. (2006) used a 3 dimensional approach of MRI to measure 
ocular shape in a group of 7 individuals (refractive error range -16.25 D to +3.50 D). MRI 
measurements showed differences in eye size, symmetry and shape contradicting the 
overall correlations between eye shape and refractive error. Two eyes with refractive error 
of -7.00 differed greatly in axial length (25.00 mm and 28.00 mm respectively) and 
correspondingly in shape, while 3 eyes, with similar axial lengths had a variety of refractive 
errors, ranging from -3.00 to +3.25 D, and two nearly emmetropic eyes (refractive error -
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0.12 D and +0.50 D) were oblate and spherical respectively (Singh et al. 2006). Results 
from the study conducted by Atchison and colleagues (Atchison et al. 2004) assessing eye 
shape in 88 emmetropic and myopic subjects suggested that most myopic eyes tend to 
expand more in the horizontal dimension than the vertical dimension, but less than in axial 
dimension (global expansion), therefore justifying observations reported by Singh et al. 
(2006) and proposition made by Stone and Flitcroft (2004). Stone and Flitcroft suggested 
(2004) that ocular shape should not be classified as prolate, oblate or spherical as unique 
characteristics of refractive error, but rather could be used in the treatment strategies for 
myopia progression by modifying the spherical image shell (i.e. how image is projected onto 
retina) which would mimic the retinal shape of the eye and eliminate peripheral hyperopic 
defocus (Figure 1.1.). 
 
Figure 1.1 Schematic drawing of the relationship between image shell (black hemi-sphere), 
which is assumed to be spherical, and approximated eyeball shapes (blue half-sphere and 
ellipsoids) based on peripheral refraction; a. prolate, image shell is displaced posteriorly 
form the retina at periphery, b. spherical, image shell mimics retinal shape c. oblate, image 
shell is displaced anteriorly from the retina. Adapted from Stone and Flitcroft (2004). 
 
1.2.5 Myopia control 
An increase in hyperopic peripheral defocus has been observed in a cohort of Chinese 
children wearing SVS (n=28) (Lin et al. 2010). Peripheral defocus has been found to trigger 
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development of myopia even in the absence of foveal vision in the monkey model, even if 
clear central vision is present (Smith et al. 2009b). Various alternatives have been proposed 
to manage myopia more effectively and counter the mechanisms driving myopia 
progression (Sankaridurg and Holden 2014). Treatment strategies include undercorrection 
(Chung et al. 2002; Adler and Millodot 2006), progressive addition (PALs) and bifocal 
spectacle lenses (Goss and Uyesugi 1995; Fulk et al. 2000; Gwiazda et al. 2003), soft and 
rigid single vision and multifocal contact lenses (Walline et al. 2013), as well as specially 
designed spectacle and contact lenses (Sankaridurg et al. 2010; Sankaridurg et al. 2011), 
orthokeratology (ortho-k) (Cho and Cheung 2012; Chen et al. 2013), pharmaceuticals (Tan 
et al. 2005; Chia et al. 2012b) and increased outdoor activity (Wu et al. 2013). These 
management strategies target various factors linked to the development of progressive 
myopia with variable success (Goss and Uyesugi 1995; Leung and Brown 1999; Fulk et al. 
2000; Chung et al. 2002; Gwiazda et al. 2003; Tan et al. 2005; Adler and Millodot 2006; 
Walline et al. 2009; Yang et al. 2009; Sankaridurg et al. 2010; Anstice and Phillips 2011; 
Sankaridurg et al. 2011; Chia et al. 2012a; Cho and Cheung 2012; Walline et al. 2013; 
Hasebe et al. 2014), using traditional spectacle lenses as a reference point to their relative 
efficacy (Figure 1.2).  
 
Figure 1.2 Summary of studies investigating the efficacy of myopia control strategies 
(Wolffsohn et al. 2016). 
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1.2.5.1 Management strategies designed to reduce accommodative demand 
1.2.5.1.1 Progressive addition and bifocal spectacle lenses 
Traditional progressive addition and bifocal lenses have been prescribed to reduce the 
demand of accommodation, as well as mitigate the blur associated with increased lag of 
accommodation in myopia (Gwiazda et al. 1995; Gwiazda et al. 1999; Gwiazda et al. 2003). 
Bifocal lenses are hypothesised to impose a slight myopic defocus on the peripheral retina 
within the pus segment of the lens and also attribute towards slowing down myopia 
progression in such way (Aller and Wildsoet 2008; Sankaridurg and Holden 2014) 
The success rate of studies employing PALs and bifocals have varied greatly from no effect 
(Shih et al. 2001; Edwards et al. 2002) to up to around 26% for PALs (Hasabe et al. 2008). 
One of the earliest studies employing PALs as a treatment strategy achieved reduction of 
46% of myopia progressionn, dependidng on the treatment additive power chosen and its 
interaction to the accommodative system (Leung and Brown 1999). Meanwhile, some 
studies employing bifocols and executive bifocals have shown efficacy around 44-56% 
(Goss and Uyesugi 1995; Cheng et al. 2014). However, overall findings reported by other 
studies have shown more modest retardation rates, around 14% to 24% (Fulk et al. 2000; 
Gwiazda et al. 2003; Hasebe et al. 2008; Yang et al. 2009; Gwiazda et al. 2011b). 
Interestingly undercorrection, which was believed not only to reduce accommodative 
demand, but also induce not only foveal but peripheral myopic defocus too, which has been 
hypothesised to act as a halting signal to myopia development in animal studies (Shaikh et 
al. 1999; Smith and Hung 1999), has been found to rather accelerate the rate of myopia 
progression for 17-23% (Chung et al. 2002; Adler and Millodot 2006). 
1.2.5.1.2 Conventional soft and rigid bifocal contact lenses 
Various approaches of adjusted fitting methods of conventional soft and rigid single vision 
and bifocal contact lenses have been found to have no effect on myopia progression 
(Horner et al. 1999), however, on individual occasions, they can even arrest the progression 
of myopia (Aller and Wildsoet 2008). The rationale behind prescribing contact lenses is the 
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same as for PALs and bifocal spectacle lenses, nevertheless, the bifocal or multifocal optics 
are always aligned with the position of gaze as the lens moves with the eye and there would 
be an improvement in the retinal image quality as the contact lens is positioned directly onto 
the eye (Gwiazda et al. 2003; Aller and Wildsoet 2008; Gifford and Gifford 2016). 
1.2.5.1.3 Pharmaceutical approaches 
The premise of introducing pharmaceutical agents for myopia control (MC) was to reduce 
the accommodative demand. Conversely, animal models and human trials suggest that the 
mechanism of action could be non-accommodative in nature and involve retinal and scleral 
factors (McBrien et al. 1993; Trier et al. 2008). 
Pharmaceutical treatment strategies, such as low dose atropine (0.01% – 0.5%) and 1% 
atropine in the earlier studies, pirenzepine and 7-methylxanthine (7MX) have shown high 
success rates (46% to 76%), however, there has been a lack of consensus for the optimum 
concentration to prevent adverse effects and regression once treatment is ceased, as well 
as the commercial availability of the product (Tan et al. 2005; Chua et al. 2006; Tong et al. 
2009; Chia et al. 2012b).  
1.2.5.2 Management strategies designed to modify peripheral refraction 
The growing evidence of the involvement of peripheral retina in myopia development (Smith 
et al. 2005; Smith et al. 2007) and the impact of optical defocus (Smith 1998; Shaikh et al. 
1999; Smith and Hung 1999; Whatham and Judge 2001) have remodelled the concept of 
the optimal optical treatment strategy for MC. Smith (2011) proposed a model that would 
provide clear vision in the fovea and induce myopic defocus in the periphery (Figure 1.3). 
This model of correction can be applied for myopia management with multifocal soft contact 
lenses (Walline et al. 2013), specially designed spectacle (Sankaridurg et al. 2010; Hasebe 
et al. 2014) and contact lenses (Sankaridurg et al. 2011) and ortho-k, an overnight 
application of special lenses (Swarbrick 2006; Walline et al. 2009).  
The relative efficacy of multifocal lens (Walline et al. 2013), and specially designed 
spectacle (Sankaridurg et al. 2010; Hasebe et al. 2014) and contact lenses (Sankaridurg et 
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al. 2011) compared to single vision spectacle controls has been reported to be 50%, 20-
30% and 34% respectively, whereas for ortho-k the relative efficacy is ~50% (Cho and 
Cheung 2012; Walline 2012; Chen et al. 2013; Si et al. 2015; Sun et al. 2015). 
 
Figure 1.3 Schematic drawing of different correction approaches used for myopia control 
and the location of image shell (thicker black line); a. undercorrection, image shell is 
displaced posteriorly form the retina, b. classical approach to myopia correction, image shell 
is placed onto the retina centrally, but located posteriorly in the periphery c. perceived 
optimal correction, image shell is placed onto the retina centrally, but located anteriorly in 
the periphery. Adapted and reprinted with premission from Smith (2011). 
 
Methods employing the modification of peripheral refraction are still evolving, exploring the 
adequate amount of peripheral defocus for an optimal treatment outcome (Sankaridurg and 
Holden 2014; Gifford and Gifford 2016). They have showed their potential by slowing down 
the progression of myopia by 30 to 50% ( Sankaridurg et al. 2010; Cho and Cheung 2012; 
Walline et al. 2013).  
However, out of all optical management strategies discussed above, ortho-k offers a great 
advantage by providing clear spectacle or contact lens-free vision to a patient during the 
day (Swarbrick 2006). It is believed that the change in the corneal thickness and the corneal 
topgrraphical changes induced by the reverse geometry (ortho-k) lens (Swarbrick et al., 
1998) creates an optimum peripheral retinal image as proposed by Smith (2011). Also, the 
mechanisms involving increased positive spherical aberration have been proposed to 
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contribute towards the optimal ocular environment for MC. (Joslin et al, 2003; Berntsen et 
al. 2005; Gifford et al. 2013; Gifford and Gifford 2016). Sperical abberations do not impact 
the optical quality of the central vision; however with an increasing pupil size (5 mm), 
spherical aberations are the driving force for the visual quality and could have influence on 
peripheral refraction (Berntsen et al. 2005; Smoth 2011); for further information on ortho-k 
please refer to Section 1.3). Longitudinal studies conducted by various authors (Cho et al. 
2005; Walline et al. 2009; Kakita et al. 2011; Cho and Cheung 2012; Chen et al. 2013) have 
proven the efficiency of ortho-k for MC by reducing myopia up to -5.00 centrally, whilst 
inducing a myopic shift in the periphery (Charman et al. 2006; Queiros et al. 2010; Kang 
and Swarbrick 2013). It is hypothesised that modification of ortho-k lens parameters and 
design could enhance the myopia control effect; however, as noted by Kang et al. (2013) it 
is a difficult task and various aspects remain to be studied. A pilot study conducted by 
Loertscher (2013) introduced a multifocal ortho-k lens design and over a 26 day period was 
able to observe anti-myopic changes. Thirty children (10 to 14 years of age) were randomly 
fitted with a standard ortho-k lens in one eye and a multifocal ortho-k lens in the fellow eye 
overa an average period of 26 ± 16 days. An equal VA and peripheral refraction was 
developed over the time, however only in the eyes fitted with the multifocal ortho-k lens, a 
significant decrese in axial elongination, vitreous chamber depth and thickening of choroid 
were seen (Loertscher 2013). Therefore, it was suggested that simultenious myopic defocus 
in the central retina, rather than the refractive changes in the peripheral retina, are the 
probable cause of MC effect in the short term ortho-k lens wear (Loertscher 2013). However, 
not only this but other work should be extended in order to create an optimal myopia control 
intervention (Gifford and Gifford 2016). 
1.3 Orthokeratology 
Orthokeratology (also known as ortho-k or corneal reshaping or corneal refractive therapy) 
is defined as a transient mitigation of refractive error usually by overnight application of 
specially designed rigid gas permeable contact lenses, inducing corneal shape changes 
(Swarbrick 2006).  
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The clinical application of ortho-k is not a novel approach (Jessen 1962; Kerns 1976a; Polse 
1977) and has primarily, although not widely, been used for mild to moderate myopia 
correction (Jessen 1962; Kerns 1976c; Polse et al. 1982; Brand et al. 1983). However, over 
the last two decades ortho-k has recaptured the interest of practitioners and scientists owing 
to innovations in lens designs (Wlodyga and Bryla 1989; Harris and Stoyan 1992) and 
materials (MacKeen et al. 1992), as well as instrumentation (Klyce 2000), making the 
outcome of treatment more persistent and predictable (Mountford 1997), but mostly, due to 
its promising halting effect of myopia progression (Cho et al. 2005; Walline et al. 2009; Cho 
and Cheung 2012). 
1.3.1 Evolution of orthokeratology 
Jessen (1962) was the first to describe an application of contact lenses to intentionally 
change corneal curvature and, therefore, the refractive status of an eye. His technique, 
which he named ‘orthofocus’, was designed based on his own previous clinical 
observations pertaining to myopic patients fitted with flatter micro type lenses (maximum 
total diameter 9.0 mm, which was later increased to 9.5 - 10.5 mm to improve the centration 
and to stabilise the fit). An improvement in unaided visual acuity after a year of lens wear 
was seen. To correct myopia, a flattening of the central cornea was desired. Hence, a 
conventional plano-powered hard contact lens made of a polymethyl methacrylate (PMMA) 
was fitted flatter than the flattest keratometry (flattest K) reading by the amount of patient’s 
refractive error in a high-riding position. This lens fitting position was chosen, so that it 
would interact with the upper eyelid, which then would act as a lever enhancing the 
flattening effect. Conversely, in hyperopia, this method required steepening of the cornea 
and, hence, a lens with a small diameter (usually between 7.6 and 8.6 mm) and steeper 
curvature than the flattest K was fitted centrally onto cornea. Astigmatism was corrected 
by fitting a low-riding lens in such a manner that the upper lid was resting above the superior 
margin of the contact lens, eliminating its pressure being exerted on the eye. Jessen (1962) 
hypothesised that eyelid-cornea interaction has a major role in the development of the 
refractive status of an eye. The bi-curve design with an edge lift was preferred, however, 
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for larger myopic and hyperopic refractive errors, a tri-curve design was introduced. In 
addition, a toric lens with prism ballast enhanced the treatment outcome of an astigmatic 
patient as it allowed better lens centration. Notably, the orthofocus technique was more 
easily applied in case of hyperopia and astigmatism owing to the lens position on the 
cornea and relatively small lens size. On contrary, in myopia, larger lens diameter was 
required (usually 9.5 to 10.5 mm), causing discomfort during the lens wear and increasing 
the risk of ocular complications due to hypoxia. Nonetheless, in the paper discussing 
orthofocus techniques (Jessen, 1962), a successful treatment outcome of a patient with -
3.00 dioptres of bilateral myopia, a relatively high refractive error to be corrected by this 
method, was reported. The full correction of myopia was achieved gradually over a period 
of two months of lens wear on daily basis with an unaided visual acuity ranging between 
20/20 and 20/25. Lens wear for several hours a day was required to maintain the treatment 
effect. Overall, Jessen suggested that the method was promising, and tended to give a 
permanent effect if the treatment is commenced in an early age in cases of hyperopia and 
astigmatism. In cases of myopia, the effect tended to be more temporary. Nevertheless, 
the long lasting effects of this technique remained to be studied (Jessen 1962). 
Later Jessen (1964) suggested the use of de Carle bifocal lens design for correction of 
hyperopia and reverse de Carle bifocal lens design for correction of myopia to stabilise lens 
centration and increase comfort during lens wear. The de Carle bifocal lens design 
consisted of a steep central base curve that corrected vision in distance and flatter 
peripheral zone to produce the near addition. Jessen also concluded that children up to 
+3.50 D of hyperopia respond well to lens wear and, after a year, refractive error tends to 
diminish by half (Jessen 1964). 
Over the next several years, studies investigating various fitting philosophies and aspects 
of ortho-k were conducted. Emmetropisation through contact lenses was proposed by 
Neilson, May and Grant (1964). They discussed the importance of the cornea-contact lens 
relationship, suggesting that the optimal fit regarding lens centration and comfort was 0.12-
0.37 D flatter than the flattest K, as a flatter fit than this might, on the contrary, promote 
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steepening of the cornea. Furthermore, once the reduction of myopia was observed, new 
keratometric readings were obtained and a lens 0.25 D flatter than the flattest K reading 
was chosen. The length of treatment was patient-dependent, defining the endpoint of 
treatment as a state when 20/20 visual acuity is reached and plano lenses are used to 
retain the effect achieved (Neilson et al. 1964). 
In 1968, Ziff (1968a; 1968b) discussed his approach of gradually fitting increasingly flatter 
contact lenses over a period of 1 to 3 years to halt the progression of myopia, emphasising 
the importance of the patient’s age on the course of treatment. Age was found to have an 
impact on eye growth. Ziff also proposed the use of retainer lenses for a few hours a day 
to preserve the effect achieved. His extrinsic suggestion of overnight application of ortho-
k to retain a good visual acuity during daytime in the later stages of treatment programme, 
when the visual maturity (18-22 years as defined by Ziff) is reached, however, was 
perceived as controversial. He reported 41 cases out of which 39 cases demonstrated an 
improvement in visual acuity after removal of the lenses and the optimum result of the 
course of treatment was defined as 1.00 D or greater change in the aspect of corneal 
curvature (Ziff 1968a; 1968b). 
However, the inconsistency, and in many cases anecdotal nature of clinical trials (Kerns 
1976a; Coon 1982), indicated the need for controlled studies to be conducted in order to 
establish orthokeratology as a clinical technique.  
Kerns (1976a, 1976b, 1976c, 1977a, 1977b, 1977c, 1977d, 1978) carried out a study 
investigating the corneal response to ortho-k and rigid contact lenses in general, dividing 
myopic subjects in two control groups (3 non-contact lens wearers and 13 conventional 
rigid lens wears respectively) and one experimental group (18 subjects) that underwent 
ortho-k treatment over a period of 946 ± 158 days. Lenses in the control contact lens wearer 
group were fitted in accordance to keratometry readings and remained unchanged during 
the study period, whilst in experimental group, lenses were initially fitted in accordance to 
keratometry readings or up to 0.50 dioptre flatter than the flattest keratometry reading and 
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worn on a daily basis. The fit in orthokeratology group was gradually adjusted, when 
flattening of the cornea or reduction in myopia was observed. The initial refractive error in 
spherical equivalent form was -3.50 D or less. In order to assess corneal changes, and 
safety and recovery aspects of the procedure, refraction and over-refraction were 
measured, and keratometry and central/peripheral pachimetry were performed. Lens 
centration and lag, and corneal integrity were also assessed by biomicroscopic 
examination during every visit (Kerns 1976b). The results indicated an average reduction 
in myopia of 1.06 ± 0.98 D (ranging between 3.00 D decrease to 0.75 D increase in 
refraction) in the horizontal meridian and 0.68 ± 0.90 D (ranging between 3.25 D decrease 
to 1.00 D increase) in the vertical meridian, with changes in vertical meridian being more 
unpredictable and fluctuating, especially if lens was fitted more than 0.59 D flatter than 
keratometry reading, and were speculatively linked to the different pressure distribution 
under the lens in both meridians. Hence, concerns of induced with-the-rule astigmatism 
were expressed. The changes observed in both control groups did not exceed those 
relating to diurnal fluctuations (Kerns 1976c). Also, contact lenses in the experimental 
group had a tendency to decentre and ride high as the cornea changed its curvature and 
underwent sphericalisation, emphasising the importance of corneal shape factor. 
Therefore, in order to maintain an acceptable cornea-lens relationship and achieve good 
centration, most of the lens parameters were manipulated on an individual basis. Corneal 
integrity, as observed by fluorescein pattern and keratometry, was maintained in 
acceptable limits in most of the subjects (Kerns 1977a). Kerns (1978) concluded that, 
although most of the factors involved in this procedure are individual and 20/20 visual acuity 
is not reached, and once a full understanding of mechanisms involved in corneal reshaping 
is achieved, especially the aspects of corneal rigidity, the procedure could become more 
widely used. 
A study conducted by Binder et al. (1980) affirmed conclusions drawn by Kerns (1978) on 
the unpredictably and variability of ortho-k and the corneal response to it, as there was no 
clear correlation between keratometric changes and treatment process. In its design and 
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fitting philosophy, this study was similar to the one carried out by Kerns (1976b). Of 20 
subjects that underwent treatment, 9 responded well to corneal reshaping, 6 showed an 
unpredictable and variable response, and 5 did not respond to treatment at all. The flatness 
of the fit, similar to studies mentioned beforehand, was adjusted during the course of study 
on an individual basis and varied between 0.50 to 2.75 D flatter than the flattest corneal 
meridian. Overall, an average reduction in myopia of 1.50 D was achieved when moderate 
myopia was present. Whilst, low myopes showed either no response or a negligible 
response to the treatment (Binder et al. 1980).  
The Berkley orthokeratology study (BOS) was a single centre masked randomized study 
carried out over a period of 2 years that monitored corneal changes, and the safety and 
efficiency of ortho-k in 40 subjects (Polse et al. 1982; Brand et al. 1983; Polse et al. 1983). 
A group of 40 conventional contact lens wearers were chosen as controls. The refractive 
error of the participants varied between 1 D and 4 D of myopia, with initial flattest 
keratometric readings falling into the range of 40.50 to 47.00 D. Initially, all participants 
were fitted with PMMA material lenses, however, at later stages of study they were refitted 
with PMMA-silicon combination, if oedema occurred. Measurements of visual acuity, 
keratometry, and endothelial cell density were obtained and a slit lamp examination was 
performed. Over the course of study, the lens fit was gradually adjusted and lens wearing 
time was moderately reduced in the experimental group to investigate the rebound effect 
(the reduction of effect achieved once the treatment is ceased), with greater changes 
occurring at the first 132 days from the baseline measures. The mean refractive change 
achieved in the treatment group by the end of the study was 1.01 D reduction of myopia, 
compared to 0.54 D refractive change in conventional contact lens wearer group. As the 
wear of lenses was reduced to 4 hours per day, the refractive changes achieved mitigation 
rapidly (an average decrease of 45% was observed). However, although not clinically 
significant, 26% of changes achieved did not reduce even after 79.6 days, suggesting that 
this procedure could have a small permanent impact on the cornea. No clinically significant 
adverse corneal response to the treatment was observed. The authors concluded that the 
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results obtained in this study are in agreement with those of previous studies conducted by 
Kerns (1978) and Binder et al. (1980), regarding the average refractive changes achieved 
and the fluctuating nature of them. However, it was implied that patients with myopia of 
1.50 D could succeed from ortho-k treatment.  
Soon afterwards Coon (1984) investigated different approach to ortho-k by fitting PMMA 
lenses slightly steeper (+0.25 – +0.50 D depending on the astigmatism present) than the 
actual corneal curvature in the flattest meridian, in order to mitigate the risk of induced 
astigmatism over a period of 80 weeks. The lenses were fitted with an apical clearance 
which enhanced the reshaping effect of orthokeratology by manipulating the tear reservoir 
(TR), a percentage of posterior lens surface inhabited by peripheral and intermediate 
curves. He speculated that forces acting underneath the lens surface are crucial to the 
refractive changes achieved by this technique. The TR was gradually increased from initial 
32.5% up to 45% or more over the course of study to promote corneal reshaping. However, 
when the TR reached 45%, the lens centration became unstable and was compensated 
for by increasing the total diameter of the lens. The results showed a reduction in myopia 
among both groups, with a slightly greater reduction in the experimental group (0.49 D @ 
180/ 0.43 D @ 90 and 0.56 @ 180/ 0.60 @ 90 respectively), and the equal reduction of 
myopia along both meridians indicated that no with-the-rule astigmatism was induced over 
the course of study. No clinically significant adverse effects were observed. Interestingly, 
changes in corneal thickness in the experimental group were noted. Central thinning and 
peripheral thickening of the cornea was observed, prompting speculation on the 
mechanisms involved in the process of corneal reshaping. Coon concluded that 
orthokeratology is clinically safe method which does not induce more complications than 
conventional PMMA lens wear (Coon 1984). 
To summarise, the studies listed above are not the only ones discussing early attempts of 
development of corneal reshaping, however, they highlight the problems encountered in 
the primary stages of this procedure, such as the lack of a consistent fitting protocol, the 
poor lens centration with the fit gradually becoming flatter, the length of treatment 
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compared to the improvement in visual acuity, but most importantly, the unpredictably of 
the outcome of treatment. In many cases there was no clear correlation between 
keratometric readings and the improvement in visual acuity. Factors that were more 
dominant than the possible gains of the procedure, impacting its further clinical use, 
however, were gradually overcome in later stages of method development as more suitable 
lens designs were established. 
1.3.2 Reverse geometry lens design 
Jessen (1964) noted the optimal lens centration observed in his orthofocus techniques was 
achieved using the de Carle bifocal design, containing relatively flat peripheral curve 
(approximately 12.50 mm), an intermediate zone ranging in-between 0.50-0.75 D flatter 
than the central keratometric reading of a patient and central zone that was 3 times steeper 
the required reading add than the intermediate zone. Jessen speculated that a modified 
reverse design de Carle bifocal could be suitable for myopia correction and could overcome 
the superior centration observed with conventional contact lenses. He described the desired 
design as a lens with a concave back surface that has a flatter centre, which would flatten 
the corneal apex, and a steeper periphery, which would enhance tear exchange, whilst the 
intermediate curve would provide a good lens centration. Typically, for myopia correction, 
this lens was 9.8 mm in diameter horizontally and 8.8 mm vertically respectively, and 
truncated in shape, having a central zone 5.50 mm wide and a peripheral curve of 11 mm 
radius. 
Later Fontana (1972) introduced a new approach to ortho-k by fitting myopic patients with 
a one-piece bifocal. He described this lens as consisting of a central zone (6 mm) that had 
a 1 D flatter base curve than the paracentral area, which was chosen in accordance with 
the keratometric readings to fit the flattest corneal meridian, and having 8 mm wide optic 
zone and 9.6 mm total diameter. It was implied that changes occur within the first six weeks 
and that three to four pairs of lens are needed over the course of treatment, the latter pair 
serving as a retainer lenses. Reflecting on 78 patients, Fontana concluded that in 96% of 
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cases an improvement in visual acuity was noted and that there is no limitation in patient 
selection. Nevertheless, to achieve a full correction of refractive error, it was advisable to 
select patients with up to 3 D of myopia (Fontana 1972). 
However, it was not until 1989 that accelerated orthokeratology and a novel reverse lens 
design was introduced by Wlodyga and Bryla(1989) The use of temporal keratometric 
readings was highlighted as a crucial part of their fitting approach. Only horizontal temporal 
readings were measured and they were recorded by asking patient to fixate nasally on the 
‘+’ sign of the keratometer ring. The difference between central and temporal K readings 
was used as a predictor for the success of treatment, assuming that a flatter temporal K 
reading than the central one is a good indicator. The lens, referred to as Ortho-K 60, had a 
6-mm wide primary base curve, 1 mm wide peripheral secondary base curve, which was 
0.6 mm steeper than primary base curve, and 0.7 mm wide peripheral curve with a total 
diameter ranging from 8.5 to 11.0 mm. Over the course of treatment, which was suggested 
to be 6 weeks long, three to four pairs of lenses were required with each lens set being 1 D 
flatter than the flattest K reading. The first set was worn for a few hours over a period of one 
to two days, whereas set two was worn up to one week. The third set was worn for one to 
three weeks, and, finally, the fourth set was worn for a period of three to six weeks. A 
retainer pair of lenses were used afterwards on a daily basis until a stable 20/20 level at 
vision was reached, gradually reducing wearing time to a few hours in the mornings and 
evenings. Data from 15 patients, undergoing their treatment programme, were presented. 
The amount of myopia reduced, varied between 1 to 4 dioptres with several patients 
achieving plano refraction. 
Harris and Stoyan (1992) investigated the effects of the OK-3 lens design in 80 myopic 
patients, using the fitting approach described by Wlodyga and Bryla (1989). Harris and 
Stoyan predicted that the maximum amount of myopia corrected with this procedure is twice 
the difference between central and temporal K readings, emphasising the importance of 
corneal eccentricity (e), the amount by which corneal shape diverges from a sphere. The 
lens design used was described as having a 6-mm wide optic zone diameter and tear 
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reservoir or intermediate zone of 3.00 D dioptres steeper than the base curve of optic zone 
to enhance tear exchange, which was then followed by flatter aspheric peripheral zone. The 
total diameter of the lens was 9.5 mm. The procedure consisted of 4 to 5 steps and was 
proposed to last from 3 months to a year. The first pair of lenses was prescribed 1.00 to 
1.50 D flatter than the flattest K reading and was worn for 2 to 7 days, when rapid corneal 
flattening within the first hours of lens wear occurred. When central pooling in the fluorescein 
pattern could not be seen and no lens movement was observed, a new lens 0.50 D flatter 
than the previous lens was prescribed. After 1 to 3 weeks a third lens, again 0.50 flatter 
than the previous lens, was prescribed and the lens diameter was increased, if needed. 
Subsequent lenses maintaining the same regression in base curve were prescribed at one-
month intervals until an unaided vision of 20/20 was achieved. To retain the achieved effect, 
a retainer lens of same design was typically worn for two-to-three hours in the mornings 
and evenings. The authors suggested that the optimum myopia range was up to 6.00 D and 
astigmatism up to 3.00 D. The average reduction of myopia achieved in the study, however, 
was 2.62 D (Harris and Stoyan 1992).  
The lens designs described above have contributed towards the establishment of modern 
ortho-k and the four/five zone reverse geometry lens design commonly used nowadays. 
Various lens designs are currently available, with their parameters being specified by the 
manufacturer (Tahhan et al. 2003). Nevertheless, Swarbrick (2006) describes a typical 
reverse geometry lens for myopia reduction as being composed of a relatively flat central 
treatment zone (usually 6 mm wide), adjoined by one or few slightly steeper reverse curves, 
which stabilise the fit. The outer boarder of the reverse curve is surrounded by an alignment 
curve, designed to improve lens centration, which then is followed by a peripheral curve to 
ensure edge clearance (Figure 1.4).  
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Figure 1.4 Schematic drawing of a reverse geometry lens. Adapted from Swarbrick (2006). 
 
1.3.3 Current state of orthokeratology 
Innovations in contact lens materials and the approval of rigid gas permeable contact lenses 
for overnight use (MacKeen et al. 1992; Gleason and Albright 2003) have re-established 
interest in ortho-k, which offers spectacle or contact lens free vision during the day and is 
speculated to have a halting effect on myopia progression (Fan et al. 1999; Cho, et al. 2002; 
Cho et al. 2003a; Cho et al. 2003b; Walline et al. 2004a). For further information on MC and 
ortho-k refer to section 1.5.2. 
Various reverse geometry lens designs have been evaluated and are proven to reduce 
myopia effectively by an overnight application and achieve the refractive changes required 
within a week (Cho et al. 2003a; Tahhan et al. 2003; Maldonado-Codina et al. 2005; 
Marcotte-Collard et al.2018). The fitting guidelines are specified by individual manufacturers 
and the optimal effect achieved varies between studies and the optimum lens design 
eliciting maximum myopia reduction remains undefined. However, it is generally agreed that 
ortho-k can effectively reduce up to 4.00-5.00 D of myopia and 1.50-2.00 D of with-the-rule 
astigmatism (Mountford 1997; Fan et al. 1999; Nichols et al. 2000; Rah et al. 2002; Cho et 
al. 2003b; Tahhan et al. 2003; Walline, Rah, et al. 2004; Cho et al. 2005; Maldonado-Codina 
et al. 2005). Swarbrick et al. (1998) and Alharbi and Swarbrick (2003) associated the 
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maximum amount of myopia reducible with reverse geometry lenses with corneal epithelial 
thickness changes occurring in orthokeratology (up to 20 µm). For detailed discussion of 
mechanisms underlying ortho-k please see Section 1.5. 
The standard reverse geometry lens design have four to five curves (Swarbrick 2006). An 
example of a five curve ortho-k lens design is DremLens reverse geometry lens. DreamLens 
is available under various names in different countries. In the UK DreamLens ortho-k lenses 
are provided by the No7 Contact Lenses (Hastings, United Kingdom) and were employed 
for conducting study described in Chapter 5. DreamLens ortho-k lens design is a five curve 
reverse geometry lens design. The zones are devided in a central zone, a reverse zone, 
two distinct aligment zones and a peripheral edge curve (please see Figure 1.4 for 
illustration of the reverse geometry lens zone composition). The central curve is flatter and 
exert a positive pressure to the central cornea. The back optic zone radius (BOZR) usually 
ranges from 6.0 to 8.0 mm depending on the specific design and creates a treatment zone 
of around 5.0 mm). The central zone is then rounded by a steeper reverse curve, aligning 
with the mid periphery of the cornea and creating a negative pressure owing to the tear film 
annularlry pooling under the zone. This curve has a radius of 0.5 to 1.0 mm or is 
manufactured 3.0 to 5.0 D steper than the back optic zone radius and provides an area for 
the corneal epithelial cells and intracellular fluid to expand to. The third to fourth zone is the 
aligment curve that is again flatter than reverse curve and its main purpose is to aid with 
the lens centration. The curve lands on the corneal periphery and it is generally 1.0 to 1.5 
mm wide dependidng on the lens design. The final outer zone is the peripheral edge curve 
that is flatter than the aligment curve and provides and edge lift for an adequate lens 
movement, ocular comfort and the tear-debris exchange (Bauch and Lomb 2004;  
http://www.no7contactlenses.com/eyedream.html#philosophy; accessed 13.12.2018).  
An example of the four curve lens is Paragon CRT reverse geometry lens (Paragon Vision 
Sciences, Gilbert, Arizona, USA). The lens have congruent anterior and posterior surfaces 
each consisting of central zone, a mathematically designed sigmoidal corneal proximity 
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return zone, a noncurving tangent landing zone and a convex elliptical edge zone that joins 
both surfaces (Paragon Z package insert, Paragon Vision Sciences. Available at: 
https://www.accessdata.fda.gov/cdrh_docs/pdf5/P050031c.pdf; accessed 13.12.2018). 
The overall diameter range from 9.5 mm to 12.0 mm. The central base curve radius can be 
manufactured within range of 6.50 mm to 10.5 mm. The return zone is typically smaller and 
is 0.75 mm to 1.5 mm wide, whilst the landing zone is 0.5 mm to 2.75 mm (radius: to infinity). 
Peripheral edge curve width depends on the size of the landing zone and can be 
manufactured within a range of 0.04 mm to landing zone width. 
The lenses are usually fitted based on topographic maps. Any further adjustments to the 
lens fit are made using the original BL map and the map obtained after the overnight lens 
wear. 
Reverse geometry lenses were designed to reduce myopia, however, attempts to apply 
ortho-k for correction of hyperopia (Gifford and Swarbrick 2008; Gifford et al. 2009) and also 
presbyopia (Gifford and Swarbrick 2013) have been made. The effect achieved, however, 
is approximately three times less than that of a myopic ortho-k (Gifford and Swarbrick 2008; 
Gifford et al. 2009; Gifford and Swarbrick 2009, 2013). 
1.4 Corneal biomechanics 
Aspects discussed previously (Section1.3) demonstrate that a strong cornea-tear film-
contact lens interaction is present in ortho-k. The hypothesis proposed by Kerns (1978) on 
corneal rigidity and observations made by Coon (1984) regarding corneal thickness 
changes, indicate that the cornea itself plays an important role towards a successful 
treatment outcome. Hence, an appropriate lens design is not the only determining factor for 
a successful treatment outcome. Close relationship between corneal tissue, tear film and 
the ortho-k lens exists. Therefore study of its biomechanical properties could provide a 
deeper understanding of the underlying mechanisms of this technique. 
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1.4.1 Cornea 
The cornea is a highly specialised transparent avascular tissue that, together with the 
sclera, forms the outer tunic of the eye. The mechanical properties of the cornea to 
withstand internal and external forces to maintain the shape of an eyeball, as well as its 
optical features, which provide two thirds of eye’s refractive power, are well established 
(Klyce and Beuerman 1998; Klyce 2005; Ruberti et al. 2011). The cornea is elliptic in shape 
with an average horizontal diameter of 12.6 mm and 11.7 mm vertically (Klyce and 
Beuerman 1998) (Figure 1.5). The central thickness of the cornea is approximately 520 µm, 
which gradually increases towards the periphery, reaching approximately 650 µm (Klyce 
and Beuerman 1998; González-Méijome et al. 2003). Microscopically, the cornea is 
composed of five distinct layers (Klyce and Beuerman 1998). Recently, however, it has 
been proposed that the sixth Dua’s layer of cornea in the posterior part of stroma exist (Dua 
et al. 2013). Nevertheless, the classic five-layer composition of the cornea will be discussed 
in structural order: epithelium, Bowman's layer, stroma, Descemet’s membrane and 
endothelium (Klyce and Beuerman 1998).  
 
Figure 1.5 Microscopic structure of the cornea. Adapted from Klyce and Beuerman (1998). 
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1.4.1.1 Epithelium 
The corneal epithelium is a stratified squamous non-keratinized epithelium, around 50 µm 
in thickness, and is the most regularly arranged of all squamous epithelia in the body (Ehlers 
1969; Hogan et al. 1971). The epithelium is mainly composed of three types of cells, which 
are arranged in 5 to 6 layers and compose ~10% of the overall corneal thickness. The 
number of epithelial layers increase towards the limbus (Hogan et al. 1971).  
The two layers of superficial cells, which are the outermost layer of epithelial cells, interact 
with the tear film directly, providing a smooth ocular surface and enhancing active transport 
and diffusion (Hogan et al. 1971). Superficial cells are are wide and thin, measuring around 
20 to 45 µm in width and around 4 µm in thickness. The tear-side surface of them is covered 
with a large number of microplicae and microvilli that enhance the surface area of epithelium 
and anchors tear film to it.The inner surface of these cells are in a direct contact with the 
wing cells (Hogan et al. 1971; Fatt and Weissman, 1992). Superficial cells are the only 
epithelial cells have the tight cell junctions, zonula occludentes that decrease the possibility 
of harmful substances from entering into the intraocular tissue. Other tight cell junction 
types, that are present in the superficial layer and closely interlinks these cells, are 
desmosomal attachments and maculae occludentes (Pedler 1962; Hogan et al. 1971). 
Wing cells are ordered in two to three layers and are connected to basal cells, the only cells 
capable of mitosis (Hogan et al. 1971; Gipson et al. 2005). Wing cells are derived from basal 
cells and are pushed towards the epithelial surface. They are polygonal in shape with wing-
like extensions and are firmly interconnected with each other and the surrounding epithelial 
cell layers (Hogan et al. 1971; Fatt and Weissman, 1992). They are connected with 
desmosomal junctions and maculae occludentes. Wing cells do not proliferate frequently, 
however, they have a role in the process of re-epitelhelazion and they passively take part 
in tear spreading (Pedler 1962; Dohlman 1971; Hogan et al. 1971; Klyce 2005).  
The single layered basal cells lay on epithelial basement membrane, an anchor like 
structure involved in the process of epithelial wound healing and regeneration (Vracko 1974; 
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Gipson et al. 1987; Torricelli et al. 2013). Basal cells are columnar shaped and small. They 
compose one third of epithelial thiclness and are ~20 µm tall and 10 µm wide (Hogan et al. 
1971; Fatt and Weissman, 1992; Klyce 2005). The cells are joined by desmosomes and 
maculae occludentes (Perera 1969; Hogan et al. 1971). They are the only epithelial cells 
capable of mitosis and play an important role in the regeneration of corneal epithelium 
(Dohlman 1971; Fatt and Weissman, 1992). The epithelial basment membrane is ~0.05 µm 
thick granular layer that separates epithelium from Bowman’s layer. It has an important role 
in cell migration, adhesion, differentiation and signal transduction (Dohlman 1971; Vracko 
1974; Gipson et al. 1987; Torricelli et al. 2013). Mechnically epithelium is very easy 
mouldable and, unlike stroma, which defines corneal biomechanical response, does not 
contribute to the corneal mechanical properties as much (Elsheikh 2010). 
The average lifespan of epithelial cells is 7 days, rapid cell turnover being a crucial 
component of its protective nature and helping maintain a smooth ocular surface (Hanna 
and O'Brien 1960; Klyce 2005). 
1.4.1.2 Bowman’s layer 
Bowman’s layer is a ~8-12 µm thick acellular non-regenerative layer, composed of randomly 
arranged collagen fibrils that condensates into the underlying stroma (Tisdale et al. 1988; 
Komai and Ushiki 1991; Kenyon and Chaves 2005). The function of it is still a controversial 
topic, however, it is hypothesised that it might serve as a bounding element to maintain 
corneal structure and a biological barrier against viruses (Fite and Chodosh 1998; Wilson 
and Hong 2000; Lagali et al. 2009). 
1.4.1.3 Stroma  
The corneal stroma or Substantia Propria contributes ~ 90%, approximately 500 µm, of 
corneal thickness and is mainly composed of collagen type I (Klyce and Beuerman 1998). 
The collagen is ordered in uniform sized, closely and strictly packed fibrils that further are 
arranged into sheets of 200-250 lamellae (Komai and Ushiki 1991). This elegant 
organisation is crucial for corneal transparency and optical performance (Maurice 1957; 
69 
  
Meek and Boote 2004). The relatively small cellular part of the stroma is composed of 
keratocytes, initially quiescent fibroblast cells that have a crucial role in synthesis and 
renewal of stromal collagen (Jester et al. 1987; Klyce 2005). Whilst the ground substance 
of stroma consists of proteoglycans, macromolecules that helps to stabilise and organise 
collagen fibrils (Gipson et al. 2005). The primary role of the stroma is to provide a 
transparent pathway for light and, secondary together with the sclera, helps to maintain 
intraocular pressure (Gipson et al. 2005). 
1.4.1.4 Descemet’s membrane 
Descemet’s membrane is an elastic, homogeneous ~6-13 µm thick structure that lies 
between the stroma and endothelium and has a tendency to thicken during life (Johnson et 
al. 1982; Klyce and Beuerman 1998; Hayashi et al. 2002). It is considered the basement 
membrane of the corneal endothelium and is mainly composed of different types of 
collagen. Descemet’s membrane is able to regenerate if damaged (Hayashi et al. 2002; 
Klyce 2005; Kabosova et al. 2007). The function of Descemet's membrane is not well 
understood; nevertheless, it has been hypothesised that it may have a role in endothelial 
cell differentiation and proliferation (Joyce 2012). Furthermore, it could be crucial for 
preservation of corneal curvature and radius (Danielsen 2004). 
1.4.1.5 Endothelium 
The corneal endothelium, a monolayer of polygonal cells, lines the posterior corneal 
surface. It mostly consists of hexagonal, ~4-6 µm thick, metabolically active cells (Rao et 
al. 1982; Waring et al. 1982). Endothelial cells have limited capacity of proliferation and they 
tend to reduce in number with age (Klyce and Beuerman 1998; Joyce 2012). In order to 
maintain a continuous cell layer, for example in response to injury, endothelial cells change 
in shape (polymorphism) and size (polymegathism) (Klyce and Beuerman 1998). The 
primary function of the endothelium is to fulfil its role as a pump to ensure corneal 
transparency by regulation of corneal hydration (Klyce 2005).  
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1.4.1.6 Corneal metabolism  
The cornea is an avascular tissue. Therefore, most of the nutrition needed for the vital 
processes of corneal tissue is supplied by the surrounding environment, with the cellular 
layers of the cornea being responsible for the vast majority of the metabolic activity (Riley 
1969; Freeman 1972). In open-eye conditions, the oxygen is supplied to the cornea by 
diffusion through the tear film with small amounts of oxygen being acquired from the 
aqueous humor, a clear fluid that fills the anterior and posterior chambers (Goel et al. 2010), 
and limbar capillaries (Cogan and Kinsley 1942; Fatt and Bieber 1968; Fatt et al. 1969). 
Glucose and most of the amino acids are supplied by the aqueous humor (Riley 1969; Klyce 
and Beuerman 1998). During closed-eye conditions, vital processes of the cornea are highly 
dependent on the aqueous humor. The oxygen pressure in tears decreases from 
approximately 155 mmHg to 55 mmHg and two thirds of the oxygen required is supplied 
from the palpebral capillaries (Smelser and Ozanics 1952; Fatt and Bieber 1968; Fatt et al. 
1969).  
Glucose is one of the most important nutrients required by the cornea. The metabolism of 
glucose involves aerobic and anaerobic pathways. Fifteen percent of glucose is oxidized 
and 85% is converted into lactate respectively, with lactate production increasing in 
anaerobic environments (Fatt and Bieber 1968; Klyce 1981). Lactate is eliminated from the 
cornea through diffusion into the aqueous humor. An excessive accumulation of lactate in 
the corneal tissue can induce epithelial and stromal oedema (Riley 1969; Klyce 1981).  
Therefore, when a contact lens is introduced to an eye for an overnight application as is in 
case of ortho-k, it is crucial that it does not interfere with normal corneal metabolism. An 
oxygen tension ranging between 11.4-37.0 mmHg has been found to be the critical 
threshold for intact corneal metabolism to be preserved (Polse and Mandell 1970; Mandell 
and Farrell 1980). Also, it is important for undisturbed endothelial function as the corneal 
endothelium does not posses capacity of cell proliferation and has an important role in the 
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maintenance of corneal metabolism and transparency (Klyce and Beuerman 1998; Joyce 
2012). 
1.4.2 Corneal biomechanical characteristics 
The cornea is a viscoelastic tissue, possessing both elastic and viscous properties (Dupps 
2007; Elsheikh 2010). Elastic materials regain their initial shape in a reversible linear 
manner once the sheer-stress or the external load or force has been removed (Figure 1.6-
A). Viscous materials, on the other hand, flow under a load and do not return to their initial 
shape Figure 1.6-B). Corneal layers possess different biomechanical properties (Elsheikh 
et al. 2007; Elsheikh et al. 2008a; Elsheikh 2010). However, the viscoelastic nature is 
dominated by its bulk component, the stroma, which inhibits two phase stress-strain 
(deformation) relationship (extracellular matrix driven and collagen driven phase 
respectively) (Elsheikh et al. 2008a; Elsheikh 2010). Additionally, regional differences in the 
corneal response to external stress have been reported (Hjortdal 1996; Anderson et al. 
2004; Elsheikh et al. 2007; Elsheikh 2010; Thomasy et al. 2014; Whitford et al. 2015). 
The energy that viscoelastic material absorbs within itself due to its mechanical properties 
(in this case corneal tissue) in a stress-strain cycle is referred to as hysteresis, a 
characteristic often used for descriptive purposes of corneal biomechanics and a direct 
measure of the viscoelastic nature of the corneal tissue (Figure 1.6-B) (Elsheikh 2010). 
Young’s modulus (YM) is classic measure of corneal elastic properties in a laboratory 
setting (Elsheikh et al. 2008b; Elsheikh 2010). It is defined as a ratio of an applied stress or 
force to a cross sectional area to a resultant strain or deformation (Elsheikh 2010). Creep, 
another biomechanical characteristic, is defined as a ratio of stress and strain change 
material exhibits under a constant load, with a tendency to increase under the same amount 
of load (Elsheikh 2010). Once the load is removed, especially if the stress-strain cycle is 
repeated multiple times, the deformation to some extent is permanent (Elsheikh 2010). 
Conversely, the stress relaxation is the decrease in deformation under the same amount of 
load (Elsheikh 2010). Therefore, material does not return to its original shape instantly when 
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load is removed. Unlike creep, stress relaxation is only visible when the load is completely 
removed. Also, in stress relaxation the strain or force decreases, whilst the strain or 
deformation remains constant (Elsheikh 2010).
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Figure 1.6 Typical stress-strain behaviour of a perfectly elastic material (A) and corneal tissue (viscoelastic material) (B). Adapted from (Elsheikh 2010). 
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1.4.2.1 In-vitro versus in-vivo testing 
Knowledge available on corneal biomechanics at present is mostly based on tests 
conducted in a laboratory environment with donor tissue or using numerical simulation 
(Anderson et al. 2004; Elsheikh et al. 2008b; Elsheikh et al. 2009; Elsheikh 2010; 
Whitford et al. 2015). These tests have deepened understanding of corneal tissue 
changes within normal aging and disease (Elsheikh 2010). However, as they remove the 
cornea from its normal environment, are highly dependent on the availability of donor 
tissue and donors’ age (Elsheikh 2010), 
The advances in instrumentation (Luce 2005; Hon and Lam 2013) over the recent years 
have enable in-vivo testing, under more physical conditions than previously possible. 
Therefore, allowing dynamic structural analysis and observation of the anterior eye and 
ocular globe in various clinical settings and ocular pathologies (Luce 2005; Gonzalez-
Meijome et al. 2008; Kirwan and O’Keefe 2008; Chen et al. 2009; Frings et al. 2015; 
Koprowski et al. 2015; Perez-Rico et al. 2015; Wang et al. 2015). The devices that are 
most frequently used and are available for clinical application, are the Ocular Response 
Analyzer (ORA) (Reichert Ophthalmic Instruments, Buffalo, NY, USA)  (Corvis ST 
(Oculus, Wetzlar, Germany). Both devices use an air puff to temporarily deform the 
cornea to enable dynamic monitoring and by using bespoke technologies and 
mathematical calculations, records the mechanical nature of the cornea (Luce 2005; Hon 
and Lam 2013). The ORA and Corvis ST and their specific parameters are described 
extensively in Chapter 2. 
The parameters of the corneal biomechanical response (for detailed list of the 
parameters, please refer to Section Chapter 2) are not an exact comparison to the 
biomechanical measures obtained by the methods used in the classical mechanical 
setting (Elsheikh 2010). Therefore, classical descriptors of the corneal tissue such as 
stiffness or elasticity should be applied with caution and a prefix ‘ORA derived/specific’ 
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and ‘Corvis ST derived/specific’ should be always used, especially in the context of 
hysteresis. 
1.4.3 Factors affecting corneal biomechanics 
It has been found that corneal biomechanics, measured in-vivo, are affected by age, 
intraocular pressure (IOP), central corneal thickness (CCT) (Kotecha et al. 2006; Shen, 
Wang, et al. 2008; Kotecha et al. 2014) and, controversially, refractive error (Chang et 
al. 2001; Shen et al. 2008). As discussed before, corneal biomechanical properties in-
vivo setting are mainly messured using an air-puff applanation (Luce 2005; Hon and Lam 
2013). The energy absorption in corneal tissue during rapid corneal deformation delays 
induced by the air-puff, results in a difference between the applanation pressures. The 
difference between these inward and outward motion applanation pressures is called 
corneal hysteresis (CH) (Luce 2005).  
The cornea undergoes age-related changes as does all the tissue in the human body. A 
study investigating ageing of the human corneal stroma (Malik et al. 1992) revealed that 
over a life span (birth to 90 years) there is an increase in spacing between collagen 
molecules possibly owing to the increasing crosslinking between collagen over the time. 
In addition, a decrease in the inter-fibrillar spacing, presumably due to changes in 
proteoglycan arrangement, is present, resulting into corneal stiffening with age (Malik et 
al. 1992). The mechanism of corneal tissue stiffening has been questioned (Elsheikh et 
al. 2007). Recently, an updated biomechanical model of the human cornea was 
proposed and age-related stiffening of corneal tissue was linked to changes in fibril 
behaviour not fibril layout (Whitford et al. 2015). 
The well-established ORA derived parameter CH, which is a measure of viscous 
damping properties of the cornea (Luce 2005; Kotecha et al. 2006; Kotecha et al. 2014), 
for example, has a tendency to decrease with age. Huang et al. (2011) measured CH in 
a population of Chinese school-children (aged 7-12 years) and found it to be 10.4 ± 2.2 
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mmHg. Foster et al. (2011) investigated CH in British adult population (aged 48 to 91 
years) and found it to be 10.0 ± 1.67 mmHg. A study conducted in 2006 showed a 0.28 
mmHg decrease in CH per decade (Kotecha et al. 2006), whereas Shen et al. (2008) 
found no significant correlation between age and CH in 45 highly myopic (-6.00 to -15.00 
D) subjects and 90 healthy individuals (0.00 to -3.00 D). Foster and colleagues (2011) 
reported an average decrease of 0.31 mmHg in CH per decade as well as 0.34 mmHg 
decrease in CRF per decade (Foster et al. 2011). 
1.4.4 Corneal biomechanics and orthokeratology 
Ortho-k utilises the viscoelastic nature of corneal tissue (Elsheikh 2010). Creep and 
stress relaxation are the effects predominantly seen in the eyes undergoing ortho-k 
treatment from the classic mechanics point of view (Elsheikh 2010). Kerns (1978) 
speculated that corneal rigidity could influence the corneal response to orthokeratology 
as a large individual variability in response to treatment was observed. A pilot study 
conducted by Gonzalez-Meijome and his colleagues (2008) investigated the influence of 
short term ortho-k on the corneal biomechanical properties measured with ORA in 8 
subjects with moderate myopia. ORA measurements showed that corneas with lower 
CH and corneal resistance factor (CRF), which is believed to described the overall rigidity 
of the cornea (Luce 2005), responded more rapidly to treatment and also had a tendency 
to recover more quickly. Chen et al. (2009) reported a reduction in CRF after an overnight 
wear of ortho-k lenses from 10.7 to 10.1 mmHg in 20 mild to moderate myopic subjects. 
Interestingly, no strong trends in the CH were detected. Unsurprisingly, age has been 
observed to influence the corneal response to ortho-k lens wear, as the cornea has a 
tendency to become more rigid with increasing age (Jayakumar and Swarbrick 2005). 
1.5 Mechanisms of orthokeratology 
The mechanisms underlying ortho-k are still not fully understood. In the early stages of 
orthokeratology development, an overall bending, or moulding, of the cornea was 
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proposed to be the mechanism of action (Jessen 1962; Kerns 1978). However, the 
central corneal thickness changes noted by Coon (1984), using the hydraulic fitting 
approach established by Tabb, and later studied in detail by Swarbrick et al. (1998) in 
myopic individuals, has suggested a theory of individual, mostly anterior corneal layer 
contribution towards the refractive change achieved. Swarbick et al. (1998) reported a 
central epithelial thinning of 7.1 ± 7.1 µm (corresponding to 30%) over a period of 28 
days. Mid-peripheral corneal thickening of 11.0 ± 8.6 µm was found to be stromal in 
origin. Swarbrick and co-workers (1998) proposed a redistribution of epithelial and 
stromal tissue, first noted by Greenberg and Hill (1973), to induce the refractive changes 
and underpinned their statement by mathematical calculations using customised 
Munnerlyn’s formula. Munnerlyn’s formula is primarily used to predict the outcome of 
refractive surgery (Munnerlyn et al. 1988): 
𝒕 =
−𝑺𝟐𝑫
𝟖(𝒏−𝟏)
, 
were t originally is ablation depth, but in the case of ortho-k is change in sagittal height, 
S originally is ablation diameter but in case of ortho-k is flattened corneal zone, D is 
desired refractive change and n is refractive index of cornea (1.377). 
 
Swarbrick and colleagues (1998) presumed that the tear film forces acting under the lens 
could enhance the corneal thickness changes observed. They also assumed that the 
stromal changes induced by orthokeratology cannot alter stromal structure and that the 
posterior part of cornea is not involved in the reshaping process. The finding of anterior 
corneal thickness changes was later confirmed by Alharbi and Swarbrick (2003) and 
others (Reinstein et al. 2009; Nieto-Bona et al. 2011a, 2011b; Qian et al. 2013). 
However, in 2004, Owens et al. reported curvature changes in the posterior cornea and 
supported a theory involving overall bending of the cornea in the initial stages of ortho-
k. They observed flattening of the posterior corneal radii within the first week that 
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diminished with time (Owens et al. 2004). Therefore, theory proposing a mechanism 
involving initial overall bending of the cornea combined with anterior corneal tissue 
redistribution that, in later stages of the ortho-k treatment, is dominated by the theory of 
redistribution of anterior corneal tissue (Owens et al. 2004). 
Interestingly, opposite corneal thickness changes, to those seen in myopic ortho-k, were 
observed in hyperopic ortho-k. Gifford et al. (2009a, 2009b) investigated short time 
effects of overnight ortho-k in hyperopia and reported central corneal steepening and 
para-central flattening. Later studies by Gifford et al. (2011) supported the finding of para-
central epithelial thinning, which in return triggers the overall corneal thickness changes.  
1.5.1.1 Mechanical forces acting under reverse geometry lens 
Mountford (2004) proposed that a model of mechanical forces induced by reverse 
geometry lens is involved in ortho-k. In his model, Mountford (2004) incorporated the 
idea of hydraulic tear film force model, proposed by Tabb and evaluated by Coon (1984), 
and eyelid pressure. When a reverse geometry lens is introduced to the eye, an 
imbalance between forces exists. The central part of the cornea, corresponding to 
treatment zone of the reverse geometry lens, is exposed to compressive forces, whilst 
tensile forces are present at the very edge of treatment zone. The tangential stress, 
arising from the interaction between the viscoelastic cornea and incompressible tear film 
across the corneal surface, triggers the corneal shape changes until the equilibrium in 
the post-lens tear film is reached (Mountford 2004). Kwok (1984) presented a model of 
the anterior surface of the human cornea and reported that the smallest surface area of 
the cornea, for example, for discordant forces to reach the balance as in case of 
orthokeratology (Mountford 2004), is spherical. The cornea is aspheric in its nature and 
is characterised by eccentricity, undergoing shape changes until spherical shape or zero 
eccentricity is reached. The role of lid pressure involvement has been viewed cautiously 
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as the impact is minimal under closed eye conditions and there are no surface tension 
forces present (Allaire and Flack 1980; Hayashi and Fatt 1980; Mountford 2004). 
1.5.1.2  Morphological changes of the cornea in orthokeratology 
Animal studies support the clinical findings of myopic ortho-k (please refer to Section 
1.5.1.21.2). Matsubara et al. (2004) used a rabbit model to investigate the effects of 
ortho-k-lens wear at microscopic level over a period of 28 days. In the central part of the 
cornea, the basal cells were flattened with higher mitotic activity. Also, the number of cell 
layers was unchanged. In the mid-peripheral region, which corresponded to the 
alignment zone of the lens, the number of epithelial cell layers increased, the basal cells 
were elongated, the wing cells were stratified, and the mitotic activity of basal cells was 
reduced here. No stromal changes were reported (Matsubara et al. 2004).  
Choo et al. (2008) used a cat model to investigate morphological changes induced by 
ortho-k. Compression of central epithelial basal cells and elongation of mid-peripheral 
basal cells was noted as soon as 4 hours after ortho-k lens wear in the cat model 
mimicking myopia. After two weeks of lens wear, morphological changes in the 
epithelium became more pronounced and relative stromal thinning was observed. 
Centrally, changes in the number of epithelial cell layers was hard to assess, however, 
in mid-peripheral regions an increase in cell layers was observed (Choo et al. 2008). The 
authors speculated that morphological changes seen in early stages of treatment (e.g. 
cell compression) are accompanied by alteration in the cell metabolic processes, which 
take place at later stages. Hence, providing a possible explanation for the enhanced cell 
proliferation in mid-peripheral regions of epithelium and stromal thinning encountered. In 
the same study the effects of hyperopic ortho-k were also investigated. In hyperopic 
animals, central epithelial thickening was reported after 4 hours of lens wear. Initially, an 
elongation of central basal cells with slight changes in mid-peripheral region was 
observed. However, in later stages of treatment central epithelial basal cells regained 
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their usual appearance, whilst basal cells in mid-periphery appeared to be compressed 
(Choo et al. 2008).  
Cheah et al. (2008) reported changes induced by ortho-k lenses over a period of 24 
hours in a primate model. The number of epithelial cell layers remained unchanged 
across the whole surface area of the cornea. A central epithelial thinning together with 
compression of basal cells was reported. In the mid-peripheral region, the basal cells 
were elongated and the superficial cell nuclei were enlarged. No morphological 
alterations in stromal and endothelial structure were detected. Authors presumed that 
changes in cell shape, especially in surface cells, indicated that epithelial renewal rate is 
slower and highlighted the ambiguous nature of stromal thickness changes as no 
morphological alterations were observed (Cheah et al. 2008).  
Conversely, other studies investigating morphological changes induced by short and 
long-term wear of orthokeratology lenses in human corneas, using confocal microscopy 
(Nieto-Bona et al. 2011a, 2011b) reviled the theory of central epithelial thinning and mid-
peripheral corneal thickening, as well as decrease in basal cell density. Keratocyte 
density in stroma decreased at the initial stages of lens wear, but returned to baseline 
measures after 1 month. A thinning of Bowman’s layer and sub-basal nerve plexus was 
also noted (Nieto-Bona et al. 2011b). After 1 year of ortho-k lens wear, central epithelial 
thinning and reduction in basal cell density of 12-15% were still present, however, 
stromal keratocyte density was closer to baseline measurements (Nieto-Bona et al. 
2011a). These findings indicate that corneal response to ortho-k may involve various cell 
processes, mostly located in epithelial layer of the cornea, presumably triggering stromal 
response similar to that observed in the process of injury in the initial stages of treatment 
(Wilson et al. 1996). Corneal epithelial response to injury involves a three phase process 
of cell migration, proliferation and cell adhesion in the affected area (Dua et al. 1994). 
Corneal epithelium also triggers stromal response to injury that involves keratocyte 
apoptosis, migration and subsequently decrease in their density (Wilson et al. 2001). 
81 
 
Nieto-Bona et al. (2011a) also reported significant changes in endothelial cell density 
after a 1 year of ortho-k lens wear. Increase in the endothelial cell polymegathism 
(change in cell size) reversed after ceasation of ortho-k treatment; however, it did not 
return to baseline (BL). No changes were reported after a month of ortho-k lens wear 
(Nieto-Bona et al. 2011b). Authors noted that the area of visualisation for an image is 
relatively small and the quality of the image is highly dependant on the subject 
corporation.These factors limit the possibility of imaging the whole area corresponding 
to the ortho-k lens, therefore, number of images were taken averaged to obtain an 
accurate cell count of different corneal layers. Also, if corneal oedema is present, it 
affects the visualisation of the corneal layers and leads to an underestimation of cell 
count (Nieto-Bona et al. 2011a). 
Qian et al. (2013) supported the previously found evidence of central epithelial thinning 
and indicated that the inconsistency in mid-peripheral corneal thickness may arise due 
to the assessment in different locations as regional differences in corneal thickness and 
biomechanical properties have been observed previously (Hjortdal 1996; Shin et al. 
1997).  
1.6 Retention and reversibility of orthokeratology 
The reversibility of refractive changes achieved by ortho-k has been studied, both in short 
and long term ortho-k. For example, it was reported by Sridharan and Swarbrick (2003) 
that as little as 10 minutes of reverse geometry lens wear can induce significant refractive 
changes. However, 8 hours of lens wear was suggested to reach the optimal effect. 
Mountford (1998) investigated the effect of retention and regression of accelerated ortho-
k over a period of 90 days. The greatest reduction in refractive error occurred during the 
first week after the commencement of ortho-k. The daily regression (0.50 – 0.75 D), 
however, was observed to stabilise and decrease towards the end of the study period 
(Mountford 1998). Sorbara et al. (2005) studied regression of ortho-k effect after 72-hour 
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long wash-put period after a month of ortho-k lens wear. A recovery of approximately 
60% of initial refractive error was observed. Barr and colleagues studied aspects of 
recovery after 6 to 9 months of daily ortho-k in 96 myopic individuals (Barr et al. 2004). 
The refractive error tended to return to baseline measures within 72 hours. However, 
they speculated that the recovery aspects are patient and refractive error dependant and 
complete and stable return to the initial state can take a longer time (Barr et al. 2004). 
Soni et al. (2004) reported that corneal thickness returned to baseline measures within 
24 hours, but full corneal recovery, after one month of overnight ortho-k, occurred within 
two weeks. Wu et al. (2009) reported a corneal flattening of 0.27 D in the spherical 
component and an increase in with-the-rule astigmatism of 0.17 D after cessation of lens 
wear in myopic children, who underwent ortho-k treatment for 4 years. The authors 
speculated that wash-out period might have been insufficient; however, as the trend was 
seen in all individuals, they also concluded that the residual ‘permanent’ changes are 
mild but clinically insignificant (Wu et al. 2009).  
Nieto-Bona and co-workers observed the recovery aspects on morphological basis after 
a 1 month wash-out period in myopes who underwent ortho-k treatment for one year 
(Nieto-Bona et al. 2011a). The epithelium and stroma returned to baseline measures 
within the wash-out period. However, the 3% reduction in Bowman’s layer and sub-basal 
nerve plexus thickness did not recover. The authors, however, recommended that a 
larger study cohort would be required to establish this statement as it was difficult to 
distinguish between epithelial and stromal layer border under confocal microscopy 
during the treatment phase owing to epithelial thinning and cell compression (Nieto-Bona 
et al. 2011a). 
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1.7 Corneal insults associated with orthokeratology 
Early studies focusing on safety aspects of ortho-k indicated that orthokeratology is 
relatively safe and concluded that it does not create more complications than 
conventional rigid contact lens wear (Kerns 1978; Polse et al. 1983).  
Nevertheless, until a deeper understanding of the mechanisms underlying ortho-k and 
corneal changes induced by it is acquired, the safety aspects of ortho-k must be 
evaluated more intensely. Swarbrick and co-workers (1998) speculated that the epithelial 
thinning induced by ortho-k might compromise the permeability of epithelium and, 
therefore, its barrier function. The observations of confocal microscopy have questioned 
the stromal response to ortho-k as activation of keratocytes was observed (Nieto-Bona 
et al. 2011a). A change in tear film composition after ortho-k lens wear has also been 
noted (Choy et al. 2004). 
Microbial keratitis (MK), although rare, is one of the most severe complications 
associated with contact lens wear, causing severe complications and vision loss (Dart 
1988; Cheng et al. 1999; Stapleton et al. 2008) and has been associated with 
orthokeratology (Watt and Swarbrick 2007). In a review focusing on the occurrence of 
MK, Watt and Swarbick (2007) summarised 123 cases of MK induced by ortho-k from 
2001 to 2007. The vast majority of MK occurred in the region of East Asia (85 cases) 
and was associated with the lack of regulations regarding ortho-k technique. Sixty four 
cases originated from China, reaching the peak in prevelance around 2001, when the 
ortho-k market in China was unregulated. Lenses were fitted by untrained professionals 
using unsuitable lens materials for overnight wear (Watt and Swarbrick 2007). Good 
practice guidelines have since been established to promote patient compliance and 
standardise the routine of prescribing procedure for practitioners (Cho et al. 2008). The 
guidelines outline practitioner and supporting staff education, minimal requirments of 
instrumentation needed for ortho-k lens fitting, trial fitting, patient eductation (in practice 
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and with patient information sheets), patient consent for the ortho-k treatment and follow 
up. Bullimore et al. (2013) reviewed 50 cases of MK from 27 practitioners, which 
represented one third of all practices providing data for the study. Each practice was 
adjusted and stratified depending on the number of patients in total and those fitted with 
ortho-k lenses to diminish any bias. Limiting the sample to those patients with at least 3 
months of documented contact lens wear since 2005, resulted in a smaller sample of 
1317 patients; 640 adults (49%) and 677 children (51%) representing 2599 patient-years 
of wear (adults = 1164; children = 1435). It was estimated that the incidence of MK 
among adults was 0 per 10,000 patients-years of wear (95% CI=0 to 31.7) and 13.9 per 
10,000 patient-years of wear (95% CI = 1.7 to 50.4) with an overall estimated incidence 
of 7.7 per 10,000 patients-years of wear (95% CI = 0.9 to 27.8). 
The permeability of the epithelium was found to be unaffected in study conducted by 
Yeah and co-workers in 39 myopic individuals after 30 days of ortho-k lens wear, 
indicating that the thickness and morphological changes observed in the previous studies 
(Swarbrick et al. 1998; Alharbi and Swarbrick 2003) do not compromise epithelial barrier 
function (Yeh et al. 2013). Moreover, no clinically significant fluorescein staining was 
observed. 
Clinical case reports have indicated an occurrence of fibrillary lines and iron rings in 
ortho-k lens wear (Cho, Chui, et al. 2002; Lum and Swarbrick 2007; Gonzalez-Meijome 
et al. 2012). Fibrillary lines reported by Lum and Swarbrick (2007), in a 39 year old 
woman, and in 3 out of 150 patients over a period of 2 years by Cheung et al. (2006), 
were presumed to represent the changes in sub-basal nerve plexus owing to the 
migration of epithelium. It was later confirmed by Lum et al. (2012) that these lines 
represent altered nerve fibres. However, as they are also observed in a healthy non-
contact lens wearing individuals (Bron 1975), they are not regarded as complication of 
ortho-k lens wear.  
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In addition, iron rings, first observed by Cho and colleges (Cho et al. 2002b) and later 
detected by others (Liang et al. 2003; Gonzalez-Meijome et al. 2012), have not been 
regarded as an ortho-k complication. It has been reported that the rings can resolve 
themselves within two months after cessation of ortho-k lens wear (Cho et al. 2003). 
However, they have a tendency to increase in occurrence with the length of ortho-k lens 
wear (Cho et al. 2005). Cho et al. (2002) associated iron rings with rapid corneal 
curvature changes induced by ortho-k and tear pooling under the reverse geometry lens 
and presumed them being epithelial in origin. 
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1.8 Research rationale and aims 
Myopia is a global health problem, which is a major cause of visual impairment and 
blindness across the globe (Pan et al. 2012; Holden et al. 2014; Holden et al. 2016). The 
rapid increase in myopia has heralded a significant amount of interest in the development 
mechanisms and interventions to slow down this condition (Holden et al. 2014; 
Sankaridurg and Holden 2014; Holden et al. 2016). The wealth of research has shown 
that myopia is not solely a refractive condition or a simple inconvenience (Flitcroft 2012; 
Holden et al. 2014). It is a life-long condition, that increases the risk of ocular pathology 
in a similar manner as hypertension increases the risk of cardiovascular disease (Flitcroft 
2012). However, at present no consensus exists on how to manage this condition 
effectively and numerous questions remain unanswered. The various myopia control 
(MC) methods available are off-label and not available within a standard clinical setting 
(Johnson 2014; Gifford and Gifford 2016). The clinical efficacy versus the statistically 
significant efficacy of MC interventions has been questioned both by researchers and 
clinicians (Fulk et al. 2000; Johnson 2014).  
One of the most promising optical MC interventions, ortho-k, despite its relative success 
in slowing down myopia progression by up to 50% (Cho and Cheung 2012; Chen et al. 
2013), has been met with reluctance for adaptation into general clinical practice owing 
to the selective treatment outcome, the unclear mechanism by which the treatment 
outcome is achieved and long term effect to corneal tissue (Kwok et al. 2005; Swarbrick 
2006; Johnson 2014). New instrumentation able to dynamically assess corneal 
biomechanical properties in-vivo (Luce 2005; Hon and Lam 2013) have shown promising 
results in pilot studies, investigating corneal biomechanical response in ortho-k lens wear 
(Gonzalez-Meijome et al. 2008; Chen et al. 2009). Nevertheless, further research of 
corneal tissue and the anterior segment of the eye response to ortho-k lens wear, 
especially in progressing myopia, is required. 
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The aim of the work presented in this thesis is to aid a better understanding of the current 
clinical management of MC and in particular the application of ortho-k. Therefore, the 
following research studies were be conducted: 
1. Investigation of the attitudes of eye-care practitioners across the globe towards 
myopia control via a cross-sectional survey. 
2. A retrospective data analysis investigating corneal biomechanics in a cohort of 
progressing myopic schoolchildren undergoing ortho-k treatment over a two-year 
period. 
3. A study of short term corneal biomechanical effects of an ortho-k lens wear over 
the first 7 nights of treatment. 
4. A cross-sectional study in healthy individuals investigating factors such as age, 
ethnicity, eye and body size, and nutrition and subsequently their influence on 
the corneal biomechanical properties. 
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Chapter 2. Instrumentation 
2.1  General overview 
This chapter describes the instrumentation and general methodology used for acquiring 
measurements in Chapters 4-6. Specific details of the methodology employed within the 
experimental chapters (Chapters 3-6) are described in the methods section of each 
individual chapter. 
Several of the instruments described in this chapter and employed in the experimental 
chapters have the ability to obtain the same measurements. Part of the thesis is focusing 
on retrospective data analysis (Chapter 4). Therefore, when developing methodology for 
other chapters (Chapters 5-6), the same instruments or instruments using similar 
measurement techniques, were utilised. Summary of the instruments used in the study 
are presented in Table 2.1. 
Initially Corvis ST (Oculus, Wetzlar, Germany) was selected for the assessment of 
central corneal thickness (CCT), due to the similar imaging technique employed by the 
Pentacam (Oculus, Wetzlar, Germany), from which data were extracted for the 
retrospective analysis. The use of Corvis ST reduced the appointment time as corneal 
biomechanical response and CCT could be obtained in a single measurement. Corvis 
ST was reported to be a reliable instrument for the assessment of CCT (Hon and Lam 
2013; Hong et al. 2013). Issues experienced whilst using the instrument for data 
collection for the experimental Chapter 6 (instrument not firing up or not taking 
measurements), led to reconsideration of its use for CCT assessment. Aladdin (Topcon, 
Tokyo, Japan), which also measures CCT, had been used for measurements taken 
simultaneously for another study not included in the thesis. These measurements were, 
therefore, used instead. Later, at the data analysis stage for Chapter 5, ocular biometric 
parameters such as anterior chamber depth (ACD) and crystalline lens thickness (LT) 
became relevant for studies discussed in experimental Chapters 4 and 5 and were 
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extracted from Pentacam for the retrospective analysis and Aladdin for the prospective 
study. 
Instrument: Used for measuring: Used in Chapter: 
ORA (Reichert Ophthalmic 
Instruments, Buffalo, NY, 
USA) 
Corneal biomechanical 
properties 
Chapter 4 to Chapter 6 
Corvis ST (Oculus, 
Wetzlar, Germany) 
Corneal biomechanical 
properties 
Chapter 5 to Chapter 6 
Shin Nippon SRW-5000 Refractive error Chapter 5 to Chapter 6 
IOL Master 500 (Carl 
Zeiss, Jena, Germany) 
Axial length (AL) Chapter 4 to Chapter 6 
Aladdin (Topcon, Tokyo, 
Japan) 
CCT Chapter 5 to Chapter 6 
Pentacam (Oculus, 
Wetzlar, Germany) 
CCT Chapter 4 
Corneal Topographer 
Medmont E300 (Medmont 
Ltd, Melbourne, Australia) 
Corneal topography Chapter 4 to Chapter 6 
Specular microscope SP 
3000P (Topcon, Tokyo, 
Japan) 
Corneal endothelial 
imaging 
Chapter 4 to Chapter 6 
Table 2.1: Summary of instrumentation used in the experimental chapters of the thesis. 
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2.2 Assessment of corneal biomechanical properties 
2.2.1 Ocular Response Analyzer 
The Ocular Response Analyzer (ORA) (Reichert Ophthalmic Instruments, Buffalo, NY, 
USA) is a non-contact tonometer (NCT) that uses a rapid air pulse to indent the cornea 
and assesses its biomechanical response through a force-displacement relationship 
(Figure 2.1-A) (Luce 2005).  
The measurement takes place within a 20 ms interval and can be described by two 
separate applanation events – one that displaces the cornea inward (inward applanation) 
and the second resulting from the outwards rebound as the cornea returns to its initial 
shape (outward applanation) (Figure 2.2) (Luce 2005). During the first inward 
applanation, a controlled amount of air pressure pulse (P1), forces the cornea inwards 
past the applanation point (peak 1) into a concave shape. The first applanation event 
acts as a trigger to gradually switch off the air pressure pulse in a symmetrical time-
inverse manner after a further increase in air pressure (Pmax) has taken place. The 
cornea then returns to a convex shape past the second (outward) applanation point 
(peak 2) and pressure (P2) is recorded. P1 and P2 are determined by drawing a line 
down from each of the applanation peaks to the intersection of the pressure curve (Figure 
2.2). An electro-optical detection system monitors the corneal curvature changes, using 
an infrared light reflected from the central 3 mm of the cornea. The resulting voltage 
change during the measurement process is recorded to create an air-pressure 
deformation with time waveform curve (Figure 2.1-B and Figure 2.2). The P2 value is 
lower than the initial P1 value, which results from the viscous damping properties of the 
cornea and is termed corneal hysteresis (CH=P1-P2) (Figure 2.2) (Luce 2005; Kotecha 
et al. 2006; Elsheikh, Alhasso, et al. 2009).  
CH is thought to be a measure of the cornea’s ability to absorb and dissipate energy 
(Luce 2005; Kotecha et al. 2006). Corneal resistance factor (CRF), which is believed to 
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describe the overall resistance of the cornea, is derived from CH and is calculated as a 
linear function of the two applanation pressures, using a proprietary algorithm (CRF= k1 
x (P1 - 0.7 x P2) + k2; k1 and k2 are constants that are non-disclosed by the 
manufacturer) (Kotecha et al. 2006; Shah et al. 2006; Ortiz et al. 2007; Reinstein et al. 
2011). As a non-contact tonometer, the ORA also displays two intraocular pressure (IOP) 
measurements. Goldmann correlated IOP (IOPg) is a mean of two IOP measurements 
and corneal-compensated IOP (IOPcc), which is less affected by the corneal properties 
such as central corneal thickness (CCT) and CH Figure 2.2 (Ortiz et al. 2007; Elsheikh, 
Alhasso, et al. 2009; Reinstein et al. 2011).  
 
Figure 2.1 (A) The set-up of the second generation ORA; (B) Schematic representation 
of measurement and data generation process, scheme redrawn from Luce (2005). 
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Figure 2.2 The output of the ORA measurement. (1,5) convex cornea, (2, 4) flat cornea, 
(3) concave cornea; peak 1 representing the initial inward applanation, peak 2 
representing the subsequent rebound applanation; P1 – pressure of the first applanation, 
P2 – pressure at the point of the outward applanation; WS – waveform score represents 
the measurement signal quality (Kotecha et al. 2006; Shah et al. 2006; Ehrlich et al. 
2010). 
CH and CRF are purely empirical parameters and should be evaluated cautiously 
(Reinstein et al. 2011). No correlation between the ORA-derived parameters CH and 
CRF and the standard mechanical parameters, for example, hysteresis and Young’s 
modulus have been found; these parameters are not expected to show any correlation 
as they are obtained in two very different experimental settings (Elsheikh 2010; Lau and 
Pye 2011). Moreover, conflicting reports exist regarding the application of CH and CRF 
in different clinical situations, especially in normal aging of human eye (Malik et al. 1992; 
Kotecha et al. 2006; Kotecha et al. 2014). The cornea has been found to stiffen with age 
(Malik et al. 1992), whilst ORA-derived CH has been demonstrated to decrease with age 
(Kotecha et al. 2006; Kotecha et al. 2014). The prefix ‘ORA-derived’ should always be 
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used, when describing corneal biomechanical response using the ORA. Furthermore, 
studies in keratoconic (Fry et al. 2008; Saad et al. 2010; Mikielewicz et al. 2011; 
Wolffsohn et al. 2012) and post-Lasik patients (Kerautret et al. 2008; Landoulsi et al. 
2013) have shown that CH and CRF have low sensitivity and specificity in discriminating 
between healthy and ectatic eyes (Saad et al. 2010; Reinstein et al. 2011). An additional 
37 parameters have been derived and found to be better indicators of corneal 
biomechanical response than CH and CRF alone (Reinstein et al. 2011; Landoulsi et al. 
2013). Additional parameters are based on the results of studies, which have 
investigated the applanation signal morphology in detail and have derived their own 
applanation curve descriptive parameters (Fry et al. 2008; Kerautret et al. 2008; Saad et 
al. 2010). The waveform signal morphology and the standardised parameters developed 
for and incorporated in the Reichert ORA-Generation II will be discussed in section 
2.2.1.1. 
2.2.1.1 Signal morphology and the additional ORA-derived parameters from the 
waveform curve 
An applanation curve in normal eyes is nearly symmetrical, with its height dependent on 
the pressure needed to applanate a specific eye (Figure 2.2). The applanation signal or 
waveform, especially the raw signal (Figure 2.2) may vary in appearance between 
measurements. However, the height of the both inward and outward applanation signal 
peaks should be above the air-pressure curve (Figure 2.2). Both applanation peaks 
should have a well-defined high or end point (Figure 2.2). Also, the signal peaks should 
be similar in amplitude, approximately symmetrical and relatively free from noise (Luce 
2005; Saad et al. 2010).  
The filtered waveform is an improved version of the raw applanation signal and is 
designed to detect the optimal point of applanation in less than ideal signals. A parameter 
called waveform score (WS), with its values ranging from 0 to 10, has been incorporated 
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in the measurement process of the ORA-Generation II (version 2.04) to monitor the 
quality of the signal and subsequently the measurement itself (Ehrlich et al. 2010; Lam 
et al. 2010; Ayala and Chen 2012; Mandalos et al. 2013). Studies have recommended 
only selecting measurements when the cut-off value of WS is at least 3.5, to ensure 
reliability (Ehrlich et al. 2010; Lam et al. 2010; Ayala and Chen 2012; Mandalos et al. 
2013). The vast majority of studies are in agreement that a cut-off value for WS between 
6.0 to 7.0 and above for a reliable measurement should be chosen (Ehrlich et al. 2010; 
Ayala and Chen 2012; Mandalos et al. 2013). It is recommended to take several 
measurements with a reliable WS score and the ORA device itself will present the best 
measurement based on an internal undisclosed algorithm (Ayala and Chen 2012). 
The 37 standardised ORA-derived parameters, derived by Reichert, are intended to 
provide a detailed description of the waveform, resulting from the two applanation events 
in relation to the air pulse pressure curve (Figure 2.2). These are summarised in Table 
2.2. The interpretation of the parameters derived from the waveform needs to be applied 
to each clinical situation individually (Mikielewicz et al. 2011). A graphical representation 
of these parameters has been demonstrated in Figure 2.3. The waveform curve (referred 
to as applanation curve) has been divided into the upper 75% and upper 50% with 
regards to its height (Figure 2.3). The additional parameters are divided into two groups. 
The first group consists of 24 parameters and describes the upper 75% of each peak 
and the curve in general (slew1, slew2, mslew1, mslew2, dive1, dive2, aindex, bindex 
and alphf), whilst the second set, consisting of 13 parameters, describes the upper 50% 
of each peak (Table 2.2). 
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Figure 2.3 Graphical representation of the 37 ORA-derived parameters from the 
applanation signal. Definition of individual parameters has been provided in Table 2.2 
Summary and definition of the 37 additional parameters derived from the ORA 
applanation signal. Adapted and reprinted with permission from Wolffsohn et al. (2012). 
 
The repeatability and reliability of the four original parameters (CH, CRF, IOPg and 
IOPcc) have been widely studied and have been found to range from moderate to good 
in adult (Moreno-Montanés et al. 2008; Wasielica-Poslednik et al. 2010; Xu et al. 2011; 
Landoulsi et al. 2013) and child populations (Hon et al. 2012). However, only one study 
to date has investigated the repeatability of the waveform parameters (Landoulsi et al. 
2013). Landoulsi et al. (2013) found that the additional parameters were variable, and 
only six parameters (p1area and p2area from the upper 50% and 75% of the applanation 
peak and h1 from the upper 50% and 75% from applanation peak) were repeatable. They 
enrolled 100 patients in their study and conducted analyses of both eyes of each 
participant. Participants were divided into five subgroups: patients under 30 years of age 
with a good ocular health; patients with good ocular health between the age of 30 to 50 
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years; patients with good ocular health 50 years and older; patients who had undergone 
LASIK refractive surgery and patients with a history of photorefractive surgery. No 
information regarding the number of participants in each subgroup were provided by the 
authors. Ten consecutive ORA measurements in a single session were taken and 
interclass correlation coefficients (ICCs) were evaluated. If all ten measurements were 
analysed, 9 parameters showed substantial to perfect agreement (ICC≥0.61), 4 
parameters showed moderate agreement (ICC 0.41-0.60) and 28 parameters showed 
slight to fair agreement (ICC 0.10 to 0.40). If only three measurements with the best WS 
were selected for analysis, 10 parameters achieved substantial to perfect agreement, 7 
parameters showed moderate agreement and 24 parameters were in fair to slight 
agreement. Age had a minor effect on the repeatability of measurements (Landoulsi et 
al. 2013). Eight parameters showed substantial to perfect agreement in the subgroup of 
patients with good ocular health older than 50 years, whilst only four and five parameters 
achieved the same ICC values in the subgroup of patients younger than 30 years and 
subgroup of patients between 30 to 50 years of age (Landoulsi et al. 2013). 
Nevertheless, the final conclusions were based on the analysis of the whole group rather 
than each subgroup individually. The authors suggested that clinical decisions should be 
made based on the parameters with the highest repeatability and based on the initial 
(inward) applanation peak in order to reach consistent conclusions (Landoulsi et al. 
2013) (Table 2.2 and Figure 2.3). 
The ORA-Generation II was used in the experimental chapters (Chapters 4 to Chapters 
6). It is recommended by the manifactuer to take several measurments per eye in order 
for the ORA to select the best measurement based on WS and the applanation signal 
quality. No more than 5 measurements were taken per eye (Ehrlich et al. 2010). The 
best measurement selected by the ORA was used for the analysis. A cut-off value of 3.6 
for WS was selected for the retrospective data analysis described in Chapter 4, which 
included a child population. Children have a tendency to fixate and co-operate with the 
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examiners less effectively (Hon et al. 2012). A cut-off value for WS of 6.5 was chosen in 
experimental Chapters 5-6 (Ehrlich et al. 2010). 
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Applanation peak 1 
(inward 
applanation) 
Applanation peak 2 
(outward 
applanation) 
Definition 
slew1 slew 2 
aspect ratio of dive2 where dive2 
is divided by width 
mslew1 mslew2 
maximum single increase in the 
rise of the peak (longest 
continuous line without a break) 
dive1 dive2 
backside of downslope of peak 
(absolute value of peak until the 
first break) 
aindex bindex 
the smoothness of the peak 
(related to the noise of the 
measurement aka how many 
times peak changes the direction 
and represent local imperfections 
in the cornea, respectively 
softness of the cornea) 
alphf 
the smoothness of the region 
between the peaks (related to the 
noise of the measurement and 
represent local imperfections in 
the cornea, respectively softness 
of the cornea) 
Parameters derived from the upper 50% and 75% of the peak 
p1area p2area 
area under the curve (AUC) 
(proportional estimate of the time 
needed for the cornea to change 
from the convex/concave to the 
concave/convex form; smaller 
values indicate that the cornea is 
less dampable) 
h1 h2 
height from the lowest to the 
highest point in peak 
w1 w2 
width at the base of the peak 
region (descriptor of the time 
course) 
aspect 1 aspect 2 
aspect ratio of the peak 
(height/width) 
uslope1 uslope2 rate of increase from base to peak 
dslope1 dslope2 
rate of decrease from peak to 
base 
path1 path2 
the absolute value of path length 
around the peak 
Table 2.2 Summary and definition of the 37 additional parameters derived from the ORA 
applanation signal. Parameters are assembled in two groups – the first group contains 
parameters describing the whole applanation curve; the second group contains 
parametrs that are specific for both, the upper 50% and 75% of the peak. The definitions 
of the parameters have been adopted from Mikielewicz et al. (2011), Wolffsohn et al. 
(2012) Luz et al. (2012; 2013; 2016). Note: parameters with the highest repeatability 
based on which clinical decisions should be made, according to the study conducted by 
Landoulsi et al. (2013).  
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2.2.2 Corvis ST 
The Corvis ST (Oculus, Wetzlar, Germany) is a non-contact tonometer combined with 
Scheimpflug imaging to allow a dynamic investigation of the corneal response to an air 
pulse (Hon and Lam 2013; Hong et al. 2013) (Figure 2.4.). 
 
Figure 2.4 (A) Corvis ST setup. The Corvis ST device is connected to a laptop with an 
installed patient management software for easier patient management and observation 
of corneal response to the air puff, (B) The home screen of the measurement output. 
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A high-speed camera, alongside a slit light source, which illuminates a sectional plane 
of the cornea, is incorporated within the instrument. The camera gathers 4330 frames 
per second and produces 140 images per measurement. Subsequently, a 30 ms long 
video output is displayed. The image plane of the camera is tilted 45o to the optical axis 
of the camera lens. It allows the observation of a real time dynamic deformation of the 
cornea, particularly its cross-section, over an 8.5 mm diameter of coverage (Figure 2.4-
B). A measurement of IOP and assessment of corneal biomechanical response is 
acquired by quantifying the video output (Oliveira et al. 2011; Hon and Lam 2013; Hong 
et al. 2013; Lanza et al. 2016). The instrument is operated by a joystick and ‘fires’ 
automatically, once an optimal alignment, which can be monitored through a display, is 
achieved (Figure 2.4-A). 
The cornea is exposed to a controlled amount of the air-puff (30.3 kPa) and goes through 
three separate phases (Hon and Lam 2013; Hong et al. 2013). The initial response of 
the cornea to the air pulse is the first applanation, with the cornea then subsequently 
moving inwards and reaching the point of highest concavity (point in time in which cornea 
has reached the longest distance from its original position and shape). Thereafter, the 
cornea rebounds and returns to its original shape through the second applanation (Hong 
et al. 2013; Reznicek et al. 2013; Perez-Rico et al. 2015). A graphical representation of 
the video output and the applanation process is presented in Figure 2.5. 
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Figure 2.5 Corvis ST deformation profile. (A) Applanation 1, when a controlled amount 
of air pulse is directed onto the cornea, (B) point of highest concavity (HC), (C) rebound 
or second applanation, thorough which the cornea regains its convex shape. 
 
The quantification of the video output allows several Corvis ST specific parameters, 
which describe corneal displacement with respect to time, length (Figure 2.6-A) and 
amplitude (Figure 2.6-B), to be derived from the applanation process. These parameters 
and their definitions are summarised in Table 2.3 and a graphical representation is 
presented in Figure 2.6. 
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Parameter Definition 
IOP (mmHg) IOP base on the first applanation 
response 
Central corneal thickness (CCT) (μm) CCT based on the optical image analysis 
Deformation Amplitude (DA) maximum deformation amplitude (from 
the commencement of the delivery of air 
puff to the highest concavity) at the 
corneal apex 
A1 time (ms) time from the start of the measurement 
until the first applanation 
A1 length (mm) length of the flattened cornea during the 
first applanation 
A1 velocity (m/s) corneal velocity during the first 
applanation moment 
A2 time (ms) time from the start of the measurement 
until the second applanation 
A2 length (mm) length of the flattened cornea during the 
second applanation 
A2 velocity (m/s) corneal velocity during the second 
applanation moment 
HC time (ms) time from the start of the measurement 
until the cornea reaches the point of 
highest concavity 
Peak distance (mm) the distance between the highest point of 
non-deformed cornea 
Radius of curvature (mm) the curvature of non-deformed cornea 
A1 deformation amplitude (mm) amplitude of the deformation during the 
first applanation 
HC deformation amplitude (mm) amplitude of the deformation during at 
highest concavity 
A2 deformation amplitude (mm) amplitude of the deformation during the 
first applanation 
Table 2.3 The Corvis ST derived parameters (software version 102.r1260) and their 
definition. Definitions were adopted from Hon and Lam (2013), Matsuura et al. (2016) 
and Lanza et al. (2016). 
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Figure 2.6 Graphic representation of the Corvis ST parameters summarised in Table 
2.3. 
IOP measurements acquired with Corvis ST were found to be repeatable in a healthy 
adult population (Hong et al. 2013). The repeatability coefficient of CCT measurements 
was also found to be ±15.3 µm (95% confidence interval) (Hon and Lam 2013). The 
influence of IOP and CCT on the corneal biomechanical parameters measured by the 
Corvis ST were reported to be low (Valbon et al. 2014). Although specific modifications 
can be applied to calculate elastic modulus from the data provided by the Corvis ST 
(Roberts et al. 2011), the parameters derived from the Corvis ST are device-specific and 
have demonstrated a great variability (Hon and Lam 2013; Lanza et al. 2016; Matsuura 
et al. 2016). DA and applanation 1 time are reported to be the most repeatable 
parameters (Hon and Lam 2013; Matsuura et al. 2016). 
The accuracy and repeatability of the Corvis ST and the ORA (CH, CRF) have been 
evaluated (Matsuura et al. 2016). The ORA has shown higher reproducibility than the 
Corvis ST (Matsuura et al. 2016). The relationship between CH, CRF and Corvis ST 
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parameters is weak to moderate (Matsuura et al. 2016). Theoretically, both the ORA and 
Corvis ST measure corneal deformation. However, the ORA output is the signal intensity 
of the reflected infrared light that represented in scalar arbitrary units. Therefore, it does 
not account for direction of corneal motion. Corvis ST reports the corneal displacement 
in real time. Magnitude and direction of motion is measured (Tejwani et al. 2014). 
Application of specific algorithms have shown that not only a corneal response, but also 
the reaction of the eyeball can be evaluated, using the same Corvis ST measurement 
(Koprowski et al. 2015; Shih et al. 2015). Therefore both instruments were used for 
investigation of corneal biomechanical properties. 
The Corvis ST was used in Chapters 5-6 for the evaluation of corneal biomechanical 
response. The newest patient management software to date (version 102.r1260) was 
used and 3 measurements per eye were taken (Hon and Lam 2013; Nemeth et al. 2013). 
Only one measurement with a quality score (QS) reading ‘OK’ was selected for analysis 
(Lanza et al. 2016; Matsuura et al. 2016).  
2.3 Refractive error 
2.4 Shin Nippon SRW-5000 
Objective refractive data were obtained using an open field infrared autorefractor Shin 
Nippon SRW-5000 (Anjiomato Trading Inc., Tokyo, Japan). Autorefraction, specifically, 
using open field devices, has been found to be an appropriate method for studying 
refractive error, as it is more repeatable than retinoscopy and subjective refraction 
(Zadnik et al. 1992; Bullimore et al. 1998; Walline et al. 1999; Davies et al. 2003; 
Sheppard and Davies 2010). The open field setting ensures that the myopic shift, 
induced by the proximal accommodation, is reduced (Sheppard and Davies 2010). 
The Shin Nippon SRW 5000 employs an infrared light and calculates refractive error in 
two stages (Mallen et al. 2001). A target of infrared light is projected through the entrance 
pupil of the eye and subsequently reflected by the retina. A motorised lens track is used 
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to place the infrared ring in approximate focus and a digital analysis of the ring target in 
multiple meridians is used to calculate the toroidal prescription. The image analysis is 
conducted in 0.15 seconds, allowing 45 static prescription measurements to be taken 
within 1 minute. The instrument can determine a wide range of refractive error (± 22.00 
D sphere; ± 10.00 D cylinder), in 0.125 D steps. Cylinder axis is reported with 1o 
precision. The vertex distance can be altered. The alignment of the infrared ring can be 
monitored through a display and a hard copy of the measurements can be obtained 
(Mallen et al. 2001). 
The accuracy and repeatability of Shin Nippon SRW-5000 autorefractor have been 
studied previously, both in adult (Mallen et al. 2001) and child populations (Chat and 
Edwards 2001). The instrument has demonstrated a high repeatability and accuracy 
(Chat and Edwards 2001; Mallen et al. 2001). The instrument had a tendency to 
underestimate myopia, but showed a good repeatability (± 0.14 D for refractive sphere 
and ± 0.16 D for cylinder) in an adult population (Mallen et al. 2001). In children, improved 
repeatability was achieved under cycloplegic conditions (Chat and Edwards 2001).  
The Shin Nippon SRW autorefractor was used in experimental Chapter 5 for screening 
purposes, and Chapter 6 for determination of mean spherical equivalent (MSE). A 
modification of a Badal lens system was attached to the instrument. A +5.00 D lens set 
at a distance of 20 cm to the eye was used to induce zero accommodative demand. A 
Maltese cross was selected as a fixation target. (Rabbetts 2007) (Figure 2.7). 
Measurements were taken monocularly with one eye occluded.  
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Figure 2.7 Shin Nippon SRW setup with a Badal lens system modification. 
2.5 Ocular Biometry 
2.5.1 IOLMaster 500 
The IOLMaster 500 (Carl Zeiss, Jena, Germany), a commercially available optical 
biometer, was used to measure axial length (AL) in experimental Chapters 4-6.  
The IOLMaster 500 is a non-contact instrument (Figure 2.8-A), which was principally 
developed to aid with intraocular lens (IOL) calculations prior to cataract extraction 
(Santodomingo-Rubido et al. 2002). Owing to its fast, precise and non-invasive 
measurement technique, it has been widely used in the field of myopia research (Mallen 
et al. 2006; Logan et al. 2011; Cho and Cheung 2012; Gardner et al. 2015; Swarbrick et 
al. 2015). 
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Figure 2.8 (A) IOLMaster 500, (B) The display of the AL measurement with the signal to 
noise ratio (SNR) as an indicator of the measurement quality. 
 
The IOLMaster 500 employs dual beam partial coherence interferometry (PCI) to acquire 
AL length measurements (Santodomingo-Rubido et al. 2002; Chen et al. 2011) (Figure 
2.9). An incorporated infrared laser diode (LD) with a wavelength (λ) of 780 µm is used 
to measure the distance between the corneal apex and retinal pigment epithelium (RPE). 
Light emitted from the diode is split into two equal co-axial beams (CB1 and CB2) by a 
beam splitter (BS1), reflected by two mirrors (M1 and M2), and enters the eye. It is then 
reflected from the corneal (C) and retinal (R) interfaces (CBC1, CBC2 and CBR1, CBR2, 
respectively). Upon leaving the eye, the four light beams pass through a second beam 
splitter (BS2) and the differences in their frequencies, due to the reflection from the two 
interfaces, are detected by a photodetector (PHD). The mirror (M1) is moved at a 
constant speed to yield a particular interference pattern during the measurement 
process. The exact extent of the mirror (M1) displacement (d) can be measured and 
related to the signals received at the PHD enabling a precise estimation of the distance 
between cornea and retina (Santodomingo-Rubido et al. 2002). A resolution of 0.01 mm 
of AL measurements is achieved (Drexler et al. 1998; Mallen et al. 2006). Additionally to 
AL measurements, anterior chamber depth (ACD), corneal curvature, corneal diameter 
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and the optimal IOL calculations can be acquired with the IOLMaster 500 using image 
analysis (Eleftheriadis 2003).  
 
Figure 2.9 The operating principle of IOLMaster 500. Figure redrawn and reprinted with 
premission from Santodomingo-Rubido (2002). 
 
The IOLMaster has been found to be a safe and reliable instrument for measuring AL in 
children (Carkeet et al. 2004; Hussin et al. 2006) and adults (Santodomingo-Rubido et 
al. 2002; Rose and Moshegov 2003; Chen et al. 2011). Signal to noise ratio (SNR) is an 
indicator of measurement quality, and a value of 2.0-2.1 has been suggested as a cut-
off value for a reliable measurement (Olsen 2007; Suto et al. 2007) (Figure 2.8-B). 
The first five measurements with SNR value above 3.5, with a maximum difference of 
0.02 mm between any two readings, were averaged and selected for analysis in 
experimental Chapter 4 for retrospective data analysis (Cho and Cheung 2012). The first 
ten measurements with SNR value above 2.2, and a maximum difference of 0.02 mm 
between any two readings, were averaged and selected for analysis in experimental 
Chapters 5-6.  
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2.5.2 Aladdin 
The Aladdin (v.HW3.0, Topcon, Tokyo, Japan) is a commercially available optical 
biometry and topography system (Figure 2.10). The Aladdin device employs a low 
coherence interferometry (LCI) to acquire multiple biometry measures (AL, ACD, corneal 
curvature and topography, lens thickness, pupillometry and CCT) in 5 seconds (Mandal 
et al. 2013; Rozema et al. 2014). The Aladdin was used to measure ACD, LT and CCT 
in experimental Chapter 5 and CCT in Chapter 6. 
An 830 nm super luminescent diode is employed to measure AL, whilst anterior chamber 
depth is achieved in a similar manner to that of the IOLMaster (Wolffsohn et al. 2013; 
Huang et al. 2015; Hoffer et al. 2016) (please refer to 2.5.1). A horizontal slit of a 473-
nm blue light-emitting diode is projected onto the anterior chamber and the distance 
between the anterior corneal pole and the anterior crystalline lens is measured 
(Santodomingo-Rubido et al. 2002; Wolffsohn et al. 2013; Huang et al. 2015). A 
resolution of 0.01 mm for AL and ACD measurements is achieved. 
There is limited information available on how LT and CCT are measured by the Aladdin, 
however, the principle of employing a super luminescent diode to acquire AL 
measurements suggests that the measurement principle is also based on optical LCI 
and uses the change in signal frequencies reflected from the ocular interfaces to 
calculate the exact distance in a similar manner to the Lenstar 900 (Haag Streit AG, 
Koeniz, Switzerland). Lenstar 900 also uses a broadband light source, allowing 
measurements of AL, ACD, LT ad CCT (Cruysberg et al. 2010). 
The Aladdin has been validated (Mandal et al. 2013) and has shown a good repeatability 
and agreement with other ocular biometers for AL and ACD measurements (Mandal et 
al. 2013; Huang et al. 2015; Hoffer et al. 2016; McAlinden et al. 2017). 
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Four measurements were acquired for each patient in experimental Chapters 5-6 (Huang 
et al. 2015; Hoffer et al. 2016). The instrument allows automatic data export via Microsoft 
Excel file and displays the data as an average of all the measurements. 
 
Figure 2.10 Aladdin ocular biometry and topography system based on Placido disc 
principle (please see Section 2.6.1 for more detailed information of Placido disc 
principle). 
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2.5.3 Pentacam 
The Pentacam (Oculus, Wetzlar, Germany) is a non-contact anterior segment 
tomographer that uses Scheimpflug imaging technique to acquire measurements of 
anterior and posterior corneal topographies, corneal thickness, corneal wavefront 
aberrations and densitometry, ACD and LT (McAlinden et al. 2011; Oliveira et al. 2011). 
A rotating Scheimpflug camera is coupled with a static camera and a rotating slit light 
source. The rotating system moves around the optical axis from 0o to 180o and scans the 
cornea at a specific angle, providing cross sectional images due to the transparent and 
reflective composition of the anterior eye (Buehl et al. 2006; Oliveira et al. 2011) (for 
Scheimpflug cross sectional images please refer to Section 2.1.2). The static camera 
controls the fixation, corrects for eye movements and detects pupil contour (Oliveira et 
al. 2011). 
The Pentacam has shown a good repeatability (McAlinden et al. 2011; Oliveira et al. 
2011) and is in agreement with other ocular biometric devices. Nevertheless, caution 
should be taken when interpreting data from different devices (Rozema et al. 2014). No 
direct comparison between the Pentacam and the Aladdin has been published to date. 
Repeatability studies between Sirius (CSO, Costruzione Strumenti Oftalmici, Florence, 
Italy), an optical biometer combining Scheimpflug imaging technique with topography 
system, and Pentacam (Nasser et al. 2012; Anayol et al. 2014; Shetty et al. 2014), and 
Sirius and Aladdin (Polat et al. 2016) have been conducted. Clinically insignificant 
differences were found between Aladdin and Sirius data (Polat et al. 2016). It was 
advised to analyse the data obtained with Pentacam and Sirius with caution and not to 
use them interchangeably (Nasser et al. 2012; Anayol et al. 2014; Shetty et al. 2014). 
The Pentacam was used in the experimental Chapter 4 for CCT, ACD and LT 
measurements. Three measurements were acquired, averaged and used for the 
analysis (Khoramnia et al. 2007; Miranda et al. 2009). 
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2.6 Corneal topography 
2.6.1 Medmont E300 
Medmont E300 (v. 5.4.0 Beta 4, Medmont Ltd, Melbourne, Australia) is an automated 
videokeratoscope that uses Placido rings to map the front surface of the cornea. It 
employs 32 Placido rings (ranging from 0.25 mm to 11.0 mm in diameter) and analyses 
more than 1000 points on the corneal surface (http://www.medmont.com/products/e300-
topographer/).  
The Placido disc-based systems use the cornea as a convex mirror, reflecting the rings 
off the tear film overlying the cornea and measuring the size of a reflection of a given 
light source at known distance. A camera records the reflected image, which is 
subsequently analysed, using a Medmont-specific algorithm (Figure 2.11-A) (Cho, Lam 
et al. 2002; Wolffsohn and Peterson 2006).  
An automated range-finder is incorporated within the videokeratoscope system, ensuring 
a precise determination from the corneal apex to the instrument’s camera, ensuring only 
images with a good focus and alignment are captured (Read et al. 2009). A quality score 
from 0 to 100 is available to aid with the measurement process. A quality score above 
75 is advised as a cut-off value for a good measurement (Chui and Cho 2005). 
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Figure 2.11 Medmont E300 setup. (A) The videokeratoscope with the Placido rings, (B) 
the display of the data in a form of tangential map. 
 
The instrument provides simulated keratometry (K) readings in steep and flat meridian 
over the central 3 mm of the cornea, corneal astigmatism (ΔK), eccentricity (e), apical 
radius, corneal shape profile, and displays various types of topographical maps (axial, 
tangential and difference). In addition, tear film stability and contact lens fit can be 
monitored with incorporated software (Figure 2.11-B) (Cho, Lam et al. 2002; González-
Méijome et al. 2007; Read et al. 2009).  
The instrument has been shown to be accurate and repeatable on test surfaces (Tang 
et al. 2000), in child (Chui and Cho 2005) and adult (Cho, Lam et al. 2002; Wang et al. 
2012; Hamer et al. 2016) populations. 
Three simulated K and eccentricity readings, in flat and steep meridian, were taken and 
analysed in experimental Chapters 4-6 (González‐Méijome et al. 2004; Wang et al. 
2012). Tangential and difference maps were acquired to monitor lens fit in experimental 
Chapters 5-6. A quality score of 98 was choose as a cut-off value for a reliable 
measurement in Chapters 4-6 (Read et al. 2009).  
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2.7 Endothelial health 
2.7.1 SP3000P 
The SP3000P (Topcon Corporation, Tokyo, Japan) is an automated non-contact 
specular microscope which allows acquisition of corneal endothelium images and 
measurement of CCT (Bao et al. 2014) (Figure 2.12). It succeeded the SP2000P 
(Topcon Corporation, Tokyo, Japan), which was studied in detail to improve the 
measurement process and the automated cell analysis (Cheung and Cho 2000; Cho and 
Cheung 2000; Bao et al. 2014).  
 
Figure 2.12 Specular microscope Topcon SP3000P with IMAGEnet software for detailed 
endothelial cell analysis. 
Non-contact specular microscopes have experienced various modifications (Bourne and 
Kaufman 1976; Olsen 1979; Cheung and Cho 1998; McCarey et al. 2008). They still 
employ the principle introduced by Maurice (1968) (McCarey et al. 2008): a high 
magnification view of specularly reflected light is necessary to image the corneal 
endothelium and is obtained by incorporating a concave lens in the instrument (Figure 
2.13). The specular reflex is achieved by light reflecting off two refractive interfaces with 
different refractive indices (endothelium-aqueous humour, air-tear film/epithelium). The 
incident angle of the light must be equal to the angle of reflection. The endothelial surface 
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is less reflective, whilst the epithelial surface is highly reflective due to the large air-
epithelium refractive index difference. The relatively close proximity of the epithelium and 
endothelium restricts the light reflex and together with the radius of curvature determines 
the rectangular shape of the viewable/imaged area. The size of this area is further 
affected by corneal thickness and the width of the beam (Figure 2.13-A). As the light 
beam passes through the epithelium to the endothelium and then, subsequently, back 
through the corneal stroma, light scatter occurs due to the collagen fibril and keratocyte 
arrangement. The width of the beam is increased from narrow to wide in order to allow 
the epithelial reflex to encroach on the endothelial reflex. The endothelium can then be 
observed and captured. The acquired image has a different contrast due to the light 
scatter (Figure 2.13-B) (McCarey et al. 2008). 
 
Figure 2.13 The principle of specular microscopy (Ep - epithelium, end – endothelium). 
The observation and illumination angles are equal. When the light beam passes through 
the Ep to the End and then, subsequently, is reversed back to Ep, light scatter occurs 
due to the structure of stroma. The width of the beam is increased in order to allow the 
Ep reflex to encroach on the End reflex. The End can then be observed and captured. 
Image adapted and reprinted with permission from McCarey et al.(2008). 
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In addition to the central endothelium, the SP3000P allows for nasal, temporal, inferior 
and superior endothelium views 30o away from the horizontal axis. The instrument saves 
up to 5 images per eye and provides a quick cell count and shape analysis for screening 
purposes (Cho and Cheung 2000). An automated, semi-automated or manual mode can 
be selected for image capture. The images from the specular microscope are transferred 
to a computer with an automated cell analysis software (IMAGEnet ibase, Topcon 
Corporation, Tokyo, Japan) for a detailed analysis. Cell count, hexagonality and average 
cell size are displayed (Cheung and Cho 2000; Cho and Cheung 2000) (Figure 2.12).  
The Topcon SP specular microscope series has been shown to produce reliable 
measurements (Cheung and Cho 1998; Cheung and Cho 2000; Cho and Cheung 2000; 
Mccarey et al. 2008), which are in agreement with other commercially available 
instruments for CCT and corneal endothelial assessment (McCarey et al. 2008; Bao et 
al. 2014; Gasser et al. 2015). 
The automated image capture mode was employed in the studies described in Chapter 
4, 5 and 6. IMAGEnet ibase v. 3.18. software was used for the cell analysis. Three 
images of central endothelium per eye were captured and saved. Using the grading 
system validated before (Cheung and Cho 2000; Cho and Cheung 2000), the clearest 
images with a minimum of 100 cells were selected for the analysis (Doughty and Aakre 
2008; Doughty 2013). 
  
117 
 
Chapter 3. Current trends of myopia management in clinical practice 
3.1 General overview 
This chapter describes the purpose, design and findings of the ‘Global trends in myopis 
management attitudes and strategies in clinical practice’ (Wolffsohn et al. 2016). In total 
nine hundred seventy one responses from the eye care practitoners across the globe 
were received, analaysed and reflect on the current state of myopia management in 
clinical practice. The survey also tidentifies problems associated with myopia control 
(MC) interventions. 
3.2 Introduction 
The prevalence of myopia has doubled in the last three decades (Lin et al. 2004; Vitale 
et al. 2009; Pan et al. 2012; Holden et al. 2016; Mccullough et al. 2016), reaching 20-
50% in America and Europe (Sperduto et al. 1983; Vitale et al. 2008; Logan et al. 2011; 
Williams et al. 2015; Mccullough et al. 2016) and approaching 70-90% in regions of 
South East Asia (Lin et al. 1988; Goh and Lam 1994; Edwards and Lam 2004; Lin et al. 
2004; Ting et al. 2004) amongst schoolchildren and young adults (for more detailed 
prevalence rates of myopia, please refer to Section 1.2.2). If myopia prevalence 
continues to increase at the same rate, evidence-based models predict that half of the 
world’s population will be myopic by 2050 (Holden et al. 2016). Moreover, a shift towards 
a more myopic refraction has been observed in the last two generations (Lin et al. 2004; 
Liang et al. 2013), leading to an increased level of high myopia (≥-6.00 D). Lin et al. 
(2004) compared the age of onset and prevalence of myopia amongst schoolchildren 
between 1983 and 2000. The mean age of myopia onset was 11 years in 1983, whereas 
it was 8 years in 2000 (Lin et al., 2004). The mean refractive status at 8 years was 0.45 
± 1.03 D and -0.15 ± 1.40 D, in 1983 and 2000, respectively; whereas, at 11 years it was 
-0.27 ± 1.72 D and -1.20 ± 1.93 D, in 1983 and 2000 respectively. An evidence-based 
model of progression rates of myopia in Asian countries, introduced by Sankaridurg and 
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Holden (Holden et al. 2014; Sankaridurg and Holden 2014), predicts that a child with -
1.00 D of myopia at 6 years of age will be expected to progress to -7.00 D on average 
by the age of 15. Therefore, more people at a younger age will encounter the economic 
and health burdens associated with this condition (Holden et al. 2014). High myopia is 
strongly linked to ocular pathologies, such as retinal detachment, glaucoma and 
cataracts (Brown and Hill 1987; Leske et al. 1995; Mitchell et al. 1999; Vongphanit et al. 
2002; Saw et al. 2005; Flitcroft 2012). Flitcroft (2012) demonstrated that the risk of 
developing ocular pathology increases with the level of myopia. For example, compared 
to emmetropes, the odds ratio of developing retinal detachment is 21.5 (95% confidence 
interval: 17.3-26.7) for myopia -5.00 to -6.99 D, and increases to 44.2 (34.2-57.2) for 
myopia -7.00-8.99 D (Ogawa and Tanaka 1987; Flitcroft 2012). The risk of developing 
myopic maculopathy is 40.6 (13.3-124.4) for myopia of -5.00 to -6.99 D, but increases to 
126.8 (34.0-472.3) for myopia of -7.00 to -8.99 D (Vongphanit et al. 2002; Flitcroft 2012). 
However, even lower levels of myopia (-1.00 to -3.00 D) have been found to have an 
increased risk of developing these conditions, when compared to emmetropes (Flitcroft 
2012). The odds of developing myopic maculopathy is doubled (Vongphanit et al. 2002; 
Flitcroft 2012) and the odds of developing retinal detachment is tripled (Li et al. 2003; 
Flitcroft 2012). Thus, similarly to Holden (2014), Flitcroft (2012) highlighted the need to 
slow down the progression of myopia and reduce the levels of high myopia.  
Brennan (2012), Holden (2014) and Sarkanidurg and Holden (Sankaridurg and Holden 
2014) have discussed the potential benefit of reducing the rate of myopia progression. 
Brennan estimated that slowing down the progression of myopia by 33%, would lead to 
a reduction of 73% of high myopia (>-5.00 D), but if a retardation rate of 50% was 
achieved, 90% of high myopia would be eliminated (Brennan 2012). Sarkanidurg and 
Holden used an evidence-based model to demonstrate that if myopia could be retarded 
by 30% over a time span of 8 years, myopia progression would be reduced from an 
average of -7.00 D to -5.50 D (Holden et al. 2014; Sankaridurg and Holden 2014).  
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Perhaps, the most challenging aspect of myopia management, is its multifaceted 
aetiology. A range of factors including genetic predisposition (Zadnik, Karla 1997; 
Pacella et al. 1999; Mutti et al. 2002; Farbrother et al. 2004; Kurtz et al. 2007; Cheng et 
al. 2013), inadequate accommodation response (Gwiazda et al. 1993; Gwiazda et al. 
1995), elevated accommodative convergence to accommodation, the AC/A ratio and/or 
esophoria (Drobe and Desaintandre 1995; Gwiazda et al. 1999), excessive time spent 
undertaking near work (Mutti et al. 2002; Ip et al. 2008; Vasudevan and Ciuffreda 2008; 
Woodman et al. 2010), low levels of outdoor activity (Jones et al. 2007; Rose, Morgan, 
Ip, et al. 2008; Wu et al. 2010; Guggenheim et al. 2012; Guo et al. 2013; Wu et al. 2013), 
lightning levels (Ashby et al. 2009; Ashby and Schaeffel 2010; Cohen et al. 2011; Smith 
et al. 2012) and magnitude of hyperopic peripheral defocus (Hoogerheide et al. 1971; 
Rempt et al. 1971; Millodot 1981; Mutti et al. 2000; Seidemann et al. 2002; Schmid 2003; 
Logan et al. 2004; Charman et al. 2006; Mutti et al. 2007; Kang et al. 2010; Mutti et al. 
2011) have been linked to the development and/or progression of myopic refractive error. 
However, the exact mechanisms surrounding myopia development and progression are 
not yet fully understood (for the factors of myopia development please refer to Section 
1.2.4). 
Although it is not yet possible to prevent the onset of myopia, extensive research in the 
area of myopia control (MC) has yielded promise in the reduction in myopia progression. 
Optical interventions, most predominantly contact lenses, pharmaceutical treatment and 
behavioural approaches, targeting various aspects of the underlying mechanisms of 
myopia development, have demonstrated retardation rates of 14 to 72% in longitudinal 
clinical studies and trials (Goss and Uyesugi 1995; Leung and Brown 1999; Fulk et al. 
2000; Chung et al. 2002; Edwards et al. 2002; Gwiazda et al. 2003; Tan et al. 2005; 
Adler and Millodot 2006; Walline et al. 2009; Yang et al. 2009; Anstice and Phillips 2011; 
Gwiazda et al. 2011; Sankaridurg et al. 2011; Berntsen et al. 2012; Chia et al. 2012b; 
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Cho and Cheung 2012; Chen et al. 2013; Walline et al. 2013; Wu et al. 2013; Cheung et 
al. 2014; Hasebe et al. 2014; Paune et al. 2015).  
Conventional single vision spectacle lenses seem to be ineffective for MC as they induce 
peripheral hyperopic defocus, a factor speculated to promote eye growth. (Smith, Huang, 
et al. 2009; Smith, Hung, et al. 2009; Lin et al. 2010; Smith 2011). However, some 
authors have questioned whether peripheral defocus is the primary mechanism driving 
eye growth, having reported that some myopic children wearing single vision spectacles 
were actually exposed to greater relative myopic defocus. Thus, myopia progression was 
less in these children than it was in those wearing single vision spectacles with relatively 
greater hyperopic defocus (Berntsen et al. 2012; Atchison et al. 2015). Other large scale 
human studies have also found peripheral refraction to neither affect myopia onset or 
development (Gwiazda et al. 2003; Mutti et al. 2011). Progressive addition (PALs) and 
bifocal lenses have been prescribed to reduce accommodative demand, and mitigate 
the blur associated with increased lag of accommodation in myopia (Gwiazda et al. 1993; 
Gwiazda et al. 1995; Gwiazda et al. 1999; Gwiazda et al. 2003). It is presumed that an 
insufficient amount of accommodation might cause a relative retinal blur and, hence, be 
a triggering factor for axial elongation. The success rate of studies employing PALs and 
bifocals have varied from no effect (Shih et al. 2001; Edwards et al. 2002), to 46% for 
PALs (although this study was not randomised; Leung and Brown 1999); and 44 to 56 
% for bifocals and executive bifocals, respectively (Goss and Uyesugi 1995; Cheng et 
al. 2014). However, other studies have reported retardation rates of 14% to 24% (Leung 
and Brown 1999; Fulk et al. 2000; Gwiazda et al. 2003; Hasebe et al. 2008; Yang et al. 
2009) which are less convincing (Wolffsohn et al. 2016). 
Undercorrection, which was believed not only to reduce accommodative demand, but 
induce myopic defocus, has been hypothesised to act as a halting signal to myopia 
development in animal studies (Shaikh et al. 1999; Smith et al. 1999). Contrarily, 
undercorrection has been found to accelerate the rate of myopia progression by 17 to 
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29% in human clinical studies (Chung et al. 2002; Adler and Millodot 2006; Wolffsohn et 
al. 2016). 
Soft single vision contact lenses (Horner et al. 1999; Walline, Jones, et al. 2004; Walline 
et al. 2008), and conventional rigid gas permeable (RGP) contact lenses (Khoo et al. 
1999; Katz et al. 2003; Walline, Jones, et al. 2004) have been found to have no effect 
on myopia progression. However, multifocal contact lens designs appear to be effective 
in reducing myopia progression by 34 to 50%; it may result from the optics of a contact 
lens, including the near portion, being consistently aligned with the position of gaze as 
the lens moves with the eye, (Gwiazda et al. 2003; Aller and Wildsoet 2008; Anstice and 
Phillips 2011) and possibly more consistency in wearing time, which seems to be an 
important factor for efficacy (Lam et al. 2014). Orthokeratology (ortho-k), on the other 
hand, has been consistent in the level of myopia retardation shown and is able to slow 
the progression of myopia by 50%, (Walline et al. 2009; Cho and Cheung 2012; Chen et 
al. 2013). Therefore, it is considered the optical treatment with the strongest accumulated 
evidence to date (Gonzalez-Meijome et al. 2016; Wolffsohn et al. 2016). 
Pharmaceutical treatment strategies, such as atropine (Shih et al. 2001; Chua et al. 
2006; Chia et al. 2012b), and pirenzepine (Siatkowski et al. 2004; Tan et al. 2005; 
Siatkowski et al. 2008), have shown high success rates (32% to 72%). However, the 
limited commercial availability of the low dose atropine and the unlicensed status of 
pirenzepine for medical use, and also the unknown effects of long term use and the 
rebound effect following cessation of treatment (Tan et al. 2005; Tong et al. 2009; Yang 
et al. 2009; Cheng et al. 2014; Chia et al. 2015; Wolffsohn et al. 2016) limit the clinical 
use of them. 
Epidemiology studies in the general population and in monozygotic twins, have generally 
demonstrated that time spent outdoors reduces the likelihood of myopia onset (Sherwin 
et al. 2012; Lee et al. 2013; Parssinen et al. 2014; Ramessur et al. 2015). The 
behavioural approach of increased outdoor activity has been shown to retard the onset 
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of myopia by 11-34%. (Wu et al. 2013) It is postulated that the higher luminance levels, 
which exist outdoors compared to indoors, trigger the release of the retinal transmitter, 
dopamine, which is believed to prevent axial growth and myopia development. (Ashby 
et al. 2009; Ashby and Schaeffel 2010; French et al. 2013) In addition, it has been 
suggested that components of sunlight itself, could activate vitamin D, which could play 
a potential role in preventing eye growth. (Mutti et al. 2011; French et al. 2013) Additional 
factors like increased viewing distance that reduces the accommodation demand and 
improved image quality due to the smaller pupil in bright light conditions and, hence, 
increased depth of focus, when compared to indoor conditions, could further contribute 
towards the protective effects of increased outdoor activity (Rose, Morgan, Ip, et al. 
2008) (for MC interventions please refer to Section 1.2.5). 
However, if and how these approaches are employed in clinical practice is still unclear, 
and the information in scientific literature on this topic is sparse. In 2013 the Vision 
Research Institute (Ferris State University Michigan Collage of Optometry) conducted a 
survey with 700 eye care professionals (ophthalmologists, optometrists, opticians, 
ophthalmic technicians) concerning the increasing rates of myopia prevalence (available 
online: http://www.myopiacontrol.org/how-do-you-myopia-control-.html; accessed 
01.10.2015). The results showed that practitioners in United States of America were 
aware of the growing issue and tended to familiarise themselves with the current 
literature in the field. Also, they chose to prescribe ortho-k as the main option for MC. 
However, their rationale for prescribing different MC strategies was not included in the 
survey. Similarly, Contact Lens Spectrum has also surveyed over 400 practitioners in 
the United States of America, in both 2014 and 2015, showing that, in both years, 24% 
of practitioners report using contact lenses to control myopia. Practitioners reported 
using soft multifocal and orthokeratology contact lens designs predominantly, with very 
few reporting that they used rigid multifocal contact lenses (Nichols 2016). 
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Johnson (2014) and Holden (2014) stressed the need for more scientific studies as most 
of them have looked at retardation rates of myopia progression over the period of two 
years, and little is known about the rebound effects. Moreover, Johnson (2014) doubted 
clinicians’ ability to see the bigger picture – do clinicians understand the benefit of annual 
retardation rates, when they are converted into dioptres, the most commonly used 
measure of refraction in optometric practice, and the long term effect of myopia 
progression and the potential risks of developing ocular pathologies? Several studies 
have reported statistically, but not clinically, significant reductions in the rates of myopia 
progression retardation (Edwards et al. 2002; Gwiazda et al. 2003; Gwiazda et al. 2011), 
and some authors doubt the retardation effect achieved (Fulk et al. 2000), presumably 
leaving practitioners confused and sceptical about the various management strategies 
available. Therefore, a better understanding of current trends of myopia management in 
clinical practice is required before targeted education and recommended criteria for 
intervention can be introduced (Wolffsohn et al. 2016).  
3.3 Method 
A self-administrated, internet-based, cross-sectional survey in 6 languages (English, 
French, Spanish, Italian, Portuguese and Chinese) was distributed using online software 
SurveyMonkey (www.surveymonkey.com; SurveyMonkey Inc. San Mateo, California, 
USA) through various professional bodies across the world to target eye care 
professionals (optometrists, dispensing opticians, ophthalmologists and others) globally. 
Before the global distribution, survey was piloted internally on a small number of eye 
care professionals (n=5).  
The survey comprised of nine questions (forced choice and multiple choice), relating to 
the self-reported clinical management behaviours of practitioners for progressive myopia 
and practitioner’s current opinions on MC related clinical care including: 
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 How concerned are you about the increasing frequency of paediatric 
myopia in your practice? (rated as ‘not at all,’ to ‘extremely,’ on a 10-point 
scale); 
 From what you have heard/read about the effectiveness of myopia control 
options to date, what % reduction do you think the following options can 
achieve? (modalities provided: undercorrection, single vision spectacles, 
bifocal spectacles, progressive addition spectacles, RGP (alignment fit), 
single vision contact lenses, standard multifocal contact lenses, specific 
myopia control contact lenses, orthokeratology, pharmaceuticals such as 
atropine, refractive surgery, increased time spent outdoors; rated as a 
percentage from 0 to 100%); 
 How active would you consider your clinical practice in the area of myopia 
control? (rated as ‘Not at all,’ to ‘fully,’ on a 10-point scale); 
 How many times have you prescribed the following correction options for 
progressing/young myopes over an average month (please consider the 
total number of progressing/young myopes and include all in your 
response)? (modalities provided: single vision spectacles, bifocal 
spectacles, progressive addition spectacles, RGPs (alignment fit), single 
vision soft contact lenses, standard multifocal contact lenses, specific 
myopia control contact lenses, orthokeratology, pharmaceuticals such as 
atropine, refractive surgery);  
 How old (in years) would the patient have to be for you to consider each 
of the following options (not just for myopia control and assuming average 
handling skills and child/parent motivation)? (modalities provided single 
vision spectacles, bifocal spectacles, progressive addition spectacles, 
RGPs (alignment fit), single vision soft contact lenses, standard multifocal 
contact lenses, specific myopia control contact lenses, orthokeratology, 
pharmaceuticals such as atropine, refractive surgery; prescribing age 
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listed starting from 5 years up to 18 years in one-year steps with an option 
‘would not prescribe this’ available); 
 What would be the minimum amount of myopia (in dioptres) for you to 
consider each of the following correction options for a patient? (modalities 
provided single vision spectacles, bifocal spectacles, progressive addition 
spectacles, RGPs (alignment fit), single vision soft contact lenses, 
standard multifocal contact lenses, specific myopia control contact 
lenses, orthokeratology, pharmaceuticals such as atropine, refractive 
surgery; level of myopia to consider specific modality provided in half 
dioptre steps from -0.50D to >-5.00D with an option ‘would not prescribe 
this’ available); 
 What is the minimum level of myopia progression you consider 
necessitates a myopia control approach? (level of myopia progression 
listed in quarter dioptre steps per year from 0D/year up to >1.00D/year 
with an option ‘myopia control is not warranted’ available); 
 Do you use undercorrection as a strategy to slow myopia progression? 
(options provided: ‘no’, ‘sometimes’, or ‘always’); 
 If you have only ever fitted single vision spectacles/contact lenses for 
myopic patients, what has prevented you prescribing an alternative 
method? (options specified: ‘I don’t think they are more effective’, ‘the 
outcome is unpredictable’, ‘safety concerns’, ‘cost to the patient makes it 
uneconomic’, ‘additional chair time’, ‘inadequate information/knowledge’, 
‘benefit/risk ratio’).  
An option to add further comments to each of the questions and the topic as a whole was 
available (for the full questionnaire in English please refer to Appendix 1.2).  
Following an explanation of the research via email, in which participants were invited to 
devote 5 minutes of their time and complete an international survey, regarding their 
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opinion on the currently available myopia management strategies to enhance the 
knowledge of how well myopia is managed in everyday practice by them and their 
colleagues across the globe, participants consented to take part in it by clicking a link 
that re-directed them to the survey (for invitation email please refer to Appendix 1.1). 
Participation in the survey was voluntary and anonymous, however respondents were 
asked to provide basic demographic information about themselves (highest qualification, 
number of years since qualification, everyday working environment and their 
geographical location) before submitting their responses.  
A sample size of 1000 respondents was targeted as it is the suggested size for a general 
purpose survey, and allows a fairly reliable comparison up to 3 subgroups (Ornstein 
2013). Moreover, in this case, the target population was profession-specific, therefore, 
around 1000 responses were considered to be a reliable representation of eye care 
professionals’ opinion around the globe. Power analysis was not conducted as the 
survey was predicted to have more than one definite outcome and sample size would be 
strongly affected by the size of the subgroups, that could not be easily predicted 
(Ornstein 2013). The data was collected between January and June 2015. For full 
questionnaire, please refer to Appendix 1.2. The methodology and survey itself has 
already been published (Wolffsohn et al. 2016). 
3.3.1 Statistical Analysis 
Statistical analysis was conducted using SPSS (IBM SPSS Statistics for Windows, 
Version 21.0. IBM Corp. Armonk, New York, USA). Median, confidence intervals (CI, 
where applicable), mean and standard deviations were calculated for each question 
response. The results were grouped by continent (Asia, Australasia, Europe, North 
America and South America; Africa was excluded as only 7 responses were received), 
and countries within a continent, where response rate allowed (n≥30). Kruskal-Wallis test 
was applied to determinate the differences (taken as p<0.05) between the groups (using 
bootstrapping approach, where applicable), due to the non-parametric nature of the data. 
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For conciseness, only significant comparisons have been reported (non-significant 
comparisons are listed, if relevant). For full list of comparisons and results please refer 
to Appendix 1.3. 
3.4 Results 
3.4.1 Responses 
A total number of 971 complete survey responses from Africa (n=7; not included in further 
analysis), Asia (n=291), Australasia (n=119), Europe (n=339), North America (n=133), 
and South America (n=82) were received. Country-specific responses could be extracted 
from: 
 Europe: France (n=34), Italy (n=72), Netherlands (n=38) Portugal (n=48), Spain 
(n=34) and United Kingdom (UK)/Ireland (EIRE) (n=52) 
 Asia: China (n=137), Hong Kong (n=61) and India (n=37) 
 North America: Canada (n=33) and USA (n=100). 
The response rate could not be estimated exactly as the survey was distributed via 
various professional bodies and the overall denominator population was unknown. 
However, it is likely that the response rate of this survey corresponds to the lower limit 
of those reported previously for email/internet based surveys (9-32%, with mean 
response rate of 20% (Deutskens et al. 2004; Kaplowitz et al. 2004; Nulty 2008)). 
Of the study participants, 72.4% (n=698) were optometrists, 18.6% (n=180) were 
ophthalmologists, 5.8% (n=56) were contact lens opticians and 3.2% (n=31) were other 
types of eye care specialists. The principal working environment for 84.4% was in clinical 
practice (n=814), 11.3% worked in academia (n=109), 1.6% worked within industry 
(n=16) and 2.7% (n=26) worked in other environments. However, all study participants 
were registered eye care practitioners. The vast majority of the practitioners that took 
part in the survey have been qualified professionals for 11-20 years (calculated as 
median).  
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3.4.2 Self-reported concern about the increasing frequency of paediatric myopia 
in their practice 
Practitioners’ concern about increasing frequencies of paediatric myopia in their 
practices on a global scale was 8/10 (median) (Appendix 1.3). Continental division 
revealed that practitioner concern was higher (9/10) in Asia than any of the other 
continents (p<0.001), with a similar level of concern (all with a median of 7/10; p>0.05) 
across Australasia, Europe, North and South America (Figure 3.1). 
In Asia, Chinese practitioners were more concerned (10/10) than those in Hong Kong 
(8/10; p=0.001) or India (8/10; p=0.002). In Europe, Portuguese (8/10) and Spanish 
(9/10) practitioners were more concerned than those in Italy (7/10, p=0.046, p=0.027 
respectively), the Netherlands (7/10, p=0.002, p=0.001 respectively) or the UK/EIRE 
(6/10, p<0.001, p<0.001 respectively). In the North American continent, practitioners 
from the USA (7/10) were more concerned than Canadian practitioners (6/10, p=0.005) 
(Appendix 1.3). 
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Figure 3.1 Concern regarding increasing myopia amongst paediatric patients for 
practitioners located in different continents (n=964), (Wolffsohn et al. 2016). Note: line 
within the box represent median, error bars represent 95% CI. 
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3.4.3 Perceived efficacy of myopia control options 
Practitioners self-reported relative efficacy of various myopia management strategies to 
slow down the myopia progression was the highest for orthokeratology. They perceived 
that ortho-k slows down myopia progression by 44% (on average across the globe). It 
was followed by increased time spent outdoors (32%) and pharmaceutical approaches 
(28%). Single vision distance undercorrection and single vision spectacles were 
perceived to be the least effective method (6% and 11%, respectively). These findings 
were consistent across all continents except for South America (p<0.05), where all the 
interventions had similar perceived efficacy (12-24%), apart for increased outdoor 
activity (35%). Compared with practitioners from all other continents, practitioners from 
Asia considered single vision, bifocal spectacle lenses and PALs to be relatively more 
effective for reducing childhood myopia progression (p<0.01). Australian and North 
American practitioners perceived single vision contact lenses as less effective than 
practitioners from other continents (p<0.01). North American practitioners were less 
convinced by ortho-k and pharmaceutical treatment as appropriate methods for MC than 
those from Asia or Australasia (p=0.001). Similarly, European practitioners were less 
convinced by the effect of pharmaceutical pharmaceuticals (p<0.001). North American 
practitioners were also more sceptical about the potential benefit of increasing time spent 
outdoors on myopia progression compared with practitioners from other continents 
(p<0.05).  
Country-specific comparisons showed that there were variations in the perceived 
effectiveness across all MC options, especially among French practitioners and their 
European colleagues (please refer to Table 3.1 and Appendix 1.3). 
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Table 3.1 Perceived effectiveness (defined as the expected level of reduction in childhood myopia progression in percent) of myopia control interventions by 
practitioners in different continents. Note: data are presented as mean±SD. 
 
Continent 
 
Asia Australasia Europe North America South America 
Intervention Perceived efficacy (%) 
S
p
e
c
ta
c
le
s
 
 
Undercorrection 6.5±13.9 2.5±7.4 6.4±15.8 2.9±7.9 13.4±23.1 
Single Vision 16.0±23.6 4.2±12.5 10.0±21.8 4.0±14.0 18.1±30.7 
Bifocals 18.4±21.1 14.1±14.8 12.4±17.5 11.6±14.4 12.3±24.2 
Progressive 
Addition (PALs) 
21.3±21.2 16.0±14.0 14.7±18.6 11.3±13.5 12.8±24.8 
C
o
n
ta
c
t 
L
e
n
s
e
s
 
Rigid Gas 
Permeable (RGP), 
alignment fit 
23.9±26.9 9.6±13.8 14.1±20.8 9.9±15.4 13.6±27.0 
Single Vision Soft 11.9±20.6 4.1±11.5 10.1±20.5 2.9±10.5 16.0±29.0 
Multifocal Soft 15.5±20.2 22.5±19.3 16.4±25.7 18.4±20.5 11.5±19.7 
Novel Myopia 
Control Soft 
24.4±26.0 29.1±19.3 25.2±25.7 21.5±23.1 18.8±28.5 
Ortho-k 48.6±29.6 47.8±25.3 44.3±29.0 36.9±30.1 23.9±32.3 
Pharmaceutical 31.7±27.8 39.0±32.4 24.2±29.4 21.8±27.0 14.6±23.3 
Refractive Surgery 17.4±29.7 11.4±24.3 12.8±25.6 13.5±30.6 18.0±29.4 
Increased Time Spent Outdoors 38.7±27.5 29.7±22.0 29.4±26.2 20.5±17.9 35.3±32.0 
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3.4.4 Perceived level of clinical activity in the area of myopia control 
Overall, practitioners rated their level of clinical activity as 7 out of 10 (median value) in 
the area of MC across the globe. Practitioners in Asia considered their clinical activity in 
MC to be more active (median 8/10) than practitioners in Australasia (median 7/10; 
p=0.028), Europe (median 7/10; p<0.001), North America (median 4/10; p<0.001) and 
South America (median 5/10, p<0.001). North American practitioners perceived 
themselves to be less active in this area of practice than those from Europe (p<0.001) 
and Australasia (p<0.001). Within Europe there were no differences between countries, 
however, within Asia, practitioners from India (6/10) considered themselves less active 
than practitioners in China (8/10, p<0.001) or Hong Kong (8/10, p=0.002) practitioners. 
Similarly, regional differences within North America could be observed. Canadian 
practitioners (2/10) reported themselves to be less active than those from the USA (5/10, 
p=0.034) (Figure 3.2 and Appendix 1.3). 
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Figure 3.2 Perceived level of clinical activity in the area of myopia control for practitioners 
located in different continents (n=964), (Wolffsohn et al. 2016). Note: lines within the box 
represent median, error bars represent 95% CI. 
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3.4.5 Frequency of prescribing different myopia correction options for 
progressing/young myopes  
The majority of progressing myopic patients across the globe were being prescribed 
either single vision (full correction) spectacles (47.8 ± 31.7%), or single vision contact 
lenses (15.2±17.3%). Whereas, ortho-k (14.3 ± 24.3%), PALs (6.5 ± 14.3%), RGPs (4.5 
± 10.5%), multifocal contact lenses (4.1 ± 11.3%), bifocal spectacles (2.6 ± 8.2%), novel 
MC contact lenses (2.1 ± 7.9%), pharmaceuticals (1.9 ± 8.7%) and refractive surgery 
(1.0 ± 5.4%) were utilised less frequently (Appendix 1.3).  
Practitioners in Asia reported prescribing single vision (full correction) spectacles most 
frequently, whereas those from Australia prescribed them least often (p<0.001). 
Similarly, European practitioners were more reluctant to prescribe single vision 
spectacles than Asian practitioners (p<0.001). North American practitioners indicated 
prescribing bifocal spectacles most frequently (p<0.001) for progressing/young myopes. 
Australian practitioners, and to a lesser degree, practitioners in Asia, prescribed PALs 
more frequently (p<0.001) than those from other continents. Australian and North 
American practitioners prescribed RGPs (alignment fit) (p<0.001) more for progressing 
myopic patients than those in Asia, Europe or South America. Single vision contact 
lenses were prescribed less in Asia than in any other continent, whilst standard multifocal 
contact lenses were prescribed more in North America (p<0.001) than anywhere else.  
Practitioners in Europe, however, tended to prescribe this modality more often than those 
in Asia. Whereas, specific MC contact lens designs were not utilised in any of the 
continents (Table 3.2 and Appendix 1.3). 
Ortho-k was utilised less frequently by the practitioners in South America (p<0.001) than 
by those in Asia, Australasia, Europe or North America. Practitioners in Asia prescribed 
pharmaceutical treatment more frequently (p<0.001) than practitioners from other 
continents for young myopic patients. Refractive surgery was advised more in the 
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regions of South America and Australasia than in any other continent (p<0.001) for these 
patients, however, the prescribing frequency was still low (2.8 ± 7.6% and 0.3 ± 1.3% 
respectively; expressed as mean ± SD) (Table 3.2).  
Intra-region comparisons showed large variations in prescribing habits for all MC options 
(Appendix 1.3). Within Europe practitioners in the Netherlands, and to a lesser extent in 
Italy, prescribed single vison spectacles less than in other European countries (p<0.001) 
for progressing myopes. Similarly, in Asia, practitioners in India prescribed single vision 
spectacles to a lesser extent than those in China or Hong Kong (p<0.001). Whereas, in 
Northern America, Canadian practitioners prescribed single vision spectacles more 
frequently than their colleagues from the USA (p=0.028). Bifocal spectacles and PALs 
were prescribed with a similar frequency across Europe, but differences existed among 
practitioners in Asia (all p<0.001 and all p=0.007 respectively) and Northern America 
(p=0.023 and p=0.032 respectively). Practitioners in the UK chose RGP contact lenses 
less frequently for their progressing myopic patients than their European colleagues 
(p<0.001). Whereas, within Asia, Indian practitioners prescribed this type of correction 
more frequently than those in Hong Kong and China (p<0.001). Single vision contact 
lenses were prescribed at similar rates among European and Northern American 
practitioners, whilst, within Asia, they were prescribed relatively more frequently in India 
than other countries (p<0.001). Within Europe, ortho-k was chosen more often by 
practitioners in the Netherlands than any other country in Europe (p≤0.001), whereas in 
Asia, practitioners in China chose this modality for progressing/young myopes more 
frequently than their colleagues in India (p<0.001), and relatively more frequent than their 
neighbours in Hong Kong (p<0.001). 
Great inter-regional variations were reported for prescribing of standard multifocal and 
specific M contact lenses, pharmaceutical treatment and refractive surgery (Appendix 
1.3). 
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Continent Asia Australasia Europe North America South America 
Technique Prescribing frequency (%) 
S
p
e
c
ta
c
le
s
 
 
Single Vision 
57.6±31.3 36.8±30.2 42.2±30.7 49.6±31.3 52.1±30.5 
Bifocals 
2.9±7.3 1.3±4.4 2.1±7.0 5.1±13.6 1.9±7.0 
Progressive Addition (PALs) 
7.4±13.3 17.4±23.0 4.1±12.2 3.7±9.2 1.8±5.2 
C
o
n
ta
c
t 
L
e
n
s
e
s
 
Rigid Gas Permeable (RGP) 
4.9±8.5 0.6±2.1 6.1±13.6 2.4±8.3 6.8±10.8 
Single Vision Soft 
5.7±9.9 13.9±13.4 20.2±18.8 18.8±16.5 21.0±20.3 
Multifocal Soft 
0.8±2.9 6.2±11.9 4.3±11.0 8.5±17.5 2.1±7.2 
Novel Myopia Control Soft 
2.2±8.1 1.5±4.7 2.4±8.8 0.9±5.1 3.0±10.6 
Ortho-k 
11.1±17.6 21.2±29.1 18.3±27.6 9.4±18.5 7.9±25.2 
Pharmaceutical 
5.6±14.5 0.8±3.3 0.1±1.2 1.1±6.8 0.7±5.0 
Refractive Surgery 
2.0±8.3 0.3±1.3 0.3±1.6 0.6±4.5 2.8±7.6 
Table 3.2 Frequency of prescribing myopia correction options for progressing/young myopes by practitioners in different continents for progressing/young 
myopes. Note: data are expressed as mean±SD. 
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3.4.6 Minimum patient age that practitioners consider myopia correction options 
Globally, single vision spectacles were prescribed from the youngest age (5.4 ± 1.5 
years). Multifocal spectacles (bifocal: 6.3 ± 2.3 years; PALs: 7.3 ± 2.8 years) and 
pharmaceuticals (6.4 ± 2.6 years) were considered from an older age. Contact lenses 
were prescribed for older children, especially those with a novel MC design (single vision: 
6.5 ± 3.4 years; novel MC soft: 8.8 ± 3.1 years; ortho-k: 8.8 ± 3.1 years; multifocal: 8.9 ± 
3.1 years; RGPs: 9.9 ± 3.3 years). Most practitioners did not recommend refractive 
surgery to patients under 18 years of age (Appendix 1.3.).  
Continental comparisons revealed that single vision spectacles, bifocal spectacles and 
PALs were prescribed for relatively older ages in Asia and Europe than in Australasia or 
North America (p<0.05). Whereas, all soft contact lens modalities were fitted from older 
age in Asia and South America than in Australasia, Europe or North America (p<0.01). 
No difference in the minimum age between practitioners in different continental locations 
who would consider prescribing RGP contact lenses, ortho-k, pharmaceuticals or 
refractive surgery correction options was observed (p>0.05) (Table 3.3). 
Country-specific comparisons showed that within Europe, practitioners from the 
Netherlands fitted single vision spectacles from an older age (5.9 ± 1.7 years, p<0.001) 
than their colleagues across the continent. French practitioners considered fitting single 
vision contact lenses from an older age compared to those from the rest of the continent, 
with the exception of Portuguese practitioners, who were conservative with their 
minimum fitting age of all types of contact lenses (p<0.05). Within Asia, practitioners in 
India fitted RGPs from an older age than their colleagues in China (11.7 ± 3.4 years; 
p=0.003), whereas practitioners in China were more conservative in their minimum fitting 
age for single vision soft contact lenses than those from either Hong Kong or India 
(p<0.05). Ortho-k was prescribed at an earlier age in Hong Kong than India or China 
(p<0.001) and in the USA than in Canada (p=0.029). Pharmaceuticals were considered 
at an earlier age in China than in Hong Kong or India (p=0.001). Variations in the 
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appropriate age for refractive surgery existed among European practitioners (p=0.295), 
whereas practitioners in North America and Asia were in agreement with the 
recommended age for refractive surgery (p=0.241 and p=0.574 respectively) (Appendix 
1.3.).
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Continent Asia Australasia Europe North America South America 
Intervention Age (years) 
S
p
e
c
ta
c
le
s
 
 
Single Vision 
5.9±3.9 5.3±0.5 7.4±3.0 5.2±0.6 5.5±1.2 
Bifocals 
6.6±2.6 6.0±1.3 7.4±2.6 5.1±0.5 7.5±2.9 
Progressive Addition 
(PALs) 
7.8±3.0 6.5±1.4 7.8±2.8 6.7±2.9 8.0±3.2 
C
o
n
ta
c
t 
L
e
n
s
e
s
 
Rigid Gas Permeable 
(RGP) 
10.1±3.3 9.0±1.7 7.9±2.4 9.3±3.0 10.2±4.3 
Single Vision Soft 
10.9±3.8 8.3±0.8 7.8±2.7 7.9±2.4 10.3±3.7 
Multifocal Soft 
11.1±4.0 8.3±0.8 7.4±2.5 8.1±2.7 11.0±3.6 
Specific Myopia Control 
Soft 
10.8±3.5 8.3±0.8 7.3±2.5 7.9±2.6 10.3±3.9 
Ortho-k 
9.6±3.2 8.0±1.1 8.1±2.3 8.0±3.1 12.3±4.8 
Pharmaceuticals 
6.4±2.6 6.7±3.9 7.9±3.6 6.4±3.3 6.3±2.2 
Refractive Surgery 
16.9±2.9 18.0±0.0 12.8±4.5 18.0±0.0 15.5±5.2 
Table 3.3 Minimum patient age considered necessary by practitioners (from different continents who prescribed these options for different myopia correction 
options). Note: data are represented as mean±SD years. 
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3.4.7 Minimum degree of myopia that needs to be present for practitioners to 
consider myopia control options  
Global comparisons showed that practitioners indicated that myopia would be corrected 
with single vision spectacles at a lower degree (-1.07 ± 0.90 D) than it would with 
refractive surgery (-3.06 ± 1.62 D). All other modalities would be considered at 
approximately -2.00 D (Appendix 1.3.).  
Continent specific comparisons revealed that practitioners in Asia required a higher level 
of myopic refractive error before they would consider single vision spectacles than their 
colleagues in other continents (p<0.01). Australasian practitioners were willing to fit 
bifocals and PALs at a lower level of myopia than clinicians in Asia, Europe or South 
America (p<0.01). North American practitioners prescribed bifocal and PALs to children 
with a lower degree of myopia than those from Asia (p=0.001). However, practitioners 
from Asia were willing to consider single vision soft contact lenses, MC specific contact 
lenses, ortho-k and pharmaceutical intervention at a lower level of myopia than those 
from Australasia or Europe (p<0.01), and single vision soft contact lenses and 
pharmaceutical treatment than those from North and South America (p<0.01). Multifocal 
contact lenses were considered at a lower level of myopia by Australasian practitioners 
than those from Asia, Europe or South America (p<0.01). In Asia, practitioners fitted 
RGPs at higher level of myopia than those from Europe and North America (p<0.01). 
Practitioners in Asia and Europe would consider recommending refractive surgery at a 
significantly higher level of myopia than those from Australasia, North or South America 
(p<0.05) (Table 3.4).  
Within Europe, Portuguese and French practitioners required a higher level of refractive 
error before they would consider fitting RGPs than their colleagues across the continent 
(p<0.05). Higher level of refractive error was required in Portugal before ortho-k (p<0.01) 
or refractive surgery (p<0.001) was considered in contrast to other European countries. 
In Asia, practitioners in India considered prescribing bifocals (p<0.05), PALs (p<0.01) or 
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ortho-k (p=0.001) at higher levels of myopia than practitioners from China or Hong Kong. 
Practitioners in China considered prescribing pharmaceuticals to patients with a lower 
level of myopia (-0.66 ± 0.4D) compared to practitioners from India (-2.86 ± 1.01D) or 
Hong Kong (-2.39 ± 1.75D; p<0.001). Within North America, practitioners from Canada 
and USA were in agreement with the levels of myopia required to prescribe all modalities 
except for PALs (p=0.012), which were fitted at higher levels of myopia by Canadian 
practitioners (Appendix 1.3).
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Continent Asia Australasia Europe North America South America 
Intervention Level of myopia (D) 
S
p
e
c
ta
c
le
s
 
 
Single Vision 
-1.2±1.0 -0.8±0.3 -0.8±0.9 -0.8±0.7 -1.3±0.4 
Bifocals 
-1.8±1.1 -0.8±0.4 -1.8±1.4 -1.1±0.7 1.5±0.0 
Progressive Addition (PALs) 
-2.1±1.4 -0.9±0.6 -1.8±1.4 -1.1±0.7 -1.5±0.0 
C
o
n
ta
c
t 
L
e
n
s
e
s
 
Rigid Gas Permeable (RGP) 
-3.1±1.9 -2.8±1.4 -2.2±1.8 -1.5±1.4 -1.8±0.4 
Single Vision Soft 
-2.6±1.8 -1.8±0.9 -1.1±0.8 -0.9±0.7 -1.5±0.0 
Multifocal Soft 
-2.6±1.7 -1.8±1.0 -1.9±1.5 -1.1±0.7 -1.5±0.0 
Novel Myopia Control Soft 
-2.7±1.8 -1.7±0.9 -1.9±1.5 -1.5±1.2 -1.5±0.0 
Orthokeratology 
-2.4±1.5 -1.6±0.8 -2.3±1.6 -1.5±1.2 -1.5±0.0 
Pharmaceuticals 
-1.6±1.5 -2.1±0.9 -3.1±1.6 -1.5±1.3 -2.5±2.1 
Refractive Surgery 
-3.5±1.6 -2.9±1.5 -2.9±1.5 -1.7±1.3 -2.8±1.8 
Table 3.4 Minimum level of patient myopia (in dioptres) before myopia correction options would be considered by practitioners. Note: data are presented as 
mean±SD.
141 
3.4.8 Minimum annual amount of patient myopia progression that would prompt a 
practitioner to specifically adopted a myopia control approach  
Globally, the minimum myopia progression rate that practitioners considered required a MC 
approach was 0.51 to 0.75 D/year for the majority of respondents (31.1%), with 74% indicating 
a level between 0.25 and 1.00 D/year (Appendix 1.3).  
Continental comparisons showed that Australian practitioners adopted MC strategies for 
myopia progressing at slower rates than practitioners from Asia, North or South American 
(p<0.001). In Europe, practitioners were willing to treat myopia progression at slower rates 
than those from Asia (p<0.001) or South America (p=0.003). No differences in the minimum 
annual myopia progression rate, requiring MC intervention, between Europe (p=0.090), Asia 
(p=0.365) or North America (p=0.057) were reported (Figure 3.3). 
Free text responses (40 in total) identified other factors, apart from the annual progression 
rate of myopia that would prompt clinicians to consider MC intervention, including family 
history of myopia (6 respondents), age of myopia onset (10 respondents), absolute degree of 
refractive error at the time (2 respondents), ocular biometry (3 respondents), environmental 
factors/lifestyle (6 respondents), lighting exposure (3 respondents) and parental decisions (3 
respondents) (Appendix 1.3). 
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Figure 3.3 Minimum myopia progression in dioptres per year (D/year) that necessitates use 
of a myopia control approach for practitioners located in different continents (n=964; presented 
as percentage of practitioners that would prescribe myopia control intervention), (Wolffsohn et 
al. 2016). 
 
3.4.9 Use of single-vision undercorrection as a strategy to slow myopia progression  
Most practitioners across the globe did not consider single-vision distance undercorrection to 
be an effective strategy for slowing down myopia progression (72.7%) (Appendix 1.3.). 
Continent specific comparisons revealed undercorrection was utilised relatively more often in 
South America than Australia, Asia or North America (p<0.01) (Appendix 1.3).  
Within Europe, no differences apart from Spanish and Portuguese practitioners, who reported 
using undercorrection as a strategy to control myopia more often than their colleagues from 
the UK and Ireland (p<0.05), were observed. Within Asia, practitioners in India employed 
undercorrection more than those from China or Hong Kong (p<0.001). Within North America, 
there was no difference in the use of undercorrection between the USA and Canada (p=0.719) 
(Figure 3.4 and Appendix 1.3).  
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Figure 3.4 Use of undercorrection as a strategy to slow myopia progression by practitioners 
located in different continents (n=964), (Wolffsohn et al. 2016). 
 
3.4.10 Factors preventing the prescription of a myopia control approach  
The most common reason reported by the practitioners that would prevent them from adapting 
MC strategies was the increased cost (35.6%) and the inadequate information about the 
modalities available (33.3%). Practitioners also felt that the treatment outcomes were 
unpredictable (28.2%) and were concerned about the safety aspects of MC modalities 
(25.3%). The ineffectiveness of MC modalities for slowing down myopia progression (23.8%); 
and the low risk/benefit ratio (20.5%) were also considered as strong arguments not to 
consider MC interventions. No significant difference in the distribution of these factors between 
or within continents (p=1.00) was observed (Figure 3.5 and Appendix 1.3).  
Free text comments identified other factors affecting the prescription of these strategies to 
relate to the relative availability of the MC treatments and the instrumentation necessary to 
prescribe them, and the need for consistent regulations and informational materials (Appendix 
1.3). 
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Figure 3.5 Factors prevent prescribing a myopia control approach by practitioners located in 
different continents (n=964), (Wolffsohn et al. 2016). 
3.5 Discussion 
This is the first study to date to investigate the self-reported attitudes of eye care practitioners 
towards myopia management and control interventions across the globe. The number of 
responses, the principal spread of them across, and within five continents, and the 
professional qualification of the respondents (91% were optometrists and ophthalmologists) 
provided professional, yet cynical and enthusiastic opinion on the topic. Overall, the survey 
provides an insight into a challenging field of research that has flourished in recent years, 
addresses the questions raised before by people working in a clinical and/or research 
environment (Johnson 2014), and highlights issues in the field of MC. 
Unsurprisingly, practitioners in Asia, especially those from China, were more concerned about 
the increasing prevalence of paediatric myopia in clinical practice than their colleagues from 
other continents. Similarly, practitioners in the region of Asia reported themselves to be more 
active in the area of MC. It is undeniable, that the prevalence rates of myopia are reaching 
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epidemic levels in Asia (Lin et al. 2004; Pan et al. 2012). However, recent studies have showed 
that, within Europe and the United States of America, the prevalence of myopia has doubled 
over the past three to four decades (Vitale et al. 2009; Mccullough et al. 2016), showing similar 
trends to Asia, where higher levels of myopia are observed in younger cohorts (Williams et al. 
2015), reaching levels of 30% among schoolchildren and young adults (Montes-Mico and 
Ferrer-Blasco 2000; Jorge et al. 2007; Vitale et al. 2008; Hendricks et al. 2009; Williams et al. 
2015; McCullough et al. 2016). Therefore, practitioners from other parts of the world should 
not be ignorant to myopia management approaches, and myopia should be addressed as a 
world-wide issue.  
When asked to identify the relative efficacy of various MC approaches, practitioners correctly 
identified ortho-k as one of the most effective methods for attenuating childhood myopia 
progression, which was in accordance with the current evidence of retardation rates of 45-
50% (Si et al. 2015; Wen et al. 2015). However, despite its relative efficacy, ortho-k only 
constitutes of only 1% of all the contact lens fits world-wide (Efron et al. 2013). The relative 
efficacy of behavioural approaches of increased outdoor activity was slightly overestimated 
and pharmaceutical treatment was underestimated (32% and 28% on average) in comparison 
to 11-34% (Wu et al. 2010; Wu et al. 2013) and 32-72% (Tan et al. 2005; Chua et al. 2006; 
Chia et al. 2012b; Chia et al. 2015), based on scientific evidence. Single vision spectacles and 
single vision undercorrection, which has been reported to increase rather than decrease the 
progression of myopia (Chung et al. 2002; Adler and Millodot 2006), were considered to be 
least effective. However, some practitioners, particularly those in South America, Spain and 
Portugal within Europe and India within Asia (Figure 3.4 and Appendix 1.3.), were more willing 
to employ distance undercorrection in their practice for young and progressive myopes. 
Interestingly, even though most of the practitioners would consider themselves to be active in 
the field of MC within their practices, two thirds of them reported prescribing single vision 
spectacles or contact lenses (68%) to young or progressing myopes, with the uptake of more 
effective methods varying between and within the continents.  
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One third of the practitioners not adopting any of the more effective MC approaches reported 
their reluctance to be linked with the increased costs and (or) an inadequate amount of 
information was available to them. Around one quarter of the practitioners felt that the outcome 
of MC approaches is unpredictable, and that these methods are not effective. Relative safety 
of these procedures also was considered, albeit to a lesser extent. Free text responses further 
revealed the possible reasons for not employing MC approaches, and were linked to the 
relative availability of various MC options, especially specific MC contact lens designs, and 
the lack of regulatory guidelines as most of the currently available interventions are still ‘off-
label’. Furthermore, the availability of specific instrumentation required to fit more 
sophisticated contact lens designs, such as a corneal topographer for fitting orthokeratology 
contact lenses, in most practices is limited. Also, if the modification of peripheral refraction is 
to be successfully employed in human trials more often, rather than only in animal trials (Smith, 
Hung, et al. 2009; Mutti et al. 2011; Atchison et al. 2015), instrumentation to rapidly assess 
the peripheral eye shape and refraction would be required. 
When asked to describe how their preferences for prescribing different MC options would vary 
according to patient’s age, degree of myopia and the annual progression of this condition, 
practitioners were comfortable to prescribe refractive corrections with a simpler optic design 
and pharmaceuticals from an earlier age (5-6 years). Whereas, they tended to wait until a child 
is older to prescribe more sophisticated optical designs, including bifocals, PALs, RGPs, 
multifocal and specific MC contact lenses and ortho-k. Similarly, more complex modalities 
were considered appropriate for mild to moderate myopia, whilst single vison glasses were 
fitted at lower levels. The rate of myopia progression that would trigger practitioners to 
consider MC approach largely mirrored the prevalence rates in the specific region or country. 
In addition to the rate of myopia progression, practitioners indicated family history, age of 
onset, the level of myopia, ocular biometry, lightning levels, lifestyle effects and environmental 
factors and also parental involvement (Cheung et al. 2014) to play a role in the decision making 
of most suitable type of intervention. Research suggests that a lower level of hyperopia (<6 
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years old) is a good predictor of subsequent myopia development and correlates well with the 
age (Thorn et al. 2005; Zadnik et al. 2015). Also, myopia progresses at a faster rate in children 
compared to adolescents (Dong et al. 2013), therefore suggesting that young progressing 
myopes would benefit more, if the MC interventions would be employed earlier.  
More research on the relative benefits of MC interventions, especially on contact lens 
modalities, that have shown the most promising effects of all optical interventions, in children, 
adolescents and young adults, is needed. This, in return, will encourage practitioners to 
employ these approaches at an earlier age. Practitioners in Hong Kong can be considered the 
pioneers of ortho-k lens fitting and, unsurprisingly, fitted this modality from an earlier age than 
any other country or continent. Hong Kong is a good example how, with a simple procedure 
of establishing guidelines for a safe ortho-k practice (Cho et al. 2008) , both practitioners and 
parents of young myopic patients, can be encouraged to employ ortho-k for MC. 
Several limitations of the present study exist. The survey was piloted on a very small number 
of eye care practitioners (n=5) at the initial stage of the study; this phase should have been 
more extensive. Although survey was distributed globally and similar regional respose level 
was aimed for, the fact that more proactive eyecare practitoners took part in the survey and, 
therefore, possibly slightly overestimated the true situation of MC adaptation in clinical 
enviroment. Also, the fact that not all practices are equipped the same should be 
acknowledged. The availability of clinical instrumentation required for fitting different MC 
modalities, time constraints and the policy of employer might affect their decision to uptake 
MC in their daily routine. 
In summary, this survey, investigating practitioners’ self-reported attitudes towards MC, shows 
that, despite the growing evidence of the sight threatening and social-economic aspects of 
myopia, the moderate level of practitioners’ concern and perceived activity in the area of MC 
and the uptake of appropriate techniques in clinical practice, is insufficient. It is clear, that the 
research findings do not translate well into a clinical setting. Furthermore, practitioners do not 
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apply MC techniques early enough in a child’s ocular development to achieve the optimal 
effect. Adequate education of practitioners is lacking, whilst MC interventions are still 
unapproved by professional bodies. Therefore, safety regulations and appropriate guidelines 
for myopia management in clinical practice, which would address the epidemic nature of this 
lifelong condition, and highlight the benefits of myopia retardation strategies, needs to be 
established in order to enhance patient care and protect patients from the risks, costs and 
quality of life issues associated with myopia.  
In order to provide a further education for practitioners and establish internationally 
acknowledged guidelines further, a large-scale longitudinal study investigating the effects of 
MC interventions and their application in a clinical setting, should be designed and conducted. 
The scope of this thesis is to investigate the biomechanical aspects of ortho-k, which is one of 
the most promising optical approaches for slowing down myopia progression at present. 
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Chapter 4. Long term corneal biomechanical response to orthokeratology and the 
role of anterior eye segment in myopic schoolchildren 
4.1 General overview 
This chapter describes a retrospective data analysis of corneal biomechanical properties 
measured by the ORA after 2 years of ortho-k lens wear in Chinese children that were 
collected as a part of three studies [‘Retardation of myopia in orthokeratology’ (ROMIO) (Cho 
and Cheung 2012), ‘Myopia control using toric orthokeratology’ (TO-SEE) (Chen et al. 2013) 
and ‘High myopia – partial reduction ortho-k: a 2-year randomized study’ (HM-PRO) (Charm 
and Cho 2013)] primaly investigating the efficacy of ortho-k lens wear for MC and were 
conducted by collaborators at the Hong Kong Politechincal University but not published before.  
4.2 Introduction 
The ability of orthokeratology (ortho-k) to achieve consistent myopia retardation rates of 40% 
to 50% (Cho, Pauline et al. 2005; Walline et al. 2009; Cho and Cheung 2012; Charm and Cho 
2013; Chen et al. 2013; Swarbrick et al. 2015) has established the method as one of the most 
promising approaches for myopia control (MC) (Holden et al. 2014; Huang et al. 2016). 
However, the inter-individual variations in treatment response (Cho et al. 2005; Walline et al. 
2009; Kakita et al. 2011; Hiraoka et al. 2012; Santodomingo-Rubido et al. 2012; Swarbrick et 
al. 2015), a lack of consensus on the underlying mechanisms of ortho-k (Swarbrick et al. 1998; 
Owens et al. 2004; Cheah et al. 2008; Tsukiyama et al. 2008) and, subsequently, the 
mechanisms by which it inhibits myopia progression (Berntsen et al. 2005; Kang and 
Swarbrick 2011; Hiraoka et al. 2015; Swarbrick et al. 2015; Santodomingo-Rubido, Villa-
Collar, Gilmartin, Gutiérrez-Ortega, et al. 2016), have highlighted the need to better 
understand the corneal response to ortho-k lens wear and, subsequently, the contribution of 
the anterior eye to myopia progression. 
The transient alteration of corneal shape by the ortho-k lens, to temporarily eliminate myopic 
refractive error, achieved by the the topographical changes  induced by the ortho-k lens 
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(Mountford 2004; Chan et al. 2010), is either attained by tissue re-distribution induced by the 
interaction between tangential forces exerted by the lens and their interaction with the tear film 
(Swarbrick et al. 1998; Alharbi and Swarbrick 2003; Mountford 2004; Swarbrick 2004; 
Swarbrick et al. 2015), or the interaction between the tear film, the compressive forces exerted 
at the centre of the lens and tensile forces exerted at the edge of the lens (Mountford 1997; 
Mountford 1998, 2004). The optical effects of topographical chages achieved by the ortho-k 
lens are believed to underpin the mechanisms, by which the reduction in myopia progression 
is attained. The thinning of the central cornea and thickening of the mid-peripheral cornea 
induced by ortho-k lens has been proposed to create an environment which alters peripheral 
refraction and eliminates hyperopic defocus, thereby slowing down myopia progression 
(Walline et al. 2009; Kang and Swarbrick 2011; Swarbrick et al. 2015; Kang and Swarbrick 
2016). Peripheral hyperopic defocus has been found to act as a stimulus for axial elongation 
in animal models (Smith, Hung, et al. 2009; Liu and Wildsoet 2011) and, therefore, 
presumably, affect the refractive development in children (Sng et al. 2011; Berntsen et al. 
2013) (for detailed information on mechanisms underlying ortho-k, please refer to Section 1.5). 
However, this theory is under debate as a recent study has shown no correlation between 
peripheral refraction and myopia progression (Atchinson et al. 2015) and also demonstrated 
that axial elongation and changes in corneal power in Caucasian schoolchildren undergoing 
ortho-k therapy for 2 years (Santodomingo-Rubido, Villa-Collar, Gilmartin and Gutiérrez-
Ortega 2016). Furthermore, correlation between corneal aberrations and changes in axial 
length (AL) has been observed, suggesting that other optical phenomena can contribute to 
the MC effect of ortho-k (Berntsen et al. 2005; Hiraoka et al. 2015; Santodomingo-Rubido, 
Villa-Collar, Gilmartin, Gutiérrez-Ortega, et al. 2016). Hiraoka et al. (2015) hypothesised that 
the higher order aberrations (especially spherical aberration) observed in adults, undergoing 
ortho-k therapy (Joslin et al. 2003; Berntsen et al. 2005), could act as an inhibitory factor to 
axial elongation and myopia progression in children. Hiraoka’s study investigated Japanese 
schoolchildren over a period of one year and did not find a correlation between axial elongation 
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and the altered corneal shape of the flattened central zone surrounded by a steepened annular 
area in the mid-periphery. This has been reported to induce spherical aberrations and 
simultaneously reduce hyperopic defocus (Berntsen et al. 2005). Instead, a correlation 
between coma-like aberrations, corneal multifocality and axial elongation was found, 
suggesting that asymmetric components of optics contributed towards the ‘MC’ effect of the 
ortho-k (Hiraoka et al. 2015). 
The inter-individual variability in treatment outcome of ortho-k in MC has been associated with 
age, sex, age of myopia onset, rate of myopia progression and level of parental myopia, 
anterior chamber depth (ACD), corneal power and shape, and iris and pupil diameter 
(Santodomingo-Rubido et al. 2013). Ortho-k was found to be more successful in comparison 
to single vision spectacles (SVS) in white European children of older age (range 6 to 12 years) 
with earlier onset of myopia, lower level of parental myopia, larger iris and pupil diameter, 
longer anterior chamber (AC), greater corneal power and a more prolate corneal shape at 
baseline, over a two-year study period (Santodomingo-Rubido et al. 2013). However, these 
factors together could only account for 50.6% of total variance in AL changes in ortho-k 
wearing children and 49.5% of total variance in SVS wearing children (Santodomingo-Rubido 
et al. 2013). Interestingly, no change in ACD of ortho-k wearing schoolchildren of Chinese 
ethnicity (7-10 years of age) was observed over the same time period, compared to SVS 
wearing children, whose ACD increased significantly (Cheung and Cho 2016). Regardless of 
the modality prescribed, no change in overall anterior segment length (ASL) and crystalline 
lens, was seen in both SVS and ortho-k wearing children. However, authors concluded that 
no firm conclusion can be drawn form the study and further research in the area should be 
warranted due to the small sample size (37 ortho-k wearing children vs 41 SVS wearing 
children), the relatively small changes in the anteriror segment over the period of 2 years and 
possibly different accommodative demand in the two groups. Also, the changes seen in the 
control group (SVS wearing children) accounted for a small amount of overall axial 
elongination (Cheung and Cho 2016). In the same cohort, a reduction in CCT was detected 
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over the first six months of ortho-k lens wear, which subsequently stabilised (Cheung and Cho 
2013, 2016).  
Studies investigating the efficacy of ortho-k for MC have shown similar reduction rates by 
employing various lens designs in children of different ethnicities (Kakita et al. 2011; Cho and 
Cheung 2012; Hiraoka et al. 2012; Charm and Cho 2013; Chen et al. 2013; Swarbrick et al. 
2015). It is highly unlikely that ethnicity and lens design would explain much of the total 
variance of successful treatment outcome and myopia progression. Therefore, the anterior 
eye segment, particularly the corneal response to ortho-k lens wear in long term, is of interest. 
A synchronised interaction between all optical components and AL of the eye is required for 
the process of emmetropisation to be successful (Mutti 2010; Mutti et al. 2013). In case of 
myopia this vital ocular equilibriumis disrputed (Mutti et al. 2013). In order to better understand 
the driving forces behind myopia development and to find an optimal intervation for MC, it is 
crucal to comprehend the involvement of anterior segment in the process of slowing down 
myopia progression and the role of its components in process of the axial elongination. 
Ortho-k therapy is a dynamic process whereby short and long-term responses to ortho-k lens 
wear differ (Zhong et al. 2009; Nieto-Bona et al. 2011a, 2011b). The treatment effect is 
achieved within the first seven to ten nights of lens wear, but stabilises within the first thirty to 
ninety nights (Mountford 1998; Sridharan and Swarbrick 2003), suggesting that initial 
adaptation is followed by the retention of the achieved treatment effect. Studies of long term 
corneal response to ortho-k wear provide evidence of the technique’s safety, efficacy, effect 
on corneal adaptation and reversibility (Zhong et al. 2009; Nieto-Bona et al. 2011a). However, 
in the context of MC, long term studies are required to understand the factors by which ortho-
k regulates and stabilises myopia progression. If the changed corneal morphology induced by 
the reverse geometry lens is crucial for slowing down myopia progression, then stabilisation 
and adaptation to the new corneal shape is necessary before the ‘MC’ effect can take place. 
If the primary inhibitory factor, by which ortho-k slows down myopia progression could be 
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elucidated, the method could be optimised and the underlying mechanisms could presumably 
be applied to other MC interventions. 
The Ocular Response Analyser (ORA, Reichert Ophthalmic Instruments, Buffalo, NY, USA) 
has enabled the assessment of corneal biomechanical properties in-vivo (Luce 2005) (for 
more information on the ORA and corneal biomechanical measures, please refer to 2.2.1). 
Corneal hysteresis (CH) and corneal resistance factor (CRF), which are ORA specific 
parameters and describe the viscous damping properties and the overall resistance of the 
cornea respectively (Luce 2005), have been found to be affected by ortho-k lens wear 
(Gonzalez-Meijome et al. 2008; Chen et al. 2009; Mao et al. 2010; Yeh et al. 2013). CRF 
(Chen et al. 2009; Mao et al. 2010; Yeh et al. 2013) and CH (Mao et al. 2010; Yeh et al. 2013) 
both decrease over the first thirty nights of lens wear and return to baseline levels within 3 
months of lens wear (Mao et al. 2010). However, CH and CRF on their own are not able to 
fully discriminate between healthy and ectatic corneas (Kerautret et al. 2008; Saad et al. 2010; 
Mikielewicz et al. 2011). Saad et al. (2010) reported CH and CRF values in normal, 
keratoconic and keratoconus suspect corneas and concluded that in all three groups a large 
scatter of CH and CRF values was seen. Similar CH and CRF values but different air-pressure 
characteristics were not a rarity, therefore, suggesting that the signal from the applanation 
curve should also be analysed when evaluating corneal biomechanical response. The 
morphological changes induced by the ortho-k lens reported in animal (Matsubara et al. 2004; 
Cheah et al. 2008; Choo et al. 2008) and human (Zhong, XW et al. 2009; Nieto-Bona et al. 
2011a, 2011b) studies are not as severe as the ones observed in advanced keratoconus 
(Saad et al. 2010). A detailed analysis of the applanation curve could provide more information 
about the corneal biomechanical changes occurring in ortho-k than CH and CRF alone.  
None of the previous studies investigating corneal biomechanical response to ortho-k have 
been conducted for longer than six months, and no comparison of corneal biomechanical 
response in healthy control individuals not undergoing ortho-k therapy has been reported 
(Gonzalez-Meijome et al. 2008; Chen et al. 2009; Mao et al. 2010; Yeh et al. 2013). Therefore, 
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studies following both individuals undergoing and not undergoing ortho-k therapy, and 
investigating the ORA applanation peak in detail, over a longer study period, are required as 
they would provide a better understanding of corneal biomechanical response to ortho-k and 
the role of anterior eye segment in myopia progression. 
The purpose of this study was to conduct a retrospective analysis of yet unpublished data 
obtained as a part of three studies (ROMIO, TO-SEE and HM-PRO studies, a two-year 
randomized clinical trials evaluating the effectiveness of myopia control using ortho-k) 
conducted by collabrators at The Hong Kong Polytechnic University (Cho and Cheung 2012; 
Chen et al. 2013; Charm and Cho 2013), monitoring corneal biomechanical response to ortho-
k lens wear in comparison to naturally progressing myopia in myopic schoolchildren fitted with 
single vision spectacles over a two-year period. The investigation of long term corneal 
biomechanical response to would aid to a better understanding of the involvement of anterior 
segment in myopia progression and to evaluate the role of corneal tissue in ortho-k. 
4.3 Methods 
4.3.1 Subjects and study protocol 
A retrospective analysis of data pooled from three studies [‘Retardation of myopia in 
orthokeratology’ (ROMIO) (Cho and Cheung 2012), ‘Myopia control using toric 
orthokeratology’ (TO-SEE) (Chen et al. 2013) and ‘High myopia – partial reduction ortho-k: a 
2-year randomized study’ (HM-PRO) (Charm and Cho 2013)] was conducted to investigate 
the corneal biomechanical response to ortho-k lens wear and the contribution of the anterior 
eye to myopia progression over a two year period.  
Data from 164 subjects (83 ortho-k wearing children, 81 single vision spectacles wearing 
children) were retrieved from the participants of the three aforementioned studies and 
combained for the analysis (Table 4.2). Participants who attended all study visits were 
included in analysis.Sudy design, refraction and axial length data have been reported 
previously (Cho and Cheung 2012; Charm and Cho 2013; Chen et al. 2013).  
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In summary, Chinese children living in Hong Kong, China (6 to 12 years old) with refraction 
between -0.50 to -8.00 D, with-the-rule astigmatism up to -3.50 D, and good ocular and general 
health were assigned either to treatment (ortho-k) or control (single vision spectacle group). 
Subject recruitment was adjusted for age, sex and manifest refraction to minimise systematic 
bias. Subjects in the ortho-k group were fitted with reverse geometry lenses (for lens 
specifications please refer to Table 4.2) by experienced orthokeratology practitioners, and 
asked to wear the lenses overnight, adhering to an 8-10 hour sleeping schedule.  
For ROMIO and TO-SEE Menicon Z Night (NKL Contactlenzen B.V., Emen, Netherlands) and 
Menicon Z toric (NKL Contactlenzen B.V., Emen, Netherlands) ortho-k lenses were used, 
respectively. These are four zone reverese geometry lenses (Table 4.2, Section 1.3.3).The 
total lens diameter was ordered in three steps – 10.20 mm, 10.60 mm (standard) and 11.0 
mm. Treatment zone was 6 mm in diameter (Cho and Cheung 2012; Charm and Cho 2013). 
The base curve ranged from 7.20 mm to 10 mm in 0.05 mm steps. Tangential angle (50o – 65o 
(1o step) and sagittal depth (0.50 – 0.99 mm (0.01 mm step) were adjusted depending on the 
topography readings. The lens fitting and ordering was based on topography maps and Easyfit 
software 
(http://www.menicon.com/pro/our-products/gp-lens/menicon-z-night/; accessed 13.12.2018; 
Cho and Cheung 2012; Charm and Cho 2013). For the HM-Pro Procornea DreamLite (Pro 
Cornea Ltd., Eerbeek, Netherlands) ortho-k lenses were used (Table 4.2). Procornea 
DreamLite is a four zone reverse geopmetry lens (Table 4.2, Section 1.3.30 THAT has a 10.50 
mm total diameter, treatment zone (optic zone) of 6 mm and back optic zone radius from 7.20 
mm to 9.50 mm in 0.05 mm steps (Chen et al. 2013). 
Lens adjustments (maximum 3 times) to reach an optimal fit (good centration and ‘bull’s eye’ 
pattern) were made if necessary. Subjects in the spectacle group were provided with single 
vision spectacles and asked to wear them during waking hours. No significant adverse events 
were reported in any of the studies (Cho and Cheung 2012; Charm and Cho 2013; Chen et 
al. 2013). Double masking in the study could not be achieved do to the vast differencies in the 
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both modalities for myopia control. However, one study investigator, who took AL 
measurments could be masked as ortho-k do not present manifest signs during the estimation 
of AL. Other examiners who did the slit lamp assessment and assessed the lens fit could not 
be masked as manifest signs of ortho-k wear were present during these procedures (Cho and 
Cheung 2012). The demographic and refractive data of the pooled cohort are summarised in 
Table 4.1. For individual specifications of study design, cohort demographic and refractive 
data of each study please refer to Table 4.2. 
All studies complied with the Declaration of Helsinki and were approved by the Departmental 
Research Committee of the School of Optometry of the Hong Kong Polytechnic University. All 
three studies were registered at ClinicalTrials.gov (ROMIO: NCT00962208, TO-SEE: 
NCT00978692, HM PRO: NCT00977236). 
 Control Ortho-k 
Number of participants 
(male:female) 
81 
(35:45) 
83 
(43:40) 
Age (years) 
9.0 ± 1.4 (Mean ± SD), 
range (6 to 12) 
9.0 ± 1.2 (Mean ± SD), 
range (6 to 12) 
Refractive 
Error 
Sphere (D) 
-3.15 ± 1.95, range (-0.50 to 
-8.00) 
-2.86 ± 1.95, range (-0.50 to 
-7.75) 
Cylinder (D) 
-0.95 ± 0.85, range (0 to -
3.50) 
-1.00 ± 0.89, range (0 to -
3.50) 
Table 4.1 Cohort demographics and refractive data. 
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 ROMIO TO-SEE HM-PRO 
Study design Randomised Non-randomised Randomised 
Masking Examiners masked to axial length measurements 
Ethnicity Chinese 
Age (years) 6-10 6-12 8-12 
Myopia (D) -0.50 to -4.00 -0.50 to -5.00 -5.00 to -8.00 
With-the-rule 
astigmatism (D) 
up to -1.25 -1.25 to -3.50 up to -1.50 
Astigmatism axis 
(degrees) 
180 ± 30 180 ± 20 180 ± 20 
Ortho-k group (n=) 37 43 26 
Control group (n=) 41 37 26 
Ortho-k lens 
Type 
Menicon Z 
Night (NKL 
Contactlenzen 
B.V., Emen, 
Netherlands) 
Menicon Z Night 
Toric (NKL 
Contactlenzen B.V., 
Emen, Netherlands) 
Procornea 
DreamLite (Pro 
Cornea Ltd., 
Eerbeek, 
Netherlands) 
Ortho-k lens 
material (Dk 
[cm2•mLO2]/(s•mL•mmHg]) 
Tisilfocon A 
(163 x 10-11) 
Tisilfocon A 
(163 x 10-11) 
Hexafocon A 
(100 x 10-11 ) 
Control group 
Single vision spectacles (CR-39 material, Hong Kong Optical 
Lens Co., Hong Kong, China) 
Data collection Baseline, 6, 12, 18 and 24 months 
Refraction 
method 
Cycloplegic subjective refraction 
AL 
measurement 
IOLMaster 500 (Zeiss Humphrey Systems, Dublin, CA, USA) 
Anterior eye structure 
measurements 
Pentacam (Oculus Inc., Jena, Germany) 
Corneal topography 
measurements 
Medmont E300 (Version 3.9.3 Medmont Pty. Ltd., 
Camberwell, Australia) 
Corneal biomechanical 
measurements 
Ocular Response Analyser (2nd generation ORA, Reichert 
Inc., Buffalo, NY, USA) 
Table 4.2 Summary of ROMIO (Cho and Cheung 2012), TO-SEE (Chen et al. 2013) and HM-
PRO study design (Charm and Cho 2013). 
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4.3.2 Measurements 
Data were collected at baseline (BL), 6, 12, 18 and 24 months after commencement of the 
study. Subjective refraction was conducted under cycloplegia. AL was measured, using partial 
coherence interferometry (IOLMaster 500), by taking an average of the first 5 measurements 
with a signal-to-noise ratio above 3.5, and a maximum difference of 0.02 mm between any 
two readings (Cho and Cheung 2012). Corneal topography in the steep and flat meridian, 
using Medmont E300 was assessed by selecting the best of four images captured (image 
score above 98) (Cho and Cheung 2012). CCT at the thinnest point of the cornea, and ACD 
were determined using a Scheimpflug imaging system, by taking an average of three 
measurements per eye. The ORA was used to assess corneal biomechanical properties, by 
selecting the best of four measurements (waveform score of 3.6 or above and true best signal 
value) (Lam et al. 2010; Hon et al. 2012). Table 4.2 provides an overview of the 
instrumentation used in these three studies. 
Detailed information on instrumentation used in all studies is discussed in Chapter 2. 
4.3.3 Data analysis 
Data were recorded using Microsoft Excel (Microsoft Office Professional Plus 2013, Microsoft 
Corp. Redmond, Washington, USA). Statistical analysis was conducted using SPSS (IBM 
SPSS Statistics for Windows, Version 21.0. IBM Corp. Armonk, New York, USA).  
Data were tested for normality using the Kolmogorov-Smirnov (K-S) test (p>0.05). Repeated 
measures analysis of variance (ANOVA) was employed to examine the changes in response 
variables over time, when data were normally distributed. Friedman analysis of variance was 
used for non-normally distributed data. Statistically significant changes from baseline were 
further investigated, using post hoc tests with Bonferroni correction. 
Multivariate regression analysis (stepwise) was used to further examine the relationship 
between refractive changes, simulated keratometry readings, corneal eccentricity in the 
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steepest and flattest meridian, CCT, AL and corneal biomechanical properties over the two-
year period of ortho-k lens or spectacle wear.  
A critical p-value of 0.05 was chosen to denote statistical significance, and only data from the 
right eye were analysed.  
The study was designed to achieve 80% power (α=0.05, Cohen’s d=0.25) to detect at least 
0.4 mmHg change in CRF (Cohen’s d=0.27) (Hon et al. 2012), based on the repeated 
measures ANOVA with correlation coefficient between the repetitions set to 0.5, and required 
a minimum of 25 participants in each group. Study power was determined, using statistical 
power program G*Power 3.0 (version 3.0.10) (Faul et al. 2007; Faul et al. 2009). 
4.4 Results 
4.4.1 Changes in refractive error, corneal curvature and central corneal thickness 
Ortho-k lens wear reduced the initial mean myopic spherical refractive error of -2.86 ± 1.78 D 
(mean ± SD) to -0.39 ± 0.94 D by the six-month appointment (p<0.001), and this remained 
stable throughout the rest of the study period (p>0.05). Mean corneal astigmatism significantly 
decreased between BL and the six-month appointment (p<0.001), and remained stable 
thereafter (p>0.05) (Table 4.3).  
Conversely, myopia progressed in the spectacle wearing group, with mean spherical refractive 
error increasing from -3.15 ± 1.95 D to -4.09 ± 1.91 D over the two-year period (p<0.001). A 
similar increase was observed in mean corneal astigmatism (p=0.039) (Table 4.3). 
In the ortho-k group, a decrease in flat and steep eccentricity (‘e’) was seen between BL and 
the six-month appointment (both p<0.001), then both flat and steep ‘e’ remained stable over 
the remaining eighteen months of the study (p>0.05) (Table 4.3). Similarly, a flattening in the 
flattest and steepest meridian between the BL and six-month visit (both p<0.001) was 
detected, which stabilised thereafter (p>0.05) (Table 4.3). Keratometric astigmatism (ΔK) did 
not change over the two-year period (p=0.245) (Table 4.3). 
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In the spectacle wearing group, steep and flat ‘e’, simulated keratometry in the flattest 
meridian, and keratometric astigmatism remained stable throughout the study period (all 
p>0.05), with the exception of fluctuations in the simulated keratometry in the steepest 
meridian, which could not be described as consistently increasing or decreasing (p<0.001), 
(Table 4.3). 
The effect of group (ortho-k vs spectacle) was significant for all parameters (p<0.05), except 
for steep ‘e’ (p=0.951) (Table 4.3). 
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BL 6 months 12 months 18 months 24 months p p F p F 
Refractive 
sphere (D) 
SVS -3.15±1.95 -3.25±1.85 -3.52±1.78 -3.85±1.87 -4.09±1.91 0.031* <0.001 184.02 
<0.001 273.28 
OK -2.81±1.78 -0.39±0.94 -0.43±0.97 -0.35±0.97 -0.27±0.89 0.029* <0.001 69.68 
Refractive 
astigmatism 
(D) 
SVS -0.95±0.85 -0.98±0.81 -1.02±0.73 -1.02±0.83 -1.10±0.83 0.120 0.039 2.709 
<0.001 37.7 
OK -1.00±0.89 -0.43±0.45 -0.50±0.47 -0.52±0.41 0.52±0.51 0.006* <0.001 58.667 
Steep e 
SVS 0.40±0.12 0.41±0.16 0.40±0.13 0.40±0.14 0.38±0.11 0.218 0.587 0.708 
0.951 0.004 
OK 0.46±1.21 0.35±0.13 0.35±0.12 0.36±0.12 0.39±0.11 0.399 <0.001 5.424 
Flat e 
SVS 0.63±0.09 0.63±0.09 0.62±0.09 0.63±0.09 0.64±0.09 0.889 0.373 1.058 
<0.001 153.09 
OK 0.66±0.09 0.36±0.16 0.32±0.15 0.33±0.14 0.32±0.14 0.792 <0.001 90.459 
Steep K (D) 
SVS 44.77±1.67 44.89±1.59 44.91±1.67 44.89±1.73 44.90±1.66 0.900 <0.001 11.458 
<0.001 44.10 
OK 44.74±1.61 42.80±1.44 43.07±1.51 43.03±1.50 43.04±1.46 0.692 <0.001 61.655 
Flat K (D) 
SVS 43.31±1.40 43.34±1.37 43.32±1.40 43.29±1.42 43.30±1.61 0.694 0.303 1.131 
<0.001 40.30 
OK 43.12±1.25 41.57±1.34 41.75±1.29 41.70±1.37 41.64±1.24 0.978 <0.001 70.877 
ΔK (D) 
SVS 1.46±0.64 1.55±0.62 1.59±0.66 1.59±0.65 1.60±0.89 0.153 0.116 2.314 
0.016 6.02 
OK 1.62±0.75 1.23±0.70 1.32±0.63 1.33±0.57 1.40±0.65 0.385 0.245 1.37 
Table 4.3 Changes in refractive sphere, astigmatism and corneal topography over the two-year study period in spectacle (SVS) and ortho-k (OK) 
wearing groups. *If p<0.05, Friedman’s test procedures were carried out. Note: statistically significant p values (p<0.05) are underlined.
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The CCT, measured using Pentacam (Oculus Wetzlar, Germany), in the ortho-k group 
reduced initially (F(1.345, 49.752)=6.051, p<0.001) and was significantly thinner between BL 
and the 6-month visit (568 ± 36 µm vs 565 ± 32 µm; p<0.001), and BL and the 18-month 
visit (568 ± 36 µm vs 564 ± 31 µm; p=0.002). However, CCT returned to BL levels after 
two years of ortho-k lens wear (568 ± 36 µm vs 569 ± 31 µm; p=0.269) (Figure 4.1).  
In the spectacle group, a slight, but significant, increase in the CCT was observed 
between BL and the 24-month visit (576 ± 28 µm vs 584 ± 28 µm respectively; F(2.421, 
104.108)=6.846, p<0.001) (Figure 4.1). 
The effect of treatment (ortho-k lens wear) on CCT was significant (F=5.0, p=0.028). 
 
Figure 4.1 Changes in CCT over the two-year study period in the ortho-k wearing group 
(OK) and single vision spectacle wearing group (SVS). Note: data are presented as 
mean ± SD (nOK=83 and nSVS=81), error bars represent 1 SD. 
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4.4.2 Corneal biomechanical response measured with the Ocular Response 
Analyzer 
The ORA derived parameters that changed significantly over the two-year study period 
are summarised in Table 4.4 and Table 4.5. The non-significant parameters are 
presented in Table 4.6 and Appendix 2). 
Goldmann correlated intraocular pressure (IOPg), corneal biomechanics corrected 
intraocular pressure (IOPcc), CH and CRF did not change significantly over the study 
period in the ortho-k wearing group (pIOPg=0.536, pIOPcc=0.603, pCH=0.933 and 
pCRF=0.912 respectively; Appendix 2). Decrease in CH and CRF, as well as in IOPg and 
IOPcc have been reported after one week of ortho-k lens wear that stabilises thereafter 
(at 3 and 6 month follow-up) in a group of schoolchildren of similar age (Mao et al. 2010). 
Also changes in CH (Gonzalez-Meijome et al. 2008) and CRF (Chen et al. 2009) have 
been reported in an adult population after just a few hours of ortho-k lens wear, whilst 
decrese CRF has been reported after one night of lens wear (Chen et al. 2009). 
Therefore, it is possible that the initial corneal response to ortho-k lens wear is different 
to that of a long term as the cornea adjust to the reshaping effect induced by the lens 
(Gonzalez-Meijome et al. 2008; Chen et al. 2009; Mao et al. 2010). 
In contrast, IOPg, IOPcc and CH fluctuated significantly in the spectacle wearing group; 
however, they did not consistently increase or decrease (Table 4.5). CRF remained 
stable (p=0.515). The effect of treatment was significant for IOPg, CH and CRF 
(pIOPg=0.032, pCH=0.012 and pCRF=0.005 respectively; Appendix 2). 
Some of the 37 additional ORA-derived metrics appeared to be more sensitive in both 
groups, with the initial applanation peak affected the most (Figure 4.2 and Figure 4.3). 
The corneal biomechanical response in the spectacle wearing group was more varied 
than it was in the ortho-k wearing group (Figure 4.3 and Table 4.5). There was no effect 
of time for some parameters (path1 from the upper 50% of the initial applanation peak 
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or the absolute value of the path around the peak), but the effect of group (ortho-k wear) 
was significant (pOK time=0.238, pSVS time=0.535, peffect of group=0.018; Table 4.6 and Appendix 
3).  
In the ortho-k group, significant changes in corneal biomechanical response were seen 
between BL and the 6-month appointment (p>0.05, post-hoc pairwise comparisons), but 
this stabilised thereafter (p>0.05).  
In the spectacle wearing group, some fluctuations in the corneal biomechanical response 
occurred between BL and 12-month appointment (p<0.05) (Figure 4.2).  
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Figure 4.2 The significant changes in the ORA applanation curve in the ortho-k group 
over the two-year period are highlighted with a blue line. Figure adapted and reprinted 
with permission from Wolffsohn et al. (2012). 
 
Figure 4.3 The significant changes in the ORA applanation curve in the spectacle group 
over the two-year period are highlighted with a blue line. Figure adapted and reprinted 
with permission from Wolffsohn et al. (2012). 
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Table 4.4 The ORA derived metrics that reached statistical significance over the two-year study period in the ortho-kgroup. *If p<0.05, Friedman’s 
test procedures were carried out. 
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BL 6 months 12 months 18 months 24 months p p F 
slew1 64.45±22.90 61.19±21.81 61.27±24.53 58.13±19.12 60.89±23.18 0.705 0.05 2.418 
mslew1 100.3±28.5 97.2±26.2 99.4±33.4 92.9±28.3 93.5±29.1 0.402 0.003 4.087 
dive1 322.3±101.4 296.5±104.8 302.9±108.9 302.3±101.6 305.2±101.2 0.152 0.042 2.537 
aindex 9.49±0.63 9.31±0.82 9.50±0.73 9.40±0.83 9.48±0.65 <0.001* 0.032 10.53 
Values from upper 75% of peak 
h1 244.5±54.4 239.9±54.2 236.1±60.2 232.7±55.6 230.4±61.8 0.515 0.013 3.254 
aspect1 17.13±4.28 16.35±4.04 16.53±5.32 16.05±4.35 15.75±4.77 0.397 0.021 2.966 
dslope1 24.13±6.29 23.14±6.30 23.52±7.99 22.93±6.77 22.21±7.14 0.622 0.027 2.807 
Values from upper 50% of peak 
h1 244.5±54.4 239.9±54.2 236.1±60.2 232.7±55.6 230.4±61.8 0.515 0.013 3.254 
aspect1 23.22±6.64 22.16±6.87 22.51±9.74 22.17±7.70 21.58±8.18 0.904 0.026 2.826 
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BL 6 months 12 months 18 months 24 months p p F 
IOPg (mmHg) 15.40±2.78 15.67±3.35 15.11±3.03 15.40±3.26 15.11±3.16 0.340 0.046 2.465 
IOPcc (mmHg) 
15.07±2.88 15.44±3.21 14.66±2.94 14.74±3.39 14.64±2.92 
0.868 0.005 3.891 
CH (mmHg) 
11.17±1.55 11.05±1.52 11.30±1.37 11.48±1.61 11.34±1.50 
0.847 0.019 3.028 
slew1 62.03±18.39 59.55±20.64 56.82±16.60 61.37±24.65 66.79±26.53 0.946 0.049 2.43 
slew2 82.07±30.73 89.28±30.95 76.31±31.64 86.21±35.56 88.92±36.43 0.604 0.036 2.622 
mslew1 100.5±28.4 92.59±30.89 88.54±22.25 98.89±34.03 105.4±36.3 0.982 0.007 3.619 
dive2 246.2±82 233.5±76.3 219.5±68 243.3±92.6 255.7±107 0.868 0.03 2.746 
Values from upper 75% of peak 
p1area 3456±838 3293±859 3020±777 3412±1113 3475±1087 0.833 0.012 3.599 
h1 371.5±78.01 348.3±90.5 326.1±70.2 365.1±110 376.2±108.2 0.458 0.003 4.722 
h2 307.3±89.8 292.5±76.7 278.4±64.9 307.9±86.8 322.3±94.1 0.745 0.013 3.533 
uslope1 62.24±18.05 58.87±20.22 56.74±16.16 61.78±23.62 66.90±26.60 0.893 0.046 2.476 
uslope2 81.28±30.74 85.74±30.68 76.11±31.71 85.57±36.33 89.42±35.51 0.550 0.026 2.818 
dslope1 24.07±6.24 22.12±6.71 21.09±6.46 23.85±8.25 24.01±7.42 0.241 0.03 2.742 
Values from upper 50% of peak 
p1area 1495±414 1407±382 1296±363 1465±541 1462±469 0.920 0.023 3.176 
h1 247.7±52 232.2±60.3 217.4±46.8 243.4±73.3 250.8±72.1 0.458 0.003 4.722 
h2 204.9±59.9 195±51.1 185.8±43.3 205.2±57.9 214.8±62.7 0.745 0.013 3.533 
aspect1 16.97±3.96 15.57±4.50 14.95±3.98 16.81±5.52 17.23±5.41 0.927 0.009 3.461 
Table 4.5 The ORA derived metrics that reached statistical significance over the two-year study period in the spectacle group. *If p<0.05, Fried-
man’s test procedures were carried out.
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Additional ORA-
derived 
parameter 
 
 
Definition of the metric in relation to the changes 
induced by the ortho-k lens wear 
Group 
SVS OK 
p value p value 
slew2 aspect ratio of dive2 where dive2 is divided by width  0.262 
mslew2 
maximum single increase in the rise of the peak 
(longest continuous line without a break) 
 0.109 
dive1 backside of downslope of peak (absolute value of peak 
until the first break) 
0.146  
dive2  0.299 
aindex the smoothness of the peak (related to the noise of the 
measurement aka how many times peak changes the 
direction and represent local imperfections in the 
cornea, respectively softness of the cornea) 
0.337  
bindex 0.365 0.507 
aplhf 
the smoothness of the region between the peaks 
(related to the noise of the measurement and 
represent local imperfections in the cornea, 
respectively softness of the cornea) 
0.847 0.750 
Values from upper 75% of peak  
p1area 
area under the curve (proportional estimate of the time 
needed for the cornea to change from the concave to 
the convex form) 
 0.17 
p2area 
area under the curve (proportional estimate of the time 
needed for the cornea to change from the concave to 
the convex form) 
0.178 0.108 
h2 height from the lowest to the highest point in peak  0.053 
w1 width at the base of the peak region (descriptor of the 
time course) 
0.802 0.24 
w2 0.276 0.088 
aspect2 aspect ratio of the peak (height/width) 0.069 0.08 
uslope1 
rate of increase from base to peak 
 0.08 
uslope2  0.257 
dslope2 rate of decrease from peak to base 0.147 0.09 
path1 
the absolute value of path length around the peak 
0.845 0.309 
path2 0.636 0.962 
Values from upper 50% of peak  
p1area 
area under the curve (proportional estimate of the time 
needed for the cornea to change from the convex to 
the concave form) 
 0.341 
p2area 
area under the curve (proportional estimate of the time 
needed for the cornea to change from the concave to 
the convex form) 
0.207 0.084 
h2 height from the lowest to the highest point in peak  0.053 
w1 
width at the base of the peak region (descriptor of the 
time course) 
0.972 0.674 
w2 0.872 0.420 
aspect1 
aspect ratio of the peak (height/width) 
0.08  
aspect2 0.421 0.421 
uslope1 rate of increase from base to peak 
 
0.089 0.06 
uslope2 0.123 0.177 
dslope1 
rate of decrease from peak to base 
0.221 0.058 
dslope2 0.992 0.458 
path1 
the absolute value of path length around the peak 
0.535 0.238 
path2 0.472 0.476 
Table 4.6 Summary of the additional ORA-derived parameters that did not significantly change 
over the two-year study period in ortho-k (OK) and spectacle (SVS) group. 
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4.4.3 Axial length, anterior chamber depth and endothelial cell count 
AL increased in the ortho-k group over the two-year period (p<0.001), but at a slower rate than 
in the spectacle wearing group (p<0.001) (Table 4.7). 
ACD did not increase in the ortho-k group over the study period (p=0.836), whereas it did in 
the spectacle wearing group (p<0.001). ACD increased steadily over the first 18 months of the 
study period (p≤0.013), but stabilised thereafter (p=0.295) (Table 4.7). 
The endothelial cell count fluctuated significantly between BL and the six months visit in the 
ortho-k group (p=0.046), but stabilised thereafter (p>0.05). No significant changes in the 
spectacle group over the two-year period occurred (p=0.216) (Table 4.7). 
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BL 6 months 12 months 18 months 24 months p p F p F 
AL (mm) 
SVS 24.72±1.12 24.85±1.08 25.02±1.09 25.18±1.09 25.25±1.03 0.998 <0.001 201.40 
0.178 1.835 
OK 24.68±0.97 24.73±0.93 24.80±0.91 24.87±0.88 24.90±0.87 0.623 <0.001 45.08 
ACD (mm) 
SVS 3.33±0.24 3.34±0.23 3.36±0.23 3.37±0.24 3.38±0.24 0.998 <0.001 7.065 
0.195 1.70 
OK 3.33±0.21 3.31±0.21 3.31±0.21 3.32±0.20 3.32±0.21 0.632 0.836 0.361 
END cell 
count 
(cells/mm2) 
SVS 3563.73±260.14 3602.04±304.64 3596.70±275.63 3595.28±276.11 3531.83±263.06 0.821 0.216 1.48 
0.29 0.589 
OK 3570.40±250.63 3689.14±300.62 3636.31±251.12 3631.34±256.61 3608.82±302.49 0.200 0.046 2.453 
Table 4.7 Changes in AL, ACD, LT and endothelial (END) cell count over the two-year study period of ortho-k lens wear compared to baseline. 
*If p<0.05, Friedman’s test procedures were carried out.
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4.4.4 Relationship between axial, refractive, topographic and corneal thickness 
changes and corneal biomechanics 
The changes in AL, myopic refractive error and astigmatism, corneal topography and 
thickness have been summarised in Table 4.8 and Table 4.9. In both groups, corneal 
biomechanical parameters, measured with the ORA, contributed towards the change in AL, 
refractive sphere and astigmatism, corneal topography and CCT over the two-year period, 
explaining 1% to 75% of the total variance.  
Corneal biomechanical parameters contributed most towards the variance in CCT between 
BL and the 6 month appointment in the ortho-k group (43.4%) (Table 4.8), whereas in the 
spectacle group they contributed most to refractive astigmatism between BL and the 6 month 
appointment (74.9%) (Table 4.9). 
The changes in refractive sphere in both groups were mostly accounted for by the change in 
AL. The changes in refractive astigmatism were explained by the variance in the topographic 
astigmatism ΔK. The variance in CCT was accounted for by the changes in corneal 
biomechanics, whilst most of the topographic changes observed were influenced by the 
variance in other topographic parameters. No multicollinearity between different topographic 
parameters occurred within the presented models (Table 4.8 and Table 4.9).  
In the ortho-k group, the variance in AL was mostly explained by the change in refractive 
sphere (Table 4.8), whereas in the spectacle group, changes in AL were mostly accounted for 
by the increase in refractive sphere and ACD (Table 4.9).
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Parameter 
Visit ‘x’ vs visit 
‘y’ 
Multiple regression equation p values 
Total variance 
explained by the MR 
model (%) 
Variance explained 
by the corneal 
biomechanical 
parameters (%) 
Refractive sphere 
(D) 
6M vs BL 
∆sphere = 2.76 – 2.86 x ∆AL + 0.18 x ∆CH + 2.00 
x ∆e steep 
<0.05 29 7.3 
12M vs BL 
∆sphere = 1.27 – 0.16 x ΔAL – 3.89 x Δflat e + 
0.07 x Δsteep K 
≤0.006 42.6 – 
18M vs BL 
∆sphere = 1.59 – 0.14 x ΔAL – 2.98 x Δflat e + 
Δsteep K 
≤0.021 29.2 – 
24M vs BL 
∆sphere = 3.12 – 2.77 x ΔAL – 0.02 x path21 – 
0.04 x Δflat K 
≤0.035 35.6 11.2 
Refractive 
astigmatism (D) 
6M vs BL ∆refractive astigmatism = 0.36 – 0.46 x Δdelta K <0.005 27.1 – 
12M vs BL ∆refractive astigmatism = 0.30 – 0.57 x Δdelta K ≤0.004 30.1 – 
18M vs BL 
∆refractive astigmatism = 0.27 – 0.46 x Δdelta K – 
0.04 x Δdslope1 + 0.01 x Δmslew2 
≤0.001 42.1 18.4 
24M vs BL ∆refractive astigmatism = 0.37 – 0.39 x Δdelta K ≤0.011 13 – 
CCT (µm) 
6M vs BL 
∆CCT = -5.41 + 7.11 x ΔACD + 0.31 x Δpath2 – 
5.16 x Δrefractive astigmatism – 0.14 x 
Δdslope11 
<0.04 49.4 43.4 
12M vs BL ∆CCT = -7.09 + 3.22 x ΔACD ≤0.013 12.3 – 
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18M vs BL ∆CCT = 75.24 + 83.09 x ΔACD – 28.83 x Δsphere ≤0.044 24.4 – 
24M vs BL None of the variance explained by the model 
Steep e 
6M vs BL None of the variance explained by the model 
12M vs BL Δsteep e = -0.08 + 0.01 x Δflat K ≤0.006 17.7 – 
18M vs BL 
Δsteep e = -0.08 + 0.01 x Δflat K – 0.003 x 
Δdslope2 
≤0.002 41.5 6.9 
24M vs BL Δsteep e = -0.04 + 0.01 x Δflat K <0.001 30.6 – 
Flat e 
6M vs BL Δflat e = -0.32 +0.12 x ΔIOPcc ≤0.035 0.1 0.1 
12M vs BL 
Δflat e = -0.16 +0.01 x Δsteep K – 0.05 x Δsphere 
– 0.08 x Δ aplhf 
≤0.028 40.2 12.6 
18M vs BL 
Δflat e = -0.12 +0.01 x Δsteep K – 0.05 x Δsphere 
– 0.01 x ΔAL + 0.05 x Δdelta K 
≤0.008 47.5 – 
24M vs BL Δflat e = -0.29 + 0.01 x Δsteep K <0.001 27.9 – 
Steep K (D) 
6M vs BL 
Δsteep K = -0.36 + 1.028 x Δflat K +0.99 x Δdelta 
K 
<0.001 99.9 – 
12M vs BL 
Δsteep K = 0.15 + 1.0 x Δflat K +0.99 x Δdelta K + 
0.02 x ΔCCT 
<0.001 100 – 
18M vs BL Δsteep K = -0.01 + 1.0 x Δflat K +0.96 x Δdelta K ≤0.001 100 – 
24M vs BL 
Δsteep K = 0.03 – 1.0 x Δ flat K + 0.98 x Δdelta K 
– 0.04 x ACD – 0.09 x ΔAL + 0.02 x Δpath2 – 
0.01 x Δslew2 
<0.001 100 0.6 
Flat K (D) 6M vs BL Δflat K = -0.36 + 0.97 x Δsteep K +0.98 x Δdelta K <0.001 99.9 – 
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12M vs BL 
Δflat K = 0.15 + 1.0 x Δflat K +0.99 x Δdelta K + 
0.03 x ΔCCT 
<0.001 100 – 
18M vs BL Δflat K = 0.01 + 0.99 x Δflat K - 0.96 x Δdelta K ≤0.001 100 – 
24M vs BL 
Δflat K = 0.03 -0.99 x Δsteep K – 0.98 x Δdelta K 
+ 0.42 x ΔACD – 0.9 x ΔAL – 0.01 x Δpath2 + 
0.001 x Δslew1 
<0.001 100 0.6 
ΔK (D) 
6M vs BL Δdelta K = -0.81 -0.56 x Δrefractive astigmatism <0.001 27.1 – 
12M vs BL 
Δdelta K = -0.31 -0.54 x Δrefractive astigmatism + 
0.28 x Δsteep K 
<0.001 38.9 – 
18M vs BL 
Δdelta K = -0.33 -0.49 x Δrefractive astigmatism 
+1.79 x Δ e flat - 0.49 x Δaplhf + 0.001 x Δdive2 
 42.8 6.7 
24M vs BL Δdelta K = -0.01 + 1.02 x Δsteep K <0.001 100 – 
AL (mm) 
6M vs BL ∆AL = 0.19 – 0.05 x ∆sphere <0.05 13.3 – 
12M vs BL ∆AL = 2.84 – 1.39 x ∆sphere + 0.09 x Δbindex ≤0.016 28.8 10.5 
18M vs BL 
∆AL = 1.09 – 1.43 x ∆sphere + 0.09 x Δpath2 – 
6.68 x Δflat e 
≤0.003 34.7 10.3 
24M vs BL ∆AL = 0.49 – 0.07 x ∆sphere ≤0.002 18.2 – 
Table 4.8 Changes in AL, refractive sphere, astigmatism, CCT, steep e, flat e, steep k and flat K explained by the contribution of corneal 
biomechanical parameters measured by the ORA and other metrics in the ortho-k group over the two-year period. Note: when a parameter from 
the upper 50% of the curve is entered in equation, ‘1’ is added to the parameter name, to distinguish it from the parameters from upper 75% of 
the peak; if no β value is entered in the equation, SPSS output displayed it as ‘<0.001’. 
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Parameter 
Visit ‘x’ vs 
visit ‘y’ 
Multiple regression equation p values 
Total variance 
explained by 
the MR model 
(%) 
Variance 
explained by the 
corneal 
biomechanical 
parameters (%) 
Refractive 
sphere (D) 
6M vs BL 
∆sphere = 0.23 + 0.83 x ∆ACD – 2.53 x ∆AL – 0.21 x 
∆aindex + 0.15 x ∆w11 + 0.02 x ∆dslope11 + 0.03 x 
∆w2 
<0.05 73 23.5 
12M vs BL ∆sphere = -0.41 – 0.24 x ∆AL – 0.001 x ΔCCT ≤0.022 59.4 – 
18M vs BL 
∆sphere = -0.67 – 0.21 x ∆AL – 0.04 x Δflat K -0.001 
x Δh1 
≤0.013 73.4 2.1 
24M vs BL ∆sphere = 0.13 – 2.0 x ∆AL <0.001 70.1 – 
Refractive 
astigmatism 
(D) 
6M vs BL 
∆refractive astigmatism = 1.26 + 0.003 x Δh2 – 0.56 x 
Δaplhf + 0.03 x Δpath21 +0.08 x Δaspect21 – 0.06 x 
Δpath1 
≤0.002 74.9 74.9 
12M vs BL 
∆refractive astigmatism = -0.01 - 0.05 x ΔAL +0.001 
ΔCCT – 0.36 x Δdelta K 
≤0.024 35.8 – 
18M vs BL 
∆refractive astigmatism = -0.03 - 0.03 x ΔAL - 0.21 
Δdelta K – 0.01 x ΔIOPg 
≤0.035 42 9.3 
24M vs BL 
∆refractive astigmatism = -0.23 – 1.51 x Δflat e + 
0.003 x ΔCCT – 0.13 x ΔACD 
≤0.038 37.5 – 
CCT (µm) 
6M vs BL None of the variance explained by the model 
12M vs BL 
∆CCT = -1.14 +141.42.88 x ΔACD – 1.08 x Δh2 – 
20.83 x ΔCH 
≤0.029 39 8.7 
18M vs BL 
∆CCT = 7.82 +133.63 x ΔACD – 1.99 x Δmslew1 – 
11.56 x ΔIOPg 
≤0.013 46.4 9.5 
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24M vs BL 
∆CCT = 42.19 + 59.88 x ΔACD – 0.52 x Δh11 + 8.86 
x Δaindex 
<0.001 87.6 31.6 
Steep e 
6M vs BL 
Δsteep e = -0.02 + 0.01 x Δflat K + 0.01 x Δdslope1 – 
0.08 x Δaplhf 
≤0.047 65.7 11.8 
12M vs BL Δsteep e = -0.01 + 0.64 x Δflat e ≤0.007 16.1 – 
18M vs BL Δsteep e = -0.01 + 0.54 x Δflat e <0.001 47.4 – 
24M vs BL Δsteep e = -0.02 + 0.59 x Δflat e ≤0.007 18.5 – 
Flat e 
6M vs BL Δflat e =-0.18 + 0.01 x Δsteep K -0.05 x Δsphere ≤0.036 43.4 – 
12M vs BL 
Δflat e = -0.17 +0.26 x Δsteep e – 0.02 x Δsphere – 
0.001 x ΔCCT 
≤0.044 32.5 – 
18M vs BL 
Δflat e = -0.26 +0.09 x Δsteep K – 0.02 x Δsphere – 
0.001 x ΔCCT +Δdive2 
≤0.043 81.9 1 
24M vs BL 
Δflat e = -0.04 +0.29 x Δsteep e – 0.08 x ∆refractive 
astigmatism 
≤0.018 31.8 – 
Steep K (D) 
6M vs BL 
Δsteep K = -0.02 + 1.0 x Δflat K +1.01 x Δdelta K + 
0.001 x Δh21 
<0.001 100 0.3 
12M vs BL Δsteep K = 0.15 + 1.0 x Δflat K +1.0 x Δdelta K <0.001 100 – 
18M vs BL Δsteep K = 0.15 + 1.0 x Δflat K <0.001 99.9 – 
24M vs BL None of the variance explained by the model 
Flat K (D) 
6M vs BL 
Δflat K = 0.15 + 1.0 x Δsteep K +1.02 x Δdelta K + 
0.001 x Δh21 
<0.001 100 0.3 
12M vs BL Δflat K = 0.001 + 1.0 x Δsteep K -1.0 x Δdelta K <0.001 100 – 
18M vs BL Δflat K = -0.15 + 0.95 x Δsteep K <0.001 99.9 – 
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24M vs BL 
Δflat K = 0.01 - 1.0 x Δdelta K +1.05 x Δsteep K+ 0.001 
x ΔCCT 
<0.001 100 – 
ΔK (D) 
6M vs BL Δdelta K = -0.29 + 1.75 x Δflat e – 0.01 x Δuslope21 ≤0.007 36.4 7.8 
12M vs BL Δdelta K = 0.09 – 0.97 x Δflat K + 1.00 x Δsteep K <0.001 100 – 
18M vs BL Δdelta K = 0.15 + 0.05 x Δflat K <0.001 68.2 – 
24M vs BL 
Δdelta K = 0.09 – 0.97 x Δflat K – 0.99 x Δsteep K + 
0.001 x ΔCCT 
<0.001 100 – 
AL (mm) 
6M vs BL 
∆AL = 0.15 – 0.13 x ∆sphere + 0.09 x ∆ACD + 0.04 x 
∆w11 + 0.02 x ∆path1 
<0.05 43.8 22.1 
12M vs BL 
∆AL = -1.01 – 1.07 x ∆sphere + 14.17 x ∆flat e -2.77 
x ∆refractive astigmatism - 0.64 x ∆ACD + 0.05 x 
Δpath11 
≤0.019 73.7 2 
18M vs BL 
∆AL = -1.93 – 2.31 x ∆sphere -2.18 x ∆refractive 
astigmatism - 0.18 x ∆flat K 
0.014 69.5 – 
24M vs BL ∆AL = 0.23 – 0.35 x ∆sphere <0.01 70.1 – 
Table 4.9 Changes in AL, refractive sphere, astigmatism, CCT, steep ‘e’, flat ‘e’, steep ‘k’ and flat ‘k’ explained by the contribution of corneal 
biomechanical parameters measured by the ORA and other metrics in the spectacle group over the two-year period. Note: when a parameter 
from the upper 50% of the curve is entered in equation, ‘1’ is added to the parameter name, to distinguish it from the parameters from upper 75% 
of the peak; if no β value is entered in the equation, SPSS output displayed it as ‘<0.001’.
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4.5 Discussion 
This study investigated the long-term effects of ortho-k wear on corneal biomechanical 
properties and the possible contribution of the anterior eye to myopia progression in 
myopic schoolchildren. 
Ortho-k lens wear effectively reduced refractive sphere and astigmatism, slowing down 
myopia progression and axial elongation by 42%. Ortho-k also slowed down the ACD 
growth. In contrast, in the spectacle wearing (control) group, refractive sphere, 
astigmatism, AL and ACD increased significantly over the two-year period. These results 
are in agreement with the previous work on which they are expanding (Cho and Cheung 
2012; Charm and Cho 2013; Chen et al. 2013). 
The topographic changes observed in the present study are also in agreement with 
previous work (Cho et al. 2005; Santodomingo-Rubido et al. 2012). Ortho-k lens wear 
initially induced a corneal flattening in both meridians, which stabilised within 6 months 
of lens wear. Previously reported results in similar cohorts also suggested that significant 
flattening and changes in the eccentricity occur during the first six months of ortho-k lens 
wear (Cho et al. 2005; Santodomingo-Rubido et al. 2012). 
The small fluctuations in corneal topographic parameters seen in the spectacle group 
have been reported before. In a study of similar design, investigating the efficacy of 
ortho-k for MC, all of the topographical parameters in the spectacle group, except for 
steep simulated keratometry readings, remained the same (Santodomingo-Rubido et al. 
2012). A longitudinal study conducted in Portuguese university students over the course 
of three years showed that, regardless of the refractive status and progression of myopia, 
topographic changes remained stable (Jorge et al. 2007). 
Changes in CCT support the previously reported results of the ROMIO cohort data 
(Cheung and Cho 2016), in which a significant thinning was observed within the first six 
months of the ortho-k lens wear, with stability thereafter. In the present study, CCT in the 
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ortho-k group thinned significantly over the first six months, remained stable between the 
6 and 18-month appointments, but returned to baseline level at 24 months (Figure 4.1). 
However, these findings contradict the results of a significant central corneal thinning 
after 5 years of ortho-k lens wear reported by Zhong and colleagues (2009), and the well 
established evidence of central epithelial thinning and mid-peripheral thickening of the 
cornea underlying the mechanisms of ortho-k (Swarbrick et al. 1998; Swarbrick 2006). 
Cheung and colleagues (2016) suggested that caution must be taken when interpreting 
results, owing to the relatively small sample size. The current study is expanding the 
cohort (Cheung and Cho 2016) and obtaining similar results. Fluctuations seen in the 
spectacle group, however, still raise questions. Zhong and colleagues (2009) measured 
CCT using confocal microscopy and suggested that other methods, such as anterior 
segment optical coherence tomography (AS-OCT) could be more sensitive in detecting 
thickness changes. Nieto-Bona et al. (2011a) contradicted this theory by comparing 
corneal thickness measurements obtained by confocal microscopy with the ones from 
optical coherence tomography and found no difference between the two methods. CCT 
was measured using the Pentacam in this study. It has been shown that devices based 
on Scheimpflug imaging like Pentacam and optical coherence tomography can be used 
interchangeably for measuring CCT (Bayhan et al. 2014). It is, therefore, unlikely that 
differences in instrumentation could cause these discrepancies. It is more likely that 
mechanical forces exerted by the lens and the duration of the ortho-k therapy could 
account for these variations (Swarbrick et al. 1998; Owens et al. 2004; Cheah et al. 2008; 
Choo et al. 2008; Zhong et al. 2009; Elsheikh 2010).  
Zhong et al. (2009) proposed that short term and long term corneal morphological 
changes are different. The mid-peripheral thickening observed after the first night of lens 
wear was thought to be mainly caused by temporary oedema induced by overnight wear 
and mechanical pressure exerted by the lens. On the other hand, thickness changes 
(central thinning and mid-peripheral thickening) observed after years are thought to be 
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mainly caused by changes in topography and cell morphology. Animal work investigating 
the effects of ortho-k lens wear support these findings, but suggest that the plasticity of 
epithelium, cell compression and inter-cell processes, especially in the first days of ortho-
k lens, should be taken into account (Matsubara et al. 2004; Cheah et al. 2008; Choo et 
al. 2008). The changes in the current study may reflect the processes described above. 
The initial changes (formation of the treatment zone, mechanical stress exerted by the 
lens and reorganisation of the corneal topography) all stabilise within the first six months 
of the treatment and could be mostly accounted for by the re-modelling of the corneal 
epithelium. At later stages, adaptation to lens wear has occurred, and the treatment 
outcome is not so much reliant on central corneal thickness, but on other aspects, such 
as mid-peripheral corneal thickening or the overall corneal shape. Furthermore, most of 
the studies looking at thickness changes have been conducted in an adult population 
(Swarbrick et al. 1998; Alharbi and Swarbrick 2003; Owens et al. 2004; Yeh et al. 2013). 
Significant changes seen in the spectacle group (Figure 4.1) may indicate that 
fluctuations in CCT are normal in a myopic child population. Shorter and long-term 
studies monitoring corneal thickness changes and the mechanical impact of ortho-k lens 
wear to the cornea are required to gain a deeper understanding of the underlying 
mechanisms of ortho-k. However, diurnal changes in CCT have been reported before. A 
trend of gradual corneal thinning throughout are normal, with cornea being the thickest 
upon awakening (Kiely et al. 1982; Harper et al. 1996). Although visits were aimed to be 
schedualed at the same time of the day, it was not always possible due to the busy 
scheduale of schoolchildren and their parents. Therefore, diurnal fluctuations in CCT 
could also account for some variance seen in the results. 
This is the first study to examine ORA-derived applanation peak in response to ortho-k 
lens wear in detail, and to examine corneal biomechanics over a two-year period. Saad 
and colleagues (2010) and Kerautret et al. (2008) demonstrated the importance of signal 
morphology analysis of applanation curves alongside CH and CRF, both of which have 
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a limited discriminatory ability. Since then parameters derived from applanation curves 
have proven to be a useful tool in the detection of keratoconus (Mikielewicz et al. 2011; 
Wolffsohn et al. 2012). Previous studies have only considered CH and CRF as the 
descriptors of corneal biomechanical response to ortho-k wear (Gonzalez-Meijome et al. 
2008; Chen et al. 2009; Mao et al. 2010; Yeh et al. 2013). The longest running study 
investigating the influence of ortho-k lens wear was conducted over a six month period 
(Mao et al. 2010). Reduction of myopic refractive error, changes in corneal thickness and 
morphology do not occur simultaneously (Swarbrick et al. 1998; Alharbi and Swarbrick 
2003; Zhong et al. 2009; Nieto-Bona et al. 2011a; Cheung and Cho 2016). Alharbi and 
Swarbrick (2003) suggested that the first 10 nights of ortho-k lens wear are critical, as 
the vast majority of corneal thickness changes take place over this period and stabilise 
thereafter. Other studies have demonstrated that initial thickness changes and the 
subsequent morphological changes in corneal structure are different from long term 
changes (Zhong et al. 2009; Nieto-Bona et al. 2011a, 2011b; Cheung and Cho 2016). 
Alterations in keratocyte density and morphology (Zhong et al. 2009; Nieto-Bona et al. 
2011a, 2011b) indicate that the mechanical stress induced by the lens account for the 
initial corneal thickness changes (1 night to 1 month of lens wear). These are 
predominantly epithelial in origin (Alharbi and Swarbrick 2003; Matsubara et al. 2004; 
Cheah et al. 2008). Kerotocyte density tends to return to BL levels at later stages of 
treatment (1 year to 5 years of lens wear) (Zhong et al. 2009; Nieto-Bona et al. 2011a), 
suggesting that corneal response to ortho-k lens wear is a dynamic process and should 
be evaluated for longer than for six months. 
CH, which is a descriptor of the viscous damping properties of the cornea (Luce 2005), 
did not change over the study period in the ortho-k group, but fluctuated significantly in 
the spectacle group. CRF, which characterises the overall resistance of the cornea (Luce 
2005; Lau and Pye 2011), remained stable in both groups. These findings are in general 
agreement with an earlier study conducted over a period of 6 months, which reported a 
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decrease in CH and CRF after one week of ortho-k lens wear. These values were found 
to return to BL level at three and six month follow up visits (Mao et al. 2010). Mao et al. 
(2010) concluded that the initial changes in CH and CRF can be explained by the 
reshaping effect of the cornea, and that ortho-k does not cause damage to corneal 
microstructure. The current study did not assess the initial response to ortho-k lens and 
cannot confirm these findings. However, such assumptions need to be made cautiously. 
The ORA assesses the mechanical properties of the cornea based on an applanation 
signal (Luce 2005; Lau and Pye 2011) and does not directly assess corneal structure at 
a microscopic level. Studies investigating the effects of ortho-k at a microscopic level 
have shown that lens wear induces changes in the corneal structure (Matsubara et al. 
2004; Cheah et al. 2008; Choo et al. 2008; Zhong et al. 2009; Nieto-Bona et al. 2011a). 
The statistically significant fluctuations seen in the spectacle group in the present study 
also suggest that CH and CRF describe the overall corneal mechanical behaviour, rather 
than structural changes at microscopic level, as no treatment apart form conventiel SV 
glasses that did not interact with the corneal tissue directly, was applied to control group. 
The cornea reaches adult size during the first two years of life and does not undergo 
major structural changes thereafter (Kaufman 1998). Myopia development has been 
linked to changes in corneal shape (Davis et al. 2005). A less prolate corneal shape has 
been associated with myopia and increased AC growth during myopia development, 
suggesting that deeper AC may require less flattening of the peripheral cornea to 
preserve its junction at the limbus (Davis et al. 2005). There are other corneal 
biomechanical parameters derived from the ORA applanation curve that need to be 
considered. 
Detailed analysis of the applanation curve demonstrated that, in both groups, significant 
changes were mostly limited to the initial applanation peak, but the corneal 
biomechanical response in the spectacle group was much more varied (Figure 4.2 and 
Figure 4.3). Ortho-k lens wear affected 9 of the additional ORA-derived parameters 
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during the first 18 months of lens wear, whilst 14 of the parameters changed significantly 
over the two-year study period in the spectacle group. Nevertheless, datapresented in 
this chapter are skewed and with large SDs. Moreover, children are les corporative with 
the ORA and the acceptable waveform score (WS) for children is lower (3.6≥) (Hon et 
al. 2012) and these factors could account for some of the variations observed. 
Parameters like slew1 (an aspect ratio of the absolute value of the initial applanation 
peak to the first break), mslew1 (the maximum single increase of in the rise of the initial 
applanation peak), h1 from the upper 50% and 75% of the initial applanation peak (the 
height from the lowest to the highest point of the peak) and aspect1 from the upper 50% 
of the initial applanation peak (aspect ratio of the peak height/width) underwent 
significant changes in both groups. In the ortho-k group these parameters followed a 
certain trend of decrease over the study period, whereas in the spectacle group 
fluctuations in the parameters were observed. However, no consistent trends were 
identified. 
Parameters such as slew2 (an aspect ratio of the absolute value of the rebound peak to 
the first break); dive2 (the absolute value of the rebound peak until the first break); p1area 
or the area under the curve of the upper 50% and 75% of the initial applanation curve 
(proportional estimate of the time needed for the cornea to change from the convex to 
the concave form), h2 (the height from the lowest to the highest point) of the upper 50% 
and 75% of the rebound peak and others that underwent changes over the two year 
period in the spectacle group (Table 4.5) also fluctuated and did not follow a certain 
trend. These fluctuations could reflect the ocular biometric changes occurring in 
progressing myopia (Lam et al. 1999; Saw et al. 2005). Cornea together with sclera forms 
the outer shell of the eye. Corneal and scleral biomechanical and structural changes 
(namely weaking of the tissue and preservation of the limbar junction) during myopia 
development and the subsequent stretching of an eyball have been reported before 
(McBrien and Gentle 2003; Davis 2005). Therfore, these observations might indicate that 
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certain parameters of the ORA applanation peak could be used as predictors, or 
descriptors, of myopia progression, and that ortho-k has a stabilising effect on the 
cornea. However, more work is needed to support this theory. Researchers have 
questioned the ORA’s ability to purely assess the corneal biomechanical response and 
have proposed that it might measure the whole globe response instead (Iomdina et al. 
2009; Elsheikh 2010). Studies investigating corneal response in emmetropes, stable and 
progressive myopes could provide a new perspective for the application of the ORA and 
its specific parameters in the field of myopia research. 
The other parameters that were affected in the ortho-k group, but not in the spectacle 
group, could reflect on the mechanical effects of the lens wear and the corneal structural 
changes previously reported (Choo et al., 2008, Matsubara et al., 2004, Cheah et al., 
2008, Zhong et al., 2009, Nieto-Bona et al., 2011). Aindex represents the smoothness of 
the peak which, in turn, represent the softness and the local imperfections in the cornea 
(Table 4.6). The changes seen in this parameter could mirror the long term effects of 
ortho-k lens wear to corneal structure. Elsheikh (2010) suggested that both epithelial 
remodelling and creep (persistant deformation or in the context of ortho-k, the response 
of further time-dependent increase in deformation or corneal flattening after lens removal 
(Mountford 1998)), take place simultaneously in ortho-k wear. Epithelial remodelling is 
an important contributor towards the thickness changes induced by ortho-k lens wear 
(Swarbrick et al. 1998; Alharbi and Swarbrick 2003; Cheah et al. 2008; Choo et al. 2008; 
Zhong et al. 2009). Aindex could, therefore, represent the re-modelling effect achieved 
by the reverse geometry lens on the epithelium. However, as collagen fibrils are the main 
carriers of the load, they dominate corneal mechanical behaviour and, subsequently, its 
response to ortho-k, (Boote et al. 2005; Elsheikh 2010). Hence, it is more likely that the 
significant changes in this ORA-derived parameter could be a result of alterations in 
collagen fibril architecture induced by the repeated application of the reverse geometry 
lens. The decrease in dive1 (the absolute value of initial applanation peak until the first 
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break), dislope 1 (the rate of decrease from initial applanation peak to base from the 
upper 75% of the peak) and aspect1 (the aspect ratio of the initial applanation peak 
height/width from the upper 75% of the peak) could reflect the flattening effect of the 
reverse geometry lens or suggest that the cornea becomes more pliable (the basic 
methodology of the ORA) and less resistant as a result of the ortho-k lens wear (Elsheikh, 
Ross, et al. 2009; Terai et al. 2012).  
Endothelial cell count remained stable over the study period in the spectacle wearing 
group, however, this fluctuated in the ortho-k group. Endothelial cells have a limited 
capacity of proliferation, and they tend to decrease in number with every decade (Klyce 
and Beuerman 1998; Joyce 2012). The apparent increase between BL and six-month 
appointment in the ortho-k group is likely to be due to enhanced visibility of the 
endothelium following corneal reshaping.  
Multiple regression analysis further supported the hypothesis of the stabilising effect of 
ortho-k on the anterior eye, and revealed the complex relationship between axial, 
refractive, topographical, corneal thickness and biomechanical changes over the two 
year period (Table 4.8 and Table 4.9). Over the first six months of the study period, 
corneal biomechanical properties contributed significantly towards the changes 
observed in the spectacle wearing group (1-75%), but diminished thereafter. In the ortho-
k group corneal biomechanical parameters explained 1%-18% of the total variance in 
the selected parameters, except for CCT, in which they accounted for 44.6%. 
Interestingly, the variance in CCT in the ortho-k group was mainly accounted for by the 
additional ORA-derived parameters within the first six months, but they did not account 
for any of the subsequent variance. As this is the first study to investigate corneal 
response to ortho-k lens wear in progressing myopes in detail, no comparisons can be 
made. However, presumably, the first six months are crucial for the treatment effect of 
the ortho-k to stabilise. These findings, together with the analysis of the effect of time on 
the ORA-derived applanation curve, provide a new insight to the mechanisms by which 
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ortho-k slows down myopia progression, suggesting not only contribution of optical 
factors (Berntsen et al. 2005; Kang and Swarbrick 2011; Hiraoka et al. 2015; Swarbrick 
et al. 2015), but also of mechanical factors. 
Although all three studies followed the same recruitment, inclusion/exclusion and overall 
study model (Cho and Cheung 2012; Charm and Cho 2013; Chen et al. 2013), the 
limitations of the current study include different lens types used (the fitting parameters 
were kept similar) and the fact that for HM-PRO study myopia was corrected only partially 
(up to 4.00 D). Also, not all children could attend the visits as schedualed and diurnal 
variations could affect the trends seen in this study (Kieley et al. 1982; Harper et al. 
1996). Moreover, children are less complient with the ORA (Hon et al. 2012), which also 
could have had an impact on the overall results, considering that the data are relatively 
scattered and have large standard deviations. 
In summary, this study demonstrates that the corneal biomechanical characteristics of 
the cornea are affected by long term ortho-k wear. It also shows that ortho-k has a 
stabilising effect to the components of the anterior eye in progressing myopia and raises 
interesting questions regarding the mechanisms by which ortho-k slows down myopia 
progression. Further short and long-term studies are needed to support these findings. 
They should specifically investigate corneal biomechanical response to ortho-k lens wear 
within the first six months of the treatment, which has been found to be the critical time 
period. These studies could contribute towards a deeper understanding of the 
mechanisms underlying ortho-k and potentially their contribution in slowing down myopia 
progression. 
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Chapter 5. Short-term corneal biomechanical changes in orthokeratology 
5.1 General overview 
This chapter describes a study designed to investigate the corneal biomechanical 
response over the first seven nights of ortho-k lens wear in a cohort of young adults using 
the Ocular Response Analayzer (ORA) (Reichert Ophthalmic Instruments, Buffalo, NY, 
USA) and Corvis ST (Oculus, Wetzlar, Germany); and observe if the short term corneal 
biomechanical response is different from that of a long one discussed in Chapter 4. 
5.2 Introduction 
One of major limitations that orthokeratology (ortho-k) as a clinical procedure has 
encountered over the years, is the large inter-individual variability in treatment response 
(Kerns 1976c; Sridharan and Swarbrick 2003; Swarbrick 2006; Gonzalez-Meijome et al. 
2008). Different clinical outcomes in patients with similar topography measurements, 
refractive errors and the same amount of desired refractive changes, is not a rarity 
(Sridharan and Swarbrick 2003; Gonzalez-Meijome et al. 2008). Subsequently, it has 
raised questions regarding the corneal tissue response to ortho-k (Gonzalez-Meijome et 
al. 2008). 
Previous long-term studies have focoused on the ability of ortho-k to slow down myopia 
progression (Cho, et al. 2005; Walline et al. 2009; Cho and Cheung 2012; Chen et al. 
2013; Lin et al. 2014; Si et al. 2015; Sun et al. 2015; Swarbrick et al. 2015), and also the 
reversibility (Sorbara et al. 2005) and safety aspects (Kerns 1978; Polse et al. 1983; 
Walline, Rah, et al. 2004; Van Meter et al. 2008) of the method. In contrast, previous 
short-term studies have principally investigated the refractive and corneal profile 
changes, induced by reverse geometry lenses in the open- and closed-eye environments 
(Mountford 1998; Swarbrick et al. 1998; Alharbi and Swarbrick 2003; Sridharan and 
Swarbrick 2003; Owens et al. 2004; Soni et al. 2004; Yoon and Swarbrick 2013), 
reversibility (Barr et al. 2004; Soni et al. 2004; Wu et al. 2009; Santodomingo-Rubido et 
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al. 2014) and the efficacy of various lens designs, which have proven to not affect the 
treatment outcome (Cho Cheung, Sin and Edwards, 2003; Soni et al. 2003; Tahhan et 
al. 2003; Soni et al. 2004; Maldonado-Codina et al. 2005). These studies in tandem with 
the investigation of mechanical forces acting under the reverse geometry lens (Coon 
1984; Kwok 1984; Mountford 2004) have helped to establish a standardised clinical 
profile of ortho-k. The method is effective for correcting mild to moderate myopia 
(Mountford 1997; Mountford 1998; Nichols et al. 2000; Rah et al. 2002; Alharbi and 
Swarbrick 2003; Tahhan et al. 2003; Swarbrick 2006), achieving the refractive changes 
required, by reshaping the anterior corneal tissue (Swarbrick et al. 1998; Alharbi and 
Swarbrick 2003; Swarbrick 2006; Chen et al. 2010). On average up to forty per cent of 
the refraction can be corrected within the first 8 hours of overnight lens wear (Mountford 
1998; Swarbrick et al. 1998; Nichols et al. 2000; Alharbi and Swarbrick 2003; Soni et al. 
2004; Swarbrick 2006). The treatment effect tends to reach the optimum within the first 
7-10 days of overnight lens wear and stabilise within the first 30 days (Mountford 1998; 
Swarbrick et al. 1998; Nichols et al. 2000; Alharbi and Swarbrick 2003; Soni et al. 2004; 
Swarbrick 2006).  
The central epithelial thinning and mid-peripheral stromal thickening, first reported by 
Swarbrick and colleagues (1998), that reached statistical significance by day 7, and 
stabilised after 28 days of lens wear, suggested that the refractive changes are achieved 
by the re-distribution of the anterior corneal tissue. However, the tissue re-distribution 
did not account for the refractive changes achieved during the first day of ortho-k lens 
wear (Swarbrick et al. 1998). Therefore, a transient overall bending of the cornea as the 
initial corneal response to lens wear, which is then followed by tissue re-distribution, was 
suggested (Swarbrick et al. 1998; Owens et al. 2004). The involvement of posterior 
corneal surface, which would support the hypothesis of overall bending of the cornea in 
the initial stages of the treatment, however, is still unclear (Owens et al. 2004; Tsukiyama 
et al. 2008; Chen et al. 2010; Yoon and Swarbrick 2013) and the theory of the shape 
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change of the anterior corneal tissue is favoured (Chen et al. 2010). Moreover, several 
studies (Tsukiyama et al. 2008; Santodomingo-Rubido et al. 2014; Santodomingo-
Rubido, Villa-Collar, Gilmartin and Gutiérrez-Ortega 2016), investigating the contribution 
of other ocular parameters (axial length and anterior chamber depth) to the treatment 
effect of ortho-k, have strengthened the latter assumption and have concluded that 
refractive changes are attributed to changes in anterior corneal shape. 
Studies investigating the effects of ortho-k lens wear at a cellular level, using animal 
models (Matsubara et al. 2004; Cheah et al. 2008; Choo et al. 2008) and confocal 
microscopy in the human population (Zhong et al. 2009; Nieto-Bona et al. 2011a, 2011b) 
to reflect the short- and long-term behaviour of the cornea in ortho-k lens wear, support 
the clinical observations of the corneal profile changes, induced by ortho-k. Animal 
models suggest that the compression of the easily mouldable epithelium, due to the 
mechanical stress exerted by the reverse geometry lens, is the major contributor to the 
refractive changes achieved in the first hours and nights of ortho-k lens wear (Cheah et 
al. 2008; Choo et al. 2008) (for more information on mechanisms of ortho-k, please refer 
to Section 1.5). 
From the viewpoint of classic mechanics, the cornea is a viscoelastic material, the 
behaviour of which is dominated by its bulk component, the stroma (Boote et al. 2005; 
Elsheikh et al. 2007; Elsheikh et al. 2008a, 2008b; Elsheikh 2010; Whitford et al. 2015). 
The stroma is fibrous and hence possess high mechanical stiffness (Boote et al. 2005; 
Elsheikh 2010). In contrast, the epithelium (Elsheikh et al. 2008a; Thomasy et al. 2014), 
and similarly the endothelium (Thomasy et al. 2014), have low mechanical stiffness and 
are easily re-modelled due to their cellular composition (Elsheikh et al. 2008a). The 
cornea’s biomechanical response to the external forces is both time- and load-dependant 
(Boote et al. 2005; Elsheikh et al. 2008b; Elsheikh 2010). If corneal tissue is exposed to 
the external loads repeatedly, as in the case of overnight application of ortho-k lenses, a 
mild creep (or permanent deformation) (Wu et al. 2009; Elsheikh 2010) in response to 
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mechanical stress of the reverse geometry lens, in combination with strain and 
epithelium re-modelling, occurs (Elsheikh 2010) (for more information on corneal 
biomechanics, please refer to Section 1.4.2).  
Nevertheless, few studies (Cheah et al. 2008; Choo et al. 2008; Gonzalez-Meijome et 
al. 2008; Chen et al. 2009) have considered the corneal thickness, profile and 
morphological changes observed in ortho-k lens wear in the context of corneal 
mechanical behaviour. Clinical researchers should not be ignorant of this aspect, as it 
could enhance the understanding of the underlying mechanisms of ortho-k. 
Instrumentation, such as Ocular Response Analyser (ORA, Reichert Ophthalmic 
Instruments, Buffalo, NY, USA) and Corvis ST (Oculus Opticgeraete, Wetzlar, Germany) 
are available to monitor corneal biomechanical response dynamically and non-
destructible in-vivo (Luce 2005; Hon and Lam 2013). Studies investigating the corneal 
biomechanical properties in-vivo, using ORA and its specific biomechanical parameters 
corneal hysteresis (CH) and corneal resistance factor (CRF), which describe the viscous 
damping properties and overall rigidity of the cornea, respectively (Luce 2005; Shah et 
al. 2006; Ortiz et al. 2007; McMonnies 2012), have reported changes in corneal 
biomechanical behaviour induced by short-term ortho-k (Gonzalez-Meijome et al. 2008; 
Chen et al. 2009). However, none of the studies have examined the 37 additional ORA-
derived parameters which have been found to be better descriptors of corneal 
biomechanical response, rather than CH and CRF alone (Kerautret et al. 2008; 
Mikielewicz et al. 2011; Wolffsohn et al. 2012). The Corvis ST has not yet been employed 
in the field of ortho-k (for detailed information about the ORA along with its specific 
parameters and the Corvis ST, please refer to Sections 2.2.1 and 2.1.2. 
The purpose of this study was to investigate corneal biomechanical changes over the 
first seven subsequent nights of ortho-k lens wear. The study will provide a deeper 
understanding of the initial corneal response to ortho-k lens wear during the first night 
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and the adoption, stabilisation and deformation processes that take place over the first 
7 nights, in which the optimal treatment effect is achieved. 
5.3 Methods 
5.3.1 Subjects and study protocol 
Twenty-five mild to moderate myopic volunteers (refractive error between -1.00D and –
4.75D, with refractive with-the-rule astigmatism of less than 1.50D or against-the-rule 
astigmatism of less than 1.00D) with good ocular and general health were recruited from 
the population of Aston University optometry students. Exclusion criteria were any history 
of ocular trauma, surgery or disease, rigid contact lens wear and any contradiction to 
ortho-k lens wear. The risks and benefits of ortho-k were explained and written consent 
was obtained before the commencement of the study. 
Participants were invited to attend a 60-minute baseline assessment at the Aston 
University Health Clinic to obtain the required measurements for ortho-k lens 
manufacturing and the baseline measurements of corneal biomechanics. After the initial 
visit they were asked to return for the lens fitting and teaching session, which then was 
followed by a visit after the first night of ortho-k lens wear and subsequent 30 minutes 
follow up visits for the next 6 days, when all the necessary measurements were taken. 
Initial appointments were scheduled at least 2 hours after waking to diminish the impact 
of overnight and contact lens wear induced oedema (Armitage and Schoessler 1988; 
Harper et al. 1996; Fonn et al. 1999; Du Toit et al. 2003). Participants were also advised 
to cease soft contact lens wear at least 24 hours before the initial appointment. 
Subsequently, they were advised to adhere to a healthy 6-8 hour sleeping schedule to 
achieve optimal treatment effect, once the ortho-k lenses were dispensed (Mountford 
1998; Alharbi and Swarbrick 2003). The visits were scheduled during the first half of the 
day after the first night of lens wear, whilst the rest of the follow up visits took place during 
the working day. 
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Twenty-one participants completed the study. Two participants dropped out before the 
commencement of the ortho-k lens wear. One participant could not cope with lens 
handling and dropped out after the first night of lens wear, whilst another participant, who 
was atopic, discontinued lens wear after 3 nights due to an allergic reaction (giant 
papillary conjunctivitis). Two participants could not attend one of eight schedualed visits 
due to family and work emergency. Average data for the absent appointment were used 
for analysis in these two cases. For the cohort demographics please refer to Table 5.1. 
The study was conducted in accordance with the tenets of the Declaration of Helsinki 
and approved by the Aston University Research Ethics Committee (Appendix 6.1). Data 
were collected from November 2016 to February 2017. 
Number of participants 
(male:female) 
21 (6:15) 
Age (years) 21.04 ± 2.67 (Mean ± SD; range 18 to 28) 
Refractive Error (MSE, 
dioptres) 
-2.83 ± 1.11 D; range -1.00 to -5.25) 
Ethnicity 
Asian 13 
Black 1 
Caucasian 7 
Table 5.1 Cohort demographics 
5.3.2 Lens design and fitting philosophy 
Ortho-k reverse geometry lenses (DreamLens lens design, Eyedream, No7 Contact 
Lenses, Hastings, UK), tailored in Boston XO (hexafocon A; nominal Dk=100 x 10-11 
[cm2•mLO2]/(s•mL•mmHg]) material (Bauch & Lomb, Rochester, New York, USA), were 
ordered and fitted based on the manufacturers guidelines and specifications. The lenses 
were suitable for correction of myopic refractive error from -0.75D to -4.50D (although up 
to -5.00D can be corrected), with refractive with-the-rule astigmatism up to 1.50D or 
against-the-rule astigmatism up 1.00D. Topography maps (Medmont E300, Medmont 
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Ltd, Melbourne, Australia) and up to date subjective refraction were required for the lens 
to be manufactured, both of which were acquired at the baseline appointment.  
Lenses were available in three diameters (10.10mm, 10.50mm and 10.90mm), had 
aspheric blend curves and the typical DreamLens reverse geometry lens profile 
(Swarbrick 2006; please refer to Section 1.3.3). The treatment zone was 6 mm wide. 
Lens fit and fluorescein pattern were assessed upon lens dispensing, after the first night 
of lens wear and on day seven. Images of the lens fit were captured at the same stages 
of the study (CSO digital slit-lamp biomicroscope; camera Digital Vision, Epsilon Lyrae 
image software, Epsilon imaging Inc., Ann Arbor, Michigan, USA). Between nights 2 to 
7 corneal topography was used to monitor the fit. 
No modifications or adjustments to the lens initially dispensed were made during the 
study, even if the fit was acceptable, but not optimal (Nichols et al. 2000) as the main 
aim of the study was to investigate the initial changes in corneal biomechanics, induced 
by ortho-k lens wear. If the fit was not acceptable, lens wear would be discontinued. 
A sterile saline, Boston Simplus multi-action solution (Bauch & Lomb, Rochester, New 
York, USA) for lens cleaning and storage and Biotrue re-wetting eye drops (Bauch & 
Lomb, Rochester, New York, USA) to aid with the lens insertion and removal were 
provided. 
If an over-correction was required to achieve optimal vision during the day within the 
study period, Acuvue Moist daily disposable contact lenses (Johnson & Johnson Vision 
Car Inc., Jacksonwille, Florida, USA) were fitted and dispensed. 
5.3.3 Measurements 
At baseline appointments, full sphere-cylinder refraction together with a thorough slit 
lamp examination and corneal topography readings (Medmont E300, software version 
5.4.0 Beta 4, Medmont Ltd, Melbourne, Australia) to measure corneal shape, specifically 
eccentricity (e) and simulated keratometry (K) readings, were conducted. The 
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biomechanical properties of the cornea were measured, using the ORA (Reichert 
Ophthalmic Instruments, Buffalo, USA) and Corvis ST (Oculus Opticgeraete, Wetzlar, 
Germany) (for detailed list of instrument specific corneal biomechanical parameters, 
please refer to 2.2.1) Central corneal thickness (CCT), anterior chamber depth (ACD) 
and lens thickness (LT) were measured, using the Aladdin ocular biometer and 
topography system (Topcon, Tokyo, Japan). Axial length (AL) was measured, using the 
IOL Master 500 (Carl Zeiss Meditec Ltd, Jena, Germany). The health of the central 
corneal endothelium was assessed, using the Topcon specular microscope SP-3000P 
(Topcon Corporation, Tokyo Japan). IMAGEnet ibase software (version 3.18., Topcon 
Corporation, Tokyo, Japan) was used for cell count.  
Lens fit was assessed and a thorough slit-lamp biomicroscope examination was 
conducted at the lens dispensing visit. 
The same battery of tests as in baseline appointment were performed after the first and 
seventh night of the lens wear, except for the full sphere-cylinder refraction. A subjective 
spherical over-refraction (the results will be presented as best vision sphere, BVS) was 
performed instead. Also, the lens fit was assessed. 
During the follow up visits (second to sixth night of lens wear) the same battery of test 
as in the appointment after the first night of the lens wear, except for the assessment of 
the lens fit and health of the central endothelium, were conducted. The tests performed 
at each visit are summarised in Table 5.2. 
For detailed information on all instrumentation used in the study, measurement recording 
and quality assessment protocol, please refer to Chapter 2 and Sections 2.5.1 - 2.5.2, 
2.6 - 2.7.
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) 
Visit 
BL 
Lens 
dispensing 
Night 1 Night 2 Night 3 Night 4 Night 5 Night 6 Night 7 
Sphere-
cylinder 
refraction 
x  
Subjective 
over-refraction 
 x x x x x x x x 
Topography 
(Medmont 
E300) 
x 
 
x x x x x x x 
Corneal 
biomechanical 
properties 
(ORA/Corvis 
ST) 
x x x x x x x x 
CCT 
(Aladdin) 
x x x x x x x x 
ACD 
(Aladdin) 
x x x x x x x x 
AL (IOL Master 
500) 
x x x x x x x x 
Endothelial 
health (SP-
3000P) 
x x 
 
x 
Lens fit 
assessment 
 x x x 
Slit lamp 
examination 
x x x x x x x x x 
Table 5.2 Summary of the measurements taken at each visit. Note: ‘x’ indicates the measurement was performed. 
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5.3.4 Statistical analysis 
Data were recorded, using Microsoft Excel (Microsoft Office Professional Plus 2013, 
Microsoft Corp. Redmond, Washington, USA). Statistical analysis was conducted using 
SPSS (IBM SPSS Statistics for Windows, Version 21.0. IBM Corp. Armonk, New York, 
USA).  
Data were tested for normality, using the Shapiro-Wilk (S-W) test (p>0.05). Repeated 
measures analysis of variance (ANOVA) was employed to examine the changes in 
response variables over the time when data were normally distributed, and Friedman 
analysis of variance was used, when they were not. Statistically significant changes from 
baseline were further investigated, using post hoc tests with Bonferroni correction. 
Multivariate regression analysis (stepwise) was used to further examine the relationship 
between refractive changes, simulated keratometry readings, corneal eccentricity in the 
steepest and flattest meridian, CCT and corneal biomechanical properties over the 
seven-day period of ortho-k lens wear.  
A critical p-value of 0.05 was chosen to denote statistical significance and only data from 
the right eye were analysed.  
Study was designed to achieve 80% power (α=0.05, Cohen’s d=0.25) to detect at least 
0.6 mmHg change in CRF after overnight ortho-k lens wear (Cohen’s d=0.46) (Chen et 
al. 2009), based on the repeated measures ANOVA with correlation coefficient between 
the repetitions set to 0.5, and required 16 participants. However, nine additional 
participants were recruited to account for the drop out and unsuccessful initial fits. The 
power design calculations and subsequently the sample size was based on the results 
of previous studies (Moreno-Montanés et al. 2008; Wasielica-Poslednik et al. 2010; Hon 
and Lam 2013; Hong et al. 2013). Study power was determined, using statistical power 
program G*Power 3.0 (version 3.0.10) (Faul et al. 2007; Faul et al. 2009). 
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5.4 Results 
5.4.1 Changes in refractive error, corneal curvature and central corneal 
thickness 
Ortho-k lens wear effectively reduced myopic refractive error over the seven-day period 
(F(2.716,51.599)=50.145, p<0.001). The average refraction was -2.83 ± 1.11 D at the BL, 
reducing to -1.69 ± 0.69 D and -0.64 ± 0.65 D, after the first and seventh night of lens 
wear, respectively (Figure 5.1). Post hoc pairwise comparisons showed that refraction 
was significantly different from the BL and the first night of lens wear (p≤0.001), but 
stabilised after the second night (p>0.05). 
 
Figure 5.1 Refractive changes over the seven-day period of ortho-k lens wear compared 
to baseline. Note: refraction is presented as BVS and plotted as mean ± SD (n=21), error 
bars represent 1 SD. 
A similar pattern could be seen within the topography readings (Table 5.3). Steep and 
flat eccentricity (e) changed within the first night of ortho-k lens wear (BL vs first night 
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p<0.001; all nights p<0.05) and stabilised thereafter (p>0.05). Also, a gradual corneal 
flattening, in both the steep and flat meridians, was observed (Table 5.3) and reached 
statistical significance after the seventh night of lens wear in the steep meridian (p=0.01) 
and second night in the flat meridian (p=0.06). 
A gradual thinning of the central cornea (F(2.155,43.098)=1.971, p=0.035), that reached 
statistical significance after the seventh night (p=0.008), occurred during the study 
period. CCT at BL was 545 ± 41 µm, 545 ± 42 µm after the first night and 539 ± 43 µm 
after the seventh night of lens wear (Figure 5.2). 
 
Figure 5.2 Changes in CCT over the seven-day period of ortho-k lens wear compared 
to baseline. Note: data are presented as mean ± SD (n=21), error bars represent 1 SD. 
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BL Night 1 Night 2 Night 3 Night 4 Night 5 Night 6 Night 7 p p F 
Steep e 0.42±0.14 0.29±0.11 0.29±0.13 0.28±0.11 0.27±0.06 0.27±0.08 0.26±0.11 0.28±0.09 0.181 <0.001 6.117 
Flat e 0.65±0.10 0.53±0.12 0.47±0.16 0.50±0.13 0.43±0.15 0.39±0.16 0.39±0.17 0.42±0.16 0.986 <0.001 15.692 
Steep K (D) 43.90±1.51 43.80±1.52 43.67±1.54 44.24±1.53 43.57±1.55 43.72±1.63 43.38±1.52 43.50±1.51 0.723 0.003 3.27 
Flat K (D) 42.86±1.39 42.70±1.39 42.54±1.38 43.03±1.22 42.51±1.40 42.46±1.35 42.40±1.40 42.39±1.40 0.310 0.017 3.774 
ΔK (D) 1.00±0.42 1.11±0.45 1.11±0.50 1.19±0.64 1.05±0.54 1.26±0.86 0.99±0.59 1.09±0.62 0.150 0.342 1.281 
Table 5.3 Changes in corneal topography over the seven-day period of ortho-k lens wear compared to baseline. *If p<0.05, Friedman’s test procedures were 
carried out, statistically significant (p<0.05). 
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5.4.2 Changes in corneal biomechanical properties 
5.4.2.1 Corneal biomechanical properties measured with Ocular Response 
Analyser 
The main ORA parameters, Goldman correlated intraocular pressure IOPg 
(F(7,133)=0.792, p=0.595), intraocular pressure adjusted for corneal thickness IOPcc 
(F(7,133)=1.211, p=0.306), CH (F(4.373,83.087)=1.824, p=0.126) and CRF (F(7,133)=1.03, 
p=0.413) were unaffected by the ortho-k lens wear over the 7-day period. The average 
CH was 10.42 ± 1.29 mmHg at the baseline appointment, 10.26 ± 1.19 mmHg after the 
first night of lens wear, and 10.04 ± 1.50 mmHg after seven nights of lens wear. CRF 
was 9.35 ± 1.71 mmHg, 9.42 ± 1.51 mmHg and 9.13 ± 2.00 mmHg, respectively at the 
same time points (please refer to Appendix 3 for the full ORA results table). 
Conversely, the additional ORA derived parameters were affected by the lens wear. 
Twelve of thirty-seven parameters that reached statistical significance over the seven-
day period are summarised in Table 5.4. The ortho-k lens wear mostly affected the first 
(initial applanation) peak (Figure 5.3), rather than the second (rebound peak) with the 
vast majority of changes occurring during the first four nights (Table 5.5). The metrics of 
the initial applanation peak and rebound peak that were unaffected by the ortho-k lens 
wear are summarised in Table 5.6 (please refer to Appendix 3 for full table and results). 
For the full explanation of the applanation peak, please refer to Section 2.2.1. 
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Figure 5.3 The affected regions by the ortho-k lens wear of the ORA applanation curve 
marked with a blue line and letters. Figure adapted and reprinted with permission from 
(Wolffsohn et al. 2012). 
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BL Night 1 Night 2 Night 3 Night 4 Night 5 Night 6 Night 7 p p F 
dive1 
421.30±13
8.39 
454.50±74.90 
414.70±118.9
3 
412.47±66.46 380.32±81.60 384.32±131.61 
416.93±107.8
7 
379.63±129.80 0.001* 0.021 2.619 
Values from upper 75% of peak 
p1area 
4817.07±7
83.76 
4833.19±1233.
09 
4585.91±983.
69 
4558.19±834.
29 
4464.56±6.16.
58 
4753.93±1162.
44 
4691.06±977.
86 
4582.30±1168.
29 
0.574 0.033 2.265 
h1 
486.36±68.
28 
479.43±80.69 462.74±81.74 439.52±59.70 420.25±51.42 446.88±81.52 458.16±87.52 438.19±76.59 0.512 0.008 2.892 
aspect1 22.56±3.91 21.70±3.75 21.87±4.72 19.60±2.97 19.00±3.39 20.21±4.47 21.46±4.98 19.92±3.59 0.225 0.007 2.994 
uslope1 
69.15±14.7
7 
70.14±14.05 65.59±17.81 62.16±14.03 58.35±12.50 60.43±16.15 67.27±17.18 57.18±15.05 0.032* 0.015 2.592 
dslope1 34.66±7.17 32.41±6.12 34.20±8.13 29.52±4.94 28.94±5.96 30.99±6.77 32.64±8.39 31.62±5.47 0.342 0.049 2.086 
Values from upper 50% of peak 
h1 
324.24±45.
52 
319.62±53.79 308.49±54.49 293.02±39.80 
280.136±34.2
8 
297.92±54.35 305.44±58.34 292.13±51.06 0.512 0.001 3.692 
h2 
305.01±31.
91 
286.96±50.16 286.60±46.80 248.64±50.16 282.81±41.90 273.46±44.80 278.88±41.35 273.03±36.04 0.645 <0.001 21.152 
w1 12.14±1.65 12.14±1.74 11.71±1.87 12.33±1.59 13.33±1.59 12.84±2.29 12.43±1.80 12.90±2.57 0.007* 0.007 2.548 
w2 11.86±2.35 12.71±3.59 12.57±3.43 13.53±3.98 13.00±3.26 12.89±2.66 13.14±3.21 12.14±2.92 0.312 <0.001 11.367 
aspect1 27.20±5.43 26.58±4.24 26.96±6.36 24.14±4.39 21.38±4.09 24.06±6.28 25.23±6.39 23.53±6.04 0.437 0.003 3.224 
dslope1 
46.78±11.8
7 
44.75±11.13 48.24±12.62 41.51±10.20 36.95±9.35 42.08±12.01 41.73±12.77 40.23±9.78 0.414 0.026 2.36 
Table 5.4 The twelve additional ORA derived metrics that reached the statistical significance over the 7-day period of ortho-k lens wear compared to BL. *If 
p<0.05, Friedman’s test procedures were carried out.
203 
 
O
R
A
 
p
a
ra
m
e
te
r 
(M
e
a
n
 ±
 S
D
) 
When effect of time is significant 
(post hoc test with Bonferroni corrections) 
night ‘x’ vs night ‘y’ p value 
dive1 night 1 vs night 4 0.015 
Values from upper 75% of peak 
p1area BL vs night 1 0.005 
h1 BL vs night 4 0.006 
aspect1 BL vs night 4 0.048 
uslope1 night 1 vs night 7 0.010 
dslope1 BL vs night 4 0.014 
Values from upper 50% of peak 
h1 
BL vs night 4 0.006 
night 7 vs BL and all nights <0.001 
h2 
BL vs night 4 0.022 
BL vs night 7 0.033 
night 1 vs BL and all nights <0.001 
w1 night 2 vs night 4 0.021 
w2 night 1 vs BL and all nights <0.001 
aspect1 
BL vs night 2 0.027 
BL vs night 4 0.01 
night 1 vs night 4 0.04 
dslope1 
BL vs night 1 <0.001 
night 1 vs night 2 0.001 
night 1 vs night 3 0.004 
BL vs night 4 0.004 
Table 5.5 Statistically significant pairwise post hoc (with Bonferroni correction) 
comparisons, showing the effects ortho-k lens wear on ORA-derived metrics after each 
night. 
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Explanation of the metric in relation to the 
changes induced by the ortho-k lens wear 
p value 
slew1 aspect ratio of dive2 where dive2 is divided by 
width 
0.510 
slew2 0.938 
mslew1 maximum single increase in the rise of the peak 
(longest continuous line without a break) 
0.157 
mslew2 0.151 
dive2 
backside of downslope of peak (absolute value of 
peak until the first break) 
0.475 
aindex the smoothness of the peak (related to the noise 
of the measurement aka how many times peak 
changes the direction and represent local 
imperfections in the cornea, respectively softness 
of the cornea) 
0.731 
bindex 0.352 
aplhf 
the smoothness of the region between the peaks 
(related to the noise of the measurement and 
represent local imperfections in the cornea, 
respectively softness of the cornea) 
0.339 
Values from upper 75% of peak 
p2area 
area under the curve (proportional estimate of the 
time needed for the cornea to change from the 
concave to the convex form) 
0.117 
h2 height from the lowest to the highest point in peak 0.08 
w1 width at the base of the peak region (descriptor of 
the time course) 
0.348 
w2 0.377 
aspect2 aspect ratio of the peak (height/width) 0.540 
uslope2 rate of increase from base to peak 0.915 
dslope2 rate of decrease from peak to base 0.264 
path1 
the absolute value of path length around the peak 
0.088 
path2 0.471 
Values from upper 50% of peak 
p1area 
area under the curve (proportional estimate of the 
time needed for the cornea to change from the 
convex to the concave form) 
0.889 
p2area 
area under the curve (proportional estimate of the 
time needed for the cornea to change from the 
concave to the convex form) 
0.247 
aspect2 aspect ratio of the peak (height/width) 0.896 
uslope1 rate of increase from base to peak 
 
0.204 
uslope2 0.934 
dslope2 rate of decrease from peak to base 0.243 
path1 
the absolute value of path length around the peak 
0.521 
path2 0.492 
Table 5.6 Summary of the additional ORA-derived parameters that did not significantly 
change over the study period. 
  
205 
 
5.4.2.2 Corneal biomechanical properties measured with Corvis ST 
All parameters measured with the Corvis ST over the seven-day period have been 
summarised in Table 5.7. None of the parameters, except for the A1 length (the cord 
length of the initial applanation), χ2(7)=39.214, p<0.001 and A2 length (χ2(7)=39.214, 
p<0.001), reached statistical significance. When outliers were removed (identified, using 
Box and Whisker plots and normality plots), A1 length approached statistical significance 
(χ2(7)=13.037, p=0.007), whilst A2 length remained significant (Figure 5.4). The post hoc 
tests revealed that A2 length was significantly different between baseline appointment 
and all 7 nights of lens wear (all p<0.001, except for BL vs 5th day – p=0.017). For the 
full explanation of the applanation metrics, please refer to Section 2.2.2. 
 
Figure 5.4 The affected region – Corvis ST derived metric (A2 length) by the ortho-k lens 
wear marked with a blue line. 
 
5.4.3 Axial length, anterior chamber depth, lens thickness and endothelial cell 
count 
No significant changes in AL, ACD or LT were observed over the 7-day period of lens 
wear (Table 5.8). Also, no changes in endothelial (END) cell count or shape were found, 
when adjusted for age (Table 5.8). However, significant changes in shape were found 
between BL and first night of lens wear (F(2,40)=4.703, p=0.015; post hoc p=0.025) when 
results were not adjusted for age. 
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BL Night 1 Night 2 Night 3 Night 4 Night 5 Night 6 Night 7 p p F 
IOP 13.38±1.82 13.37±2.04 13.17±1.93 13.87±2.07 13.31±1.84 13.19±1.55 13.36±2.18 13.36±2.16 0.784 0.866 0.66 
Def. Amp. 1.09±0.12 1.07±0.08 1.08±0.09 1.05±0.11 1.07±0.10 1.07±0.08 1.07±0.11 1.05±0.10 0.656 0.685 0.317 
A1 time 
(ms) 
7.24±0.22 7.26±0.24 7.22±0.24 7.31±0.26 7.24±0.22 7.22±0.19 7.24±0.27 7.25±0.27 0.618 0.689 0.191 
A1 length 
(mm) 
1.75±0.09 1.78±0.03 1.78±0.03 1.74±0.12 1.79±0.03 1.74±0.11 1.78±0.04 1.73±0.14 <0.001* 0.002 22.205 
A1 velocity 
(m/s) 
0.16±0.01 0.15±0.02 0.16±0.02 0.16±0.02 0.16±0.01 0.16±0.01 0.15±0.02 0.15±0.02 0.112 0.112 0.368 
A2 time 
(ms) 
22.17±0.42 22.10±0.27 22.16±0.32 22.0±0.38 22.06±0.34 22.07±0.31 22.01±0.39 22.05±0.37 0.075 0.657 0.717 
A2 length 
(mm) 
1.78±0.24 1.73±0.29 1.74±0.23 1.71±0.24 1.70±0.31 1.62±0.28 1.62±0.32 1.73±0.28 <0.001* <0.001 39.214 
A2 velocity 
(m/s) 
-0.38±0.07 -0.38±0.06 -0.38±0.06 -0.37±0.06 -0.38±0.08 -0.38±0.05 -0.38±0.06 -0.38±0.07 0.386 0.844 0.484 
HC time 
(ms) 
16.89±0.38 16.89±0.30 16.93±0.42 16.82±0.32 16.78±0.35 16.85±0.26 16.82±0.47 16.73±0.40 0.129 0.331 1.165 
Peak dist 
(mm) 
3.07±1.04 3.59±1.24 4.23±1.17 4.06±1.18 4.34±1.10 3.98±1.18 3.82±1.21 3.88±1.31 <0.001* 10.428 0.166 
Radius 
(mm) 
7.27±0.81 7.25±0.61 7.09±0.71 7.20±0.60 7.01±0.58 6.99±0.72 6.94±0.63 7.21±0.69 0.662 0.119 1.700 
A1 Def. 
Amp. (mm) 
0.13±0.01 0.12±0.01 0.12±0.01 0.13±0.01 0.12±0.01 0.12±0.01 0.12±0.01 0.12±0.01 0.754 0.456 0.719 
HC Def. 
Amp. 
1.09±0.12 1.07±0.08 1.08±0.09 1.05±0.11 1.07±0.10 1.07±0.08 1.07±0.11 1.05±0.10 0.656 0.560 0.0.461 
A2 Def. 
Amp. (mm) 
0.40±0.03 0.38±0.04 0.38±0.05 0.38±0.04 0.38±0.05 0.38±0.04 0.39±0.04 0.37±0.05 0.658 0.435 0.916 
Table 5.7 Changes in corneal biomechanical properties measured with Corvis ST over the seven-day period of ortho-k lens wear compared to baseline. *If 
p<0.05, Friedman’s test procedures were carried out, statistically significant (p<0.05). 
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BL Night 1 Night 2 Night 3 Night 4 Night 5 Night 6 Night 7 p p F 
AL (mm) 24.67±0.72 24.65±0.73 24.65±0.72 24.64±0.69 24.65±0.72 24.68±0.72 24.63±0.71 24.64±0.72 0.331 0.185 1.914 
ACD (mm) 3.79±0.18 3.77±0.18 3.77±0.19 3.78±0.22 3.77±0.19 3.75±0.29 3.77±0.19 3.78±0.17 0.708 0.351 1.036 
LT (mm). 3.51±0.20 3.53±0.18 3.53±0.21 3.54±0.20 3.53±0.21 3.53±0.21 3.52±0.21 3.51±0.22 0.267 0.452 0.897 
END cell count 
(cells/mm2) 
2693.45± 
298.33 
2556.23± 
588.21 
 
2684.07± 
296.61 
0.006* 0.446 1.614 
END cell 
hexagonality (%) 
62.38±8.82 56.81±8.81 60.3±9.24 0.895 0.129 0.88 
Table 5.8 Changes in AL, ACD, LT and endothelial cell count over the seven-day period of ortho-k lens wear compared to baseline. *If p<0.05, Friedman’s 
test procedures were carried out.
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5.4.4 Relationship between refractive, topographic and corneal thickness 
changes and corneal biomechanics 
After the first night of lens wear multiple modelling revealed that changes in the ORA-
derived parameter h2 compared to BL explained 28.3% of total variance in BVS (ΔBVS 
= 1.04 + 0.06 x Δh2; ph2=0.023). Whereas after 7 night of lens wear compared to BL 
94.5% of total variance in BVS was accounted for by the flat e (52.7%), age (13%), flat 
K (11.2%), Corvis ST-derived parameter A1 length (7.2%), delta K and ORA-derived 
parameter CH (6.5%); (ΔBVS = -5.16 – 7.27 x Δflat e + 0.26 x age -0.84 x Δflat K – 4.71 
x ΔA1 length – 0.57 x Δdelta K + 0.27 x ΔCH; pall<0.001). 
Around 28% of changes in steep e after first night of lens wear were accounted by 
changes in BVS (Δsteep e = -0.56 - 0.62 x ΔBVS; pBSV=0.024). After the seven nights of 
lens wear compared to BL, 23% of changes were explained by the variance in the ORA-
derived parameter aspect2 from the upper 50% (entered in equation as aspect21) of the 
peak; (Δsteep e = -0.19 - 0.02 x Δaspect21; paspect21=0.024). 
Variance in flat e was partially accounted for (22.5%) by changes in ORA-derived 
parameter w1 from the upper 50% of the peak (Δflat e = 2.53 + 3.96 x Δw11; pw11=0.047). 
After seven nights of lens wear 82.4% of the total variance in flat e was explained by age 
(17.9%), changes in BVS (52.9%) and Corvis ST-derived parameter A2 Def. Ampl. 
(11.6%); (Δflat e = -0.47 – 0.81 x ΔBVS + 0.21 x age + 0.99 x ΔA2 Def. Amp.; pBVS<0.001, 
page=0.002, pA2 De. Amp.=0.005). 
No other variables were found to contribute towards the multiple regression model, apart 
from flat K, which explained 69.4% of total variance in steep K after the first night of lens 
wear (Δsteep K = 0.04 +0.88 x Δflat K, pflat K<0.001). Similarly, 69.4% of variance in the 
flat K was explained by the changes in steep K (Δflat K = -0.08 +0.78 x Δsteep K, psteep 
K<0.001). After seven nights of lens wear, however, 89.8% of the variance observed in 
the steep K was accounted for flat K (37.6%), CCT (21.1%), ORA-derived parameters 
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path2 (10.2%) aspect2 from the upper 50% of the peak (6.1%) and CRF (7.2%) and the 
Corvis ST derived parameter Peak Dist. (7.6%) (Δsteep K = -0.02 +0.66 x Δflat K + 0.02 
x ΔCCT + 0.18 x Δpath2 + 0.16 x ΔPeak Dist. -0.08 x Δaspect21 -0.15x ΔCRF, 
pall≤0.001). Whereas, the variance in flat K at the same time point (55.2%) was explained 
by changes in BVS (26.8%) and the ORA-derived parameter dslope2 (28.4%) (Δflat K = 
0.17 -0.37 x ΔBVS – 0.06 x Δdslope2; pBVS=0.001, pdslope2=0.004). 
Twenty-two per cent of total variation in CCT after the first night lens wear was accounted 
for by changes in Corvis ST derived metric Peak Dist. (ΔCCT = -0.002 x ΔPeak Dist.; 
pPeak Dist.=0.049). After seven nights of lens wear 75.5% of the changes in CCT were 
explained by the variation in the ORA-derived parameters path2 from the upper 50% of 
the curve (20.2%), mslew1 (19.1%), steep e (17.3%) and age (18.9%) (ΔCCT = 0.05 + 
0.01 x Δpath21 + 0.03 x Δsteep e – 0.002 x age + Δmslew1; ppath21=0.007, psteep e<0.001, 
page<0.001, pmslew1=0.004). 
The daily variations over the study period that could be explained by corneal 
biomechanics, and the other ocular parameters, are summarised in Table 5.9.
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Parameter 
Night ‘x’ vs 
night ‘y’ 
Multiple regression equation 
p 
values 
Total variance 
explained by 
the MR model 
(%) 
Variance 
explained by 
the corneal 
biomechanical 
parameters (%) 
BVS (D) 
2 vs 1 ΔBVS = 0.58 -0.02 x Δslew2 0.017 34.3 34.3 
3 vs 2 
ΔBVS = 1.74 - 0.79 x age – 27.72 x ΔA2 Def. Ampl. – 0.02 x Δdive2 + 
Δp2area – 16.22 x ΔA1 velocity -6.27 x ΔACD 
≤0.005 85.3 50.5 
4 vs 3 ΔBVS = 0.41 – 0.04 x Δdslope2 – 0.17 x ΔCH ≤0.028 54.2 54.2 
5 vs 4 ΔBVS = -0.21 – 2.06 x Δflat e – 0.03 x Δaspect11 ≤0.019 58 19.3 
6 vs 5 ΔBVS = 0.13 -1.70 x Δflat e 0.019 25.6 – 
7 vs 6 
ΔBVS = -5.16 – 7.27 x Δflat e + 0.26 x age – 0.84 x Δflat K – 4.71 x ΔA1 
length – 0.57 x Δdelta K + 0.27 ΔCH 
<0.001 94.5 15.3 
 
 
 
CCT (µm) 
 
 
 
 
2 vs 1 None of the variance explained by the model 
3 vs 2 ΔCCT= -0.01 – 0.01 x ΔIOP – 0.26 x ΔA1 Def. Amp. ≤0.004 64.4 64.4 
4 vs 3 ΔCCT= -0.02 + 0.02 x ΔCRF – 0.02 x Δaindex ≤0.006 64.8 64.8 
5 vs 4 ΔCCT= -0.002 + 0.01 x Δsteep K 0.018 30.4 – 
6 vs 5 
ΔCCT= 0.11 + 0.13 x Δflat K – 0.12 x Δpath1 + 0.21 x ΔRadius + 0.01 x 
Δdelta K + 0.02 x Δpath11 + Δp1area 
≤0.009 100 99.1 
7 vs 6 ΔCCT= 0.05 + 0.01 x Δpath21 + 0.03 x Δsteep e – 0.002 x age + Δmslew1 ≤0.007 75.7 39.3 
Steep e 
2 vs 1 None of the variance explained by the model 
3 vs 2 Δsteep e = 0.17– 10.16 x ΔA1 Def. Ampl. <0.001 52.9 52.9 
4 vs 3 Δsteep e = -0.01 - 0.01 x Δdslope1 <0.001 51.5 51.5 
5 vs 4 Δsteep e = -0.01+ 0.01 x Δsteep K 0.049 22.1 – 
6 vs 5 Δsteep e = -0.01+ 0.42 x ΔCCT – 0.03 x Δdslope11 ≤0.04 55.2 12.2 
7 vs 6 Δsteep e = -0.19+ 0.02 x Δaspect21 0.033 23 23 
Flat e 
2 vs 1 Δflat e = -0.75 + 0.03 x Δdive2 + 3.16 x ΔCH + 130.84 x ΔLT + 0.03 x Δp1area <0.05 97.3 72.4 
3 vs 2 None of the variance explained by the model 
4 vs 3 
Δflat e = 0.05 + 0.01 x Δdslope11 + 0.03 x ΔIOPg + 0.15 x ΔA2lenght + 0.65 
x Δsteep e - 0.16 x Δalphf + 0.02 x ΔPeak Dist. 
≤0.025 88.7 75.7 
5 vs 4 Δflat e = -0.06 – 0.15 x ΔBVS 0.06 38.7 – 
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6 vs 5 Δflat e = 0.01 – 0.01 x Δflat K <0.001 48.5 – 
7 vs 6 Δflat e = 0.01 – 0.01 x Δflat K <0.001 48.5 – 
 
 
 
Steep K 
 
 
 
2 vs 1 None of the variance explained by the model 
3 vs 2 Δsteep K = -0.01 + 0.92 x Δflat K - 0.87 x ΔBVS + 0.58 x ΔA2 velocity <0.05 99.1 1.1 
4 vs 3 Δsteep K = 2.01 – 0.09 x age + 0.92 x Δflat k + Δparea ≤0.01 84.4 8.3 
5 vs 4 Δsteep K = 0.07 – 94.41 x ΔCCT – 1.66 x ΔA2 length – 1.54 x Δaindex ≤0.006 69.8 39.4 
6 vs 5 
Δsteep K = -0.27 + 7.33 x ΔCCT+ 0.93 x Δflat K OR Δsteep K = -0.27 + 1.04 
x Δflat K - 0.91 x Δw21 – 0.09 x ΔIOPcc 
<0.05 99.9 1 
7 vs 6 Δsteep K = -0.84 + 0.68 x Δflat K 0.04 37.6 – 
Flat K 
 
2 vs 1 Δflat e = -0.15 – 0.41 x Δsteep K <0.001 60.4 – 
3 vs 2 
Δflat K = -0.10 + 0.23 x Δ alphf – 0.09 x Δaspect21 + 0.002 x Δdive2 + 0.04 
x Δdslope21 + 0.08 x Δbindex -0.33 x Δsteep e – 0.01 x Δpath11 
≤0.036 94.1 84.9 
4 vs 3 Δflat K = 0.16 + 0.95 x Δflat e + 0.52 x Δsteep K ≤0.05 76.9 – 
5 vs 4 Δflat K = -1.72 + 0.75 x age + 0.31 x Δsteep K ≤0.019 55.9 – 
6 vs 5 Δflat K = 0.21 + 20.71 x ΔCCT + 0.67 x Δsteep K – 0.01 x Δuslope21 <0.05 99.9 1 
7 vs 6 Δflat K = -0.73 + 0.35 x ΔBVS – 0.06 x Δdslope2 ≤0.004 55.2 28.4 
Table 5.9 Daily variations in BVS, CCT, steep e, flat e, steep k and flat K explained by contributions of corneal biomechanical parameters measured by the 
ORA and Corvis ST and other metrics. Note: when a parameter from the upper 50% of the curve is entered in equation, ‘1’ is added to the parameter name, 
to distinguish it from the parameters from upper 75% of the peak; if no β value is entered in equation, SPSS output displayed it as ‘0’.
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5.5 Discussion 
This is the first study to date to investigate the corneal biomechanical response to ortho-
k lens wear in detail, utilising the ORA and Corvis ST and examining the first seven days 
of the lens wear, when the vast majority of the refractive changes occur (Mountford 1998; 
Swarbrick et al. 1998; Nichols et al. 2000; Alharbi and Swarbrick 2003; Soni et al. 2004; 
Swarbrick 2006). 
As expected, ortho-k lens wear, effectively reduced myopic refractive error over the 
seven-day period and corrected around 60% of initial myopic refractive error within one 
night of lens wear, which is in agreement with previous work (Mountford 1998; Swarbrick 
et al. 1998; Nichols et al. 2000; Alharbi and Swarbrick 2003; Soni et al. 2004). Also, a 
gradual flattening of the corneal curvature, with significant changes occurring in the 
flattest corneal meridian first, was observed. This finding is supported by the previous 
findings of Swarbrick and colleagues (1998) and others (Soni et al. 2003; Sorbara et al. 
2005). The observations of central corneal thinning that reached significance after the 
seventh night of lens wear, however, contradicts the work by Swarbrick and co-workers 
(1998). Although they reported central corneal thinning, it failed to reach statistical 
significance even after 28 days of ortho-k lens wear. The changes in CCT reported in 
the present study also contradicts the findings of Alharbi and Swarbrick (2003) and 
Haque et al. (2004), but are in agreement with Nichols and colleagues (2000) and others 
(Owens et al. 2004; Yoon and Swarbrick 2013), who postulated that the vast majority of 
epithelial thinning occurs between the first and seventh night of lens wear. These 
discrepancies between studies could arise from different techniques employed to 
measure corneal thickness (Swarbrick et al., 1998, Nichols et al., 2000, Owens et al., 
2004) or experiment conditions (closed- vs open-eye environment) (Swarbrick et al., 
1998, Alharbi and Swarbrick, 2003, Owens et al., 2004, Yoon and Swarbrick, 2013). 
Swarbrick and colleagues(1998) used modified Holden-Payor optical micropachometer 
at eight different locations (central, 0.5 mm, 1.25 mm, 2.75 mm and 4.25 mm nasal and 
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0.25 mm, 1.00 mm, 2.50 and 4.00 mm temporal). Later Alharbi and Swarbrick (2003) 
used the same approach, but different corneal locations (centre (0.25 mm nasal), 3.50 
mm and 5.00 mm nasal and 3.25 mm and 4.75 mm temporal). Whilst, Nichols (2000) 
employed Orbtek Orbiscan (Salt Lake City, UT, USA) to measure centrally and 3mm 
from the centre nasally, temporally, inferiorly and superiorly. Owens et al. (2004) used 
the EyeSys corneal topographer (EySys Technologies, Huston, TX, USA) to measure 
corneal thickness at 1.25 mm radius from the centre for central readings and at 2.5 mm 
radius for the mid-periphery. Although authors justify their choice of locations as 
instrument specific (Nichols et al. 2000; Owens et al. 2004) or corresponding to the 
reverse geometry lens zones (Nichols et al. 2000; Alharbi and Swarbrick 2003; Owens 
et al. 2004; Yoon and Swarbrick 2013),  
Also, it could account for the assumptions made by various researchers that different 
mechanisms and complex interactions within the cornea take place in the initial stages 
of ortho-k lens wear (Swarbrick et al., 1998, Owens et al., 2004, Yoon and Swarbrick, 
2013). The flattening of the anterior cornea, central epithelial thinning and mid-peripheral 
thickening is well documented in the literature (Swarbrick et al. 1998; Alharbi and 
Swarbrick 2003; Tsukiyama et al. 2008); however, the overall mechanisms of these 
changes are still obscure. Swarbrick et al. (1998) was the first group to demonstrate the 
central corneal thinning and mid-peripheral stromal thickening and hypothesised it could 
be due to the tissue re-distribution of the anterior cornea. A study conducted later (Owens 
et al. 2004), however, questioned the involvement of the anterior corneal tissue and 
demonstrated that transient changes in posterior corneal curvature can be observed in 
the first week of ortho-k lens wear. Other studies (Tsukiyama et al. 2008; Chen et al. 
2010; Yoon and Swarbrick 2013), have failed to support the findings by Owens et al. 
(2004) and support the theory of anterior corneal shape changes as the main attributor 
of the refractive changes achieved by ortho-k. The observations at microscopic level in 
animal models (Matsubara et al. 2004; Cheah et al. 2008; Choo et al. 2008) support the 
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findings of the corneal thickness changes. However, they question the tissue re-
distribution as the main mechanism of these changes and consider the mechanical 
effects of the lens, the plasticity of epithelium, cell compression and inter-cell processes, 
especially in the first days of ortho-k lens, instead (Matsubara et al. 2004; Cheah et al. 
2008; Choo et al. 2008).  
In terms of corneal biomechanics, CH (descriptor of the viscous damping properties) and 
CRF (the overall resistance of the cornea) measured by the ORA were not affected by 
the ortho-k lens wear. Previous work suggests that significant changes in CH (Mao et al. 
2010) and CRF (Chen et al., 2009, Mao et al., 2010) can be observed after as little as 
one night of ortho-k lens wear. Furthermore, work presented by Yeh and colleagues 
(2013) demonstrates, that changes in both parameters become significantly apparent 
after 30 nights of ortho-k lens wear. Age (Kotecha et al. 2006; Shen, Fan, et al. 2008; 
Kotecha et al. 2014) and ethnicity (Yeh et al., 2013) have both been linked to the corneal 
biomechanical properties measured by the ORA. However, it is unlikely that these factors 
could account for the discrepancy between the results of the previous work and the 
results reported in the present study as both the age (range 18-36 years) and ethnicity 
(predominantly Asian or Asian ethnicity) of the cohorts were similar (Chen et al., 2009, 
Yeh et al., 2013), with the exception of the study conducted by Mao and colleagues 
(2010), in which Chinese children (mean ± SD, 11.67 ± 2.56) participated. 
It is more likely that the differences between the findings of the present study and 
previous work (Kerautret et al. 2008; Saad et al. 2010; Mikielewicz et al. 2011) could be 
explained by other factors. Researchers have previously questioned the CH and CRF 
ability to discriminate between normal and ectatic corneas, and demonstrated that CH 
and CRF should not be the only corneal biomechanical factors considered. Moreover, 
CH and, subsequently, CRF (as it is derived from CH) are suggested to be descriptors 
of the viscosity of the extracellular matrix components proteoglycans and glycoproteins 
and their interaction with collagen fibrils, (Nishimura et al. 1998; Spörl et al. 2009; Terai 
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et al. 2012), rather than collagen fibrils themselves. Collagen fibrils dominate the corneal 
mechanical behaviour and, subsequently, its response to ortho-k, as they are the main 
carriers of the load (Boote et al. 2005; Elsheikh 2010). Also, if the refractive changes 
during the first days of ortho-k lens wear are predominately achieved by epithelium 
(Matsubara et al. 2004; Cheah et al. 2008; Choo et al. 2008), CH and CRF could not 
reflect these changes, as both of these parameters are descriptors of stromal behaviour. 
The epithelium has been found to account for only 3% of the overall mechanical 
behaviour of the cornea (Elsheikh et al. 2008a). It is established that corneal behaviour 
is time and load-dependent (Elsheikh, 2010) and, therefore, changes in CH and CRF 
could become significant within a longer study period, as demonstrated by Yeh and co-
workers (2013).  
Detailed analysis of the air-pressure curve revealed that 12 of the additional 37 ORA-
derived parameters were affected by ortho-k lens wear. The vast majority of the changes 
occurred during the initial applanation and were more pronounced in the upper 50% of 
the applanation peak, suggesting that ortho-k lens wear affects the transition of the 
cornea from the convex to concave form more than the original applanation phase 
(Figure 5.3). A time-dependent variability in the different ORA-derived metrics was 
observed with most of the significant changes occurring during the first four nights of the 
ortho-k lens wear.  
A reduction in the absolute value of the first break of the initial applanation peak, which 
is a descriptor of the speed of the deformation past the concave phase, was observed. 
It might reflect the corneal shape changes induced by ortho-k lens wear. Ortho-k treated 
cornea might be deformed or flattened more easily as it is already undergoing flattening 
induced by the reverse geometry lens. The area under the curve (AUC), p1area 
decreased over the 7 nights, alongside with the height (h1 and h2 from upper 50% and 
h1 from upper 75% of the curve). AUC is the proportional estimate of the time needed 
for the cornea to change from the convex to concave form and is dependent on the peak 
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height and width. Therefore, the ortho-k treated cornea again could be more easily 
flattened due to the changes induced by the reverse geometry lens. Decrease in the 
AUC over the time could also reflect the increasing deformation (Elsheikh 2010) and 
epithelial remodelling (Cheah et al. 2008; Choo et al. 2008; Elsheikh 2010), induced by 
the repeated exposure to the ortho-k lens. Also, the upward slope from the upper 75% 
of the peak, downward slope (dslope1) from the upper 75% and 50% (uslope1) and width 
(w1) from the upper 50% and, subsequently, aspect 1 or the aspect ratio of the peak 
height/width from the upper 75 and 50% of the applanation peak, were reduced. This 
may indicate that the cornea becomes more bendable (the basic methodology of the 
ORA) and less resistant as a result of the ortho-k lens wear (Elsheikh, Ross, et al. 2009; 
Terai et al. 2012), or yet again it could reflect the flattening effect of the reverse geometry 
lens. The latter assumption could help to explain the changes in the height (h2) from the 
upper 50% of the rebound peak, reflecting the reshaping effect of the ortho-k lens wear 
(Cheah et al. 2008; Choo et al. 2008; Elsheikh 2010). 
The fact that aindex, bindex and aplhf or the descriptors of the smoothness of the 
applanation curve and, subsequently, the local imperfections of the corneal structure, 
suggest that short term ortho-k lens wear does not disrupt the structure stromal 
extracellular matrix. Observations at microscopic level in primates have shown that even 
4 hours of reverse geometry lens wear induces marked changes in the central corneal 
epithelial and stromal thickness (Cheah et al. 2008). Therefore, this assumption needs 
to be viewed cautiously and more work is needed to support this theory. Also, the role 
and, subsequently, the interpretation of the specific ORA-parameters (aindex, bindex 
and aplhf) need to be investigated more thoroughly. 
From the 14 parameters provided by the Corvis ST, only applanation 1 length (A1 length) 
and applanation 2 length (A2 length) were found to be affected by the ortho-k lens wear. 
Applanation length is an estimate of the cord or length of the area of the cornea that is 
flattened by the air puff. An apparent decrease in the A2 length was seen and it most 
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likely reflects the changes in formation of central treatment zone, induced by the reverse 
geometry lens (Figure 5.4). However, contrary to the findings of the ORA, the parameters 
of the Corvis ST, relating to the speed of the deformation (A1, A2 velocity) and the 
deformation amplitude (deformation amplitude (DA), deformation amplitude of the first 
(A1 Def. Ampl,) and second (A2 Def. Ampl.) applanation and highest concavity (HC Def. 
Ampl.)), remained unchanged. Although, a weak to moderate correlation between 
different Corvis ST and ORA (specifically CH and CRF) parameters, has been found 
(Matsuura et al. 2016), Corvis ST measures the actual corneal movement (Hon and Lam 
2013; Koprowski 2014; Matsuura et al. 2016), induced by the air puff, whilst the ORA 
analyses the change in reflectance angle of the light incident on the central cornea (Luce 
2005; Matsuura et al. 2016). No papers to date have investigated the correlation between 
the Corvis ST and the additional ORA-derived parameters, however, as they are derived 
from the same applanation signal as CH and CRF, the differences between findings of 
the Corvis-ST and ORA are not surprising.The different measurement approaches 
between instruments makes it difficult to make direct comparisons between findings of 
the ORA and Corvis ST (Tejwani et al. 2014). The arbitrary technique employed by the 
ORA and the measurement of horizontal corneal displacement in real time by the Corvis 
ST provides a significant information about corneal response in vivo, however, further 
studies are required to better establish all parameters from each device to ease the 
clinical application of them in different scenarios. The fact that Corvis ST did detect less 
changes than the ORA in the current application could indicate either that the ortho-k 
lens does not induce significant corneal displacement in horizontal plane or the time 
period of the current study was too short for the Corvis ST to detect any changes induced 
by the reverse geometry lens. As this is the first study investigating corneal 
biomechanical response in ortho-k, using Corvis ST, it is diffucult to make any 
comparisons or assumptions. 
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As expected, AL, ACD and LT were not affected by the ortho-k lens wear over the study 
period, suggesting that mechanisms underlying ortho-k therapy are corneal in origin. This 
finding is supported by Santodomingo-Rubido and colleagues (2014) who studied short-
time changes in axial elongation and other ocular biometric parameters after 1 week of 
discontinuation of long term ortho-k lens wear in Caucasian schoolchildren and 
concluded that refractive changes were primarily accounted by the recovery of corneal 
shape. Subsequently Santodomingo-Rubido and colleagues (2016) investigated the 
corneal power changes over 3 and 24 months of ortho-k lens wear in the same cohort 
and concluded that the changes in corneal power (central, peri- and para- central) were 
not correlated with the increasing AL. A study, investigating ACD in a cohort of myopic 
adults (mean age ± SD, 29.6 ± 3.8 years) also concluded that the refractive changes, 
induced by the ortho-k lens are primarily attributed to the changes in the anterior corneal 
shape (Tsukiyama et al. 2008). 
Multiple regression analysis revealed complex interactions between refractive, corneal 
curvature, thickness and biomechanical changes over the initial seven nights of ortho-k 
therapy (Table 5.9). After the first night of the lens wear only up to 30% of the total 
variance in the changes of BVS, CCT and steep and flat meridian eccentricity could be 
explained by the fitted model, with little or no contribution of corneal biomechanical 
properties. However, as the treatment effect progressed over the subsequent days, 50-
99% of the total variance were accounted for by the multiple regression modelling. 
Corneal biomechanical characteristics contributed significantly to the model and on 
average explained around 45% of the total variance in BVS, CCT, simulated keratometry 
readings and eccentricity. These interactions, presumably, reflect the stress, strain, 
shear and creep processes occurring within the corneal tissue in response to the static 
deformation induced by the ortho-k lens and the ability of the dynamic deformation, 
induced by the ORA and Corvis ST to detect these changes (Elsheikh, Ross, et al. 2009; 
Elsheikh 2010; Terai et al. 2012). 
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The study has several limitations. Although study reached the required power not all 
participants were able to attend both study visits. Also, not all participants could attend 
the schedualed appointments at the same time of the day, therefore, diurnal variances 
could have had an influence on the results summarised in this chapter (Kiely et al. 1982; 
Harper et al. 1996). Initial inclusion criteria of myopia -2.00D to -4.00D with with-the-rule-
astigmatism of up to 1.50D were also changed due to available participant pool. Subjects 
with these parameters of refractive error have been found to respond to ortho-k treatment 
better (Swarbrick 2006) and would have provided a more controlled environment for the 
investigation of corneal biomechnical properties. 
To conclude, this study demonstrates marked changes in corneal biomechanical 
parameters measured by the ORA and Corvis ST, occurring over the initial 7 nights of 
ortho-k lens wear. The refractive and curvature changes take place during the first night 
of the lens wear, whilst thickness changes of the central cornea and biomechanical 
parameters measured by ORA and Corvis ST happen more gradually, occurring over 
the first seven nights of ortho-k lens wear. It highlights the complex processes underlying 
the mechanisms of ortho-k, providing further evidence for the corneal involvement in the 
treatment response. However, ortho-k itself and the anterior segment structures 
undergoing changes during the corneal reshaping process are unable to explain all of 
the variation in treatment response, indicating that other patient specific factors could 
affect treatment outcome. Therefore, a better understanding of corneal biomechanical 
parameters in healthy individuals is required to potentially establish a list of predictors 
that would enhance the chances of achieving desired treatment effect.  
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Chapter 6. Factors influencing corneal biomechanics 
6.1 General overview 
This chapter describes a study investigating corneal biomechanical response in cohort 
of 158 healthy individuals by using the Ocular Response Analayzer (ORA) (Reichert 
Ophthalmic Instruments, Buffalo, NY, USA) and Corvis ST (Oculus, Wetzlar, Germany); 
in relation to various factors like age, ethnicity, diet, eye and body size. The aim of this 
study is to aid a better understanding to factors that might influence corneal 
biomechanical response in healthy population and if any of these factors could act as 
predictors for treatment outcome in different clinical scenarios, for example in case of 
application of ortho-k and myopia control (MC). 
6.2 Introduction 
The cornea is a unique structure that, together with sclera, forms the outer tunic of the 
eye and provides two thirds of eye’s optical power (Hogan et al. 1971; Fatt and 
Weissman 1992; Klyce and Beuerman 1998). As the anterior surface and primary optical 
element of the eye, the cornea can be compromised by several conditions such as: 
keratoconus, in which a progressive, non-inflammatory thinning of the corneal stroma 
occurs (Rabinowitz 1998; Ruberti et al. 2011); Fuchs endothelial dystrophy, which is 
characterised by the formation of cornea guttae and increased loss of corneal endothelial 
cells (Repp et al. 2013); and trauma, which may result in reduced visual acuity. Likewise, 
the cornea can be re-shaped to correct the mismatch between eye’s axial length (AL) 
and optical power, and the resulting refractive error. Techniques to address such issues 
include: refractive surgery, in which the required refractive changes are achieved by the 
ablation of corneal tissue (Roberts 2000; Ruberti et al. 2011); and orthokeratology (ortho-
k), in which a specific reverse geometry lens is worn overnight to induce the desired 
corneal shape changes (Swarbrick 2006) (as discussed in more detail in Chapter 1). 
Regardless of whether the changes are caused by pathology or induced artificially, 
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corneal structure and material properties, factors which are crucial for the eye’s optical 
performance, are altered (Fatt and Weissman 1992; Swarbrick et al. 1998; Roberts 2000; 
Ruberti et al. 2011). Therefore, a close and dynamic monitoring of the corneal tissue is 
required to predict the course of disease and the treatment outcome. 
Until recently, the monitoring and follow-up of disease progression, procedure outcomes, 
or corneal behaviour mostly relied upon the geometrical and biometrical measurements 
of the cornea (namely topography and corneal thickness), mathematical modelling, and 
observations of destructive in-vitro testing (Ethier et al. 2004; Elsheikh 2010; Ruberti et 
al. 2011). Destructive in-vitro testing has provided a detailed understanding of the 
different biomechanical properties possessed by corneal layers (Elsheikh et al. 2008a; 
Thomasy et al. 2014). It has also identified the viscoelastic nature of corneal tissue, 
which is dominated by its bulk component, the stroma, which exhibits a two phase stress-
strain relationship (Anderson et al. 2004; Boyce et al. 2008), and regional differences of 
corneal response to external stress (Hjortdal 1996; Anderson et al. 2004; Elsheikh et al. 
2007; Whitford et al. 2015). Age-related stiffening of the cornea, presumably due to the 
changes in collagen fibril behaviour and distribution, has also been reported (Malik et al. 
1992; Elsheikh et al. 2007). These studies highlight the contributing factors in the varied 
progression of disease and the selective treatment outcome. In-vitro testing is limited by 
a range of factors, such as the availability of donor tissue (Myung et al. 2008); the 
suitability of an appropriate experimental model (Boyce et al. 2008; Elsheikh et al. 
2008b); and, its inability to mimic in-vivo conditions (Elsheikh et al. 2007), which are also 
multifactorial (for example the impact of lifestyle or ethnicity). Measurements which were 
easily obtainable in-vivo, such as pachymetry and corneal topography, are incapable of 
detecting such biomechanical changes. 
The introduction of the Ocular Response Analyser (ORA, Reichert Technologies, NY, 
USA) in 2005 (Luce 2005) and the Corvis ST (Oculus, Wetzlar, Germany) in 2011 (Hon 
and Lam 2013) have allowed corneal biomechanics to be clinically examined (the 
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working principles of and parameters derived from both instruments have been 
discussed in detail in Section Chapter 2).  
ORA-specific parameters corneal hysteresis (CH) and corneal resistance factor (CRF) 
have been studied in association with age (Kotecha et al. 2006; Kamiya et al. 2009; 
Landoulsi et al. 2013), ethnicity (Detry‐Morel et al. 2012), a range of ocular conditions 
(Luce 2005; Sullivan-Mee et al. 2008; Abitbol et al. 2010; Fontes et al. 2010; Saad et al. 
2010; Wolffsohn et al. 2012), and several procedures, including ortho-k and refractive 
surgery (Gonzalez-Meijome et al. 2008; Kirwan and O’keefe 2008; Chen et al. 2009). 
The Corvis ST has been shown to be effective for examining the effect of ocular clinical 
conditions such as diabetes mellitus (Perez-Rico et al. 2015) and glaucoma (Salvetat et 
al. 2015; Wang et al. 2015), and procedures such as refractive surgery (Frings, A. et al. 
2015; Frings, Andreas et al. 2015). However, there is a distinct lack of population based 
studies investigating the biomechanical properties of the cornea in healthy individuals 
(Kamiya et al. 2009; Landoulsi et al. 2013; Valbon et al. 2014). Moreover, only a few 
studies (Kerautret et al. 2008; Mikielewicz et al. 2011; Wolffsohn et al. 2012; Landoulsi 
et al. 2013) have examined the additional 37 parameters of applanation curve provided 
by the second generation ORA, which are believed to be better descriptors of the corneal 
mechanical behaviour than CH and CRF alone (Saad et al. 2010; Mikielewicz et al. 
2011). 
The aim of this study was, therefore, to investigate the applanation curve provided by 
the ORA and the Corvis ST specific parameters in healthy individuals in association with 
age, ethnicity, nutrition, and eye and body size. This would provide a deeper 
understanding of corneal biomechanical response, not only observed in normal aging, 
but also from the viewpoint of lifestyle effects, which have not yet been studied widely. 
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6.3 Methods 
6.3.1 Subjects and study protocol 
One hundred and fifty-eight volunteers with good ocular and general health were 
recruited from the population of Aston University’s students, staff, and their families and 
friends. Exclusion criteria were: any history of ocular trauma, surgery, disease, and rigid 
contact lens wear. Written consent was obtained before the examination in accordance 
with the tenets of the Declaration of Helsinki. The study was approved by the Aston 
University Research Ethics Committee (included in Appendix 6.2). 
Participants were invited to attend a 60-minute appointment at the Aston University 
Health Clinic. They were advised to cease soft contact lens wear 24 hours before the 
appointment. Appointments were scheduled at least 2 hours after waking to diminish the 
impact of overnight and contact lens wear induced oedema (Armitage and Schoessler 
1988; Harper et al. 1996; Fonn et al. 1999; Du Toit et al. 2003). All participants filled out 
personal details sheet specifying their age and ethnicity based on the recommendations 
from the Office of National Statistics  
(https://www.ons.gov.uk/methodology/classificationsandstandards/measuringequality/et
hnicgroupnationalidentityandreligion; accessed 01.10.2015). 
6.3.2 Measurements 
Participants were optimally positioned in front of each instrument and asked to fixate on 
an appropriate target. Manufacturer recommendations (if any) were taken into account 
in order to obtain optimum readings. Both eyes were examined during the appointments, 
however, only the readings of the right eye (RE) for all measurements taken were 
included in the analysis. Refraction was measured monocularly using an open-field 
autorefractor (Shin-Nippon SRW, Anjiomato Trading Inc., Tokyo, Japan) with 
accommodation relaxed using a (+5.00D) Badal lens system. Ten measurements were 
averaged to calculate mean spherical equivalent (MSE). 
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A corneal topographer (Medmont E300, Medmont Ltd, Melbourne, Australia) was used 
to measure corneal shape, specifically eccentricity and keratometry (K) readings. The 
corneal endothelium was assessed using the Topcon SP3000P specular microscope 
(Topcon, Tokyo Japan). Central corneal thickness (CCT) was measured using ocular 
biometer and topography system Aladdin (Topcon, Tokyo Japan). Axial length, the 
assessment taken to represent eye size, was measured, using an optical biometer (IOL 
Master 500, Carl Zeiss Meditec Ltd, Jena, Germany).  
Height and weight measurements were taken using a stadiometer (Seca, Birmingham, 
UK) and a mechanical scale (Boots UK Ltd, Nottingham, UK). Three subsequent height 
measurements were taken to the closest 0.1 cm (Taylor et al. 2006) to establish 
observers’ standard deviation (SD), as suggested by Voss (1990), and were in 
agreement with a typical SD range of 0.2 to 0.3 cm (Voss et al. 1990). Weight was 
measured to the closest 0.5 kg, and 1 kg was taken away from the final reading to 
account for the participant’s clothing (Taylor et al. 2006). Subsequently, body mass index 
(BMI=weight (kg) (height (m))2⁄ ) was calculated (Must and Anderson 2006). 
The biomechanical properties of the cornea were measured using ORA (ORA, Reichert 
Ophthalmic Instruments, Buffalo, USA) Corvis ST (Oculus, Wetzlar, Germany). For the 
ORA, 4 measurements with a waveform score (WS) ≥ 6.5 were obtained. The instrument 
automatically selected the best reading or best signal value (BSV). The WS cut-off value 
was chosen arbitrarily (Ehrlich et al. 2010; Lam et al. 2010; Ayala and Chen 2012; 
Mandalos et al. 2013). For Corvis ST three measurements with quality core (QS) were 
obtained and one reading was selected for analysis (Matsuura et al. 2016) (for specific 
details on instrumentation please refer to Chapter 2). 
6.3.2.1 Food frequency questionnaire 
Food consumption data concerning average frequency and portion sizes over the prior 
year were obtained using a 90 item Food Frequency Questionnaire (FFQ, included in 
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Appendix 4), adapted to include food items commonly consumed in the UK (Chiu et al. 
2014). For each food item, the average intake frequency (9 categories ranging from 
‘never’, or ‘less than once per month’, up to ‘6 or more times per day’) in specified portion 
sizes (3 categories: small, medium and large) was recorded. For estimation purposes, 
’medium’ portion size was considered to be the natural portion of each food item (e.g., 
one apple), standard weight (e.g., one handful of berries or rice) or volume measures 
(e.g., one glass of milk) commonly used in the UK. A ‘small’ portion was considered to 
be half of a medium portion size, and a large portion was considered to be 1.5 times that 
of a medium portion. Subsequently, all intakes and portion sizes were broken down to a 
daily intake in a medium portion size (e.g., an average intake of a large serving 5-6 times 
per week was converted to ([5.5/7]x1.5)=1.18 medium portions/day). The 90 food items 
were then divided into 37 pre-defined food groups (Table 6.1), as identified by Chiu et 
al., (2014) to minimise within-person variations and to perceive the possible influence of 
diet as whole (Hu 2002) on the corneal biomechanics. Subsequently the 90 food items 
were separated into categories of specified food groups/nutrients to evaluate the 
possible influence of specific products (Table 6.2).  
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Food group Food items 
Processed meat Hotdogs, ham, bacon, sausage 
Red meat Hamburgers. beef, beef stew, pork or lamb 
Organ meat Liver, liverwurst 
Fish and other seafood Fried fish, tuna, oysters, shrimp, other fish 
Poultry Fried chicken, chicken or turkey 
Pizza Pizza 
Soup Vegetable and tomato soup, other soup 
Eggs Eggs 
Butter or margarine Butter added to vegetables, butter on bread, margarine on 
bread 
Peanuts Peanuts or peanut butter 
Gravies Gravies 
Cold breakfast cereal Milk on cereal, other cold breakfast cereal 
Whole grains High-fibre cereals, fortified cereals, cooked cereals, brown 
bread 
Refined grains Biscuits, white bread, corn bread, pasta or, spaghetti, 
noodles 
Rice Rice 
Snacks Crisps 
High-energy drinks Regular soft drinks, fruit drinks, sugar in coffee or tea 
Sweets and desserts Doughnuts, chocolate, candy, other candy 
Chips Chips 
Liquor Liquor 
Beer Beer 
Wine Wine 
High-fat dairy products Whole milk, ice cream, other cheese, macaroni and 
cheese, milk in coffee or tea 
Low-fat dairy products Semi-skimmed milk, skimmed milk, yogurt, cottage cheese 
Condiments Red chili sauce 
Salad dressings Salad dressings 
Fruit 
Apples, bananas, peaches, melon, watermelon, 
strawberries, Oranges, grapefruit, other fruit 
Fruit juice Orange or grapefruit juice 
Cruciferous vegetables Broccoli, coleslaw, cauliflower, cooked greens 
Dark yellow vegetables Butternut squash, carrots, sweet potatoes 
Tomatoes Tomatoes 
Green leafy vegetables Raw spinach, cooked spinach, green salad 
Legumes String beans, peas, other beans, chili with beans 
Other vegetables Corn, any other vegetable 
Potatoes Potatoes 
Coffee or tea Coffee or tea 
Non-dairy creamer in 
coffee or tea 
Non-dairy creamer in coffee or tea 
Table 6.1 Summary of the 37 food groups extracted from 90 item FFQ. Adapted from 
Chiu et al. (2014). 
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Food group/nutrients Food items 
Fruit, Vegetables, Soup Apples, bananas, peaches, melon, watermelon, 
strawberries, Oranges, grapefruit, other fruit, broccoli, 
coleslaw, cauliflower, cooked greens, butternut squash, 
carrots, sweet potatoes, potatoes, raw and cooked spinach, 
cooked greens, string beans, other beans, tomatoes, other 
vegetables 
Meat Hotdogs, ham, bacon, sausage, hamburgers. beef, beef 
stew, pork or lamb, liver, liverwurst, fried chicken, chicken 
or turkey 
Dairy products Whole milk, ice cream, other cheese, milk in coffee or tea, 
semi-skimmed milk, skimmed milk, yogurt, cottage cheese 
Carbohydrates High-fibre cereals, fortified cereals, other cold cereals, 
cooked cereals, brown bread, white bread, corn bread, 
biscuits, doughnuts, chocolate, other candy, pasta or 
spaghetti, rice, noodles, crisps, pizza, chips 
Drinks Regular soft drinks, coffee or tea 
Sauces Gravies, red chili sauce, salad dressings 
Fish/ Omega 3 rich 
products 
Fired fish, tuna, oysters, shrimp, other fish 
Alcoholic drinks Beer, wine, liquor 
Vitamin E rich products Broccoli, raw spinach, cooked spinach, tomatoes, peanuts 
and peanut butter, margarine 
Table 6.2 Summary of the food groups/ nutrients subsequently extracted from 90 item 
FFQ. 
6.3.3 Statistical Analysis 
The study was designed to achieve 80% power (α=0.05) to detect a minimum association 
of r=0.25 between the variables based on the results of similar studies previously 
published (Kotecha et al. 2006; Kotecha et al. 2014), and required a minimum of 120 
participants. More participants were considered to be beneficial due to the study 
population being restricted to the university environment, and a larger sample size could 
be advantageous when analysing the association between corneal biomechanical 
properties and age. Statistical power software G*Power 3.0 (Faul et al. 2007) was used 
for the sample size calculations.  
During the data collection process, Corvis ST was not able to consistently achieve a 
measurement due to alignment issues, therefore obtaining valid measurements with QS 
‘OK’ status was difficult. As a result, data from 89 participants could be retrieved for 
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analysis, achieving 68% power. Whilst the unit was analysed for defects, the 
manufacturer did not find the instrument to be faulty.  
All data were organised using Excel (Microsoft Corporation, Redmond, USA) and 
subsequently transferred to SPSS (IBM SPSS Statistics for Windows, v. 21.0. IBM 
Corporation, Armonk, USA) for statistical analysis. Data were tested for normality 
(p>0.05) using Kolmogorov-Smirnov (K-S) test. 
As most of the data were not normally distributed, and some of the factors were 
dichotomous and ranked, Spearman’s correlation coefficient was used to investigate the 
possible association between the variables. Confidence intervals were bootstrapped. 
Multiple regression analysis (stepwise) was used to determine the relationship between 
demographic variables, dietary components, ocular biometric parameters and multiple 
potentially dependent corneal biomechanical variables, to determine the total variance 
that could be explained. 
For food consumption data, a factor or Principal Component Analysis (PCA) was 
conducted to extract the most important information (dietary components) from the given 
data set (Abdi and Williams 2010).  
6.4 Results 
6.4.1 Cohort demographics and ethnicity 
The mean age (± SD) of the participants (99 women and 59 men) was 32.4 ± 12.3 years 
(range 19 to 67). The mean spherical equivalent (MSE, ± SD) refractive error was -1.46 
± 2.25 dioptres (range -11.81 to 3.60). Forty nine percent (n=77) of the participants were 
of an Asian background (mostly from India and Pakistan), 43% (n=68) were Caucasian, 
4% (n=7) were of mixed ethnicity, 2% (n=3) of black and 2% (n=3) of another ethnicity. 
Hence only Caucasian and South West Asian ethnicities were compared in this element 
of the analysis.  
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6.4.2 Daily food consumption 
Two dietary patterns, based on eigenvalues, parameters extracted from the data set after 
it has been linearly transformed, and similar to those reported previously (Hu et al. 1999; 
Chiu et al. 2014), were identified from the data set and classified as ‘British oriental’ or 
‘British Western’ patterns, respectively. To identify which dietary pattern each participant 
had, a final score was obtained based on daily food consumption and weighted by the 
individual factor loadings. The highest score determined the dietary pattern. Individual 
factor loadings for both patterns of food items groups are summarized in Table 6.3. For 
more details please refer to Chiu et al. (2014). The ‘British Oriental’ pattern was 
associated with a higher intake of vegetables, fruit, low fat dairy products, peanuts, fish 
and poultry, whereas the ‘British Western’ pattern was associated with higher intake of 
refined grains, vegetables, rice, potatoes, red meat and high energy drinks.  
The British Oriental pattern explained 11.6% of the total variance or differences between 
participants in daily food consumption, whilst British Western Pattern accounted for 8.4% 
of total variance. Therefore, diet classification was not considered as an appropriate 
method to assess food intake, alternatively the consumption of specific food groups 
(Table 6.2) was investigated (Table 6.4 and Table 6.5). 
Moreover, the diet of 72.8% (n=115) of the study participants mainly consisted of 
vegetables, fruit, low fat dairy products, peanuts, poultry and fish, and therefore aligned 
more closely with the British Oriental pattern. Whereas 27.8% of participants were 
identified to have British Western pattern as their diet type. 
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Food item or food group 
Factor 1: British Oriental 
pattern 
Factor 2: British 
Western pattern 
Tomatoes 0.64 - 
Green leafy vegetables 0.62 - 
Fruit 0.60 - 
Legumes 0.59 - 
Dark yellow vegetables 0.54 - 
Low fat dairy products 0.46 - 
Cruciferous vegetables 0.46 - 
Peanuts 0.44 - 
Fish and other seafood 0.44 - 
Whole grains 0.36 - 
Soup 0.33 - 
Poultry 0.31 - 
Coffee or tea 0.30 - 
Refined grains - 0.70 
Other vegetables 0.42 0.58 
Potatoes 0.31 0.55 
Rice - 0.52 
Red meat - 0.46 
Chips - 0.45 
High energy drinks - 0.45 
Processed meat - 0.42 
Sweets and desserts - 0.42 
Snacks - 0.42 
Organ meat - 0.38 
Pizza - 0.37 
Butter or margarine - 0.35 
Table 6.3 Individual factor loadings for two major dietary patterns identified. Food items 
or groups with factor loading less than 0.3 were not listed and included in the subsequent 
dietary pattern calculation. 
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6.4.3 Corneal biomechanical properties in association with age, ethnicity, daily 
food consumption, eye and body size and ocular biometry 
6.4.3.1 Ocular Response Analyser 
Statistically significant correlations are summarised in Table 6.4. A full list of correlations 
is included in Appendix 5. Age had no influence on the main ORA parameters CH 
(rs=0.094, p=0.298) and CRF (rs=0.097, p=0.284) or any other ORA derived parameter 
(all p>0.05, Appendix 5). Similarly, ethnicity had no effect on the ORA specific corneal 
biomechanical parameters CH (rs=0.010, p=0.091), CRF (rs =-0.008, p=0.926) or any 
other parameter (all p>0.05, Appendix 5, Table A).  
Eye size (measured as AL) and body size (BMI) both had an effect on corneal 
biomechanical properties measured with the ORA. Eye size was positively correlated (all 
p<0.05) with 8 of 41 ORA specific parameters, mostly from the second rebound 
applanation (Table 6.4). An inverse relationship existed between body size and 5 of the 
ORA corneal biomechanical parameters (all p<0.05). Four of the parameters were from 
the initial applanation peak (Table 6.4). 
Dietary patterns extracted with the PCA analysis had no influence on CH (rs=0.125, 
p=0.116), CRF (r=0.091, p=0.314) or any other ORA specific parameter (p>0.05, 
Appendix 5, Table A). However, specific dietary components like meat (p<0.05) and fish 
(p<0.05) were correlated with 4 of the additional 37 ORA specific parameters. No 
consistent pattern in the relationship between the intake of a specific dietary component 
and the corneal biomechanical properties was observed (Table 6.4). An inverse 
relationship between CCT and only one of the forty-one ORA specific parameter alph 
(rs=-0.234, p=0.026) was observed. Similarly, endothelial cell count was positively 
correlated with only one parameter: p1area from the upper 50% of the peak (rs=0.176, 
p=0.05) (Table 6.4). 
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The relationship between corneal biomechanics and both steep and flat K did not appear 
follow a particular trend, however, the significant associations between these 
topographic parameters and ORA specific parameters were observed at the initial 
applanation peak (Table 6.4). Detailed information on the ORA applanation curve can be 
found in Section 2.2.1 and Figure 2.3 (page 95). 
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IOPg (mmHg) - - - - - - 
0.194 
(0.030) 
- - - - - - - - -  
IOPcc 
(mmHg) 
0.187 
(0.037) 
                
slew1 - - - - 
-0.214 
(0.017) 
- - - - - - - - - - -  
mslew1 - - - - 
-0.208 
(0.020) 
- - - - - - - - - - -  
mslew2 
0.188 
(0.036) 
- - - - - - - 
-0.225 
(0.012) 
- - - - - - -  
dive1 
0.190 
(0.034) 
- - - - - - - - - - - - - - 
0.195 
(0.030) 
 
dive2 - - - - 
-0.216 
(0.016) 
- - - - - - - - - -   
alph                 
-0.234 
(0.026) 
Values from upper 75% of the peak 
p1area              
0.330 
(<0.001) 
0.038 
(<0.001) 
  
p2area - - - - - - 
-0.184 
(0.039) 
- - - -   
-0.365 
(<0.001) 
0.409 
(<0.001) 
-  
h1 - - - - - - 
-0.184 
(0.039) 
- - - - - - - - -  
h2 
0.189 
(0.035) 
- - - - - - - - - - - - - - -  
aspect1 0.189 
(0.035) 
- - - - - - - - - - - - - - -  
aspect2 0.189 
(0.035) 
- - - - - - - - - - - - - - -  
uslope1    -0.216 
(0.016) 
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Continued 
Table 6.4 Summary of statistically significant correlations between the ORA derived metrics and age, ethnicity, specific dietary components, eye and body 
size and ocular biometric parameters. 
 
Values from upper 50% of the peak 
p1area - 
0.176 
(0.050) 
- - - - - - - 
-0.190 
(0.034) 
- - - 
-0.354 
(<0.001) 
0.397 
(<0.001) 
-  
p2area - - - - - - 
-0.179 
(0.045) 
- - - - - - - - -  
h2 
0.204 
(0.023) 
- - - - - - - - - - - - - - -  
aspect1 - - - - 
-0.224 
(0.012) 
- - - - - - - - -  -  
aspect2 - - - -  - - - - - - - - - - 
0.290 
(0.025) 
 
uslope1 - - - - 
-0241 
(0.007) 
- - - - - - - - - - -  
uslope2 
0.196 
(0.028) 
- - - - - - - - - - - - - - -  
path1 - - - - - - - - - 
0.225 
(0.012) 
- - - 
-0.317 
(<0.001) 
0.424 
(<0.001)- 
-  
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6.4.3.2 Corvis ST 
Statistically significant correlations are summarised in Table 6.5. A full list of correlations 
is included in Appendix X. Age and body size had no influence on the corneal 
biomechanical parameters measured with the Corvis ST (p>0.05, Appendix 5, Table B). 
Ethnicity was negatively associated with the time of the second applanation (A2 time, rs= 
-0.418, p<0.001). The A2 time was significantly slower in participants of Caucasian 
background (22.04 ± 0.39 s, mean ± SD) than in participants of Asian ethnicity (22.52 ± 
0.52 s) (p<0.001, one-way ANOVA). Ethnicity was also positively correlated with radius, 
however, no differences in pair-wise comparisons was (p=0.077, Kruskal-Wallis test).  
Eye size was correlated with four Corvis ST parameters (A1 time, A1 length and A1 
velocity), three of which were positively associated with the first applanation event (Table 
6.5). 
Dietary pattern had no influence on corneal biomechanics (all p>0.05, Appendix 5, Table 
B). Specific dietary components (meat, fish, carbohydrates and Vitamin E rich food), 
however, were positively associated (all p<0.05) with certain Corvis ST parameters 
(Table 6.5). 
CCT and endothelial cell count were negatively associated with only one Corvis ST 
parameter A2 velocity (rs=-0.029, p=0.039) (Table 6.5). 
The relationship between corneal topography and parameters derived from the Corvis 
ST were moderate to strong and were associated with the initial applanation event; 
however, no apparent trend was obvious (Table 6.5). 
For detailed explanation of Corvis ST parameters, please refer to Section 2.2.2). 
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Def. Amp.(mm) - - - - - - - - 
0.285 
(0.007) 
- - - - - - - - 
A1 time (ms) 
0.217 
(0.041) 
- - - - - - - - - - - - - - - - 
A1 length (mm) 
0.260 
(0.014) 
- - - - - 
0.229 
(0.033) 
- - - - - 
0.309 
(0.003) 
0.534 
(<0.001) 
0.612 
(<0.001) 
- - 
A1 velocity 
(m/s) 
-0.318 
(0.02) 
- - - - - - - - - 
0.246 
(0.022) 
- - 
-0.320 
(0.02) 
-0.323 
(0.02) 
- - 
A2 time (ms) - - - 
-0.418 
(<0.001) 
- - - - - - - - - - - - - 
A2 velocity 
(m/s) 
-0.219 
(0.039) 
-0.229 
(0.039) 
- - - - - 
0.292 
(0.006) 
- - - - - - - - - 
Peak dist (mm) - - - - - - - - - - - - 
-0.516 
(0.017) 
- - - - 
Radius (mm) - - - 
0.467 
(0.033) 
- - - - - 
0.478 
(0.028) 
- - - - - - - 
HC Def. Amp. - - - - - - - - - - - - - - - - 
-0.478 
(0.029) 
A2 Def. Amp. 
(mm) 
- - - - - - - - - - 
0.651 
(0.001) 
- - 
-0.491 
(0.0224) 
- - - 
Table 6.5 Summary of statistically significant correlations between the ORA derived metrics and age, ethnicity, specific dietary components, eye and body 
size and ocular biometric parameters.
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6.4.4 Multiple regression 
6.4.4.1 Ocular Response Analyser 
For multiple regression, CCT, topographic parameters (steep e, flat e, steep K, flat K and 
ΔK), MSE, dietary pattern and specific dietary components (fruit, meat, dairy, products, 
carbohydrates, fish and Vitamin E rich dietary components), eye and body size, 
alongside demographic variables (age and ethnicity) were selected as predictors and 
entered into the model. The model was designed to fit stepwise selection criteria for the 
independent variables with a significance level of p=0.05 and inclusion criteria of 2 
standard deviations (SD). 
The predictors accounted for 7% to 27% of the total variance in the ORA specific corneal 
biomechanical parameters (Table 6.6). From all predictors, the most significant 
contributors towards the various corneal biomechanical parameters were dietary pattern 
and specific food components (carbohydrates and meat), which explained variance of 
16 ORA specific parameters (Table 6.6). If dietary pattern was not included in the multiple 
regression model, higher intake of meat and steep K explained most of the variance (7-
11%) in the corneal biomechanical parameters measured with the ORA. 
6.4.4.2 Corvis ST 
The same predictors as for the ORA were chosen to execute multiple regression analysis 
for the Corvis ST specific parameters. 
Predictors explained 20% to 54% of the total variance in the corneal biomechanical 
properties measured by the Corvis ST. Contrary to the ORA, multiple regression analysis 
revealed that predominantly ethnicity rather than food intake is accountable for the most 
variance in the corneal biomechanics Table 6.7). 
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Parameter Equation 
Variance 
explained (%) 
p values Standardized β 
IOPg (mmHg) 15.363 – 1.862 x dietary pattern 7.5 pdietary pattern=0.047 βdietary pattern=-0.247 
IOPcc (mmHg) 54.407 – 0.026 x CCT – 3.43 x steep K 11.5 pCCT=0.037, psteep K=0.040 βCCT=-0.278, βsteep K=-0.274 
CH (mmHg) – – – – 
CRF (mmHg) 11.018 – 1.137 x dietary pattern 10.1 pdietary pattern=0.020 βdietary pattern=-0.319 
slew1 – – – – 
slew2 – – – – 
mslew1 – – – – 
mslew2 – – – – 
dive1 548.683 – 2.134 x age  10.5 page=0.018 βage=-0.324 
dive2 11.93.375 – 99.556 x steep K 8.4 psteep K=0.035 βsteep K=-0.290 
aindex – – – – 
bindex 9.651 – 0.048 x MSE + 0.018 x dairy products 21.7 pMSE=0.002, pdairy products=0.028 βMSE=-0.417, βdairy products=0.287 
aplhf 
 
2.106 – 0.002 x CCT + 0.022 x carbohydrates 
20.8 
pCCT=0.037, psteep K=0.040 βCCT=-0.278, βsteep K=-0.274 
Values from upper 75% of peak 
p1area 
7584.824 – 1170.889 x dietary pattern – 10.487 x 
fruit 
16.0 
pdietary pattern=0.005, pfruit=0.049 βdietary pattern=-0.441, βfruit=-0.284 
p2area 6032.208 – 732.661 x dietary pattern 8.7 pdietary pattern=0.032 βdietary  pattern=-0.295 
h1 – – – – 
h2 
456.351 + 123.312 x steep e – 38.889 x dietary 
pattern 
20.9 
psteep e=0.009, pdietary pattern=0.012 βsteep e=0.342,  βdietary pattern=-0.329 
w1 20.323 + 0.779 x BMI 9 pBMI=0.029 βBMI=0.301 
w2 – – – – 
aspect1 – – – – 
aspect2 17.468 + 0.406 x carbohydrates 7.4 pcarbohydrates=0.049 βcarbohydrates=0.271 
uslope1 – – – – 
uslope2 71.898 + 4.332 x Vitamin E 7.6 pVitamin E=0.046 βVitamin E=0.0.276 
dslope1 32.487 + 15.776 x ΔK 7.6 pΔK=0.046 βΔK=0.276 
dslope2 
78.219 – 18.338 x steep K + 13.204 x flat K – 0.005 
x endothelial cell count 
26.9 
psteep K=0.001, pflat K=0.004, pendothelial cell 
count=0.025 
βsteep K=-0.776, βflat K=0.673, βendothelial cell 
count=-0.296 
path1 17.613 + 0.304 x carbohydrates 7.4 pcarbohydrates=0.049 βcarbohydrates=0.272 
path2 31.792 + 0.467 x carbohydrates – 0.029 x CCT 17.5 pcarbohydrates=0.010, pCCT=0.032 βcarbohydrates=0.346, βCCT=-0.286 
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Continued 
Values from upper 50% of peak 
p1area 3168.023 – 518.191 x dietary pattern 10 pdietary pattern=0.021 βdietary  pattern=-0.317 
p2area 2657.113 – 335.692 x dietary pattern 8.2 pdietary pattern=0.037 βdietary pattern=-0.287 
h1 – – – – 
h2     
w1 – – – – 
w2 – – – – 
aspect1 29.1666 + 1.488 x meat – 0.0985 x age 14.8 pmeat=0.033, page=0.044 βmeat=0.287, βage=-0.270 
aspect2 16.539 – 0.695 x carbohydrates + 10.275 x steep e 16.6 pcarboydrates=0.027, psteep e=0.036 βcarboydrates=0.295, βsteep e=0.278 
uslope1 – – – – 
uslope2 – – – – 
dslope1 – – – – 
dslope2 23.326 + 1.171 x carbohydrates + 18.345 x steep e 14.9 pcarboydrates=0.042, psteep e=0.042 βcarboydrates=0.272, βsteep e=0.272 
path1 20.558 + 1.198 x Vitamin E + 3.091 x dietary pattern 18.5 pVitamin E=0.018, pdietary pattern=0.031 βVitamin E=0.018, βdietary pattern=0.031 
path2 23.145 + 0.684 x carbohydrates  9.6 pcarboydrates=0.024 βcarboydrates=0.310 
aspect2 16.539 – 0.695 x carbohydrates + 10.275 x steep e 16.6 pcarboydrates=0.027, psteep e=0.036 βcarboydrates=0.295, βsteep e=0.278 
uslope1 – – – – 
uslope2 – – – – 
dslope1 – – – – 
dslope2 23.326 + 1.171 x carbohydrates + 18.345 x steep e 14.9 pcarboydrates=0.042, psteep e=0.042 βcarboydrates=0.272, βsteep e=0.272 
path1 20.558 + 1.198 x Vitamin E + 3.091 x dietary pattern 18.5 pVitamin E=0.018, pdietary pattern=0.031 βVitamin E=0.018, βdietary pattern=0.031 
path2 23.145 + 0.684 x carbohydrates  9.6 pcarboydrates=0.024 βcarboydrates=0.310 
aspect2 16.539 – 0.695 x carbohydrates + 10.275 x steep e 16.6 pcarboydrates=0.027, psteep e=0.036 βcarboydrates=0.295, βsteep e=0.278 
uslope1 – – – – 
uslope2 – – – – 
dslope1 – – – – 
dslope2 23.326 + 1.171 x carbohydrates + 18.345 x steep e 14.9 pcarboydrates=0.042, psteep e=0.042 βcarboydrates=0.272, βsteep e=0.272 
path1 20.558 + 1.198 x Vitamin E + 3.091 x dietary pattern 18.5 pVitamin E=0.018, pdietary pattern=0.031 βVitamin E=0.018, βdietary pattern=0.031 
path2 23.145 + 0.684 x carbohydrates  9.6 pcarboydrates=0.024 βcarboydrates=0.310 
Table 6.6 Summary of multivariate regression analysis for ORA parameters.
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Parameter Equation 
Variance 
explained (R2 x 
100%) 
p values Standardised β 
IOP (mmHg) – – – – 
Def. Amp.(mm) 1.177 – 0.205 x steep e - 0.001 x CCT 40.8 psteep e=0.031, pCCT=0.034 βsteep e=0.429, βCCT=-0.419 
A1 time (ms) 7.914 – 0.861 x steep e 19.2 psteep e=0.047 βsteep e=-0.439 
A1 length (mm) 1.747 + 0.019 x MSE + 0.001 x age 48.6 pMSE=0.002, page=0.040 βMSE=0.0.627, βage=0.0.367 
A1 velocity (m/s) – – – – 
A2 time (ms) 22.792 – 0.276 x ethnicity 20.4 pethnicity=0.040 βethnicity=0.367 
A2 length (mm) 
-1.979 + 0.319 x ethnicity + 0.078 x 
carbohydrates +0.346 x flat K 
54.1 
pethnicity=0.001, 
pcarbohydrates=0.012, pflat 
K=0.048 
βethnicity=0.721, βcarbohydrates=0.469, 
βflat K=0.374 
A2 velocity (m/s) – – – – 
HC time (ms) 17.532 – 2.850 x endothelial cell count 19.6 pendothelial cell count=0.045 βendothelial cell count=-0.442 
Peak Dist. (mm) 5.420 – 3.474 x flat e 22.8 pflat e=0.029 βflat e=-0.447 
Radius (mm)  6.531 + 0.458 x ethnicity 22.9 pethnicity=0.028 βethnicity=0.478 
A1 Def. Amp. 
(mm) 
– – – – 
HC Def. Amp. 
(mm) 
1.177 + 0.205 x steep e – 0.001 x CCT 40.8 psteep e=0.031, pCCT=0.034 βsteep e=0.429, βCCT=-0.419 
A2 Def. Amp. 
(mm) 
0.400 + 0.017 x Vitamin E + 0.015 x MSE 48.8 pVitamin E=0.004, pMSE=0.015 βVitamin E=0.564, βCCT=-0.455 
Table 6.7 Summary of multivariate regression analysis for Corvis ST parameters.  
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6.5 Discussion 
6.5.1 Introduction 
Ocular Response Analyser and Corvis ST have been a helpful tool for dynamic 
monitoring of corneal biomechanical response from their inception. The ORA specific 
parameters, corneal hysteresis (CH) and corneal resistance factor (CRF), similarly to 
Corvis ST parameters, have broadened the clinical knowledge of glaucoma 
management (Martinez-De-La-Casa et al. 2006; Salvetat et al. 2015), and keratoconus 
progression (Shah et al. 2007; Wolffsohn et al. 2012; Ali et al. 2014). Despite this, few 
studies have investigated the full range of metrics that can be extracted by the ORA in 
relation to various lifestyle, ocular globe, and disease-related factors (Kerautret et al. 
2008; Mikielewicz et al. 2011; Wolffsohn et al. 2012) or Corvis ST parameters in relation 
of any other aspect than ocular condition (Ali et al. 2014; Wang et al. 2015) or 
repeatability (Bak-Nielsen et al. 2015).  
In a recent case report, Kerautret et al. (2008) discussed the possible interpretation of 
the ORA applanation peak and how it may relate to the corneal biomechanical response; 
CH and CRF should not be the only ORA-derived parameters considered. They found 
that normal and ectatic corneas could provide the same CRF and CH values, however, 
a closer examination of applanation peak and signal morphology showed variations in 
corneal biomechanical behaviour. Likewise Bak-Nielsen et al. (2015) provided an 
interesting insight on several Corvis ST parameters related to the highest concavity and 
its relation to age. Therefore, deeper knowledge of the corneal biomechanical response 
would be invaluable when dealing with clinical situations where the biomechanical 
aspects of an eye are important, as it could enable the prediction of a successful 
treatment outcome or course of a disease. This study investigated the relationship 
between age, ethnicity, diet, eye and body size, and 41 metrics extracted from the ORA 
and Corvis ST parameters in healthy individuals. 
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6.5.2 Ocular Response Analyser 
From all factors listed above, age is the most extensively studied in relationship to the 
corneal biomechanical properties in-vivo (Kotecha et al. 2006; Kamiya et al. 2009; 
Kotecha et al. 2014; Bak-Nielsen et al. 2015). The ORA parameter CH is thought to 
represent the viscoelastic nature of the corneal tissue, and, similarly to CRF, has been 
found to negatively correlate with age (Kotecha et al. 2006; Kotecha et al. 2014). These 
findings appear to support ex-vivo experimental observations of the changes in collagen 
fibril spacing and behaviour with the increasing age (Malik et al. 1992; Whitford et al. 
2015) resulting in, stiffening of the cornea. However, the assumption that CRF 
supposedly represents the overall resistance of the cornea needs to be viewed 
cautiously. CRF has a tendency to reduce with age and, therefore, it could misleadingly 
suggest that the cornea becomes less resistant. Hence, it should be assumed that CRF 
may also, to some extent, account for the elastic properties of the cornea. The metrics 
derived from the air applanation curve could further strengthen this assumption, as they 
describe the cornea’s ability to deform or regain its initial shape after the displacement 
by the air jet. Variations in these parameters could further account for the age-related 
structural changes reported previously (Malik et al. 1992; Whitford et al. 2015), and may 
represent the corneal stroma-driven stress-strain relationship (Hjortdal 1996; Thomasy 
et al. 2014; Whitford et al. 2015). Whilst no significant relationship appears between CH, 
CRF or any other ORA derived parameter and age was observed in this study, similarly 
to the results reported by Bak-Nielsen and colleagues (2015), it appears that the cornea 
does not undergo age-related structural changes.  
It is unlikely that the ORA or Corvis ST is unable to detect the age-related changes 
reported previously (Kotecha et al. 2006; Valbon et al. 2013; Kotecha et al. 2014; Bak-
Nielsen et al. 2015), or that there would be a need to question the ability of the 
instrumentation to measure the true biomechanical response in-vivo (Lau and Pye 2011). 
However, in context of the current study, a larger cohort of adult participants with a wider 
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age distribution would be required to establish the relationship between age and corneal 
biomechanical response. CH and CRF have been reported to decrease slightly with 
every decade of human life (Kotecha et al. 2006; Foster et al. 2011), however the vast 
majority of the participants in this study were at the end of their second decade (18%) or 
in their third decade of life (33%), whilst only 9% of the participants represented sixth 
and seventh decade of human life span. Therefore, the results of the current study could 
not be considered to be truly representative of a wide age cohort. 
In a recent study, Kotecha and colleagues (2014) discussed the relationship observed 
between CH, CRF, age, central corneal thickness and AL. They highlighted that these 
factors do not fully explain the variations observed in CH and CRF, and that the corneal 
biomechanical response is more complex, with additional contributors involved. The 
authors suggested that CH and CRF should be looked at along with additional ORA 
parameters. The current study alongside age, investigated the influence of CCT and the 
effects of the eye size (measured as AL). CCT was not associated to CH or CRF in the 
current study, whilst Kotecha et al. (2014) reported a strong positive correlation between 
CH, CRF and CCT (partial least squares regression, scaled coefficients CCTCH 0.62, 
p<0.001; CCTCRF 0.62, p < 0.0001). Kotecha et al. (2014), used an ultrasound 
pachymeter (Altair, Optikron 2000, Roma, Italy) to measure CCT, whilst non-contact 
measurement was obtained in the present study using an ocular biometry and 
topography system, the Aladdin (Topcon, Tokyo, Japan). The Aladdin employs a similar 
measurement technique to the Lenstar 900 (Haag Streit AG, Koeniz, Switzerland), which 
has shown a good agreement with ultrasound pachymetry (Borrego-Sanz et al. 2014). 
Previous studies, using ultrasound pachymetry to determinate CCT have reported weak 
to moderate associations between CH, CRF and CCT in a population with a similar age 
range (Medeiros and Weinreb 2006; Touboul et al. 2008). Therefore, it is likely that other 
factors (e.g., selection of the data analysis method) rather than instrumentation or patient 
age affected the significance of associations between ORA variables and CCT. Only one 
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of the additional ORA specific parameter alpfh which describes the smoothness of the 
peak, was negatively correlated with CCT.  
Contrasting to the negative association between CRF and AL reported by Kotecha and 
colleagues (2014), no significant relationship between CRF, CH and AL was found. Other 
studies, similarly to current results, have also not found a significant relationship between 
CH (Lim et al. 2008; Xu et al. 2011) or CRF (Narayanaswamy et al. 2011; Xu et al. 2011) 
and AL.  
Interestingly, Kotecha and colleagues (2014) suggested that ethnicity may account for 
the discrepancy between the study results. Their study reported the association between 
corneal biomechanical properties and AL in a Caucasian cohort, whereas most of the 
results reported previously were obtained from Asia (Lim et al. 2008; Shen, Fan, et al. 
2008; Chang et al. 2010; Narayanaswamy et al. 2011). However, that hypothesis is not 
supported by the results from this study. 
A relationship was observed between AL and dive1, aspect1 from upper 75% of the peak 
(metrics that describe the corneal response to the air jet deformation during the initial 
applanation event), and mslew2, aspect2 from the upper 75% of the peak, h2 and 
uslope2 of the upper 50% of the peak, (metrics that describe the cornea’s ability to regain 
its initial shape after the air-pressure deformation) as shown in Table 6.4 (a graphical 
representation of the curve are presented in Figure 2.3, page 95). Given an increase in 
peak height (h2), along the ratio of peak width/height (aspect1 and aspect2), and the 
changes in upward slope (uslope2) which mostly affected the second rebound peak, 
appears to suggest that the signal morphology – and therefore – corneal deformation is 
influenced by eye length. However, when multivariate stepwise modelling was applied, 
AL did not account for the variance observed.  
The associations between additional ORA parameters and AL have not been reported 
previously. Despite this, a decrease in CH along with increasing AL has been reported 
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previously (Narayanaswamy et al. 2011; Bueno-Gimeno et al. 2014). It has been 
suggested that this may be an indicator of structural changes of the anterior eye in 
myopia (Shen, Fan, et al. 2008). Another study has reported the same relationship 
between CRF and AL (Chang et al. 2010), which also would support Shen et al.’s 
hypothesis of structural alterations of the anterior eye occurring in myopia (Shen, Fan, 
et al. 2008). The statistically significant positive associations between the additional ORA 
parameters and AL observed in the current study could support this hypothesis, however 
further investigation is required to provide evidence for a relationship beyond ‘random’ 
association. 
Corneal curvature was not found to correlate with the any of the main four ORA 
parameters (CH, CRF, IOPg and IOPcc), but was found to have a moderate relationship 
with the additional ORA metrics, p1area and p2area from the upper 75% and 50% of the 
peak. Studies conducted previously have reported no relationship between corneal 
curvature and CH or CRF (Kamiya et al. 2008; Xu et al. 2011), and found it to be a non-
significant predictor in multiple regression analysis (Xu et al. 2011). The significance of 
the additional parameters, in relation to the corneal curvature could further support the 
changes of the structural alterations of the anterior eye, as proposed by Shen et al. 
(2008). Nevertheless, further studies are required and a careful interpretation of the 
associations between AL, corneal curvature and the additional ORA generated 
parameters – which appears to be positive in the present study – needs to be conducted. 
As discussed previously, the relationship between corneal biomechanical properties and 
ethnicity have not been investigated widely. One study investigating CH and CRF in a 
bi-racial cohort of healthy and glaucomatous individuals has reported significant 
differences in corneal biomechanical properties amongst African and Caucasian cohorts 
(Detry‐Morel et al. 2012), however no such association between ethnicity and CH, CRF 
(or any other biomechanical metric) was found in this study, although the study 
population was primarily composed of individuals of Caucasian and British Asian origin. 
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Group specific differences in ocular globe dimensions and components between ethnic 
groups have been noted previously (Shimmyo et al. 2003; Dai and Gunderson 2006; 
Twelker et al. 2009). For example, central corneal thickness (CCT) – which has been 
found to strongly correlate with CH and CRF (Kotecha et al. 2006; Shah et al. 2006; 
Kotecha et al. 2014) – has been associated with ethnicity in both a paediatric population 
of Afro-Americans and Caucasians (Dai and Gunderson 2006), and in a healthy adult 
population of the same ethnical background (Shimmyo et al. 2003). However, there were 
no differences observed between individuals of Asian, Caucasian, or Hispanic origin 
(Shimmyo et al. 2003). Considering the positive correlation between CH, CRF, and CCT, 
corneal biomechanical properties could inherit a similar relationship to ethnicity. 
Therefore, further research amongst various ethical groups would be required to test this 
assumption. 
Lifestyle influences have been of interest to epidemiological researchers in recent years, 
and have been associated with ocular health (Appel et al. 2003; Pasquale and Kang 
2009), however this is the first study to date to investigate the possible association of 
lifestyle (specifically food intake and body mass index (BMI)), with corneal biomechanical 
properties. Specific dietary components, such as Vitamin E, have been shown to have a 
protective effect on corneal and conjunctival health at a cellular level in a rat model 
(Fujikawa et al. 2003), and therefore, could be expected to affect corneal biomechanics. 
Whilst nutrition and increased intake of specific dietary components have been linked to 
conditions such as age-related macular degeneration (Chiu et al. 2014), glaucoma 
(Coleman et al. 2008), and cataracts (Hosseini et al. 2008), it has not yet been associated 
to corneal health directly. No significant relationship has previously been found between 
dietary patterns (Chiu, Chang et al., 2014), or individual foods or dietary components 
(e.g., Vitamin E). Nevertheless, a higher intake of meat and fish (and also adherence to 
a food pattern such as British Western), were found to account for some of the variance 
observed in corneal biomechanical response, and to correlate negatively with the 
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additional ORA derived metrics (Table 6.4). This is in agreement with previous work, 
which linked higher meat intake to an increased risk of cataracts (Appleby, Allen et al., 
2011). In the context of the negative associations found in this study, higher meat intake 
could reflect the structural changes at the tissue level, since p2area describes the area 
under the curve (AUC), whereas h2 describes the height of the curve in time and hence 
the cornea’s ability to regain its initial shape after the air-jet induced deformation. 
BMI or body size was found to be negatively correlated with the corneal biomechanical 
properties. BMI was one of the three predictors (alongside steep K and adherence to 
British Western dietary pattern) that mostly accounted for some variance within the 
metrics derived from the ORA. Alongside higher meat intake, BMI accounted for 
variations in aspect1 and uslope1 derived from the upper 50% of the initial applanation 
curve. From a structural and anatomical aspect, a higher BMI has been linked with a 
thicker retina (Wong et al. 2005) and the development of conditions such as cataract, 
glaucoma and diabetic retinopathy (Cheung and Wong 2007). The negative associations 
in the current study suggests that after the first applanation has taken place, the height 
and weight of the peak is affected by the BMI, presumably indicating that cornea is more 
easily deformed as the BMI increases. 
6.5.3 Corvis ST 
Corvis ST is a relatively new instrument to the optical industry and information regarding 
its association to various ocular parameters is still sparse (Hon and Lam 2013; Asaoka 
et al. 2015). In a study conducted by Bak-Nielsen et al. (2015), age was found to be 
associated with highest concavity (HC) and parameters derived from this event. 
Participants were divided into two groups: young (average age 25.4 years, range: 22 to 
30 years) and old (average age 75.8 years, range: 66 to 86 years). Older participants 
had a longer HC, deformation amplitude, HC deflection length (defined as horizontal 
length of the deformed cornea) and HC deflection amplitude (deformation amplitude 
corrected for the whole eye movement). In a different study, age was found to be a 
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significant predictor for first and second applanation time (A1 time and A2 time), length 
(A2 length) and velocity (A2 velocity). In addition, maximum deformation amplitude 
increased with increasing age (Asaoka et al. 2015). However, no association between 
age and any of the Corvis ST generated parameters was found in the present study. This 
may be due to the age distribution between participants, the relatively small sample size 
and the different software versions employed in each study.  
Asaoka et al. (2015) also reported AL to be a significant predictor for the same output 
measures as for subject age. AL was found to be positively related to A1 time and 
maximum deformation amplitude. A1 velocity, A2 time and peak distance exhibited a 
negative relationship with AL (Asaoka et al. 2015). In the present study, A1 time and 
length were positively correlated to AL, whilst A1 and A2 velocity was negatively 
correlated. This might suggest that longer eyes are more resistant during the initial 
applanation (resulting in longer A1 time), but once the applanation event has 
commenced, they are deformed more easily and recover quicker than shorter eyes 
(supported by the moderate inverse relationship between A1 and A2 velocity and AL). 
Despite this, AL was not found to be a significant predictor in the multiple regression 
model. 
The relationship between corneal curvature and corneal biomechanical parameters was 
also studied by Asaoka et al. (2015). The authors reported that the average corneal 
curvature was a significant predictor for the same Corvis ST specific parameters as for 
AL. The relationship, except for A1 time, was positive. The associations observed on the 
current study were significant for A1 length, A1 velocity and HC deformation amplitude. 
Corneal curvature was one of the most frequent parameters that accounted for some of 
the variance. 
No comparisons between different ethnicities have been made to date with the Corvis 
ST. In the present study, the velocity of the second applanation (A2 velocity) was 
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significantly slower among participants of Caucasian background than those of British 
Asian background, indicating that require more time to regain their initial shape following 
deformation. 
CCT has been found to influence the velocity and length of the second applanation (A2 
length and velocity), and the curvature of HC (Asaoka et al. 2015), suggesting that thicker 
corneas are more resistant to deformation. The results of this study did not find a 
correlation between any of the Corvis ST generated parameters, except for negative 
moderate associations of HC deformation amplitude. This could further support the 
hypothesis of thicker corneas’ ability to resist the deformation more than thinner ones.  
BMI and daily food consumption has not yet been studied in relation to Corvis ST 
parameters. The associations between BMI and any of the Corvis ST generated metrics, 
in contrast to the ORA parameters, were non-significant. Daily food consumption of meat, 
fish, carbohydrates, dairy products and Vitamin E had a positive effect on the first and 
second applanation events. Similar assumptions as in the case of the results obtained 
from the ORA could be made (please refer to section 6.5.2). 
6.5.4 Study limitations 
Although the inclusioun criteria for the study were not strict, current study had some 
limitations. The study was conducted on university campus, therefore, not all age groups 
were represented equally and participant recruitment of 55 years and older was difficult. 
The restricted patient pool together with the ethnical dominance of individuals of British 
Asian background influenced the diet component of the study and is not a representative 
of the population in general. 
Also, due to difficulties with instrumentation, Corvis ST data for all individuals could not 
be retrieved. Each of the instruments employed in the study for the investigation of 
corneal biomechanical parameters had more than ten paramaters to investigate in 
associaciation to the selected factors, therefore, other aspects that could potentially have 
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an influence to corneal tissue, such as smoking, UV exposure, blod type and others, 
could not studied and further research in this area is warranted. 
6.5.5 Conclusion 
The present study does not support an association between the ORA specific 
parameters of CH, CRF and age, ethnicity, daily food consumption or eye and BMI. The 
investigation of the additional ORA-derived parameters does, however, provide an 
interesting insight into their relationship with daily food consumption, ocular biometry and 
eye and body size. The proportion of the variation in the additional ORA parameters 
could not be explained by the ocular and demographic characteristics alone. Daily food 
consumption accounted for some of the variations observed, therefore suggesting that 
there are other factors contributing to the corneal biomechanical response. Analysis of 
the Corvis ST generated parameters provided further evidence of the influence of 
different factors on corneal biomechanics. Further work is required to investigate the 
additional parameters of the ORA and Corvis ST generated metrics in healthy individuals 
(and their relation to ocular and lifestyle effects) to enhance the understanding of corneal 
biomechanical response and aid with a prediction of treatment outcome in diferent 
clinical applications like ortho-k and MC. 
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Chapter 7. Conclusion and future work 
7.1 General conclusions 
The work presented in this thesis investigates the management of myopia in a clinical 
setting; aims to ameliorate the application of orthokeratology (ortho-k) by studying the 
corneal biomechanical response to the ortho-k lens wear and also looking at the various 
factors that may affect corneal tissue and, therefore, contribute towards a more 
predictable treatment outcome. 
The review of the literature (Chapter 1) identified the current challenges in the field of 
myopia control (MC) and the clinical application of ortho-k. Myopia is not a simple 
inconvenience but rather a major public health problem that is a cause of blindness and 
visual impairment worldwide (Flitcroft 2012; Pan et al. 2012; Holden et al. 2014). The 
multifaceted nature of this condition complicates the management of myopia. Genetics, 
behaviour and the environment have been identified as the causative and inherited 
factors of myopia (Wojciechowski 2011; Flitcroft 2012; Goldschmidt and Jacobsen 
2014). The optical and pharmaceutical interventions tailored to target the factors 
contributing towards myopia development are able to limit myopia progression to a 
certain level (Sankaridurg and Holden 2014). However, the clinical versus statistical 
significance has been questioned (Fulk et al. 2000; Johnson 2014). 
Only recently has the long term benefit of the application of MC interventions been 
elegantly demonstrated using evidence based models (Sankaridurg and Holden 2014), 
thus emphasising the lifelong and progressing nature of myopia and the need of 
adequate management strategy of this condition. Myopia usually manifests in childhood 
and progresses through early adolescence. At present, it is not possible to prevent 
myopia from developing, however it is possible to limit its progrssion and subsequently 
reduce the risk of associated pathologies (Flitcroft 2012). Research studies addressing 
the clinical application of the MC modalities would be beneficial to aid with raising 
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awareness of myopia and the complications and risks associated with it, as well as the 
importance of limiting the progression of myopia (Holden et al. 2016).  
Ortho-k, which is one of the most promising MC interventions (Sankaridurg and Holden 
2014), is not a new approach for myopia correction; however, reluctance to employ this 
modality has been observed mostly owing to the selective treatment outcome. Over 
recent years the approach of using the corneal topographer as the main assessment and 
fitting tool in addition to the adoptation reverse geometry lens as the treatment tool has 
enhanced the treatment outcome (Swarbrick 2004; Swarbrick 2006; Si et al. 2015; Sun 
et al. 2015). Nevertheless, some factors such as the role of corneal tissue mechanical 
properties are still widely unaccounted for. The advent of in-vivo corneal biomechanical 
assessment (described in detail in Section Chapter 2) has opened new avenues for the 
study of the anterior segment of the eye, not only in the context of ortho-k, but also of 
other clinical applications. By better understanding the role of corneal mechanical 
behaviour in ortho-k lens wear it may be possible to improve the treatment outcome and 
optimise the application of ortho-k for MC. 
7.1.1 Current trends of myopia management strategies in clinical practice 
The results of the global myopia survey (Chapter 3), which investigated the attitudes of 
the eye-care professionals towards MC, revealed that there is a preceived lack of 
information available to practitioners; although they are aware of the recent scientific 
findings in the field, the research outcomes do not translate well into the clinical setting. 
The questionnaire was designed to cover aspects of the perceived efficacy of various 
MC modalities by the clinicians, the frequency of prescribing particular interventions in 
the everyday clinical setting, the patient’s age and degree of myopia required for 
practitioner to consider each of the correction options and the limiting factors of 
prescribing various interventions. Two thirds (68%) of the 964 surveyed eye-care 
practitioners, regardless of the geographical location, chose to prescribe single vision 
glasses rather than evidence-based more effective modalities for MC, identifying the lack 
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of clear guidelines (33.3% of 964 practitioners) and unpredictability and safety (~25%) 
of the treatment outcome, achieved by the MC modalities as their main inhibiting factors. 
Interestingly, patient’s age, annual progression rate and the degree of myopia were not 
the pre-dominant factors in the decision making for the most appropriate MC intervention. 
Age is identified as a good predictor for myopia development (Thorn et al. 2005; Zadnik 
et al. 2015). The regional differences in the response to some extent mirrored the activity 
of MC research in the given area. For example, practitioners in Hong Kong and China 
considered themselves more active in the field of MC (9/10 vs all the other regions~7/10; 
median) and prescribed ortho-k more frequently than their colleges across the globe. 
To date, this is the only self-reported survey, exploring the attitudes of the eye-care 
professionals on a global scale, therefore no comparison can be made. Nevertheless, 
these findings support the concerns expressed previously in the research community 
regarding the underrated status of myopia within the clinical setting (Choo et al. 2008; 
Holden et al. 2014; Johnson 2014; Sankaridurg and Holden 2014; Gifford and Gifford 
2016; Holden et al. 2016). Results suggest, that a clear internationally acknowledged 
guidelines and safety regulations should be issued by the expertise in the field. Also, 
educational materials should be provided to clinicians, patients and if appropriate, 
patients’ parents. Clinical research studies that would address and evaluate issues 
identified in this survey and similar studies conducted in the future would be beneficial 
and could aid toward establishment of MC guidelines. 
7.1.2 Long term corneal biomechanical response to orthokeratology and the role 
of anterior eye segment in myopic schoolchildren 
The work presented in Chapter 4, in which a retrospective data analysis of myopic 
schoolchildren undergoing ortho-k treatment for a period of 2 years using the ORA to 
monitor corneal biomechanical response, was carried out, provided interesting findings 
of the corneal tissue response and metrics of the anterior segment of the eye. Also, it 
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indirectly addressed some of the problematic points identified by the eye-care 
practitioners in the global myopia survey in Chapter 3.  
This is the first study to investigate corneal biomechanical response in progressing 
myopic schoolchildren. Data from 83 ortho-k wearing children and 81 single vision 
spectacle (SVS) wearing children, who attended 5 study visits with a 6-month (M) interval 
(BL, 6 M, 12 M, 18 M and 24 M), were analysed. SVS wearing children, who were age 
matched, acted as controls for an observation of the natural progressing myopia.  
The results compare favourably with the studies conducted previously, on which the 
Hong Kong reseach group are expanding (Cho and Cheung 2012; Charm and Cho 2013; 
Chen et al. 2013) regarding the efficacy of ortho-k’s ability to limit myopia progression by 
~40%, slowing down AL and AC growth. These findings were also in agreement with the 
eye-care practitioners’’ subjective assessment of the efficacy of ortho-k of 45% (Chapter 
3, Section 3.4.3).  
The corneal topographical changes likewise support the previous work both in ortho-k 
wearing children (Cho, Pauline et al. 2005; Santodomingo-Rubido et al. 2012) and single 
vision spectacles wearing control group (Jorge et al. 2007; Santodomingo-Rubido et al. 
2012). The topography changes occur during the first six months of lens wear, stabilising 
thereafter. Fluctuations within topographical parameters in individuals with a natural 
myopia progression are to be expected and presumably describe a typical gait of myopia 
development. 
The changes in central corneal thickness (CCT) followed a similar pattern to the 
topographical changes seen within the ortho-k group, further supporting the hypothesis 
that the first six months may be the critical period for this technique for the treatment 
effect to take place. Swarbrick and colleagues (2015) however stated that a period of six 
months is insufficient to achieve a stabilisation of a progressive myopia, therefore a 
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period of 18 months or more could be beneficial for the treatment effect of MC to be 
achieved. 
Reduction in myopia, changes in CCT and corneal morphology do not occur 
simultaneously (Swarbrick et al. 1998; Zhong et al. 2015; Cheung and Cho 2016). 
Analysis of the ORA data revealed that CH (descriptor of viscous damping properties) 
was not affected by the ortho-k lens, however this parameter fluctuated significantly in 
the SVS group. CRF (characteristic of the overall resistance of the cornea) did not 
undergo significant changes in any of the study groups. These findings favourably 
support previous work of Mao et al. (2010) who observed initial changes in CH and CRF 
over the first week of the lens wear, which then return to BL within 3 to 6 months. These 
changes could reflect the classical descriptors (YM, creep and stress relaxation); 
however, they cannot be assessed in the in-vivo environment with the current 
instrumentation and only a hypothesis or premise can be made. 
The detailed analysis of the applanation curve demonstrated that significant changes in 
both groups were limited to the initial applanation peak. The critical period for the corneal 
biomechanical changes were the first 18 months of the ortho-k lens wear, stabilising 
thereafter. Several parameters (slew1, mslew1, h1 from the upper 50% and 75% of the 
initial appanation peak; for full list of the parameters please refer to Chapter 4, Section 
4.4.2, page 163) were affected, but the response in SVS group was more varied. As this 
is the first study of a kind investigating the ORA applanation peak in detail both in ortho-
k wearing children and SVS wearing children, no direct comparison can be made. 
Moreover, all of the biomechanical parameters are ORA-specific (Dupps 2007) and do 
not necessarily translate well into a clinical setting. Premises that can be drawn from 
these results are: the stabilising effect of the ortho-k lens wear in progressing myopia; 
both optical and mechanical factors contribute towards limiting myopia progression in 
ortho-k; the ORA-derived parameters reflect mechanical effects of the reverse geometry 
lens imposed on the corneal tissue; and the ORA could potentially be used as a tool for 
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monitoring the anterior segment of the eye in naturally progressing myopia. 
Nevertheless, a further work that would expand these observations, such as 
longitudianal studies of myopia development and the role of corneal biomechanical 
parameters, is required. 
7.1.3 Short-term corneal biomechanical changes in orthokeratology 
The work presented in Chapter 5 explores the critical period of ortho-k lens wear during 
the first 7 nights of treatment (Swarbrick et al. 1998; Nichols et al. 2000; Mao et al. 2010). 
Twenty one healthy individuals wore ortho-k lenses for a period of a 7 nights and 
attended a daily study visit after each night of lens wear. 
The refractive changes, changes in corneal curvature and in CCT were in agreement 
with the research conducted previously (Swarbrick et al. 1998; Nichols et al. 2000; 
Alharbi and Swarbrick 2003; Soni et al. 2003; Sorbara et al. 2005; Yoon and Swarbrick 
2013). Sixty per cent of the initial myopic refractive error was corrected over the first night 
of the lens wear. The thinning of CCT reached significance by the seventh night of lens 
wear. No anti-myopic changes in AL, ACD and LT were seen over the study period, 
comfirming that the mechanisms underlying ortho-k are corneal in nature. Also, these 
findings suggest that a longer period (months to years) of ortho-k lens wear is necessary 
if this technique is applied as a MC intervention, which is in agreement with the work 
presented in the Chapter 4. 
A detailed analysis of the ORA-derived metrics did not support the previous work in 
regard to CH and CRF (Chen et al. 2009; Mao et al. 2010). Yeah et al. (2013) reported 
significant changes in CH and CRF only after 30 night of lens wear. The CH and CRF 
remained stable during the study period in this experiment. The ability of CH and CRF 
have enough discriminative power to detect changes has been questioned before 
(Kerautret et al. 2008; Saad et al. 2010; Mikielewicz et al. 2011).  
257 
 
Other ORA-derived parameters did undergo significant changes over the study period 
and were limited to the initial applanation peak. In contrast to CCT changes, most of the 
changes in corneal biomechanical parameters occurred over the first 4 nights of the lens 
wear. The height of the initial applanation peak (h1) was reduced. The same observation 
was made in the results presented in Chapter 4. Height (h1) along other parameters 
affected by the ortho-k leans wear suggests that corneas undergoing ortho-k treatment 
are more easily deformed by the air puff (Chapter 5, Section 5.4.2.1, page 200). 
However, ORA-derived parameters (aindex, bindex and aplhf; characteristics of the 
smoothest of the curve) did not change over the course of the study, hence it can be 
speculated that short term ortho-k does not affect the corneal tissue at microscopic level. 
Although differences in the corneal movement in response to the air puff were seen in 
the video output of Corvis ST, only two parameters being applanation length 1 and 
applanation length 2 were affected by the ortho-k lens wear. Both of these parameters 
are direct measures of the flattened area of the air puff, therefore, most likely reflect the 
formation of treatment zones, imposed by the reverse geometry lens. 
These results support the groundwork conducted to date and provide a further evidence 
for the corneal involvement in the treatment response. 
7.1.4 Factors influencing corneal biomechanics 
Differences in the ocular globe dimensions due to age and body height have been 
reported previously (Wong et al. 2005; Ahmadi et al. 2007). For example, taller 
individuals are more likely to have longer eyes, deeper ACs, thinner crystalline lenses 
and flatter corneas (Wong et al. 2001). These are only a few factors that could affect 
treatment outcome of different conditions or techniques, but more specifically those 
involving manipulations of ocular structures such as corneas undergoing refractive 
surgery or ortho-k treatment. In order to optimise any technique and predict the treatment 
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outcome, factors that may increase inter-individual variations in treatment outcome must 
be identified. 
A cohort of 158 healthy individuals were recruited to study the influence of age, ethnicity, 
eye and body size, and nutrition, in relation to corneal biomechanical properties for the 
study presented in Chapter 6. 
The results of the study do not support an association between the ORA specific 
parameters of CH, CRF and age, ethnicity, daily food consumption or eye size and BMI. 
The relationship between age, ethnicity and eye size (AL) have been studied before 
(Kotecha et al. 2014) and contradicts the findings of the present study. CH and CRF 
have been found to negatively associated with age. A negative association between CRF 
and AL has also been identified (Kotecha et al. 2014). 
A detailed investigation of the additional ORA-derived parameters does, however, 
provided an interesting insight into their relationship with daily food consumption, ocular 
biometry and eye and body size. The additional ORA parameters did not increase the 
percentage of variance that could be explained by the ocular and demographic 
characteristics. Daily food consumption accounted for some of the variations observed, 
therefore suggesting that there still are undetermined other factors contributing to the 
corneal biomechanical response.  
Corvis ST is a relatively novel instrument and only a few studies have addressed the 
influence of age and AL to its output parameters (Asaoka et al. 2015; Bak-Nielsen et al. 
2015). No association between age or eye size (AL) and any of the Corvis ST specific 
parameters was found in the present study. The only significant factor that was found to 
affect corneal biomechanical properties measured by the Corvis ST was dietery 
components. 
Diet, in particular higher intake of meat, fish, carbohydrates, Vitamin E rich foods and 
dairy products showed a positive correlation between the ORA and Corvis ST 
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parameters opening new avenues for interesting future research. Further studies could 
test the hypothesis of nutrition and its effects on corneal tissue strength, which could be 
beneficial for ocular conditions such as keratoconus. 
Although participants with a wide variety of ALs and BMIs were included in the study, the 
research could have benefited from a wider age range. 
7.1.5 Future work and concluding remarks 
The collection of studies presented in this thesis explore the clinical application of MC 
strategies and investigates the corneal biomechanical properties in the eyes undergoing 
ortho-k treatment, addressing some of the research questions raised previously and 
concerns expressed within the community of eye-care practitioners (Johnson 2014; 
Sankaridurg and Holden 2014; Gifford and Gifford 2016). 
Premises and conclusions drawn from this thesis suggest that internationally 
acknowledged guidelines for MC could benefit the eye-care practitioners and 
subsequently their patients worldwide. Also, the clinical community should be further 
educated on the topic of myopia and its management. In recent years, the research 
community have openly spoken about the alarming rates of myopia progression, the 
earlier onset of this condition and the various ways in which clinicians can approach 
myopia more effectively (Sankaridurg and Holden 2014; Holden et al. 2015; Gifford and 
Gifford 2016). More clinical and survey based research, which would explore the clinical 
setting of myopia management, should be conducted. An updated version of the global 
myopia re-issued within the next few years could provide an insight of the progress in 
the field of MC. 
The work presented here, investigating both short and long-term changes in ortho-k, 
suggests that further investigation of the role of corneal biomechanical properties is 
required. Studies closely monitoring the corneal biomechanical response of the patients 
undergoing ortho-k treatment over the first six months with regular intervals (1 week, 2 
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weeks, 1, month, 2 months etc.) are required to understand the underlying mechanisms 
of ortho-k and the mechanical phenomena taking place at each point along the treatment 
cycle. Furthermore, these studies should be longitudinal in nature to understand the long 
term corneal biomechanical response to lens wear. Corneal factors are the main 
contributors to the treatment outcome of ortho-k; however, more factors (e.g. the role of 
sclera) in relation to corneal biomechanical properties should be investigated. 
Also, studies monitoring naturally progressing myopes and individuals wearing the ortho-
k modality should be designed. Results in this thesis suggest that the ORA could be a 
useful tool to for monitoring the course of the anterior segments of eye with myopia 
progression.  
Research presented here attempts to explain the 37 additional parameters derived from 
the ORA applanation curve and relate them to the clinical setting and classical 
mechanics. Further studies should be conducted to explore these parameters to 
incorporate them in a clinical setting. This in return would ameliorate the understanding 
of the processes underlying numerous ocular conditions and techniques including ortho-
k. 
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Appendix 1: Current trends of myopia management strategies in clinical practice 
1.1 An example of email, inviting eye care professionals to take part in the study 
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1.2 Questionnaire  
 
1. How concerned are you about the increasing frequency of paediatric myopia in your 
practice? 
Not at all                   
Extremely 
 
 
2. From what you have heard/read about the effectiveness of myopia control options to 
date, what % reduction do you think the following options can achieve (just type in a 
number without %)? 
 
 
 
3. How active would you consider your clinical practice in the area of myopia control? 
Not at all                    
Extremely 
Any comments? 
 
 
 
300 
 
 
4. How many times have you prescribed the following correction options for 
progressing/young myopes over an average month (please consider the total number of 
progressing/young myopes and include all in your response)? 
 
5. How old (in years) would the patient have to be for you to consider each of the following 
options (not just for myopia control and assuming average handling skills and 
child/parent motivation)? 
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6. What would be the minimum amount of myopia (in dioptres) for you to consider each 
of the following correction options for a patient? 
 
7. What is the minimum level of myopia progression you consider necessitates a myopia 
control approach? 
 
8. Do you use undercorrection as a strategy to slow myopia progression? 
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9. If you have only ever fitted single vision spectacles/contact lenses for myopic patients, 
what has prevented you prescribing an alternative method? 
 
10. Demographics 
 
Profession: optometrist, contact lens (dispensing) optician, ophthalmologist, other. 
Principal working environment: practice, academic, industry, other. 
Years qualified: 0; 1-5; 6-10; 11-20; 20-30; 31≤  
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1.3 Results 
NB: Africa has been excluded from the analysis.  
Bold = statistically significant  
 
1. How concerned are you about the increasing frequency of paediatric myopia in 
your practice? 
Globally: 
Mean ± STDEV Median, CI [] 
7.28 ± 2.50 8.00, [8.00 8.00] 
 
Continents: 
Continent Mean ± STDEV Median, CI [] 
Asia 8.37±1.80 9.00 [8.00, 9.00] 
Australasia 6.83±2.71 7.00 [7.00, 8.00] 
Europe 7.05 ±2.37 7.00 [7.00, 8.00] 
North America 6.43 ±2.63 7.00 [6.00, 7.00] 
South America 6.53 ±3.16 7.00 [6.00, 8.96] 
 
Kruskal-Wallis test: 
North-America - Asia p<0.001 
South America - Asia p<0.001 
Australasia - Asia p<0.001 
Europe - Asia p<0.001 
 
Countries: 
Country Mean ± STDEV Median, CI 95% [] 
UK, EIRE 5.84 ± 2.57 6.00 [5.00,7.00] 
Netherlands 6.34 ± 2.11 7.00 [Bigger sample needed] 
Spain 8.26±2.25 9.00 [Bigger sample needed] 
France 7.26 ±2.29 7.00 [Bigger sample needed] 
Portugal 8.18 ± 3.22 8.00 [8.00, 9.37] 
Italy 6.86 ± 2.47 7.00 [7.00,8.00] 
India 7.32±2.64 8.00 [Bigger sample needed} 
Hong Kong 7.89 ±1.68 8.00 [7.00, 9.00] 
China 8.78 ± 1.53 10.00 [8.71, 10.00] 
Canada 5.42 ± 2.65 6.00 [Bigger sample needed] 
USA 6.75 ± 2.65 7.00 [7.00.8.00] 
 
Significant differences (Kruskal-Wallis test): 
UK, EIRE-Portugal p<0.001 
UK, EIRE-Spain p<0.001 
Netherlands-Portugal p=0.002 
Netherlands-Spain p=0.001 
Italy-Portugal p=0.046 
Italy-Spain p=0.027 
India-China p=0.002 
Hong Kong-China p=0.001 
USA-Canada  p=0.005 
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2. From what you have heard/ read about the effectiveness of myopia control options to date, what % reduction do you think the following 
options can achieve? 
 
Globally: 
 Under- 
correctio
n 
SVS Bifocals PALs RGP (AF) SV CL Standard 
multifocal 
CL 
Specific 
MC soft 
CL 
Ortho-K Pharmac
euticals 
Refractiv
e surgery 
Increased 
time 
spent 
outdoors 
Mean ± 
STDEV 
6.07 ± 
14.55 
10.94 ± 
21.95 
14.50 ± 
18.70 
16.23 ± 
19.21 
15.85 ± 
22.74 
9.37 ± 
19.78 
16.77 ± 
20.25  
24.41 ± 
25.07 
43.89 ± 
30.06 
27.93 ± 
29.58 
14.55 ± 
27.89  
31.48 
±26.30 
Median, 
CI 95% [] 
0 [0,0] 0 [0,0] 10 [6,10] 10.00 
[10,10] 
5.00 [5,8] 0 [0,0] 10.00 
[8,10] 
20.00 
[15,20] 
50.00 
[50,50] 
20.00 [10, 
20] 
0 [0,0] 25.00 
[22.91, 
30.00] 
 
Continents: 
Continent Under- 
correctio
n 
SVS Bifocals PALs RGP 
(AF) 
SV CL Standard 
multifoc
al CL 
Specific 
MC soft 
CL 
Ortho-K Pharma-
ceuticals 
Refracti-
ve 
surgery 
Increas-
ed time 
spent 
outdoors 
Asia 
 
Mean ± 
STDEV 
6.53 ± 
13.88 
16.04 ± 
23.56 
18.38 ± 
21.05 
21.26 ± 
21.16 
23.87 ± 
26.92 
11.87 ± 
20.64 
15.51 ± 
20.24 
24.37 ± 
25.96 
48.57 ± 
29.61 
31.73 ± 
27.82 
17.38 ± 
29.69 
38.66 ± 
27.53 
Media
n, CI 
95% [] 
0.00 [0,0] 5.00 
[1,10] 
10.00 
[10,15] 
20.00 
[15,20] 
10.00 
[10,20] 
0.00 [0,4] 5.00 [2, 
10] 
20.00 
[10,25] 
50.00 
[50,50] 
30.00 
[20,30] 
0.00 [0,0] 40.00 
[30.00,48
.44] 
Australasia Mean ± 
STDEV 
2.53 ± 
7.43 
4.21 ± 
12.51 
14.05 ± 
14.81 
16.00 ± 
14.01 
9.61 ± 
13.79 
4.14 ± 
11.52 
22.47 ± 
19.26 
29.14 ± 
19.34 
47.82 ± 
25.32 
38.99 ± 
32.38 
11.36 ± 
24.26 
29.67 ± 
22.01 
Media
n, CI 
95% [] 
0.00 
[0.,0] 
0.00 [0,0] 10.00 
[10,10] 
10.00 
[10,15] 
2.00 
[0,10] 
0.00 [0,0] 20.00 
[15,20] 
30.00 
[25,30] 
50.00 
[50,50] 
40.00 
[30,60] 
0.00 [0,0] 25.00 
[20,30] 
Europe Mean ± 
STDEV 
6.401 ± 
15.76 
10.00 ± 
21.77 
12.94 ± 
17.54 
14.69 ± 
18.64 
14.09 ± 
20.84 
10.10 ± 
20.54 
16.37 ± 
25.71 
25.22 ± 
25.72 
44.29 ± 
29.03 
24.22 ± 
29.43 
12.79 ± 
25.60 
29.41 ± 
26.21 
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Media
n, CI 
95% [] 
0 [0,0] 0 [0,0] 5.00 
[5,10] 
10.00 
[5,10] 
5.00 
[5,10] 
0.00 [0,0] 20.00 
[10,20] 
20.00 
[10,20] 
50.00 
[40,50] 
10.00 
[9,10] 
0 [0,0] 20.00 
[20,25] 
North 
America 
Mean ± 
STDEV 
2.93 ± 
7.90 
3.95 ± 
14.04 
11.62 ± 
14.41 
11.31 ± 
13.52 
9.85 ± 
15.44 
2.85 ± 
10.50 
18.42 ± 
20.45 
21.46 ± 
23.14 
36.94 ± 
30.08 
21.79 ± 
26.97 
13.51 ± 
30.59 
20.46 ± 
17.93 
Media
n, CI 
95% [] 
0.00 [0,0] 0.00 [0,0] 10.00 
[5,10] 
10.00 
[5,10] 
2.00 [0,5] 0.00 [0,0] 10.00 
[5,20] 
10.00 
[7.00, 
21.49] 
30.00 
[25,40] 
10.00 
[5,10] 
0.00 [0.0] 20.00 
[10,20] 
South 
America 
Mean ± 
STDEV 
13.43 ± 
23.05  
18.11 ± 
30.67 
12.25 ± 
24.24 
12.76 ± 
24.80 
13.64 ± 
26.99 
15.96 ± 
28.97 
11.48 ± 
19.65 
18.76 ± 
28.47 
23.90 ± 
32.26 
14.60 ± 
23.27 
17.99 ± 
29.43 
35.25 ± 
31.95 
Media
n, CI 
95% [] 
0.00 [0,5] 0.00 [0,0] 0.00 
[0.00, 
0.46] 
0.00 [0,1] 0.00 
[0.00, 
0.46] 
0.00 [0,0] 0.00, 
[0,5] 
0.00 
[0.00. 
14.12] 
0.00 
[0.00, 
19.56] 
0.00[0,5] 0.00 
[0.00,  
0.46] 
25.00 
[20,50] 
 
      Significant differences (Kruskal-Wallis test): 
Myopia management modality  p value 
Undercorrection North-America –South America 0.028 
Australasia-South America 0.001 
SVS North-America America-Europe 0.026 
North America –South America 0.007 
North America-Asia p<0.001 
Australasia-South America 0.021 
Australasia-Asia p<0.001 
Europe-Asia p<0.001 
Bifocals South America-Australasia 0.001 
South America-Asia p<0.001 
Europe - Asia 0.008 
PALs South America-Europe 0.033 
South America-Australasia p<0.001 
South America-Asia p<0.001 
North America-Asia p<0.001 
Europe-Asia p<0.001 
RGP (AF) South America-Asia p<0.001 
North America-Asia p<0.001 
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Australasia-Asia p<0.001 
Europe-Asia p<0.001 
SV CL North America-Europe 0.001 
North America-South America 0.014 
North America-Asia p<0.001 
Australasia-Europe 0.016 
Australasia-Asia p<0.001 
Standard multifocal CL South America-North America 0.008 
South America-Australasia p<0.001 
Asia-North America p<0.001 
Europe-Australasia 0.001 
Specific MC CL South America-Europe 0.013 
South America-Australasia p<0.001 
North America-Australasia 0.011 
Asia-Australasia p<0.001 
Ortho K South America-North America 0.023 
South America-Europe p<0.001 
South America-Asia p<0.001 
South America -Australasia p<0.001 
North America-Asia 0.001 
North America-Australasia 0.001 
Pharmaceuticals South America-Europe 0.05 
South America-Asia p<0.001 
South America-Australasia p<0.001 
North America-Asia 0.003 
North America-Australasia p<0.001 
Europe-Asia p<0.001 
Europe-Australasia p<0.001 
Asia-Australasia 0.006 
Refractive surgery No significant differences No significant differences 
Increased outdoor activity North America-Europe 0.028 
North America-Australasia 0.016 
North America-South America 0.014 
North America-Asia p<0.001 
Europe-Asia p<0.001 
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Countries: 
Country Under- 
correcti
on 
SVS Bifocals PALs RGP 
(AF) 
SV CL Standard 
multifocal 
CL 
Specifi
c MC 
soft CL 
Ortho-K Pharma-
ceuticals 
Refracti-
ve 
surgery 
Increas-
ed time 
spent 
outdoors 
UK, EIRE 
 
Mean ± 
STDEV 
2.16 ± 
4.82 
8.14 ± 
20.59 
13.78 ± 
15.16 
16.39 ± 
18.07 
14.14 ± 
23.82 
9.80 ± 
21.86 
26.37 ± 
23.00 
31.88 ± 
24.45 
44.90 ± 
27.76 
27.69 ± 
28.81 
18.49 ± 
31.92 
31.90 ± 
24.42 
Median, 
CI 95% 
[] 
0.00 
[0,0] 
0.00 
[0,0] 
10.00 
[5,15] 
10.00 
[5.00, 
18.04] 
5.00 
[0,10] 
0 [0,0] 30.00 
[15,30] 
30.00 
[20,50] 
50.00 
[40,50] 
20.00 
[10,40] 
0.00 
[0.00, 
8.04] 
25.00 
[20.00, 
36.08] 
Netherlands Mean ± 
STDEV 
6.13 ± 
13.77 
2.13 ± 
5.64 
12.00 ± 
17.33 
13.24 ± 
18.53 
7.87 ± 
10.59 
2.32 ± 
7.14 
13.53 ± 
15.76 
21.26 ± 
21.44 
48.15 ± 
25.54 
29.71 ± 
26.62 
11.45 ± 
27.41 
23.74 ±2 
4.79 
Median, 
CI 95% 
[] 
0.00 
[bigger 
sample] 
0.00 8.00 5.50 5.00 0.00 10.00 10.00 50.00 21.00 0.00 27.50 
Spain Mean ± 
STDEV 
9.79 ± 
17.23 
11.32 ± 
23.30 
16.65 ± 
17.55 
14.29 ± 
16.23 
17.24 ± 
23.44 
9.94 ± 
20.13 
17.35 ± 
18.18 
37.18 ± 
26.48 
56.76 ± 
28.90 
37.94 ± 
35.78 
19.23 ± 
30.60 
26.52 ± 
26.08 
Median, 
CI 95% 
[] 
0.00 
[bigger 
sample] 
0.00 10.00 8.00 8.00 0.0 10.00 40.00 60.00 40.00 0.00 20.00 
France Mean ± 
STDEV 
0.74 ± 
2.50 
10.88 ± 
24.54 
2.02 ± 
4.61 
4.53 ± 
7.82 
18.23 ± 
14.35 
2.06 ± 
4.94 
0.74 ± 2.50 2.35 ± 
5.40 
29.32 ± 
26.49 
5.47 ± 
11.69 
2.06 ± 
5.24 
18.65 ± 
21.87 
Median, 
CI 95% 
[] 
0.00 
[bigger 
sample] 
0.00 0.00 0.00 20.00 0.00 0.00 0.00 22.5 0.00 0.00 10.00 
Portugal Mean ± 
STDEV 
14.52 
±24.76 
22.13 ± 
24.05 
10.38 ± 
20.76 
14.85 ± 
22.70 
17.83 ± 
28.08 
23.27 ± 
28.08 
16.08 ± 
25.11 
30.40 ± 
33.93 
38.96 ± 
36.29 
13.00 ± 
25.09 
26.10 ± 
33.84 
39.15 ± 
31.92 
Median, 
CI 95% 
[] 
0.50 
[0.00, 
6.79] 
10.00 
[0.00, 
18.60] 
0.00 [0,3] 1.00 
[0.00, 
14.30] 
10.00 
[0,20] 
10.00 
[0,20] 
0.00 [0.00, 
6.80] 
17.50 
[5,35] 
35.00 
[13.91, 
50.00] 
0.00 
[0.00, 
8.03] 
7.50 
[0.00, 
32.19] 
35.00 
[20,50] 
Italy Mean ± 
STDEV 
8.91 ± 
19.04 
11.71 ± 
21.86 
12.40 ± 
18.35 
16.61 ± 
21.30 
12.91 ± 
21.66 
13.22 ± 
21.80 
13.85 ± 
19.95 
23.30 ± 
26.69 
42.78 ± 
29.94 
17.31 ± 
26.14 
10.98 ± 
23.70 
28.13 ± 
27.15 
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Median, 
CI 95% 
[] 
0.00 
[0,2] 
0.00 
[0,5] 
5.00 
[0,10] 
10.00 
[4.86, 
15.69] 
5.00 [0,6] 5.00 [0,8] 5.00 [2,10] 10.00 
[5.00, 
20.69] 
50.00 
[38.72, 
50.00] 
4.00 
[0,10] 
0.00 [0,0] 20.00 
[10,30] 
India 
 
Mean ± 
STDEV 
20.27 ± 
24.21 
35.19 ± 
31.11 
16.40 ± 
21.09 
22.14 ± 
25.18 
29.68 ± 
30.54 
30.24 ± 
33.74 
17.57 ± 
24.31 
29.08 ± 
32.37 
26.57 ± 
30.43 
16.45 ± 
19.96 
23.43 ± 
30.62 
28.38 ± 
24.55 
Median, 
CI 95% 
[] 
10.00 
[bigger 
sample] 
25.00 10.00 15.00 20.00 15.00 5.00 15.00 15.00 10.00 5.00 30.00 
Hon Kong Mean ± 
STDEV 
3.94 ± 
7.68 
7.83 ± 
15.83 
21.06 ± 
17.69 
24.81 ± 
18.35 
15.13 ± 
23.25 
6.63 ± 
15.19 
15.29 ± 
17.14 
32.26 ± 
22.85 
56.84 ± 
24.56 
39.40 ± 
23.98 
9.03 ± 
21.89 
36.26 ± 
22.76 
Median, 
CI 95% 
[] 
0.00 
[0,0] 
0.00 
[0.00, 
0.82] 
20.00 
[10.00, 
25.89] 
22.50 
[20,30] 
5.00 
[0.00, 
9.36] 
0.00 [0,0] 10.00 
[0,20] 
30.00 
[20.00, 
32.68] 
50.00 
[50.00, 
66.79] 
40.00 
[30,50] 
0.00 [0,0] 40.00 
[27.50, 
50.00] 
China Mean ± 
STDEV 
2.65 ± 
7.21 
14.42 
±22.41 
10.94 ± 
17.39 
13.65 ± 
17.71 
23.21 ± 
25.58 
8.99 ± 
16.72 
12.20 ± 
19.83 
16.28 ± 
23.39 
45.12 ± 
28.38 
28.65 ± 
27.97 
17.48 ± 
30.78 
39.57 ± 
30.05 
Median, 
CI 95% 
[] 
0.00 
[0,0] 
6.00 
[0.23, 
10.00] 
[2.50, 
9.54] 
7.00 
[5,10] 
10.00 
[7.46, 
20.00] 
0.00 
[0.00, 
1.09] 
0.00 [0,2] 0.00 
[0.00, 
8.40] 
50.00 
[50,50] 
20.00 
[10,30] 
0.00 
[0.00, 
0.77] 
40.00 
[30,50] 
Canada Mean ± 
STDEV 
2.90 11.68 ± 
5.13 
10.19 ± 
25.97 
9.87 ± 
18.40 
3.58 ± 
6.92 
5.80 ± 
18.29 
11.80 ± 
20.49 
10.68 ± 
17.81 
26.29 ± 
28.61 
9.10 ± 
15.03 
18.03 ± 
35.06 
17.52 
±17.32 
Median, 
CI 95% 
[] 
0.00 
[bigger 
sample] 
0.00 5.00 5.00 0.00 0.00 0.00 0.00 20.00 2.00 0.00 10.00 
USA 
 
Mean ± 
STDEV 
3.03 ± 
8.70 
1.67 ± 
6.02 
12.37 ± 
13.11 
11.84 ± 
11.71 
11.50 ± 
6.53 
2.02 ± 
6.57 
20.17 ± 
20.06 
24.14 ± 
23.76 
39.75 ± 
30.26 
25.43 ± 
28.91 
12.51 ± 
29.52 
21.24 ± 
8.32 
Median, 
CI 95% 
[] 
0.00 
[0,0] 
0.00 
[0,0] 
10.00 
[5,10] 
10.00 
[7.83, 
10.00] 
5.00 
[0,10] 
0.00 [0,0] 15.00 
[10,20] 
20.00 
[10.00, 
27.50] 
37.50 
[25,50] 
10.00 
[5.00, 
27.17] 
0.00 [0,0] 20.00 
[12.83, 
20.00] 
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     Significant differences (Kruskal-Wallis test): 
Myopia management modality  p value 
Undercorrection France -Italy 0.044 
France - Spain 0.034 
France - Portugal 0.001 
UK/EIRE - Portugal 0.016 
SVS Netherlands - Portugal p<0.001 
UK/EIRE - Portugal 0.001 
Spain - Portugal 0.050 
Bifocals France - Netherlands 0.009 
France - Italy 0.001 
France – UK/EIRE p<0.001 
France - Spain p<0.001 
Portugal - Spain 0.013 
PALs France - Spain 0.027 
France - Italy 0.002 
France – UK/EIRE 0.002 
RGP (AF) Italy - France 0.005 
Netherlands- France 0.025 
UK/EIRE - France 0.029 
SV CL France - Portugal p<0.001 
Netherlands - Portugal p<0.001 
UK/EIRE - Portugal 0.015 
Standard multifocal CL France - Portugal 0.003 
France - Italy p<0.001 
France – Netherlands p<0.001 
France - Spain p<0.001 
France – UK/EIRE p<0.001 
Portugal – UK/EIRE 0.013 
Italy - UK/EIRE 0.049 
Specific MC CL France - Italy p<0.001 
France - Netherlands 0.001 
France - Portugal p<0.001 
France – UK/EIRE p<0.001 
France - Spain p<0.001 
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Italy - Spain 0.032 
Ortho K France - Spain 0.003 
Pharmaceuticals France – UK/EIRE p<0.001 
France - Spain p<0.001 
France - Netherlands p<0.001 
Portugal – UK/EIRE 0.027 
Portugal - Spain 0.009 
Portugal - Netherlands 0.004 
Refractive surgery France - Portugal 0.001 
Italy - Portugal p<0.001 
Netherlands - Portugal 0.048 
Increased outdoor activity France - Portugal 0.019 
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3. How active would you consider your clinical practice in the area of myopia 
control? 
Globally: 
Mean ± STDEV Median, CI [] 
6.35 ± 2.73 7.00 [7,7] 
 
Continents: 
Continent Mean ± STDEV Median, CI [] 
Asia 7.45 ± 2.07 8.00 [8,8] 
Australasia 6.46 ± 2.81 7.00 [6,8] 
Europe 6.27 ± 2.58 7.00 [6,7] 
North America 4.72 ± 2.99 4.00 [3,5] 
South America 5.45 ± 3.06 5.00 [4,6] 
 
Kruskal-Wallis test (p<0.001): 
Australasia-North America p<0.001 
Australasia - Asia 0.028 
Australasia-Europe 1.00 
Australasia-South America 0.214 
North America-Asia p<0.001 
North America-Europe p<0.001 
North America-South America 1.00 
Asia-Europe p<0.001 
Asia-South America p<0.001 
Europe-South America 0.589 
 
Countries: 
Country Mean ± STDEV Median, CI 95% [] 
UK, EIRE 5.19 ± 3.07 5.00 [4.00,6.80] 
Netherlands 6.16 ± 2.05 7.00 [bigger sample] 
Spain 6.88 ± 2.61 7.00 [bigger sample] 
France 6.65 ± 2.59 7.50 [bigger sample] 
Portugal 6.25 ± 1.99 6.00 [5,7] 
Italy 6.58 ± 2.68 7.00 [5.93,8.00] 
India 6.05 ± 1.99 6.00 [bigger sample] 
Hong Kong 7.31 ± 2.20 8.00 [6.64,8.00] 
China 7.96 ± 1.96 8.00 [8,8] 
Canada 3.97 ± 3.42 2.00 [bigger sample] 
USA 4.96 ± 2.83 5.00 [4,6] 
 
Kruskal-Wallis test (Europe p=0.046, Asia p<0.001): 
UK/EIRE-France 0.269 
UK/EIRE-Netherlands 1.00 
UK/EIRE-Italy 0.112 
UK/EIRE-Spain 0.091 
UK/EIRE-Portugal 1.00 
France-Netherlands 1.00 
France-Italy 1.00 
France-Spain 0.345 
France-Portugal 1.00 
Netherlands-Italy 1.00 
Netherlands-Spain 1.00 
Netherlands-Portugal 1.00 
Italy-Spain 1.00 
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Italy-Portugal 1.00 
Spain-Portugal 1.00 
Hong Kong-China 0.365 
Hong Kong-India 0.002 
China-India p<0.001 
Canada-USA 0.034 
 
One hundred sixty-three respondents left comments. 
Category Number of responses 
Myopia control is not actively 
employed or is not of a 
concern owing to the lack of 
myopic patients owing to e.g. 
practice location, patient 
demographics or patient’s 
poor awareness of myopia 
control or lack of access to 
myopia control interventions  
33 (mostly due to patient 
demographics) 
Myopia control is ineffective or 
not worth the effort, considering 
the increased cost, inconsistent 
information and individually 
selective outcome. 
8 
Myopia control would be 
employed more in the clinical 
practice, if unite and consistent 
regulations and informational 
materials (e.g. leaflets) existed 
and different methods would be 
certified for MC use: 
20 
Multifocal lenses/Myopia 
spectacles 
3 
Practice is new in myopia 
control. 
4 
Currently active in myopia 
control and employing one or 
more of the myopia control 
approaches available;  
68 
From them (if specified) X 
employ: 
Orthokeratology (actively 
prescribing or suggesting and 
referring to a practice in which 
it is employed). 
50 (popular within Asia, 
Australasia, Europe) 
PALs/bifocals 13 (pronounced in 
Australasia) 
Soft multifocal contact lenses 13 
Increased outdoor activity 6 
RGPs 3 
Atropine 1 
Specialised MC spectacle 
lenses 
1 
Undercorrection 2 
Patient education 2 
 
Two of the respondents criticised second question as being not well constructed: the first 
implied that undercorrection could not be viewed at as a method of MC, and the second implied 
that all MC methods are ‘off-label’ not only multifocal contact lenses.  
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4. How many times have you prescribed the following correction options for progressing/ young myopes over an average month? 
 
Globally: 
 SVS (%) Bifocals 
(%) 
PALs (%) RGP (AF) 
(%) 
SV CL (%) Standard 
multifocal 
CL (%) 
Specific 
MC soft 
CL (%) 
Ortho-K 
(%) 
Pharma-
ceuticals 
(%) 
Refracti-
ve 
surgery 
(%) 
Mean ± 
STDEV 
47.78 ± 
31.70 
2.63 ± 
8.16 
6.45 ± 
14.29 
4.54 ± 
10.48 
15.22 ± 
17.28 
4.05 ± 
11.33 
2.07 ± 
7.88 
14.32 ± 
24.25 
1.95 ± 
8.67 
1.01 ± 
5.41 
Median, 
CI 95% [] 
50.00 
[50.00, 
53.96] 
0.00 [0,0] 0.00 [0,0] 0.00 [0,0] 10.00 
[8.70,12.5
0] 
0.00 [0,0] 0.00 [0,0] 2.00 
[0.56,2.9] 
0.00 [0,0] 0.00 [0,0] 
 
Continents: 
Continent SVS Bifocals PALs RGP 
(AF) 
SV CL Standard 
multifocal 
CL 
Specific 
MC soft 
CL 
Ortho-
K 
Pharma-
ceuticals 
Refractive 
surgery 
Asia  
 
Mean ± 
STDEV 
57.59 ± 
31.26 
2.89 ± 
7.27 
7.42 ± 
13.33 
4.85 ± 
8.51 
5.66 ± 
9.92 
0.78 ± 2.94 2.19 ± 
8.12 
11.08 ± 
17.57 
5.57 ± 
14.46 
1.96 ± 8.28 
Media
n, CI 
95% [] 
65.14 
[60.98,70
.00] 
0.00 [0,0] 1.39 
[0.13,2.7
8] 
0.00 
[0.00,11.
40] 
0.00 [0,0] 0.00 [0,0] 0.00 
[0,0] 
2.90 
[2.00,5.
09] 
0.00 [0,0] 0.00 [0,0] 
Australasia  Mean ± 
STDEV 
36.79 ± 
30.15 
1.27 ± 
4.42 
17.35 ± 
23.03 
0.61 ± 
2.05 
13.93 ± 
13.35 
6.24 ± 11.93 1.53 ± 
4.65 
21.21 ± 
29.05 
0.81 ± 
3.29 
0.25 ± 1.28 
Media
n, CI 
95% [] 
33.33 
[25,40] 
0.00 [0,0] 7.14 
[2.56,11.
11] 
0.00 [0,0] 12.50 
[7.58, 
18.18] 
0.00 [0,0] 0.00 
[0,0] 
9.09 
[4.76, 
13.33] 
0.00 [0,0] 0.00 [0,0] 
Europe  Mean ± 
STDEV 
42.17 ± 
30.68 
2.10 ± 
6.99 
4.12 ± 
12.17 
6.09 ± 
13.58 
20.17 ± 
18.82 
4.27 ± 10.95 2.44 ± 
8.79 
18.26 ± 
27.64 
0.13 ± 
1.18 
0.25 ± 1.58 
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Media
n, CI 
95% [] 
45.45 
[40,50] 
0.00 [0,0] 0.00 [0,0] 0.00 [0,0] 20.00 
[15.38, 
22.81] 
0.00 [0,0] 0.00 
[0,0] 
46.50 
[11.10, 
82.00] 
0.00 [0,0] 0.00 [0,0] 
North 
America  
Mean ± 
STDEV 
49.56 ± 
31.29 
5.11 ± 
13.57 
3.65 ± 
9.21 
2.41 ± 
8.34 
18.80 ± 
16.50 
8.46 ± 17.51 0.91 ± 
5.08 
9.42 ± 
18.49 
1.08 ± 
6.78 
0.59 ± 4.50 
Media
n, CI 
95% [] 
56.60 
[50.00,58
.82] 
0.00 [0,0] 0.00 [0,0] 0.00 [0,0] 19.76 
[14.04,22
.96] 
0.00 
[0,1.38] 
0.00 
[0,0] 
0.00 
[0,0] 
0.00 [0,0] 0.00 [0,0] 
South 
America  
Mean ± 
STDEV 
52.10 ± 
30.48 
1.89 ± 
6.97 
1.77 ± 
5.20 
6.82 ± 
10.78 
20.99 ± 
20.34 
2.05 ± 7.24 3.04 ± 
10.56 
7.86 ± 
25.22 
0.68 ± 
5.03 
2.80 ± 7.62 
Media
n, CI 
95% [] 
52.33 
[45.11,63
.30] 
0.00 [0,0] 0.00 [0,0] 0.00 
[0.00,5.7
4] 
17.20 
[14.29,25
.00] 
0.00 [0,0] 0.00 
[0,0] 
0.00 
[0,0] 
0.00 [0,0] 0.00 [0,0] 
 
Kruskal-Wallis test: 
Myopia management modality  p value 
SVS Australasia-Europe 1.00 
Australasia-North America 0.028 
Australasia-South America 0.021 
Australasia-Asia p<0.001 
Europe-North America 0.485 
Europe-South America 0.309 
Europe-Asia p<0.001 
North America-South America 1.00 
North America-Asia 0.161 
South America-Asia 1.00 
Bifocals Australasia-Europe 1.00 
Australasia-North America p<0.001 
Australasia-South America 1.00 
Australasia-Asia 0.018 
Europe-North America p<0.001 
Europe-South America 1.00 
Europe-Asia 0.159 
North America-South America 0.025 
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North America-Asia 0.264 
South America-Asia 1.00 
PALs Australasia-Europe p<0.001 
Australasia-North America p<0.001 
Australasia-South America p<0.001 
Australasia-Asia 0.102 
Europe-North America 1.00 
Europe-South America 1.00 
Europe-Asia p<0.001 
North America-South America 0.680 
North America-Asia 0.002 
South America-Asia p<0.001 
RGP (AF) Australasia-Europe p<0.001 
Australasia-North America 1.00 
Australasia-South America p<0.001 
Australasia-Asia p<0.001 
Europe-North America 0.008 
Europe-South America 0.655 
Europe-Asia 0.760 
North America-South America p<0.001 
North America-Asia p<0.001 
South America-Asia 1.00 
SV CL Australasia-Europe 0.149 
Australasia-North America 0.987 
Australasia-South America 0.435 
Australasia-Asia p<0.001 
Europe-North America 1.00 
Europe-South America 1.00 
Europe-Asia p<0.001 
North America-South America 1.00 
North America-Asia p<0.001 
South America-Asia p<0.001 
Standard multifocal CL Australasia-Europe 1.00 
Australasia-North America 0.767 
Australasia-South America 0.108 
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Australasia-Asia p<0.001 
Europe-North America p<0.001 
Europe-South America 1.00 
Europe-Asia p<0.001 
North America-South America p<0.001 
North America-Asia p<0.001 
South America-Asia 1.00 
Specific MC CL Australasia-Europe 1.00 
Australasia-North America 0.730 
Australasia-South America 1.00 
Australasia-Asia 0.759 
Europe-North America 0.069 
Europe-South America 1.00 
Europe-Asia 0.507 
North America-South America 0.436 
North America-Asia p<0.001 
South America-Asia 1.00 
Ortho K Australasia-Europe 1.00 
Australasia-North America 0.006 
Australasia-South America p<0.001 
Australasia-Asia 1.00 
Europe-North America 0.02 
Europe-South America p<0.001 
Europe-Asia 1.00 
North America-South America 0.048 
North America-Asia 0.160 
South America-Asia p<0.001 
Pharmaceuticals Australasia-Europe 1.00 
Australasia-North America 1.00 
Australasia-South America 1.00 
Australasia-Asia p<0.001 
Europe-North America 1.00 
Europe-South America 1.00 
Europe-Asia p<0.001 
North America-South America 1.00 
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North America-Asia p<0.001 
South America-Asia p<0.001 
Refractive surgery Australasia-Europe 1.00 
Australasia-North America 1.00 
Australasia-South America p<0.001 
Australasia-Asia 0.02 
Europe-North America 1.00 
Europe-South America p<0.001 
Europe-Asia p<0.001 
North America-South America p<0.001 
North America-Asia 0.061 
South America-Asia 0.25 
 
Countries: 
Country SVS Bifocals PALs RGP 
(AF) 
SV CL Standard 
multifocal 
CL 
Specifi
c MC 
soft CL 
Ortho-K Pharma-
ceuticals 
Refracti-
ve 
surgery 
UK, EIRE  
 
Mean ± 
STDEV 
56.43 ± 
29.65 
4.11 ± 
10.14 
2.89 ± 
8.18 
2.68 ± 
8.35 
20.56 ± 
19.02 
4.30 ± 
14.80 
1.03 ± 
3.67 
7.18 ± 
17.41 
0.51 ± 
2.56 
0.42 ± 
2.01 
Median, 
CI 95% 
[] 
63.29 
[57.30,7
1.43] 
0.00 [0,0] 0.00 [0,0] 0.00 [0,0] 19.61 
[13.16,22
.53] 
0.00 [0,0] 0.00 
[0,0] 
0.00 
[0.00,1.9] 
0.00 [0,0] 0.00 [0,0] 
Netherlands Mean ± 
STDEV 
23.28 ± 
23.93 
1.04 ± 
3.51 
1.26 ± 
4.99 
8.64 ± 
13.07 
22.07 ± 
22.40 
5.02 ± 
12.98 
0.43 ± 
2.56 
37.85 ± 
35.71 
0.28 ± 
1.67 
0.13 ± 
0.79 
Median, 
CI 95% 
[] 
21.40 
[bigger 
sample] 
0.00 
[bigger 
sample] 
0.00 
[bigger 
sample] 
2.45 
[bigger 
sample] 
21.90 
[bigger 
sample] 
0.00 
[bigger 
sample] 
0.00 
[bigger 
sample] 
23.14 
[bigger 
sample] 
0.00 
[bigger 
sample] 
0.00 
[bigger 
sample] 
Spain Mean ± 
STDEV 
44.56 ± 
24.26 
1.53 ± 
3.18 
0.93 ± 
2.41 
9.44 ± 
21.04 
22.7 ± 
17.20 
1.66 ± 4.19 3.85 ± 
9.46 
14.57 ± 
23.53 
0.00 ± 
0.00 
0.76 ± 
3.51 
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Median, 
CI 95% 
[] 
43.86 
[bigger 
sample] 
0.00 
[bigger 
sample] 
0.00 
[bigger 
sample] 
0.00 
[bigger 
sample] 
25.00 
[bigger 
sample] 
0.00 
[bigger 
sample] 
0.00 
[bigger 
sample] 
4.88 
[bigger 
sample] 
0.00 
[bigger 
sample] 
0.00 
[bigger 
sample] 
France Mean ± 
STDEV 
56.43 ± 
30.53 
0.81 ± 
4.49 
5.34 ± 
19.04 
15.15 ± 
23.33 
11.70 
±14.83 
0.31 ± 1.51 0.37 ± 
2.05 
9.67 ± 
21.10 
0.05 ± 
0.27 
0.17 ± 
0.62 
Median, 
CI 95% 
[] 
60.24 
[bigger 
sample] 
0.00 
[bigger 
sample] 
0.00 
[bigger 
sample] 
5.66 
[bigger 
sample] 
0.00 
[bigger 
sample] 
0.00 
[bigger 
sample] 
0.00 
[bigger 
sample] 
0.00 
[bigger 
sample] 
0.00 
[bigger 
sample] 
0.00 
[bigger 
sample] 
Portugal Mean ± 
STDEV 
62.42 ± 
21.62 
0.63 ± 
4.42 
1.93 ± 
5.16 
1.31 ± 
4.49 
25.99 ± 
15.05 
1.83 ± 5.26 1.36 ± 
5.38 
4.49 ± 
18.18 
0.00 ± 
0.00 
0.04 ± 
0.26 
Median, 
CI 95% 
[] 
62.50 
[61.25,6
9.53] 
 
0.00 [0,0] 0.00 [0,0] 0.00 [0,0] 29.29 
[23.18,33
.33] 
0.00 [0,0] 0.00 
[0,0] 
0.00 [0,0] 0.00 [0,0] 0.00 [0,0] 
Italy Mean ± 
STDEV 
31.00 ± 
28.60 
3.00 ± 
10.2 
10.00 ± 
19.6 
5.00 ± 
9.50 
19.00 ± 
16.90 
4.00 ± 7.10 4.00 ± 
13.50 
23.00 ± 
29.30 
0.00 ± 
0.00 
0.00 ± 
0.00 
Median, 
CI 95% 
[] 
27.00 
[10,43] 
0.00 [0,0] 0.00 [0,4] 0.00 [0,0] 17.00 
[10,25] 
0.00 [0,0] 0.00 
[0,0] 
13.00 
[5,20] 
0.00 [0,0] 0.00 [0,0] 
India 
 
Mean ± 
STDEV 
51.70 ± 
43.31 
9.42 ± 
21.69 
4.31 ± 
11.15 
6.30 ± 
16.67 
19.11 ± 
2.44 
1.25 ± 0.54 2.39 ± 
0.97 
0.34 ± 
0.21 
0.88 ± 
0.42 
4.30 ± 
11.89 
Median, 
CI 95% 
[] 
47.37  
[bigger 
sample] 
3.45 
[bigger 
sample] 
1.33 
[bigger 
sample] 
14.30 
[bigger 
sample] 
17.65 
[bigger 
sample] 
0.00 
[bigger 
sample] 
0.00 
[bigger 
sample] 
0.00 
[bigger 
sample] 
0.00 
[bigger 
sample] 
0.00 
[bigger 
sample] 
Hon Kong Mean ± 
STDEV 
60.80 ± 
30.57 
1.73 ± 
7.16 
11.32 ± 
16.32 
1.44 ± 
5.44 
5.71 ± 
9.34 
0.86 ± 3.78 5.86 ± 
15.14 
10.78 ± 
13.12 
1.03 ± 
4.27  
0.46 ± 
0.36 
Median, 
CI 95% 
[] 
65.59 
[59.41,7
5.52] 
0.00 [0,0] 4.39 
[0.00,12.
50] 
0.00 [0,0] 0.00 [0,0] 0.00 [0,0] 0.00 
[0.00,2.
82] 
5.28 
[1.37,10.
95] 
0.00 [0,0] 0.00 [0,0] 
China Mean ± 
STDEV 
56.33 ± 
34.04 
1.32 ± 
3.61 
3.80 ± 
11.20 
7.38 ± 
9.42 
2.34 ± 
4.82 
0.43 ± 2.19 0.32 ± 
1.54 
14.04 ± 
20.51 
11.18 ± 
18.99 
2.88 ± 
11.57 
Median, 
CI 95% 
[] 
66.23 
[60.98,7
5.41] 
0.00 [0,0] 0.00 [0,0] 4.29 
[1.37,5.1
3] 
0.00 [0,0] 0.00 [0,0] 0.00 
[0,0] 
5.36 
[2.39,9.6
8] 
0.00 
[0.00,5.2
0] 
0.00 [0,0] 
Canada Mean ± 
STDEV 
60.40 ± 
32.66 
4.70 ± 
13.69 
4.98 ± 
14.46 
0.40 ± 
1.34 
16.93 ± 
18.50 
5.02 ± 
13.75 
0.52 ± 
2.95 
4.05 ± 
11.16 
0.95 ± 
4.50 
2.05 ± 
8.93 
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Median, 
CI 95% 
[] 
64.36 
[bigger 
sample] 
0.00 
[bigger 
sample] 
0.00 
[bigger 
sample] 
0.00 
[bigger 
sample] 
12.50 
[bigger 
sample] 
0.00 
[bigger 
sample] 
0.00 
[bigger 
sample] 
0.00 
[bigger 
sample] 
0.00 
[bigger 
sample] 
0.00 
[bigger 
sample] 
USA 
 
Mean ± 
STDEV 
45.98 ± 
30.14 
5.25 ± 
13.60 
3.21 ± 
6.70 
3.07 ± 
9.51 
19.42 ± 
15.84 
9.60 ± 
18.51 
1.04 ± 
5.62 
11.19 ± 
20.07 
1.12 ± 
7.41 
0.11 ± 
0.56 
Median, 
CI 95% 
[] 
51.72 
[44.12,5
8.19] 
0.00 
[0.00,1.2
2] 
0.00 [0,0] 0.00 [0,0] 20.00 
[14.61,25
.00] 
1.00 
[0.00,3.33] 
0.00 
[0,0] 
0.86 
[0.00,4.6
3] 
0.00 [0,0] 0.00 [0,0] 
 
Kruskal-Wallis test: 
Myopia management modality  p value 
SVS  Netherlands-Italy 1.00 
Netherlands-Spain 0.072 
Netherlands-France p<0.001 
Netherlands-UK/EIRE p<0.001 
Netherlands-Portugal p<0.001 
Italy-Spain 1.00 
Italy-France 0.003 
Italy-UK/EIRE p<0.001 
Italy-Portugal p<0.001 
Spain-France 1.00 
Spain-UK/EIRE 0.622 
Spain/Portugal 0.077 
France-UK/EIRE 1.00 
France-Portugal 1.00 
UK/EIRE-Portugal 1.00 
India-Hong Kong All p=0.164 
India-China 
China-Hong Kong 
Canada-USA 0.028 
Bifocals  Netherlands-Italy 1.00 
Netherlands-Spain 0.872 
Netherlands-France 1.00 
Netherlands-UK/EIRE 0.214 
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Netherlands-Portugal 1.00 
Italy-Spain 1.00 
Italy-France 0.563 
Italy-UK/EIRE 1.00 
Italy-Portugal 0.203 
Spain-France 0.263 
Spain-UK/EIRE 1.00 
Spain-Portugal 0.103 
France-UK/EIRE 0.047 
France-Portugal 1.00 
UK/EIRE-Portugal 0.010 
India-Hong Kong All p<0.001 
India-China 
China-Hong Kong 
Canada-USA 0.023 
PALs  Netherlands-Italy p<0.001 
Netherlands-Spain 1.00 
Netherlands-France 1.00 
Netherlands-UK/EIRE 0.746 
Netherlands-Portugal 1.00 
Italy-Spain 0.004 
Italy-France 0.038 
Italy-UK/EIRE 0.078 
Italy-Portugal 0.003 
Spain-France 1.00 
Spain-UK/EIRE 1.00 
Spain/Portugal 1.00 
France-UK/EIRE 1.00 
France-Portugal 1.00 
UK/EIRE-Portugal 1.00 
India-Hong Kong  All p=0.007 
India-China 
China-Hong Kong 
Canada-USA 0.032 
RGP (AF)  Netherlands-Italy 0.339 
Netherlands-Spain 1.00 
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Netherlands-France 1.00 
Netherlands-UK/EIRE 0.017 
Netherlands-Portugal 0.001 
Italy-Spain 1.00 
Italy-France 0.001 
Italy-UK/EIRE 1.00 
Italy-Portugal 0.568 
Spain-France 0.259 
Spain-UK/EIRE 0.246 
Spain/Portugal 0.034 
France-UK/EIRE p<0.001 
France-Portugal p<0.001 
UK/EIRE-Portugal 1.00 
India-Hong Kong All p<0.001 
India-China 
China-Hong Kong 
Canada-USA 0.053 
SV CL  Netherlands-Italy 1.00 
Netherlands-Spain 1.00 
Netherlands-France 0.550 
Netherlands-UK/EIRE 1.00 
Netherlands-Portugal 1.00 
Italy-Spain 1.00 
Italy-France 0.655 
Italy-UK/EIRE 1.00 
Italy-Portugal 0.308 
Spain-France 0.143 
Spain-UK/EIRE 1.00 
Spain-Portugal 1.00 
France-UK/EIRE 0.358 
France-Portugal 0.002 
UK/EIRE-Portugal 1.00 
India-Hong Kong All p<0.001 
India-China 
China-Hong Kong 
Canada-USA 0.402 
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Standard multifocal contact lenses  Netherlands-Italy (Europe all p=0.055) 
Netherlands-Spain 
Netherlands-France 
Netherlands-UK/EIRE 
Netherlands-Portugal 
Italy-Spain 
Italy-France 
Italy-UK/EIRE 
Italy-Portugal 
Spain-France 
Spain-UK/EIRE 
Spain/Portugal 
France-UK/EIRE 
France-Portugal 
UK/EIRE-Portugal 
India-Hong Kong All p=0.001 
India-China 
China-Hong Kong 
Canada-USA 0.010 
Specific myopia control CL  Netherlands-Italy 0.160 
Netherlands-Spain 0.001 
Netherlands-France 1.00 
Netherlands-UK/EIRE 1.00 
Netherlands-Portugal 1.00 
Italy-Spain 0.309 
Italy-France 0.640 
Italy-UK/EIRE 1.00 
Italy-Portugal 0.502 
Spain-France 0.002 
Spain-UK/EIRE 0.034 
Spain/Portugal 0.003 
France-UK/EIRE 1.00 
France-Portugal 1.00 
UK/EIRE-Portugal 1.00 
India-Hong Kong All p<0.001 
India-China 
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China-Hong Kong 
Canada-USA 0.643 
Orthokeratology  Netherlands-Italy 0.089 
Netherlands-Spain 0.132 
Netherlands-France p<0.001 
Netherlands-UK/EIRE p<0.001 
Netherlands-Portugal p<0.001 
Italy-Spain 1.00 
Italy-France 0.190 
Italy-UK/EIRE 0.001 
Italy-Portugal p<0.001 
Spain-France 0.781 
Spain-UK/EIRE 0.040 
Spain-Portugal p<0.001 
France-UK/EIRE 1.00 
France-Portugal 0.263 
UK/EIRE-Portugal 1.00 
India-Hong Kong All p<0.001 
India-China 
China-Hong Kong 
Canada-USA 0.004 
Pharmaceuticals Netherlands-Italy All p=0.679 
Netherlands-Spain 
Netherlands-France 
Netherlands-UK/EIRE 
Netherlands-Portugal 
Italy-Spain 
Italy-France 
Italy-UK/EIRE 
Italy-Portugal 
Spain-France 
Spain-UK/EIRE 
Spain/Portugal 
France-UK/EIRE 
France-Portugal 
UK/EIRE-Portugal 
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India-Hong Kong All p<0.001 
India-China 
China-Hong Kong 
Canada-USA 0.742 
Refractive surgery Netherlands-Italy All p=0.654 
Netherlands-Spain 
Netherlands-France 
Netherlands-UK/EIRE 
Netherlands-Portugal 
Italy-Spain 
Italy-France 
Italy-UK/EIRE 
Italy-Portugal 
Spain-France 
Spain-UK/EIRE 
Spain/Portugal 
France-UK/EIRE 
France-Portugal 
UK/EIRE-Portugal 
India-Hong Kong All p<0.001 
India-China 
China-Hong Kong 
Canada-USA 0.135 
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5. How old (in years) would the patient have to be for you to consider each of the following options (not just for myopia control and assuming 
average handling skills and child/ parent motivation)? 
 
Globally: 
 SVS 
(years) 
Bifocals 
(years) 
PALs 
(years) 
RGP (AF) 
(years)  
SV CL 
(years) 
Standard 
multifocal 
CL 
(years) 
Specific 
MC soft 
CL 
(years) 
Ortho-K 
(years) 
Pharma-
ceuticals 
(years) 
Refracti-
ve 
surgery 
(years) 
Mean ± 
STDEV 
5.44 ± 
1.52 
6.30 ± 
2.25 
7.31 ± 
2.83  
9.87 ± 
3.28 
8.51 ± 
3.44 
8.90 ± 
3.08 
8.78 ± 
3.11 
8.82 ± 
3.10 
6.41 ± 
2.55 
17.11± 
2.91 
Median, 
CI 95% [] 
5.00 [5,5] 5.00 [5,5] 7.00 [6,8] 10.00 
[8,10] 
9.00 [8,10] 9.00 [8,10] 9.00 [8,10] 9.00 [8,10] 5.00 [5,6] 18.00 
[18,18] 
 
Continents: 
Continent SVS (yrs) Bifocals 
(yrs) 
PALs 
(yrs) 
RGP (AF) 
(yrs) 
SV CL 
(yrs) 
Standard 
multifocal 
CL (yrs) 
Specific 
MC soft 
CL (yrs) 
Ortho-K 
(yrs) 
Pharma-
ceuticals 
(yrs) 
Refractive 
surgery 
(yrs) 
Asia  Mean ± 
STDEV 
5.90 ± 
3.86 
6.60 ± 
2.57 
7.83 ± 
3.04 
10.08 ± 
3.32 
10.90 ± 
3.78 
11.13 ± 4.03 10.76 ± 
3.52 
9.58 ± 
3.24 
6.40 ± 
2.61 
16.85 ± 2.86 
Media
n, CI 
95% [] 
5.00 [5,5] 5.00 [5,6] 7.50 
[6.50,8.0
0] 
10.00 
[8,10] 
10.00 
[8.50,11.
50] 
10.00 [8,12] 10.00 
[9,10] 
8.00 
[8,10] 
5.00 
[5.00,5.50
] 
18.00 [18,18] 
Australasia  Mean ± 
STDEV 
5.33 ± 
0.51 
6.00 ± 
1.26 
6.50 ± 
1.38 
9.00 ± 
1.67 
8.33 ± 
0.82 
8.33 ± 0.82 8.33 ± 
0.82 
8.00 ± 
1.10 
6.67 ± 
3.87 
18.00 ± 0.00 
Media
n, CI 
95% [] 
5.00 [5,6] 5.50 [5,7] 6.50 [5,8] 8.00 
[8,11] 
8.00 [8,9] 8.00 [8,9] 8.00 
[8,9] 
8.00 
[7,9] 
6.00 [5,9] 18.00 [18,18] 
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Europe  Mean ± 
STDEV 
7.41± 
3.04 
7.44 ± 
2.60 
7.78 ± 
2.82 
7.89 ± 
2.42 
7.78 
±2.73 
7.44 ± 2.46 7.33 ± 
2.45 
8.11 ± 
2.32 
7.89 ± 
3.62 
12.78 ± 4.49 
Media
n, CI 
95% [] 
5.00 
[5,11] 
8.00 
[5,10] 
8.00 
[5,10] 
8.00 
[5,11] 
8.00 
[5,10] 
8.00 [5,10] 7.00 
[5,10] 
8.00 
[5,10] 
5.00 [5,12] 12.00 [10,18] 
North 
America  
Mean ± 
STDEV 
5.20 ± 
0.56 
5.13 ± 
0.52 
6.67 ± 
2.85 
9.33 ± 
3.02 
7.87 ± 
2.42 
8.07 ± 2.71 7.93 
±2.55 
8.00 ± 
3.07 
6.40 ± 
3.33 
18.00 ± 0.00 
Media
n, CI 
95% [] 
5.00 [5,5] 5.00 [5,5] 
 
5.00 [5,8] 10.00 
[7,12] 
8.00 
[6,10] 
8.00 [6,10] 8.00 
[6,10] 
7.00 
[6,9] 
5.00 [5,6] 18.00 [18,18] 
South 
America  
Mean ± 
STDEV 
5.50 ± 
1.22 
7.50 ± 
2.88 
8.00 ± 
3.22 
10.17 ± 
4.26 
10.33 ± 
3.72 
11.00 ± 3.58 10.33 ± 
3.88 
12.33 ± 
4.84 
6.33 ± 
2.16 
15.50 ± 5.21 
Media
n, CI 
95% [] 
5.00 
[5.00, 
7.18] 
6.50 
[5,11] 
7.00 
[5,12] 
11.50 
[5,14] 
10.00 
[6.59,14.
00] 
10.00 
[7.58,14.00] 
10.50 
[6.09,14
.00] 
12.50 
[7.50,16
.00] 
5.00 
[5.00,9.04
] 
18.00 
[10.73,18.00] 
 
Kruskal-Wallis test: 
Myopia management modality  p value 
SVS  Australasia-Europe 0.999 
Australasia-North America 1.00 
Australasia-South America 1.00 
Australasia-Asia 0.057 
Europe-North America 0.251 
Europe-South America 1.00 
Europe-Asia 1.00 
North America-South America 1.00 
North America-Asia 0.007 
South America-Asia 0.147 
Bifocals  
Australasia-Europe 0.099 
Australasia-North America 1.00 
Australasia-South America 0.945 
Australasia-Asia p<0.001 
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Europe-North America 0.001 
Europe-South America 1.00 
Europe-Asia 0.031 
North America-South America 0.212 
North America-Asia p<0.001 
South America-Asia 1.00 
PALs  Australasia-Europe 0.001 
Australasia-North America 1.00 
Australasia-South America 0.784 
Australasia-Asia p<0.001 
Europe-North America 0.268 
Europe-South America 1.00 
Europe-Asia 0.327 
North America-South America 1.00 
North America-Asia p<0.001 
South America-Asia 0.933 
RGP (AF)  Australasia-Europe 1.00 
Australasia-North America 1.00 
Australasia-South America 0.803 
Australasia-Asia 1.00 
Europe-North America 1.00 
Europe-South America 0.029 
Europe-Asia 1.00 
North America-South America 1.00 
North America-Asia 1.00 
South America-Asia 0.253 
SV CL  Australasia-Europe 1.00 
Australasia-North America 1.00 
Australasia-South America 0.157 
Australasia-Asia p<0.001 
Europe-North America 1.00 
Europe-South America 0.004 
Europe-Asia p<0.001 
North America-South America 0.015 
North America-Asia p<0.001 
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South America-Asia 0.241 
Standard multifocal CL  Australasia-Europe 1.00 
Australasia-North America 1.00 
Australasia-South America 1.00 
Australasia-Asia p<0.001 
Europe-North America 1.00 
Europe-South America 1.00 
Europe-Asia p<0.001 
North America-South America 1.00 
North America-Asia p<0.001 
South America-Asia 0.632 
Specific MC CL Australasia-Europe 1.00 
Australasia-North America 1.00 
Australasia-South America 1.00 
Australasia-Asia 0.045 
Europe-North America 1.00 
Europe-South America 1.00 
Europe-Asia p<0.001 
North America-South America 1.00 
North America-Asia p<0.001 
South America-Asia 0.512 
Ortho K (p=0.002) Australasia-Europe 0.004 
Australasia-North America 1.00 
Australasia-South America 1.00 
Australasia-Asia 1.00 
Europe-North America 0.230 
Europe-South America 0.153 
Europe-Asia 0.131 
North America-South America 1.00 
North America-Asia 1.00 
South America-Asia 1.00 
Pharmaceuticals Australasia-Europe All p=0.814 
Australasia-North America 
Australasia-South America 
Australasia-Asia 
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Europe-North America 
Europe-South America 
Europe-Asia 
North America-South America 
North America-Asia 
South America-Asia 
Refractive surgery Australasia-Europe All p=0.148 
Australasia-North America 
Australasia-South America 
Australasia-Asia 
Europe-North America 
Europe-South America 
Europe-Asia 
North America-South America 
North America-Asia 
South America-Asia 
 
Countries: 
Country SVS Bifocals PALs RGP 
(AF) 
SV CL Standard 
multifocal 
CL 
Specific 
MC soft 
CL 
Ortho-K Pharma-
ceuticals 
Refracti-
ve 
surgery 
UK, EIRE 
 
Mean ± 
STDEV 
4.96± 
0.82 
4.30 ± 
3.09 
4.20 ± 
4.31 
6.55 ± 
4.13 
7.37 ± 
2.08 
5.18 ± 4.42 5.86 ± 
3.97 
5.49 ± 
4.75 
0.8 ± 2.07 18.49 ± 
5.57 
Median, 
CI 95% 
[] 
5.00 
[5,8] 
10.00 
[5.11] 
5.00 [5, 
18] 
8.00 
[5,14] 
8.00 
[5,11] 
7.00 [5,14] 7.00 
[5,14] 
7.00 
[5,18] 
0.00 [0,9] 15.00 
[15,18] 
Netherlands Mean ± 
STDEV 
5.94 ± 
1.65 
7.86 ± 
2.25 
8.83 ± 
2.85 
8.94 ± 
3.01 
8.11 ± 
1.95 
9.15 ± 2.14 8.53 ± 
2.14 
8.62 ± 
1.93 
6.55 ± 
2.17 
15.29 ± 
5.06 
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Median, 
CI 95% 
[] 
5.00  8.00 
 
8.00 8.00 8.00 9.00 8.00 8.00 6.00 18.00 
Spain Mean ± 
STDEV 
5.35 ± 
1.47 
6.06 ± 
2.09 
8.06 ± 
2.99 
10.00 ± 
3.73 
7.67 ± 
2.76 
7.73 ± 2.40 7.90 ± 
3.42 
8.30 ± 
3.11 
5.00 ± 
0.00 
18.00 ± 
0.00 
Median, 
CI 95% 
[] 
5.00 5.00 7.50 10.00 7.00 8.00 7.00 8.00 5.00 18.00 
France Mean ± 
STDEV 
5.31 ± 
1.06 
5.60 ± 
0.89 
8.11± 
3.89 
8.20 ± 
2.54 
10.80 ± 
3.21 
8.50 ± 4.04 7.00 ± 
2.45 
9.36 ± 
2.75 
8.00 ± 
4.24 
16.38 ± 
4.59 
Median, 
CI 95% 
[] 
5.00 5.00 7.00 8.00 11.00 8.50 6.50 9.00 6.50 18.00 
Portugal Mean ± 
STDEV 
5.46 ± 
1.96 
5.79 ± 
1.63 
7.52 ± 
3.19 
13.19 ± 
4.59 
10.48 ± 
3.94 
8.95 ± 3.95 10.83 ± 
4.42 
11.83 ± 
4.47 
5.33 ± 
0.58 
18.00 ± 
0.00 
Median, 
CI 95% 
[] 
5.00  5.00  6.00  15.00  11.00  7.50  10.00  12.50  5.00  18.00  
Italy Mean ± 
STDEV 
5.36 ± 
1.25 
6.13 ± 
1.81 
7.49 ± 
3.21 
9.74 ± 
3.45 
8.16 ± 
2.83 
7.84 ± 2.84 7.82 ± 
2.91 
10.00 ± 
3.85 
8.60 ± 
3.58 
16.50 ± 
2.83 
Median, 
CI 95% 
[] 
5.00  5.00  6.00  10.00  8.00  7.00 [2,10] 7.00  9.00  8.00  18.00  
India 
 
Mean ± 
STDEV 
6.16 ± 
2.29 
7.56 ± 
3.07 
8.17 ± 
2.76 
11.69 ± 
3.41 
11.06 ± 
3.61 
11.80 ± 
2.91 
10.63 ± 
3.37 
13.16 ± 
3.82 
7.72 ± 
4.08 
16.90 ± 
3.01 
Median, 
CI 95% 
[] 
5.00 7.00 8.00 12.00 11.00 12.00 10.00 15.00 6.00 18.00 
Hon Kong Mean ± 
STDEV 
5.50 ± 
1.43 
7.18 ± 
1.93 
7.81 ± 
2.21 
10.41 ± 
2.85 
10.02 ± 
2.73 
9.96 ± 2.96 8.71 ± 
2.30 
7.43 ± 
1.61 
7.31 ± 
2.15 
17.00 ± 
2.45 
Median, 
CI 95% 
[] 
5.00  7.00  8.00  10.00  10.00  10.00  8.00  7.00  7.00  18.00  
China Mean ± 
STDEV 
5.46 ± 
1.46 
6.88 ± 
2.79 
8.46 ± 
3.24 
9.49 ± 
3.24 
13.57 ± 
4.32 
11.53 ± 
4.43 
10.76 ± 
3.94 
8.69 ± 
2.41 
5.79 ± 
1.85 
17.57 ± 
2.01 
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Median, 
CI 95% 
[] 
5.00  5.00  8.00  8.00  15.00  10.00 [0,2] 10.00  8.00  5.00  18.00  
Canada Mean ± 
STDEV 
5.43 ± 
1.38 
5.95 ± 
1.96 
7.30 ± 
2.45 
11.56 ± 
2.28 
8.58 ± 
2.23 
8.42 ± 2.24 8.33 ± 
2.28 
10.00 ± 
3.48 
6.83 ± 
2.79 
17.82 ± 
0.60 
Median, 
CI 95% 
[] 
5.00 5.00 7.00 11.00 8.00 8.00 8.00 10.00 5.50 18.00 
USA 
 
Mean ± 
STDEV 
5.16 ± 
1.01 
5.34 ± 
0.89 
6.65 ± 
2.50 
9.53 ± 
2.67 
8.44 ± 
2.39 
8.04 ± 2.45 7.97 ± 
2.21 
7.97 ± 
2.13 
6.19 ± 
2.75 
17.48 ± 
2.60 
Median, 
CI 95% 
[] 
5.00  5.00  5.00  10.00  8.00  8.00  8.00  8.00  5.00  18.00  
 
Kruskal-Wallis test: 
Myopia management modality  p value 
SVS Netherlands-Italy 0.029 
Netherlands-Spain 0.035 
Netherlands-France 0.031 
Netherlands-UK/EIRE p<0.001 
Netherlands-Portugal 0.050 
Italy-Spain 1.00 
Italy-France 1.00 
Italy-UK/EIRE 1.00 
Italy-Portugal 1.00 
Spain-France 1.00 
Spain-UK/EIRE 1.00 
Spain/Portugal 1.00 
France-UK/EIRE 1.00 
France-Portugal 1.00 
UK/EIRE-Portugal 1.00 
India-Hong Kong 0.218 
India-China 0.025 
China-Hong Kong 1.00 
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Canada-USA 0.074 
Bifocals  Netherlands-Italy 0.064 
Netherlands-Spain 0.072 
Netherlands-France 0.759 
Netherlands-UK/EIRE 0.011 
Netherlands-Portugal 0.047 
Italy-Spain 1.00 
Italy-France 1.00 
Italy-UK/EIRE 1.00 
Italy-Portugal 1.00 
Spain-France 1.00 
Spain-UK/EIRE 1.00 
Spain-Portugal 1.00 
France-UK/EIRE 1.00 
France-Portugal 1.00 
UK/EIRE-Portugal 1.00 
India-Hong Kong All p=0.162 
India-China 
China-Hong Kong 
Canada-USA 0.226 
PALs Netherlands-Italy 0.417 
Netherlands-Spain 
Netherlands-France 
Netherlands-UK/EIRE 
Netherlands-Portugal 
Italy-Spain 
Italy-France 
Italy-UK/EIRE 
Italy-Portugal 
Spain-France 
Spain-UK/EIRE 
Spain/Portugal 
France-UK/EIRE 
France-Portugal 
UK/EIRE-Portugal 
India-Hong Kong  All p=0.828 
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India-China 
China-Hong Kong 
Canada-USA 0.191 
RGP (AF)  Netherlands-Italy 1.00 
Netherlands-Spain 1.00 
Netherlands-France 1.00 
Netherlands-UK/EIRE 1.00 
Netherlands-Portugal 0.004 
Italy-Spain 1.00 
Italy-France 1.00 
Italy-UK/EIRE 1.00 
Italy-Portugal 0.044 
Spain-France 1.00 
Spain-UK/EIRE 1.00 
Spain/Portugal 0.295 
France-UK/EIRE 1.00 
France-Portugal p<0.001 
UK/EIRE-Portugal 0.003 
India-Hong Kong 0.679 
India-China 0.003 
China-Hong Kong 0.248 
Canada-USA 0.04 
SV CL  Netherlands-Italy 1.00 
Netherlands-Spain 1.00 
Netherlands-France 0.054 
Netherlands-UK/EIRE 1.00 
Netherlands-Portugal 0.211 
Italy-Spain 1.00 
Italy-France 0.008 
Italy-UK/EIRE 1.00 
Italy-Portugal 0.027 
Spain-France 0.003 
Spain-UK/EIRE 1.00 
Spain-Portugal 0.011 
France-UK/EIRE 0.001 
France-Portugal 1.00 
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UK/EIRE-Portugal 0.002 
India-Hong Kong 0.797 
India-China 0.013 
China-Hong Kong p<0.001 
Canada-USA 0.636 
Standard multifocal contact lenses  Netherlands-Italy  All p=0.367 
Netherlands-Spain 
Netherlands-France 
Netherlands-UK/EIRE 
Netherlands-Portugal 
Italy-Spain 
Italy-France 
Italy-UK/EIRE 
Italy-Portugal 
Spain-France 
Spain-UK/EIRE 
Spain/Portugal 
France-UK/EIRE 
France-Portugal 
UK/EIRE-Portugal 
India-Hong Kong All p=0.208 
India-China 
China-Hong Kong 
Canada-USA 0.349 
Specific myopia control CL  Netherlands-Italy 1.00 
Netherlands-Spain 1.00 
Netherlands-France 1.00 
Netherlands-UK/EIRE 1.00 
Netherlands-Portugal 1.00 
Italy-Spain 1.00 
Italy-France 1.00 
Italy-UK/EIRE 1.00 
Italy-Portugal 0.016 
Spain-France 1.00 
Spain-UK/EIRE 1.00 
Spain/Portugal 0.036 
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France-UK/EIRE 1.00 
France-Portugal 1.00 
UK/EIRE-Portugal 0.244 
India-Hong Kong 0.035 
India-China 1.00 
China-Hong Kong 0.024 
Canada-USA 0.326 
Orthokeratology  Netherlands-Italy 1.00 
Netherlands-Spain 1.00 
Netherlands-France 1.00 
Netherlands-UK/EIRE 1.00 
Netherlands-Portugal 0.140 
Italy-Spain 0.313 
Italy-France 1.00 
Italy-UK/EIRE 1.00 
Italy-Portugal 0.970 
Spain-France 0.982 
Spain-UK/EIRE 1.00 
Spain-Portugal 0.005 
France-UK/EIRE 1.00 
France-Portugal 1.00 
UK/EIRE-Portugal 0.093 
India-Hong Kong p<0.001 
India-China p<0.001 
China-Hong Kong p<0.001 
Canada-USA 0.029 
Pharmaceuticals  
Netherlands-Italy All p=0.218 
Netherlands-Spain 
Netherlands-France 
Netherlands-UK/EIRE 
Netherlands-Portugal 
Italy-Spain 
Italy-France 
Italy-UK/EIRE 
Italy-Portugal 
Spain-France 
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Spain-UK/EIRE 
Spain/Portugal 
France-UK/EIRE 
France-Portugal 
UK/EIRE-Portugal 
India-Hong Kong 0.954 
India-China 0.027 
China-Hong Kong 0.001 
Canada-USA 0.454 
Refractive surgery Netherlands-Italy All p=0.295 
Netherlands-Spain 
Netherlands-France 
Netherlands-UK/EIRE 
Netherlands-Portugal 
Italy-Spain 
Italy-France 
Italy-UK/EIRE 
Italy-Portugal 
Spain-France 
Spain-UK/EIRE 
Spain/Portugal 
France-UK/EIRE 
France-Portugal 
UK/EIRE-Portugal 
India-Hong Kong All p=0.241 
India-China 
China-Hong Kong 
Canada-USA 0.574 
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6. What would be the minimum amount of myopia (in dioptres) for you to consider each of the following correction options for a patient? 
 
Globally: 
 SVS (D) Bifocals 
(D) 
PALs (D) RGP (AF) 
(D)  
SV CL (D) Standard 
multifocal 
CL (D) 
Specific 
MC soft 
CL (D) 
Ortho-K 
(D) 
Pharma-
ceuticals 
(D) 
Refractive 
surgery (D) 
Mean ± 
STDEV 
-0.83 ± 
0.55 
-1.65 ± 
1.17 
1.71 ± 
1.20 
-2.40 ± 
1.62 
-1.44 ± 
1.06 
-1.77± 
1.55 
-1.79 ± 
1.25 
-1.73 ± 
1.10 
-1.72 ± 
1.45 
-2.77 ± 1.59 
Median, 
CI 95% [] 
-1.00 [-
1.00, -
0.50] 
-1.50 [-
2.00, -
1.00] 
-1.50 [-
2.00, -
1.00] 
-2.50 [-
3.00, -
1.50] 
-1.00 [-
2.0, -1.00] 
-1.50 [-
2.50, -
1.00] 
-1.50 [-
2.50, -
1.00] 
-1.50 [-
2.50, -
1.00] 
-1.00 [-
2.0, -1.00] 
-3.00 [-3.50, -
2.50] 
 
Continents: 
Continent SVS (D) Bifocals 
(D) 
PALs (D) RGP (AF) 
(D) 
SV CL (D) Standard 
multifocal 
CL (D) 
Specific 
MC soft 
CL (D) 
Ortho-K 
(D) 
Pharma-
ceuticals 
(D) 
Refractive 
surgery 
(D) 
Asia  Mean ± 
STDEV 
-1.20 ± 
1.00 
-1.84 ± 
1.09 
-2.13 ± 
1.36 
-3.14 ± 
1.90 
-2.63 ± 
1.78 
-2.64 ± 1.71 -2.69 ± 
1.80 
-2.37 ± 
1.48 
-1.64 ± 
1.51 
-3.53 ± 1.55 
Media
n, CI 
95% [] 
-1.00 [-1,-
1] 
2.00 [-
2.00,-
1.50] 
-2.00 [-
2.50,-
1.00] 
-3.00 [-
5.00,-
1.50] 
-2.00 [-
3.50,-
1.00] 
-2.50 [-3,-1] -2.00 [-
3.50,-
1.00] 
-2.50 [-
1,-3] 
-1.00 [-
2.00,-
0.50] 
-3.50 [-4,-3] 
Australasia  Mean ± 
STDEV 
-0.79 ± 
0.27 
-0.79 ± 
0.39 
-0.92 ± 
0.61 
-2.79 ± 
1.38 
-1.79 ± 
0.91 
-1.79 ± 1.04 -1.71 ± 
0.91 
-1.64 ± 
0.75 
-2.14 ± 
0.90 
-2.93 ± 1.51 
Media
n, CI 
95% [] 
-1.00 [-
1.00,-
0.50] 
-0.50 [-
1.50,-
0.50] 
-0.50 [-
1.50,-
0.50] 
-3.00 [-
3.00,-
1.50] 
-1.50 [-3,-
1] 
-1.50 [-3,-1] -1.50 [-
3,-1] 
-1.50 [-
3,-1] 
-2.50 [-
3.00,-
1.50] 
-3.00 [-5.50,-
1.50] 
Europe  Mean ± 
STDEV 
0.81 ± 
0.88 
-1.75 ± 
1.44 
-1.81 ± 
1.39 
-2.19 ± 
1.75 
-1.06 ± 
0.82 
-1.94 ± 1.52 -1.94 ± 
1.52 
-2.31 ± 
1.56 
-3.13 ± 
1.55  
-2.93 ± 1.45 
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Media
n, CI 
95% [] 
-0.50 [-
1.75,-
0.50] 
-1.25 [-
3.00,-
0.50] 
-1.50 [-
3.00,-
0.50] 
-1.00 [-
1.00,-
0.50] 
-1.00 [-
1.00,-
0.50] 
-1.75 [-
3.00,-0.50] 
-1.75 [-
3.00,-
0.50] 
-2.25 [-
3.25,-
1.00] 
-3.00 [-
4.50,-
1.75] 
-3.00 [-3.75,-
1.50] 
North 
America  
Mean ± 
STDEV 
-0.83 ± 
0.69 
-1.05 ± 
0.69 
-1.08 ± 
0.73 
-1.54 ± 
1.39 
-0.88 ± 
0.68 
-1.08 ± 0.73 -1.50 ± 
1.17 
-1.50 ± 
1.15 
-1.50 ± 
1.30 
-1.71 ± 1.32 
Media
n, CI 
95% [] 
-0.50 [-
0.68,-
0.50] 
-0.75 [-
1.50,-
0.50] 
-0.75 [-
1.75,-
0.50] 
-1.00 [-
2.00,-
0.50] 
-0.50 [-
1.00,-
0.50] 
-0.75[-
1.75,-0.50] 
-1.25 [-
2.00,-
0.50] 
-1.00 [-
2.00,-
0.50] 
-1.00 [-
2.00,-
0.50] 
-1.25 [-2.62,-
0.50] 
South 
America  
Mean ± 
STDEV 
-1.25 ± 
0.35 
1.50 ± 
0.00 
-1.50 ± 
0.00 
-1.75 ± 
0.35 
-1.50 ± 
0.00 
-1.50  ± 0.00 -1.50  ± 
0.00 
-1.50  ± 
0.00 
-2.50  ± 
2.12 
-2.75  ± 1.77 
Media
n, CI 
95% [] 
-1.25 
[bigger 
sample] 
-1.50 
[bigger 
sample] 
-1.50 
[bigger 
sample] 
-1.75 
[bigger 
sample] 
-1.50 
[bigger 
sample] 
-1.50 
[bigger 
sample] 
-1.50 
[bigger 
sample] 
-1.50 
[bigger 
sample] 
-2.50 
[bigger 
sample] 
-2.75 [bigger 
sample] 
 
Kruskal-Wallis test: 
Myopia management modality  p value 
SVS  Australasia-Europe 1.00 
Australasia-North America 1.00 
Australasia-South America 0.468 
Australasia-Asia 0.005 
Europe-North America 1.00 
Europe-South America 1.00 
Europe-Asia p<0.001 
North America-South America 1.00 
North America-Asia p<0.001 
South America-Asia p<0.001 
Bifocals  
Australasia-Europe p<0.001 
Australasia-North America 0.131 
Australasia-South America 0.010 
Australasia-Asia p<0.001 
Europe-North America 1.00 
Europe-South America 1.00 
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Europe-Asia 0.065 
North America-South America 0.992 
North America-Asia 0.001 
South America-Asia 1.00 
PALs  Australasia-Europe p<0.001 
Australasia-North America 0.026 
Australasia-South America 0.003 
Australasia-Asia p<0.001 
Europe-North America 1.00 
Europe-South America 1.00 
Europe-Asia 0.007 
North America-South America 1.00 
North America-Asia p<0.001 
South America-Asia 1.00 
RGP (AF) Australasia-Europe 0.074 
Australasia-North America 0.318 
Australasia-South America 1.00 
Australasia-Asia 1.00 
Europe-North America 1.00 
Europe-South America 1.00 
Europe-Asia p<0.001 
North America-South America 1.00 
North America-Asia 0.004 
South America-Asia 1.00 
SV CL  Australasia-Europe 1.00 
Australasia-North America 1.00 
Australasia-South America 1.00 
Australasia-Asia p<0.001 
Europe-North America 1.00 
Europe-South America 1.00 
Europe-Asia p<0.001 
North America-South America 0.559 
North America-Asia p<0.001 
South America-Asia 0.002 
Standard multifocal CL  Australasia-Europe 0.022 
340 
 
 Australasia-North America 0.942 
Australasia-South America 0.022 
Australasia-Asia p<0.001 
Europe-North America 1.00 
Europe-South America 0.547 
Europe-Asia 0.005 
North America-South America 0.130 
North America-Asia 0.001 
South America-Asia 1.00 
Specific MC CL Australasia-Europe 0.233 
Australasia-North America 0.761 
Australasia-South America 0.972 
Australasia-Asia p<0.001 
Europe-North America 1.00 
Europe-South America 1.00 
Europe-Asia 0.010 
North America-South America 1.00 
North America-Asia 0.102 
South America-Asia 0.789 
Ortho K (p=0.001) Australasia-Europe 0.106 
Australasia-North America 0.017 
Australasia-South America 0.042 
Australasia-Asia p<0.001 
Europe-North America 1.00 
Europe-South America 1.00 
Europe-Asia 0.004 
North America-South America 1.00 
North America-Asia 1.00 
South America-Asia 1.00 
Pharmaceuticals Australasia-Europe 1.00 
Australasia-North America 1.00 
Australasia-South America 1.00 
Australasia-Asia 0.001 
Europe-North America 1.00 
Europe-South America 1.00 
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Europe-Asia p<0.001 
North America-South America 1.00 
North America-Asia 0.025 
South America-Asia 0.001 
Refractive surgery Australasia-Europe 0.042 
Australasia-North America 1.00 
Australasia-South America 1.00 
Australasia-Asia 0.001 
Europe-North America 0.002 
Europe-South America 0.007 
Europe-Asia 1.00 
North America-South America 1.00 
North America-Asia p<0.001 
South America-Asia p<0.001 
 
Countries: 
Country SVS Bifocals PALs RGP 
(AF) 
SV CL Standard 
multifocal 
CL 
Specific 
MC soft 
CL 
Ortho-K Pharma-
ceuticals 
Refracti-
ve 
surgery 
UK, EIRE 
 
Mean ± 
STDEV 
-0.78± 
0.51 
-1.64 ± 
1.01 
-1.86 ± 
1.21 
-1.80 ± 
1.12 
-1.23 ± 
0.80 
-1.58 ± 0.80 -1.63 ± 
1.01 
-1.61 ± 
1.11 
-2.39 ± 
1.87 
-2.83 ± 
1.37 
Median, 
CI 95% 
[] 
-0.50 -1.50 -2.00 -1.50 -1.00 -1.50 -1.50 -1.50 -1.50 -3.00 
Netherlands Mean ± 
STDEV 
-0.74 ± 
0.33 
-1.93 ± 
1.62 
-1.64 ± 
1.66 
--1.32 ± 
0.92 
-0.98 ± 
0.59 
-1.73 ± 1.29 -1.75 ± 
1.22 
-1.38 ± 
1.02 
-2.50 ± 
2.36 
-3.46 ± 
1.80 
Median, 
CI 95% 
[] 
-0.50  -1.50 
 
-1.00 -1.00 -1.00 -2.00 -1.75 -1.00 -2.00 -1.50 
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Spain Mean ± 
STDEV 
-0.79 ± 
0.33 
-1.69 ± 
1.18 
-1.75 ± 
1.22 
-1.66 ± 
1.16 
-1.50 ± 
1.33 
-1.82 ± 0.98 -1.65 ± 
1.13 
-1.42 ± 
0.90 
-2.63 ± 
2.14 
-1.93 ± 
0.83 
Median, 
CI 95% 
[] 
-0.75 -1.50 -1.50 -1.50 -1.00 -2.00 -1.00 -1.00 -2.00 -2.00 
France Mean ± 
STDEV 
-0.53 ± 
0.19 
-2.50 ± 
0.50 
-2.75 ± 
0.88 
-2.73 ± 
1.25 
-1.29 ± 
0.91 
-2.33 ± 1.75 -1.83 ± 
0.76 
-1.64 ± 
0.77 
-2.50 ± 
2.12 
-2.00 ± 
1.00 
Median, 
CI 95% 
[] 
-0.50 -2.50 -2.50 -3.00 -1.00 -2.50 -2.00 -1.50 -2.50 -1.50 
Portugal Mean ± 
STDEV 
-0.72 ± 
0.34 
-1.88 ± 
0.97 
-2.19 ± 
1.53 
-2.83 ± 
1.52 
-1.34 ± 
0.89 
-2.12 ± 1.46 -2.05 ± 
1.42 
-2.54 ± 
1.42 
-2.25 ± 
1.06 
-4.36 ± 
1.57 
Median, 
CI 95% 
[] 
-0.50  -1.75  -2.00  -2.50  -1.00  -1.50  -1.50  -2.00  -2.25  -5.50  
Italy Mean ± 
STDEV 
-0.74 ± 
0.36 
-1.58 ± 
1.03 
-1.52 ± 
1.08 
-1.98 ± 
1.42 
-1.23 ± 
0.90 
-1.55 ± 0.98 1.55 ± 
1.13 
-1.58 ± 
0.93 
-3.00 ± 
0.00 
-4.17 ± 
1.08 
Median, 
CI 95% 
[] 
-0.50  -1.50  -1.00 -1.50  -1.00  -1.00 -1.00  -1.50  -3.00  -3.75  
India 
 
Mean ± 
STDEV 
-1.05 ± 
104 
-2.83 ± 
1.37 
-2.85 ± 
1.32 
-3.14 ± 
1.70 
-1.92 ± 
1.27 
-2.83 ± 1.15 -2.48 ± 
1.61 
-3.06 ± 
1.56 
-2.86 ± 
1.00 
-3.70 ± 
1.56 
Median, 
CI 95% 
[] 
-0.50 -3.00 -3.00 -3.00 -1.50 -3.00 -1.75 -3.00 -3.00 -3.50 
Hon Kong Mean ± 
STDEV 
-1.03 ± 
0.54 
-1.90 ± 
0.92 
-1.83 ± 
0.87 
-2.67 ± 
1.69 
-1.73 ± 
1.15 
-1.93 ± 1.29 -1.77 ± 
1.07 
-1.66 ± 
0.86 
-2.39 ± 
1.75 
-3.71 ± 
1.07 
Median, 
CI 95% 
[] 
-1.00  -2.00  -1.75  -2.00  -1.00  -1.50  -1.50  -1.50  -2.00  -4.00  
China Mean ± 
STDEV 
-0.89 ± 
0.51 
-1.64 ± 
1.07 
-1.91 ± 
1.17 
-2.85 ± 
1.87 
-2.15 ± 
1.47 
-2.24 ± 1.67 -2.32 ± 
1.66 
-1.74 ± 
0.98 
-0.66 ± 
0.39 
-3.23 ± 
1.59 
Median, 
CI 95% 
[] 
-1.00 -1.00  -1.50  -2.00  -2.00  -2.00 -2.00  -1.50  -0.50 -3.00  
Canada Mean ± 
STDEV 
-0.84 ± 
10.57 
-1.94 ± 
1.27 
-2.09 ± 
1.22 
-2.70 ± 
1.75 
-1.28 ± 
0.99 
-1.78 ± 0.81 -1.96 ± -
1.22 
2.12 ± 
0.64 
-3.00 ± 
2.79 
-1.53 ± 
0.59 
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Median, 
CI 95% 
[] 
-0.50 -1.75 -2.00 -2.00 -1.00 -1.50 -1.75 -2.00 -3.00 -1.50 
USA 
 
Mean ± 
STDEV 
-0.81 ± 
0.62 
-1.39 ± 
1.09 
-1.39 ± 
1.09 
-1.99 ± 
1.40 
-1.13 ± 
0.78 
-1.53 ± 1.16 -1.62 ± 
1.17 
-1.76 ± 
1.15 
-1.75 ± 
1.48 
-2.11 ± 
1.21 
Median, 
CI 95% 
[] 
-0.50  -1.00  -1.00  -1.50  -1.00  -1.00  -1.00  -1.50  -1.00  -2.00  
 
Kruskal-Wallis test: 
Myopia management modality  p value 
SVS  Netherlands-Italy 1.00 
Netherlands-Spain 1.00 
Netherlands-France 0.078 
Netherlands-UK/EIRE 1.00 
Netherlands-Portugal 1.00 
Italy-Spain 1.00 
Italy-France 0.042 
Italy-UK/EIRE 1.00 
Italy-Portugal 1.00 
Spain-France 0.002 
Spain-UK/EIRE 1.00 
Spain/Portugal 1.00 
France-UK/EIRE 0.044 
France-Portugal 0.102 
UK/EIRE-Portugal 1.00 
India-Hong Kong All p=0.50 
India-China 
China-Hong Kong 
Canada-USA 0.942 
Bifocals  Netherlands-Italy All p=0.547 
Netherlands-Spain 
Netherlands-France 
Netherlands-UK/EIRE 
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Netherlands-Portugal 
Italy-Spain 
Italy-France 
Italy-UK/EIRE 
Italy-Portugal 
Spain-France 
Spain-UK/EIRE 
Spain-Portugal 
France-UK/EIRE 
France-Portugal 
UK/EIRE-Portugal 
India-Hong Kong 0.024 
India-China p<0.01 
China-Hong Kong 0.541 
Canada-USA 0.038 
PALs  Netherlands-Italy All p=0.071 
Netherlands-Spain 
Netherlands-France 
Netherlands-UK/EIRE 
Netherlands-Portugal 
Italy-Spain 
Italy-France 
Italy-UK/EIRE 
Italy-Portugal 
Spain-France 
Spain-UK/EIRE 
Spain/Portugal 
France-UK/EIRE 
France-Portugal 
UK/EIRE-Portugal 
India-Hong Kong 0.002 
India-China 0.001 
China-Hong Kong 1.00 
Canada-USA 0.012 
RGP (AF)  Netherlands-Italy 0.418 
Netherlands-Spain 1.00 
345 
 
Netherlands-France p<0.001 
Netherlands-UK/EIRE 0.866 
Netherlands-Portugal p<0.001 
Italy-Spain 1.00 
Italy-France 0.046 
Italy-UK/EIRE 1.00 
Italy-Portugal 0.087 
Spain-France 0.005 
Spain-UK/EIRE 1.00 
Spain/Portugal 0.011 
France-UK/EIRE 0.024 
France-Portugal 1.00 
UK/EIRE-Portugal 0.047 
India-Hong Kong All p=0.525 
India-China 
China-Hong Kong 
Canada-USA 0.108 
SV CL Netherlands-Italy All p=0.096 
Netherlands-Spain 
Netherlands-France 
Netherlands-UK/EIRE 
Netherlands-Portugal 
Italy-Spain 
Italy-France 
Italy-UK/EIRE 
Italy-Portugal 
Spain-France 
Spain-UK/EIRE 
Spain-Portugal 
France-UK/EIRE 
France-Portugal 
UK/EIRE-Portugal 
India-Hong Kong 0.308 
India-China 
China-Hong Kong 
Canada-USA 0.301 
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Standard multifocal contact lenses  Netherlands-Italy  All p=0.426 
Netherlands-Spain 
Netherlands-France 
Netherlands-UK/EIRE 
Netherlands-Portugal 
Italy-Spain 
Italy-France 
Italy-UK/EIRE 
Italy-Portugal 
Spain-France 
Spain-UK/EIRE 
Spain/Portugal 
France-UK/EIRE 
France-Portugal 
UK/EIRE-Portugal 
India-Hong Kong 0.058 
India-China 0.090 
China-Hong Kong 1.00 
Canada-USA 0.086 
Specific myopia control CL  Netherlands-Italy All p=0.458 
Netherlands-Spain 
Netherlands-France 
Netherlands-UK/EIRE 
Netherlands-Portugal 
Italy-Spain 
Italy-France 
Italy-UK/EIRE 
Italy-Portugal 
Spain-France 
Spain-UK/EIRE 
Spain/Portugal 
France-UK/EIRE 
France-Portugal 
UK/EIRE-Portugal 
India-Hong Kong All p=0.232 
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India-China 
China-Hong Kong 
Canada-USA 0.149 
Orthokeratology  Netherlands-Italy 1.00 
Netherlands-Spain 1.00 
Netherlands-France 0.961 
Netherlands-UK/EIRE 1.00 
Netherlands-Portugal p<0.001 
Italy-Spain 1.00 
Italy-France 1.00 
Italy-UK/EIRE 1.00 
Italy-Portugal 0.005 
Spain-France 1.00 
Spain-UK/EIRE 1.00 
Spain-Portugal 0.002 
France-UK/EIRE 1.00 
France-Portugal 0.431 
UK/EIRE-Portugal 0.09 
India-Hong Kong p<0.001 
India-China p=0.001 
China-Hong Kong 1.00 
Canada-USA 0.028 
Pharmaceuticals  Netherlands-Italy All p=0.986 
Netherlands-Spain 
Netherlands-France 
Netherlands-UK/EIRE 
Netherlands-Portugal 
Italy-Spain 
Italy-France 
Italy-UK/EIRE 
Italy-Portugal 
Spain-France 
Spain-UK/EIRE 
Spain/Portugal 
France-UK/EIRE 
France-Portugal 
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UK/EIRE-Portugal 
India-Hong Kong 0.643 
India-China p<0.001 
China-Hong Kong p<0.001 
Canada-USA 0.059 
Refractive surgery Netherlands-Italy 0.043 
Netherlands-Spain 1.00 
Netherlands-France 1.00 
Netherlands-UK/EIRE 1.00 
Netherlands-Portugal 0.001 
Italy-Spain 0.322 
Italy-France 0.139 
Italy-UK/EIRE 1.00 
Italy-Portugal 1.00 
Spain-France 1.00 
Spain-UK/EIRE 1.00 
Spain-Portugal 0.075 
France-UK/EIRE 1.00 
France-Portugal 0.015 
UK/EIRE-Portugal 0.436 
India-Hong Kong All p=0.354 
India-China 
China-Hong Kong 
Canada-USA 0.117 
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7. What is the minimum level of myopia progression you consider necessitates a myopia control approach? 
 
Globally: 
 
0.01-0.25 D/per year 0.26-0.50 D/per year 0.51-0.75 D/per year 0.76-1.00 D/per 
year 
>1.00 D/per 
year 
MC is not warranted 
60 216 301 199 132 60 
6.2 22.3 31.1 20.6 13.6 6.2 
 
Continent: 
 
Continent 0.01-0.25 D/per 
year 
0.26-0.50 D/per 
year 
0.51-0.75 D/per year 0.76-1.00 D/per year >1.00 D/per year MC is not warranted 
Number % Number % Number % Number % Number % Number % 
Asia 8 2.8 42 14.4 89 30.6 88 30.2 54 18.6 10 3.4 
Australasia 6 5 49 41.2 39 73.9 15 12.6 7 5.6 3 2.5 
Europe 32 9.5 82 24.4 124 36.9 50 14.9 32 9.5 16 4.8 
North America 8 6 22 16.5 34 25.6 30 22.6 24 18 15 11.3 
South America 6 7.3 19 23.2 13 15.9 15 18.3 13 15.9 16 19.5 
 
 
Kruskal-Wallis test: 
Australasia-North America p<0.001 
Australasia - Asia p<0.001 
Australasia-Europe 0.854 
Australasia-South America p<0.001 
North America-Asia 1.00 
North America-Europe p<0.001 
North America-South America 1.00 
Asia-Europe p<0.001 
Asia-South America 1.00 
Europe-South America 0.003 
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Countries: 
Countries 0.01-0.25 D/per 
year 
0.26-0.50 D/per year 0.51-0.75 D/per 
year 
0.76-1.00 D/per year >1.00 D/per year MC is not  warranted 
Number % Number % Number % Number % Number % Number % 
UK/EIRE 6 11.8 12 23.5 16 31.4 9 17.6 5 15.7 3 5.9 
Netherlands 5 13.2 4 10.5 19 50 4 10.5 4 10.5 2 5.3 
Spain 1 2.9 15 44.1 13 38.2 4 11.8 1 2.9 0 0 
France 1 3 4 12.1 13 39.4 5 15.2 7 21.2 1 3 
Portugal 3 6.3 6 12.5 21 43.8 8 16.7 8 16.7 2 4.2 
Italy 10 13.9 23 31.9 16 22.2 11 15.3 4 5.6 8 11.1 
India 0 0 7 18.9 10 27 7 18.9 10 27 3 11.1 
Hong Kong 2 3.2 9 14.5 16 25.8 20 32.3 10 16.1 5 8.1 
China3 3 2.2 15 11 55 40.4 40 29.4 22 16.2 1 0.7 
Canada 0 0 3 9.1 9 27.3 10 30.3 5 15.2 6 18.2 
USA 8 8 19 19 25 25 20 20 19 19 9 9 
 
Kruskal-Wallis test: Europe distribution is not significantly different (p=0.09), Asia distribution is not significantly different (p=0.365), North America 
distribution is not significantly different (p=0.057). 
Other (specify) - 40 responses 
 Subjective to patients refractive error, family history and lifestyle (2) and other combination (3) 
 Age of myopia onset (10 or 25%) 
 Refractive error of patient (2) 
 Environmental factors/lifestyle (6) 
  Family history of myopia (6) 
 Depending on preferred myopia management strategy (1) 
 Depending on parent’s decision (e.g. financial considerations) (3) 
 Lightning levels/time spent outdoors (3) 
 Not sure as abnormal progression rates of myopia are not defined (1) 
 No experience in controlling myopia progression (1) 
 Esophoria (1) 
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 K readings (1) 
 Axial length (2) 
 Motivation of patient (1) 
 Body posture 2 
 % of relative growth in body height 1 
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8. Do you use undercorrection as a strategy to slow myopia progression? 
 
Globally: 
 
No Sometimes Always 
705 223 41 
72.7% 23% 4.2% 
 
Regionally: 
 
Continent No Sometimes Always 
Number % Number % Number % 
Asia 221 75.9 61 20.96 9 3.09 
Australasia 95 79.8 21 17.64 3 2.52 
Europe 236 69.3 86 25.4 17 5 
North America 104 78.2 28 21.1 1 0.7 
South America 48 58.5 24 29.27 10 12.19 
 
Kruskal-Wallis test: 
 
Australasia-North America 1.00 
Australasia - Asia 1.00 
Australasia-Europe 0.267 
Australasia-South America 0.003 
North America-Asia 1.00 
North America-Europe 0.350 
North America-South America 0.004 
Asia-Europe 0.618 
Asia-South America 0.006 
Europe-South America 0.234 
 
Countries: 
Countries No Sometimes Always 
Number % Number % Number % 
UK/EIRE 46 88.5 6 11.5 0 0 
Netherlands 28 73.7 9 23.7 1 2.6 
Spain 19 55.9 14 41.2 1 2.9 
France 27 81.8 6 17.6 0 0 
Portugal 26 54.2 16 33.3 6 12.5 
Italy 47 65.3 22 30.5 3 4.2 
India 16 43.2 18 48.7 3 8.1 
Hong Kong 55 88.7 6 9.7 1 1.6 
China 114 83.8 19 14 3 2.2 
Canada 25 75.8 8 24.2 0 0 
USA 79 79 20 20 1 1 
 
 
Kruskal-Wallis test: 
UK/EIRE-France 1.00 
UK/EIRE-Netherlands 1.00 
UK/EIRE-Italy 0.92 
UK/EIRE-Spain 0.028 
UK/EIRE-Portugal 0.001 
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France-Netherlands 1.00 
France-Italy 1.00 
France-Spain 0.345 
France-Portugal 0.058 
Netherlands-Italy 1.00 
Netherlands-Spain 1.00 
Netherlands-Portugal 0.466 
Italy-Spain 1.00 
Italy-Portugal 1.00 
Spain-Portugal 1.00 
Hong Kong-China 1.00 
Hong Kong-India p<0.001 
China-India p<0.001 
Canada-USA 0.719 
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9. If you have ever fitted single vision spectacles/ contact lenses for myopic 
patients, what has prevented you prescribing an alternative method? 
 
Globally: 
 
Reason % 
Not more effective 23.8 
Unpredictable outcome 28.2 
Safety concerns 25.3 
Uneconomical 35.6 
Additional chair time 7.9 
Inadequate information 33.3 
Benefit/risk ratio 20.5 
 
Asia: 
 
Reason % 
Not more effective 11.4 
Unpredictable outcome 30.5 
Safety concerns 47.9 
Uneconomical 40.7 
Additional chair time 10.6 
Inadequate information 24.6 
Benefit/risk ratio 29.2 
 
Australasia: 
 
Reason % 
Not more effective 16.1 
Unpredictable outcome 31.4 
Safety concerns 41 
Uneconomical 41 
Additional chair time 10 
Inadequate information 28 
Benefit/risk ratio 28 
 
Europe: 
 
Reason % 
Not more effective 23.3 
Unpredictable outcome 23.3 
Safety concerns 15.7 
Uneconomical 33.7 
Additional chair time 4.3 
Inadequate information 39.5 
Benefit/risk ratio 15.2 
 
 
 
North America: 
 
Reason % 
Not more effective 37.8 
Unpredictable outcome 39 
Safety concerns 9.8 
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Uneconomical 35.4 
Additional chair time 9.8 
Inadequate information 34.1 
Benefit/risk ratio 17.1 
 
South America: 
 
Reason % 
Not more effective 39.4 
Unpredictable outcome 19.7 
Safety concerns 8.5 
Uneconomical 19.7 
Additional chair time 4.2 
Inadequate information 42.3 
Benefit/risk ratio 9.9 
 
23.68Kruskal-Wallis test for continents: distribution between continents is the same 
(all p=1.00) 
 
UK/EIRE: 
 
Reason % 
Not more effective 31 
Unpredictable outcome 34.5 
Safety concerns 6.9 
Uneconomical 24.1 
Additional chair time 10.3 
Inadequate information 65.5 
Benefit/risk ratio 6.9 
 
Netherlands: 
 
Reason % 
Not more effective 19.2 
Unpredictable outcome 34.6 
Safety concerns 34.6 
Uneconomical 38.5 
Additional chair time 0 
Inadequate information 19.2 
Benefit/risk ratio 23.1 
 
 
 
 
Spain: 
 
Reason % 
Not more effective 11.8 
Unpredictable outcome 23.5 
Safety concerns 17.6 
Uneconomical 52.9 
Additional chair time 5.9 
Inadequate information 11.8 
Benefit/risk ratio 17.6 
 
France: 
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Reason % 
Not more effective 29.6 
Unpredictable outcome 7.4 
Safety concerns 11.1 
Uneconomical 11.1 
Additional chair time 3.7 
Inadequate information 29.6 
Benefit/risk ratio 20.5 
 
Portugal: 
 
Reason % 
Not more effective 21.4 
Unpredictable outcome 16.7 
Safety concerns 14.3 
Uneconomical 28.6 
Additional chair time 2.4 
Inadequate information 64.3 
Benefit/risk ratio 26.2 
 
Italy: 
 
Reason % 
Not more effective 13.3 
Unpredictable outcome 36.7 
Safety concerns 20 
Uneconomical 40 
Additional chair time 10 
Inadequate information 40 
Benefit/risk ratio 6.7 
 
Kruskal-Wallis test for Europe: distribution between countries is the same (all p=1.00) 
 
 
 
 
 
India: 
 
Reason % 
Not more effective 10.8 
Unpredictable outcome 48.6 
Safety concerns 35.1 
Uneconomical 40.5 
Additional chair time 5.4 
Inadequate information 21.6 
Benefit/risk ratio 32.4 
 
Hong Kong: 
 
Reason % 
Not more effective 11.1 
Unpredictable outcome 20 
Safety concerns 53.3 
Uneconomical 40 
Additional chair time 8.9 
Inadequate information 11.1 
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Benefit/risk ratio 33.3 
 
 
China: 
 
Reason % 
Not more effective 7.1 
Unpredictable outcome 29.5 
Safety concerns 52.7 
Uneconomical 41.1 
Additional chair time 10.7 
Inadequate information 31.3 
Benefit/risk ratio 25.9 
 
Kruskal-Wallis test for Asia: distribution between countries is the same (all p=1.00) 
Canada: 
 
Reason % 
Not more effective 52 
Unpredictable outcome 52 
Safety concerns 20 
Uneconomical 40 
Additional chair time 16 
Inadequate information 52 
Benefit/risk ratio 24 
 
 
 
 
 
USA: 
 
Reason % 
Not more effective 31.6 
Unpredictable outcome 33.3 
Safety concerns 5.3 
Uneconomical 33.3 
Additional chair time 7 
Inadequate information 26.3 
Benefit/risk ratio 14 
 
Kruskal-Wallis test for North America: distribution between countries is the same (all 
p=1.00) 
 
Other (specify) – 95 responses 
 N/A or e.g. is fitting Ortho-K or using other methods (36 or 37,89%) 
 Insufficient amount of myopic patients to make it profitable/financially 
profitable (3) 
 Not actual due to e.g. practice location or patients’ demographics (2) 
 Inadequate information/contradictory information, no clear standards or 
regulations (19) 
 Decision of parents/patients (financial consideration, lack of knowledge 
about MC, motivation) or wish not to slow but stop myopia progression (20) 
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 Confusing question construction (1); maybe should have been paraphrased 
as ‘If you mostly prescribe SVS….’(M.Z.) 
 The predictability of outcome and clinical relevance (4) 
 Vision therapy as an alternative (2) 
 Availability of MC interventions and required optometric instrumentation (6) 
 Rate of progression (1) 
 Role of genetics (cannot be change with optical means) (1) 
 No experience in controlling myopia progression (1) 
 Age of myopia onset (1) 
 Outdoor activity (2) 
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10.  Demographics 
Geographical distribution: 
 
Continent Number of responses % 
Africa 6 0.6 
Asia 291 30 
Australasia 119 12.3 
Europe 339 34.9 
North America 133 13.8 
South America 82 8.4 
Total 970  
 
Country Number of responses % 
UK, EIRE 52 5.36 
Netherlands 38 3.91 
Spain 34 3.50 
France 34 3.50 
Portugal 48 4.94 
Italy 72 7.42 
India 37 3.91 
Hong Kong 61 6.28 
China 137 14.12 
Canada 33 3.40 
USA 100 10.40 
 
Profession: 
 
Globally: 
 
Optometrist 703 72.4% 
Ophthalmologist 181 18.6% 
Contact lens optician 56 5.8% 
Other 31 3.2% 
 
Africa: 
 
Optometrist 5 83.3% 
Ophthalmologist 1 16.7% 
Contact lens optician 0 0% 
Other 0 0% 
Total 6  
 
Asia: 
 
Optometrist 178 61.2% 
Ophthalmologist 84 28.9% 
Contact lens optician 1 0.3% 
Other 28 9.6% 
Total 291  
Australasia: 
 
Optometrist 118 99.2% 
Ophthalmologist 1 0.8% 
Contact lens optician 0 0% 
Other 0 0% 
Total 119  
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Europe: 
 
Optometrist 244 72% 
Ophthalmologist 41 12.1% 
Contact lens optician 51 15% 
Other 3 0.9% 
Total 331  
 
North America: 
 
Optometrist 103 99% 
Ophthalmologist 0 0% 
Contact lens optician 1 1% 
Other 0 0% 
Total 104  
 
South America: 
 
Optometrist 26 31.7% 
Ophthalmologist 54 65.9% 
Contact lens optician 2 2.4% 
Other 0 0% 
Total 82  
 
UK/EIRE: 
 
Optometrist 40 76.9% 
Ophthalmologist 0 0% 
Contact lens optician 12 23.1% 
Other 0 0% 
Total 52  
 
Netherlands: 
 
Optometrist 28 73.7% 
Ophthalmologist 0 0% 
Contact lens optician 9 23.7% 
Other 1 2.6% 
Total 38  
 
 
 
Spain: 
 
Optometrist 29 85.3% 
Ophthalmologist 0 0% 
Contact lens optician 5 14.7% 
Other 0 0% 
Total 34  
 
France: 
 
Optometrist 0 0% 
Ophthalmologist 33 97.1% 
Contact lens optician 0 0% 
Other 1 2.9% 
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Total 34  
 
Portugal: 
 
Optometrist 45 93.8% 
Ophthalmologist 2 4.2% 
Contact lens optician 0 0% 
Other 1 2.1% 
Total 48  
 
Italy: 
 
Optometrist 58 80.6% 
Ophthalmologist 0 0% 
Contact lens optician 14 19.4% 
Other 0 0% 
Total 72  
 
Hong Kong: 
 
Optometrist 59 95.2% 
Ophthalmologist 1 1.6% 
Contact lens optician 0 0% 
Other 2 3.2% 
Total 62  
 
China: 
 
Optometrist 28 20.6% 
Ophthalmologist 82 60.3% 
Contact lens optician 1 0.7% 
Other 25 18.4% 
Total 148  
 
 
India: 
 
Optometrist 36 97.3% 
Ophthalmologist 0 0% 
Contact lens optician 0 0% 
Other 1 2.7% 
Total 37  
 
USA: 
 
Optometrist 99 99% 
Ophthalmologist 0 0% 
Contact lens optician 1 1% 
Other 0 0% 
Total 100  
 
Canada: 
 
Optometrist 33 100% 
Ophthalmologist 0 0% 
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Contact lens optician 0 0% 
Other 0 0% 
Total 33  
 
 
Principal working environment: 
 
Globally: 
 
Practice 816 84% 
Academic 110 11.3% 
Industry 19 2% 
Other 26 2.7% 
 
Africa: 
 
Practice 2 33.3% 
Academic 1 16.7% 
Industry 3 50% 
Other 0 0% 
 
Asia: 
 
Practice 255 87.6% 
Academic 20 6.9% 
Industry 7 2.4% 
Other 9 3.1% 
 
 
Australasia: 
 
Practice 110 92.4% 
Academic 6 5% 
Industry 0 0% 
Other 3 2.5% 
 
Europe: 
 
Practice 307 90.6% 
Academic 13 3.8% 
Industry 7 2.1% 
Other 10 2.9% 
 
 
North America: 
 
Practice 117 88% 
Academic 12 9.0% 
Industry 2 1.5% 
Other 2 1.5% 
 
South America: 
 
Practice 24 29.3% 
Academic 58 70.7% 
industry 0 0% 
 
363 
Other 0 0% 
 
 
UK/EIRE: 
 
Practice 46 88.5% 
Academic 2 3.8% 
Industry 4 0% 
Other 52 0% 
 
Netherlands: 
 
Practice 33 86.8% 
Academic 0 0% 
Industry 3 7.9% 
Other 2 5.3% 
 
Spain: 
 
Practice 29 85.3% 
Academic 4 11.8% 
Industry 0 0% 
Other 1 2.9% 
France: 
 
Practice 32 94.1% 
Academic 0 0% 
industry 0 0% 
Other 2 5.9% 
 
Portugal: 
 
Practice 42 87.5% 
Academic 3 6.3% 
Industry 1 2.1% 
Other 2 4.2% 
 
Italy: 
 
Practice 69 95.8% 
Academic 1 1.4% 
industry 1 1.4% 
Other 1 1.4% 
 
India: 
 
Practice 29 78.4% 
Academic 5 13.5% 
industry 1 2.7% 
Other 2 5.4% 
 
Hong Kong: 
 
Practice 57 91.9% 
Academic 5 8.1% 
industry 0 0% 
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Other 0 0% 
 
China: 
 
Practice 126 92.6% 
Academic 2 1.5% 
industry 2 1.5% 
Other 6 4.4% 
 
Canada: 
 
Practice 32 97% 
Academic 1 3% 
industry 0 0% 
Other 0 0% 
 
USA: 
 
Practice 85 85% 
Academic 11 11% 
industry 2 2% 
Other 2 2% 
 
Years being qualified: 
 
Globally: 
 
0 13 1.3% 
1-5 161 16.6% 
6-10 153 15.8% 
11-20 252 26 5% 
21-30 220 22.7% 
31 or more 172 17.7% 
 
Africa: 
 
0 13 1.3% 
1-5 161 16.6% 
6-10 153 15.8% 
11-20 252 26 5% 
21-30 220 22.7% 
31 or more 172 17.7% 
 
 
Asia: 
 
0 13 1.4% 
1-5 80 27.5% 
6-10 65 22.3% 
11-20 76 26.1% 
21-30 45 15.5% 
31 or more 21 7.2% 
 
Australasia: 
 
0 5 4.2% 
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1-5 14 11.8% 
6-10 16 13.4% 
11-20 24 20.2% 
21-30 32 26.9% 
31 or more 28 23.5% 
 
Europe: 
 
0 2 0.6% 
1-5 46 13.6% 
6-10 35 10.3% 
11-20 92 27.1% 
21-30 92 27.1% 
31 or more 72 21.2% 
 
North America 
 
0 1 0.7% 
1-5 13 9.7% 
6-10 21 15.7% 
11-20 31 23.1% 
21-30 35 26.1% 
31 or more 33 24.6% 
 
South America: 
 
0 1 1.2% 
1-5 8 9.8% 
6-10 15 18.3% 
11-20 26 31.7% 
21-30 16 19.5% 
31 or more 16 19.5% 
 
 
UK/EIRE: 
 
0 0 0% 
1-5 3 5.8% 
6-10 2 3.8% 
11-20 9 17.3% 
21-30 16 30.8% 
31 or more 22 42.3% 
 
Netherlands: 
 
0 0 0% 
1-5 6 15.8% 
6-10 5 13.2% 
11-20 14 36.8% 
21-30 6 15.8% 
31 or more 7 18.4% 
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Spain: 
 
0 0 0% 
1-5 2 5.9% 
6-10 1 2.9% 
11-20 13 38.2% 
21-30 16 47.1% 
31 or more 2 5.9% 
 
France: 
 
0 1 2.9% 
1-5 1 2.9% 
6-10 2 5.9% 
11-20 6 17.6% 
21-30 14 41.2% 
31 or more 10 29.4% 
 
Portugal: 
0 0 0% 
1-5 18 37.5% 
6-10 11 22.9% 
11-20 17 35.4% 
21-30 1 2.1% 
31 or more 1 2.1% 
 
Italy: 
 
0 1 1.4% 
1-5 6 8.3% 
6-10 5 6.9% 
11-20 14 19.4% 
21-30 28 38.9% 
31 or more 18 25% 
 
India: 
 
0 2 5.4% 
1-5 8 21.6% 
6-10 7 18.9% 
11-20 12 32.4% 
21-30 5 13.5% 
31 or more 3 8.1% 
 
Hong Kong: 
 
0 0 0% 
1-5 18 29% 
6-10 15 24.2% 
11-20 14 22.6% 
21-30 14 22.6% 
31 or more 1 1.6% 
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China: 
 
0 2 1.5% 
1-5 36 26.5% 
6-10 34 25% 
11-20 37 27.2% 
21-30 17 12.5% 
31 or more 10 7.4% 
 
 
Canada: 
 
0 1 3% 
1-5 5 15.2% 
6-10 8 24.2% 
11-20 7 21.2% 
21-30 4 12.1% 
31 or more 8 24.2% 
 
USA: 
 
0 0 0% 
1-5 8 8% 
6-10 13 13% 
11-20 24 24% 
21-30 31 31% 
31 or more 24 24% 
 
Any further comments. 
148 comments left. 
 Skull size/body physiology/relative speed of growth should be taken into 
consideration (3) 
 Axial length/peripheral refraction (3) 
 Not actual due to e.g. practice location or patients’ demographics (3) 
 Immediate action is required/promotion of public/professional 
awareness (32 or 21.16%) 
 Availability of funding form government health funding organisations (1) 
 Current approaches are not effective (3) 
 Management approach depends of patient’s age (1) 
 Specialisation of practice (e.g. high street/independent) (2) 
 Inadequate information/contradictory/ insufficient information, no 
clear standards or regulations, availability of certified MC interventions 
(27 or 18.24%) 
 Ortho-K has been proven to be most effective form clinical 
observations in everyday practice (13 or 8.78%) 
 Lifestyle/the role of outdoor/visual habits/individually selective 
outcome (18 or 12.16%) 
 Decision of parents/patients (financial consideration, lack of knowledge 
about MC, motivation) or wish not to slow but stop myopia progression (9) 
 The role of accommodation/vergence system (4) 
 Age of myopia onset (34 or 22.97%) 
 Actively prescribing MC interventions 5 to 10 years (6) 
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 Criticised questions 4, 5 and 6 – the way questions are formulated will give 
skewed results, negative percentage would not be accepted (as in case of 
undercorrection), …not only for myopic patients was misleading, found the 
inclusion of refractive surgery ‘silly’ (6) 
 Vision therapy as an alternative (4) 
 Full correction at distance, none for near work (remove glasses at near or 
put reading glasses on SV CL (2) 
 The predictability of outcome and clinical relevance (4) 
 Diluted atropine (1) 
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Appendix 2: Long term corneal biomechanical response to orthokeratology and the role of anterior eye segment in myopic 
schoolchildren 
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BL 6 months 12 months 18 months 24 months p p F p F 
IOPg 
(mmHg) 
SVS 15.40±2.78 15.67±3.35 15.11±3.03 15.40±3.26 15.11±3.16 0.340 0.046 2.465 
0.032 4.71 
OK 14.66±2.89 14.93±2.72 14.30±2.71 14.68±2.80 14.52±3.02 0.389 0.536 0.748 
IOPcc 
(mmHg) 
SVS 15.07±2.88 15.44±3.21 14.66±2.94 14.74±3.39 14.64±2.92 0.868 0.005 3.891 
0.589 0.29 
OK 14.73±3.26 14.97±2.54 14.50±2.93 14.88±2.98 14.66±3.06 0.150 0.603 0.686 
CH (mmHg) 
SVS 11.17±1.55 11.05±1.52 11.30±1.37 11.48±1.61 11.34±1.50 0.847 0.019 3.028 
0.012 6.64 
OK 10.90±1.59 10.88±1.43 10.82±1.52 10.76±1.77 10.85±1.79 0.740 0.933 0.13 
CRF 
(mmHg) 
SVS 11.03±1.58 11.00±1.69 11.07±1.51 11.29±1.64 11.09±1.72 0.958 0.515 0.818 
0.005 8.22 
OK 10.59±1.46 10.65±1.59 10.41±1.48 10.47±1.77 10.51±1.86 0.899 0.912 0.168 
slew1: 
SVS 62.03±18.39 59.55±20.64 56.82±16.60 61.37±24.65 66.79±26.53 0.946 0.049 2.43 
0.945 0.005 
OK 64.45±22.90 61.19±21.81 61.27±24.53 58.13±19.12 60.89±23.18 0.705 0.05 2.418 
slew2: 
SVS 82.07±30.73 89.28±30.95 76.31±31.64 86.21±35.56 88.92±36.43 0.604 0.036 2.622 
0.734 0.12 
OK 86.64±33.80 87.11±30.56 83.55±26.23 82.12±29.59 82.68±30.65 0.759 0.262 1.34 
mslew1: 
SVS 100.5±28.4 92.59±30.89 88.54±22.25 98.89±34.03 105.4±36.3 0.982 0.007 3.619 
0.753 0.10 
OK 100.3±28.5 97.2±26.2 99.4±33.4 92.9±28.3 93.5±29.1 0.402 0.003 4.087 
mslew2: SVS 122.7±40.5 120.8±37 115.9±35.8 127.7±45.8 133.4±45.4 0.890 0.025 2.858 0.871 0.03 
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OK 127.3±43.3 126.1±36.6 121.7±33.3 123.1±44.7 121.8±37.5 0.490 0.109 1.918 
dive1: 
SVS 325.8±97.8 300.8±111.3 298.4±77 309±130.3 329.3±118.1 0.836 0.146 1.725 
0.222 1.51 
OK 322.3±101.4 296.5±104.8 302.9±108.9 302.3±101.6 305.2±101.2 0.152 2.537 0.042 
dive2: 
SVS 246.2±82 233.5±76.3 219.5±68 243.3±92.6 255.7±107 0.868 2.746 0.03 
0.418 0.66 
OK 252.3±79.4 248.6±76.5 226.2±70 231±79.3 246.7±91.1 0.801 1.231 0.299 
aindex: 
SVS 9.46±0.95 9.45±0.76 9.68±0.41 9.57±0.67 9.62±0.62 <0.001* 4.545 0.337 
0.255 1.31 
OK 9.49±0.63 9.31±0.82 9.50±0.73 9.40±0.83 9.48±0.65 <0.001* 10.53 0.032 
bindex: 
SVS 9.41±1.50 9.59±0.99 9.33±1.46 9.54±1.02 9.69±0.68 <0.001* 4.313 0.365 
0.652 0.20 
OK 9.65±0.88 9.72±0.66 9.58±0.85 9.47±1.00 9.71±0.63 <0.001* 3.31 0.507 
aplhf: 
SVS 1.37±0.74 1.27±0.37 1.27±0.36 1.28±0.34 1.23±0.33 0.001* 1.382 0.847 
0.719 0.13 
OK 1.30±0.36 1.28±0.33 1.25±0.30 1.35±0.43 1.25±0.31 0.028* 1.92 0.750 
Values from upper 75% of peak 
p1area: 
SVS 3456±838 3293±859 3020±777 3412±1113 3475±1087 0.833 3.599 0.012 
0.155 2.05 
OK 3305±854 3332±971 3215±876 3146±786 3167±861 0.818 1.673 0.17 
p2area: 
SVS 2155±731 1961±718 1940±591 2058±712 2241±814 0.974 1.64 0.178 
0.232 1.45 
OK 2201±776 2113±702 2089±753 1958±765 2123±762 0.610 2.016 0.108 
h1: 
SVS 371.5±78.01 348.3±90.5 326.1±70.2 365.1±110 376.2±108.2 0.458 4.722 0.003 
0.455 0.56 
OK 366.8±81.7 359.8±81.4 354.2±90.2 349±83.4 345.5±92.7 0.515 3.254 0.013 
h2: 
SVS 307.3±89.8 292.5±76.7 278.4±64.9 307.9±86.8 322.3±94.1 0.745 3.533 0.013 
0.492 0.48 
OK 316.8±80.8 310.9±80.6 298.1±71.8 291.4±83.1 303.3±84 0.948 2.385 0.053 
w1: 
SVS 22.13±2.19 22.63±2.31 22.12±7.64 22.11±2.75 22.15±2.55 0.123 0.409 0.802 
0.696 0.15 
OK 21.77±2.83 22.31±2.67 21.96±3.07 22.04±2.33 22.42±2.71 0.308 1.387 0.24 
w2: 
SVS 16.94±3.63 16.43±4.08 22.15±2.65 16.08±3.83 16.71±4.50 0.287 1.289 0.276 
0.159 2.02 
OK 16.58±4.27 16.28±3.81 16.78±3.82 16.18±4.49 17.11±3.89 0.139 0.982 0.088 
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aspect1: 
SVS 16.97±3.96 15.57±4.50 14.95±3.98 16.81±5.52 17.23±5.41 0.927 3.461 0.009 
0.663 0.191 
OK 17.13±4.28 16.35±4.04 16.53±5.32 16.05±4.35 15.75±4.77 0.397 2.966 0.021 
aspect2: 
SVS 18.99±6.79 19.20±8.06 16.73±5.48 20.32±8.29 20.94±9.29 0.238 2.356 0.069 
0.661 0.193 
OK 20.41±7.58 20.25±7.43 18.71±6.18 19.26±7.91 18.67±6.67 0.051 2.123 0.08 
uslope1: 
SVS 62.24±18.05 58.87±20.22 56.74±16.16 61.78±23.62 66.90±26.60 0.893 2.476 0.046 
0.971 0.001 
OK 64.34±22.14 61.78±20.66 61.46±22.24 58.27±18.58 60.27±22.58 0.373 2.12 0.08 
uslope2: 
SVS 81.28±30.74 85.74±30.68 76.11±31.71 85.57±36.33 89.42±35.51 0.550 2.818 0.026 
0.641 0.22 
OK 86.70±33.68 87.11±30.56 83.55±26.23 81.78±30.07 83.14±29.88 0.740 1.353 0.257 
dslope1: 
SVS 24.07±6.24 22.12±6.71 21.09±6.46 23.85±8.25 24.01±7.42 0.241 2.742 0.03 
0.669 0.184 
OK 24.13±6.29 23.14±6.30 23.52±7.99 22.93±6.77 22.21±7.14 0.622 2.807 0.027 
dslope2: 
SVS 25.70±10.59 26.23±14.50 22.12±7.64 27.75±12.58 28.56±15.17 0.129 1.789 0.147 
0.922 0.01 
OK 27.86±11.92 26.88±10.19 24.39±9.36 26.36±13.24 24.84±10 0.058 2.046 0.09 
path1: 
SVS 21.29±3.62 20.99±2.79 21.44±4.07 20.91±2.95 21.22±2.87 0.537 0.348 0.845 
0.233 1.44 
OK 21.93±3.27 21.69±3.47 21.85±4.32 21.82±3.26 21.49±3.93 0.992 1.208 0.309 
path2: 
SVS 27.22±7.32 29.03±9.05 27.80±8.46 28.88±8.30 27.28±6.75 0.207 0.638 0.636 
0.333 0.95 
OK 27.90±8.39 27.85±6.24 26.93±7.06 28.69±7.16 27.08±5.32 0.187 0.153 0.962 
Values from upper 50% of peak 
p1area: 
SVS 1495±414 1407±382 1296±363 1465±541 1462±469 0.920 3.176 0.023 
0.115 2.54 
OK 1389±390 1411±455 1376±424 1328±367 1328±401 0.973 1.129 0.341 
p2area: 
SVS 930±315 840±310 837±267 908±330 988±357 0.955 1.517 0.207 
0.379 0.78 
OK 972±340 921±310 919±356 854±331 927±340 0.738 2.192 0.084 
h1: 
SVS 247.7±52 232.2±60.3 217.4±46.8 243.4±73.3 250.8±72.1 0.458 4.722 0.003 
0.455 0.56 
OK 244.5±54.4 239.9±54.2 236.1±60.2 232.7±55.6 230.4±61.8 0.515 3.254 0.013 
SVS 204.9±59.9 195±51.1 185.8±43.3 205.2±57.9 214.8±62.7 0.745 3.533 0.013 
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h2 OK 211.2±53.9 207.3±53.7 198.8±47.9 194.3±55.4 202.2±56 0.948 2.385 0.053 0.492 0.475 
w1: 
SVS 11.22±2.16 11.73±1.96 11.24±2.00 11.37±2.16 11.63±1.91 0.388 0.128 0.972 
0.393 0.74 
OK 10.95±2.20 11.31±2.28 11.23±2.32 11±2.11 11.31±2.18 0.007* 2.34 0.674 
w2: 
SVS 8.5±2.28 7.91±2.14 8.29±2.68 7.93±2.31 8.35±2.14 0.025* 1.239 0.872 
0.203 1.65 
OK 8.31±2.58 8.11±2.09 8.26±2.38 7.89±2.20 8.13±1.87 0.045* 3.89 0.420 
aspect1: 
SVS 23.09±7.36 20.49±7.53 20.13±6.38 22.13±7.36 22.29±7.62 0.218 2.114 0.08 
0.93 0.008 
OK 23.22±6.64 22.16±6.87 22.51±9.74 22.17±7.70 21.58±8.18 0.904 2.826 0.026 
aspect2: 
SVS 26.24±12.14 26.90±12.18 25.13±10.81 27.92±11.33 27.59±10.79 0.200 0.977 0.421 
0.865 0.03 
OK 27.76±10.91 27.26±9.70 25.87±9.17 26.46±11.95 26.05±9.04 0.402 0.979 0.421 
uslope1: 
SVS 59.08±23.27 53.83±21.71 55.60±20.09 58.28±23.81 63.26±28.89 0.538 2.046 0.089 
0.821 0.05 
OK 62.98±24.10 57.60±23.29 58.12±24.86 55.85±23.84 58.70±24.19 0.699 2.308 0.06 
uslope2: 
SVS 68.64±26.63 69.01±29.83 62.23±29.30 70.48±28.71 72.33±30.99 0.516 1.838 0.123 
0.973 0.001 
OK 70.99±28.71 70.59±28.91 69.64±27.72 64.82±24.80 65.23±25.84 0.622 1.596 0.177 
dslope1: 
SVS 37.88±14.14 33.64±14.64 32.10±12.84 35.99±14.09 34.97±12.05 0.225 1.443 0.221 
0.36 0.83 
OK 38.39±13.49 37.86±15.61 38.68±22.12 38.75±16.15 34.75±14.84 0.297 2.323 0.058 
dslope2: 
SVS 42.52±23.70 40.37±17.14 39.32±16.76 43.05±18.67 42.64±19.28 0.046* 0.268 0.992 
0.85 0.04 
OK 44.04±19.96 41.80±16.71 39.98±17.60 42.65±20.98 38.34±14.17 0.481 0.9 0.458 
path1: 
SVS 30.25±6.25 30.35±5.83 30.74±6.89 30.35±6.54 31.33±6.60 0.576 0.786 0.535 
0.018 5.82 
OK 32.70±7.04 32.04±7.05 31.89±8.29 32.46±6.29 31.72±6.97 0.792 1.393 0.238 
path2: 
SVS 38.49±10.61 39.03±11.48 37.64±9.53 37.49± 8.77 36.49±10.38 0.388 0.889 0.472 
0.916 0.01 
OK 36.81±9.74 37.41±10.27 37.39±10.67 38.52±10.57 34.69±7.75 0.958 0.881 0.476 
Corneal biomechanical properties measured with the ORA. *If p<0.05, Friedman’s test procedures were carried out, statistically signifycant 
(p<0.05).
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Appendix 3: Short term corneal biomechanical changes ORA-derived parameters over the seven-day period of ortho-k lens wear compared to 
baseline 
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Corneal biomechanical properties measured with the ORA over the 7-night period (statistically significant (p<0.05)). 
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Appendix 4: Food Frequency Questionnaire 
Participant ID:   Date:       /     /2016 Researcher initials: 
Corneal Biomechanics Nutrition Survey 
Please choose one of the nine categories that best describes how many times over the past 
year have you eaten each food type and indicate whether you typically ate a small (S), 
medium (M) or large (L) serving. A medium serving size describes the natural or standard 
portion size e.g., 1 banana = medium portion size or 2 slices of pizza = medium portion size. 
Food 
Never 
or <1 
per 
month 
1-3 
per 
month 
1 
per 
week 
2-4 
per 
week 
5-6 
per 
week 
1 
per 
day 
2-3 
per 
day 
4-5 
per 
day 
6+ per 
day 
E.G., PIZZA   M       
Salads, vegetables & soup 
Apples          
Bananas          
Peaches          
Cantaloupe          
Watermelon          
Strawberries          
Oranges          
Grapefruit          
Other fruit          
Orange or 
grapefruit 
juice 
         
Broccoli          
Coleslaw          
Cauliflower          
Cooked greens          
Squash          
Carrots          
Sweet potatoes          
Tomatoes          
Raw spinach          
Cooked 
spinach 
         
Green salad          
String beans          
Other beans          
Peas          
Chilli with 
beans 
         
Corn          
Potatoes          
Any other 
vegetable 
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Vegetable and 
tomato soup 
         
Other soup          
Food 
Never 
or <1 
per 
month 
1-3 
per 
month 
1 
per 
week 
2-4 
per 
week 
5-6 
per 
week 
1 
per 
day 
2-3 
per 
day 
4-5 
per 
day 
6+ per 
day 
Meat & fish 
Hotdogs          
Ham          
Bacon          
Sausage          
Hamburgers          
Beef          
Beef stew          
Pork or lamb          
Liver          
Liverwurst 
 
         
Fried fish          
Tuna          
Oysters          
Shrimp          
Other fish          
Fried chicken          
Chicken or 
Turkey 
         
Dairy & eggs 
Ice cream          
Cottage cheese          
Other cheese          
Macaroni and 
cheese 
         
Milk in coffee 
or tea 
         
Milk on cereal          
Whole milk          
2% milk 
(semi-
skimmed) 
         
1% milk 
(skimmed) 
         
Yogurt          
Eggs          
Butter added 
to vegetables 
         
Butter on 
bread 
         
Margarine on 
bread 
         
Cereal foods, sweets & biscuits 
High-fibre 
cereals 
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Fortified 
cereals 
         
Other cold 
cereals 
         
Cooked cereals          
Dark bread          
White bread          
Corn bread          
Biscuits           
Food 
Never 
or <1 
per 
month 
1-3 
per 
month 
1 
per 
week 
2-4 
per 
week 
5-6 
per 
week 
1 
per 
day 
2-3 
per 
day 
4-5 
per 
day 
6+ per 
day 
Doughnuts          
Chocolate          
Other candy 
 
         
Pasta or 
spaghetti 
         
Rice          
Noodles          
Crisps          
Pizza          
Chips          
Beverages & condiments 
Regular soft 
drink 
         
Fruit drinks          
Coffee or tea          
Sugar in coffee 
or tea 
         
Non-dairy 
creamer in 
coffee or tea 
         
Liquor          
Beer          
Wine          
Gravies          
Red chili sauce          
Salad 
dressings 
         
Peanuts or 
peanut butter 
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Appendix 5: Factors influencing corneal biomechanics 
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∆
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C
C
T
 (µ
m
) 
IOPg 
(mmHg) 
12.86±3.1
6 
0.027 0.127 0.101 0.095 0.051 -0.034 0.078 0.194* 0.027 0.009 0.143 0.018 0.053 -0.003 0.019 0.093 0.111 -0.44 
IOPcc 
(mmHg) 
13.93±2.8
0 
0.2 
0.1087
* 
0.088 0.036 0.001 0.014 0.050 0.165 -0.058 -0.022 0.125 -0.022 0.044 0.044 0.014 0.126 0.003 -0.101 
CH (mmHg) 10.20±1.3
9 
0.03 -0.12 0.056 0.094 0.010 -0.095 0.013 0.039 0.125 0.013 0.025 -0.037 0.076 0.008 0.154 0.144 -0.022 0.002 
CRF 
(mmHg) 
9.45±1.67 0.039 -0.15 0.119 0.123 0.062 -0.077 0.043 0.115 0.077 0.0005 0.075 -0.028 -0.076 0.013 0.007 -0.060 0.016 0.069 
slew1 72.78± 
19.42 
0.08 0.117 0.091 -0.142 -0.084 
-
0.214* 
-0.35 -0.095 0.132 0.094 -0.020 0.069 -0.023 -0.09 -0.036 0.009 0.88 -0.05 
slew2 78.61± 
21.37 
0.2 0.151 -0.092 -0.025 -0.124 -0.024 -0.051 -0.115 -0.54 -0.107 -0.136 0.062 -0.029 0.38 0.156 0.166 0.25 0.108 
mslew1 113.69± 
25.15 
0.04 0.134 0.092 -0.056 -0.150 
-
0.208* 
0.88 -0.125 0.131 -0.024 -0.062 0.152 -0.029 0.38 0.156 0.166 0.25 -0.024 
mslew2 118.88± 
25.62 
0.2 0.188* -0.160 0.049 
-
0.1049 
-0.032 -0.057 -0.121 -0.029 
-
0.225* 
-
0.0.79 
0.123 0.010 -0.086 0.0115 0.145 -0.009 0.085 
dive1 454.6± 
114.76 
<0.00
1 
0.190* -0.003 0.082 -0.074 -0.004 -0.065 -0.080 0.043 -0.04 -0.020 0.077 0.026 -0.054 0.003 0.144 0.195* 0.017 
dive2 413..80± 
79.60 
0.001 0.133 0.079 -0.132 -0.102 
-
0.216* 
-0.44 -1.05 0.117 0.076 -0.022 -0.032 -0.015 0.016 -0.017 0.04 0.070 0.04 
aindex 9.93±0.26 
<0.00
1 
-0.063 0 0.034 -0.098 -0.026 -0.094 -0.050 0.86 0.063 -0.066 -0.160 0.034 -0.170 -0.009 0.002 -0.060 0.164 
bindex 9.79±0.47 
<0.00
1 
0.107 0.043 0.036 0.062 0.012 -0.012 -0.038 0.051 0.028 0.062 0.053 0.036 -0.001 0.003 0.058 0.090 -0.08 
aplhf 0.92±0.18 
<0.00
1 
-0.007 0.034 -0.016 -0.050 -0.059 0.005 0.078 -0.172 -0.091 0.037 -0.065 0.019 -0.077 -0.022 -0.065 -0.073 
-
0.234* 
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Values from upper 75% of peak 
p1area 5277.84± 
1383.64 
<0.00
1 
0.164 0.153 0.014 -0.003 0.010 0.030 -0.010 -0.024 -0.046 -0.174 0.053 0.086 0.114 
0.365*
* 
0.409*
* 
0.078 -0.035 
p2area 4822.19± 
1139.57 
0.2 0.067 0.055 0.097 -0.019 0.075 -0.109 
-
0.184* 
0.104 -0.013 -0.129 0.03 0.026 0.01 0.330* 0.338* -0.1 0.077 
h1 510.95± 
76.44 
0.092 0.067 0.055 0.097 -0.19 0.075 -0.109 
-
0.184* 
0.104 -0.13 -0.129 0.03 0.018 0.034 0.330 0.338 -0.39 -0.048 
h2 460.79± 
68.73 
0.023 0.189* 0.031 -0.058 -0.162 -0.239 0.114 0 0.087 -0.019 0.077 0.131 0.073 -0.036 0.031 0.081 0.029 0.101 
w1 22.06±2.3
6 
<0.00
1 
0.024 0.141 0.028 0.089 0.111 -0.036 -0.068 -0.047 0.08 -0.166 -0.002 -0.036 0.108 0.216 0.230 0.083 -0.144 
w2 24.03±4.3
9 
<0.00
1 
-0.126 0.41 -0.004 0.054 0.024 0.002 -0.036 0.059 0.037 -0.041 0.006 -0.041 0.094 0.129 0.087 -0.165 0.049 
aspect1 23.33±3.7
2 
0.2 0.189* 0.031 -0.058 -0.162 -0.239 0.114 0 0.087 -0.019 0.077 0.131 0.073 -0.036 0.031 0.081 0.029 0.049 
aspect2 19.79±4.4
6 
0.2 0.189* 0.031 -0.058 -0.162 -0.239 0.114 0 0.087 -0.019 0.077 0.131 0.089 -0.036 -0.002 0.064 0.031 0.069 
uslope1 73.98± 
16.89 
0.2 0.133 0.079 -0.132 -0.102 
-
0.216* 
-0.04 -0.105 0.117 0.076 -0.022 0.071 0.038 0.046 0.043 0.077 0.052 -0.005 
uslope2 78.55± 
21.51 
0.05 0.151 -0.093 -0.026 -0.123 0.025 -0.051 -0.113 -0.053 -0.110 -0.134 0.063 -0.027 0.037 0.157 0.166 0.024 0.110 
dslope1 35.25±6.2
1 
0.2 0.106 -0.032 -0.002 -0.124 -0.162 0.115 0.05 0.038 -0.081 0.104 0.124 0.115 -0.066 0.007 0.66 -0.009 0.062 
dslope2 27.62±7.4
6 
0.05 0.130 0.042 0.099 -0.045 0.027 -0.019 -0.055 0.035 0.030 -0.008 0.027 0.078 -0.049 0.014 0.083 0.204 -0.035 
path1 19.11±2.8
2 
0.2 0.151 -0.093 -0.026 -0.123 -0.025 -0.051 -0.113 -0.053 -0.11 -0.134 0.063 -0.027 -0.027 0.157 0.166 0.024 -0.052 
path2 18.88±3.4
6 
0.06 0.096 -0.088 -0.049 -0.060 -0.134 -0.086 -0.134 0.073 -0.040 0.023 0.142 0.075 -0.079 -0.004 0.37 -0.09 -0.136 
Values from upper 50% of peak  
p1area 2429.52± 
776.85 
<0.00
1 
0.151 0.176* 0.008 0.025 0.020 0.026 -0.142 -0.023 -0.095 
-
0.190* 
0.059 0.1 -0.10 
0.354*
* 
0.397*
* 
0.012 0.01 
p2area 2132.08± 
542.28 
0.2 0.080 0.075 0.089 -0.001 0.036 -0.107 
-
0.179* 
0.095 -0.030 -0.139 0.004 0.034 0.047 0.341 0.345 -0.37 0.055 
h1 340.63± 
50.96 
0.09 0.274 0.077 -0.058 -0.113 -0.168 0.106 -0.44 0.043 0.012 -0.21 0.097 0.117 0.021 0.253 0.319 0.08 -0.048 
h2 307.19± 
45.82 
0.033 0.204* 0.045 0.095 -0.066 0.092 -0.118 -0.211 0.102 0.041 -0.145 0.099 0.070 0.018 0.339 0.361 0.23 0.101 
w1 12.46±2.1
7 
<0.00
1 
-0.024 0.074 0.101 0.104 0.124 -0.025 -0.095 -0.064 -0.129 -0.159 -0.042 0.117 0.021 0.253 0.319 0.08 0.010 
w2 12.76±2.7
0 
<0.00
1 
0.015 -0.006 0.078 0.002 
-
0.224* 
0.23 0.002 0.023 -0.055 -0.009 -0.109 0.104 0.015 0.154 0.177 0.018 0.045 
aspect1 28.02±5.8
8 
0.2 0.157 0.002 -0.129 -0.145 -0.224 0.063 0.059 0.075 0.096 0.111 0.133 
-
0..011 
0.050 0.188 0.146 0.290* -0.087 
aspect2 25.18±6.4 0.04 0.039 0.047 0.017 -0.28 0.006 -0.105 -0.108 -0.43 0.026 -0.047 0.154 -0.037 0.016 -0.021 0.06 0.040 -0.042 
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4 
uslope1 68.80± 
17.98 
0.2 0.093 0.026 -0.080 -0.102 -0241* 0.008 -0.098 0.126 0.105 0.016 0.083 0 -0.001 -0.001 0.045 0.145 -0.092 
uslope2 69.83±19.
17 
0.032 0.196* 0.111 -0.055 
-
0.0002 
-0.137 0.038 -0.039 0.099 0.022 -0.66 0.098 0.001 -0.058 -0.060 -0.041 0.084 -0.011 
dslope1 47.62± 
12.02 
0.2 0.196 0.059 -0.001 0.010 0.036 -0.083 0.065 -0.049 -0.077 -0.005 -0.057 -0.102 -0.057 -0.136 0.073 -0.073 -0.095 
dslope2 39.21± 
12.43 
0.051 -0.007 0.094 0.056 -0.002 0.093 -0.106 -0.087 0.074 0.04 0.033 0.109 -0.008 0.159 0.217 0.247 0.016 -0.053 
path1 26.40±5.4
9 
0.2 -0.051 -0.170 -0.14 -0.075 -0.093 -0.017 0.141 -0.006 0.09 0.225* 0.027 0.009 0.006 -0.054 -0.012 0.165 -0.118 
path2 26.31±5.4
2 
<0.00
1 
0.06 -0.069 -0.002 0.053 0.104 -0.029 0.087 -0.039 -0.09 0.081 -0.078 0.028 
-
0.0112 
-0.169 -0.157 0.032 -0.093 
Table A1: Summary of the association between the ORA parameters and age, ethnicity, dietary components, eye and body size and ocular biometric 
parameters. Note: *correlation significant at <0.05 level, ** correlation significant at <0.01 level. 
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C
C
T
 (µ
m
) 
IOP 
(mmHg) 
13.65±1.
92 
0.161 0.204 0.011 
-
0.224 
0.201 
-
0.100 
0.157 
-
0.023 
0.094 
-
0.153 
0.117 0.099 
-
0.149 
-
0.088 
0.093 0.112 
-
0.127 
-
0.057 
Def. 
Amp.(m
m) 
1.07±0.0
9 
0.200 0.013 0.130 0.116 
-
0.114 
0.012 0.067 0.147 
-
0.052 
0.285
** 
0.029 0.015 0.184 
-
0.025 
-
0.079 
-
0.022 
0.196 
-
0.167 
A1 time 
(ms) 
7.44±0.3
2 
<0.00
1 
0.217* 
-
0.079 
-
0.071 
-
0.175 
-
0.192 
-0.016 
-
0.030 
0.020 
-
0.080 
-
0.062 
0.068 
-
0.109 
0.003 0.137 0.168 
-
0.171 
0.181 
A1 
length 
(mm) 
1.77±0.0
7 
0.009 0.260* 0.146 0.264 
-
0.121 
-
0.024 
0.113 
0.229
* 
0.109 
-
0.115 
-
0.016 
0.070 0.105 
0.309
** 
0.534
** 
0.612
** 
-
0.148 
0.162 
A1 
velocity 
(m/s) 
0.16±0.0
2 
0.200 
-
0.318** 
0.126 
-
0.063 
0.021 
-
0.036 
-0.028 0.002 0.040 0.207 0.162 
0.246
* 
0.150 0.174 
-
0.321
** 
-
0.323
** 
-
0.197 
-
0.098 
A2 time 
(ms) 
22.21±0.
53 
0.077 -0.082 
-
0.078 
0.200 
-
0.418
** 
-
0.061 
-0.207 0.038 
-
0.048 
0.161 
-
0.119 
-
0.122 
0.085 0.051 
-
0.032 
-
0.034 
0.061 0.159 
A2 
length 
(mm) 
1.74±0.2
7 
<0.00
1 
-0.074 
-
0.021 
0.158 0.166 0.078 0.090 
-
0.086 
-
0.092 
0.028 
-
0.071 
0.085 0.153 0.033 0.103 0.107 
-
0.052 
0.145 
A2 
velocity 
(m/s) 
-
0.36±0.0
6 
0.169 -0.219* 
-
0.229
* 
0.026 
-
0.053 
-
0.088 
0.075 
-
0.144 
0.292
** 
-
0.009 
0.012 0.092 
-
0.194 
-
0.076 
-
0.049 
-
0.114 
0.128 
-
0.002 
HC time 
(ms) 
17.07±0.
57 
<0.00
1 
-0.200 
-
0.365 
-
0.202 
-
0.144 
-
0.011 
-0.387 0.080 0.070 
-
0.112 
-
0.019 
-
0.160 
-
0.075 
0.044 -0.08 
-
0.197 
0.012 
-
0.033 
Peak 
Dist. 
(mm) 
3.3±1.01 
<0.00
1 
0.282 0.188 
-
0.035 
0.126 
-
0.016 
0.265 0.037 
-
0.084 
0.061 
-
0.374 
-
0.027 
0.323 
-
0.516
* 
0.135 0.117 0.340 
-
0.351 
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Radius 
(mm)  
7.46±0.8
2 
0.024 -0.168 0.093 0.008 
0.467
* 
0.066 0.295 0.214 0.149 0.162 
0.478
* 
0.007 0.169 
-
0.245 
-
0.076 
-
0.033 
-
0.076 
0.244 
A1 Def. 
Amp. 
(mm) 
0.13±0.0
1 
0.042 -0.215 
-
0.010 
-
0.396 
0.348 
-
0.227 
0.078 
-
0.230 
0.057 
-
0.088 
0.063 0.056 0.145 
-
0.108 
-
0.170 
-
0.113 
-
0.126 
0.108 
HC Def. 
Amp. 
(mm) 
1.07±0.0
9 
0.200 0.112 0.137 0.062 
-
0.171 
0.070 0.088 0.049 0.001 0.313 
-
0.202 
0.142 0.338 
-
0.132 
-
0.212 
-
0.110 
-
0.282 
-
0.478
** 
A2 Def. 
Amp. 
(mm) 
0.42±0.0
7 
0.200 -0.349 0.181 
-
0.181 
0.058 0.024 0.340 0.018 0.429 0.379 
0.131
2 
0.651
** 
0.204 
-
0.146 
-
0.491
* 
-
0.325 
0.144 
-
0.245 
Table A2: Summary of the association between the Corvis ST parameters and age, ethnicity, dietary components, eye and body size and ocular 
biometric parameters. Note: *correlation significant at <0.05 level, ** correlation significant at <0.01 level.
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Appendix 6: Ethical approvals for the studies (Chapter 5 and Chapter 6) 
6.1. Short term corneal biomechanical changes in orthokeratology (amended 
version) (Chapter 5) 
No: Orr, Janis 
Nosūtīts: pirmdiena, 2016. gada 5. decembrī 7:21 
Kam: Zvirgzdina, Madara (Research Student) 
Kopija: Wolffsohn, James S W 
Tēma: Fwd: Ethics Amendment Request 
FYI 
 
Begin forwarded message: 
From: "Seare, Nichola"  
Date: 4 December 2016 at 17:22:05 GMT 
To: "Orr, Janis"  
Cc: "Wolffsohn, James S W" , "Birdi, Gurkiran" 
, "Seare, Nichola"  
Subject: RE: Ethics Amendment Request 
Hi Janis 
  
Apologies for the slower than normal response to this amendment request – we 
have had a change of admin support for UREC and Gurkiran and I are still 
catching up. 
  
I am happy to give a favourable opinion to the amendment on behalf of UREC for 
which Gurkiran will send formal confirmation next week. 
  
Best wishes 
  
Nichola 
  
Dr Nichola Seare 
  
  
Personal Assistant: Gurkiran Birdi  
  
From: Orr, Janis  
Sent: 18 November 2016 12:18 
To: Seare, Nichola  
Cc: Wolffsohn, James S W  
Subject: Ethics Amendment Request 
  
Dear Dr Seare, 
  
I am writing to request an ethics amendment for an orthokeratology contact lens study 
(‘Presbyopic Corneal Reshaping’) I received ethical approval for on 5th August 2015 
(attached).  
  
Initially, we intended to investigate whether or not it is feasible to correct presbyopia 
using a novel orthokeratology lens. Due to problems with comfort and stability of this 
contact lens design, it has been necessary to adapt the study. Instead we will investigate 
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the short term (1 week) corneal response to standard commercially available CE marked 
orthokeratology lenses, fitted to correct myopia (the refractive condition it was designed 
to correct). Although this technique is established in optometric practice, the exact 
mechanism by which it achieves its effect is not fully understood. We believe that by 
closely monitoring the corneal response to orthokeratology over a short period of time, 
we will understand how orthokeratology achieves its effect, and how individual corneal 
characteristics influence its success.  
  
I have attached the original documentation and the amended versions.  
  
As the measurements that we will be performing / contact lens types we will be fitting are 
all included within the original ethics application, and the proposed study design is more 
straightforward than the original design, we hoped that it would be possible to amend the 
original application. 
  
Kind regards, 
  
Janis Orr 
 
385 
Research protocol 
 
Short time corneal biomechanical changes in corneal reshaping therapy 
 
Myopia is a global public health issue however no consensus on an appropriate, safe, 
and effective management strategy has yet been reached, despite its rapidly increasing 
prevalence (Pan et al. 2012). Orthokeratology or corneal reshaping therapy, an overnight 
application of a specially designed contact lens to temporary reduce mild to moderate 
myopia, presumably through a tissue redistribution, providing patients with clear 
spectacle- and contact lens-free vision during the walking hours, has become more 
popular method for myopia management over the recent years, owing to its non-surgical 
nature (Swarbrick 2006) and the ability to slow down myopia progression in children by 
50% (Si et al. 2015). The individually selective treatment outcome and corneal tissue 
involvement (Swarbrick et al. 1998; Choo et al. 2008) have highlighted the importance 
of understanding corneal response in orthokeratology. 
Until recently, most of the knowledge about biomechanical properties of corneal tissue 
was gained from destructive ex vivo testing or ocular biometric parameters (corneal 
thickness and curvature) alone. Introduction of instrumentation such as Ocular 
Response Analyzer (ORA, Reichert Technologies) and Corvis ST (Oculus GmbH, 
Germany) has allowed corneal biomechanical response to be clinically examined (Luce 
2005; Hon and Lam 2013). Both instruments use an air-puff displacement to evaluate 
corneal response. ORA specific parameters corneal hysteresis (CH) and corneal 
resistance factor (CRF), that describes the viscoelastic damping properties and overall 
resistance of the corneal tissue, have been found to be useful tools in keratoconus and 
glaucoma management (Luce 2005; Sullivan-Mee et al. 2008; Abitbol et al. 2010; Fontes 
et al. 2010; Wolffsohn et al. 2012). Also, they have been reported to be affected by short 
time orthokeratology (Gonzalez-Meijome et al. 2008; Chen et al. 2009). However, rarely 
any study has looked at detailed corneal biomechanical response provided by the ORA 
(Kerautret et al. 2008; Mikielewicz et al. 2011; Wolffsohn et al. 2012) or investigated 
corneal biomechanical response in orthokeratology, using Corvis ST. 
The aim of this study is to investigate corneal biomechanical response to orthokeratology 
lens wear over a time span of 7 days, when the vast majority of refractive changes occur. 
Myopic patients (preferably 19-24 years of age) will be fitted with an orthokeratology lens 
and the refractive and corneal biomechanical changes, occurring during the first seven 
days of lens wear will be monitored. Visits will involve initial assessment, lens fitting visit, 
1 day after the first night of the lens wear and then 6 subsequent visits over the course 
of a week. At each visit following measurements will be taken: 
 
Refractive error (Shin-Nippon NVision K 500, subjective refraction) 
Monocular and binocular distance visual acuity) 
Corneal topography (Medmont E300 topographer) 
Corneal biomechanical response (ORA, Corvis ST) 
Endothelial effects (Specular Microscope, Topcon SP3000P) 
Epithelial effects (thickness changes, tissue redistribution) (OCT, ALADDIN, Topcon, 
Medmont E300 topographer) 
Corneal profile changes (Corvis ST (Scheimpflug imaging), Medmont E300 topographer 
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6.2. Factors influencing corneal biomechanics (Chapter 6) 
> From: University REC Enquiries 
> Sent: 06 August 2015 16:46 
> To: Orr, Janis 
> Subject: RE: Revised documentation for ethics applications 
>  
> Dear Janis 
>  
> Please find favourable opinion letters for Projects 833 and 834 attached. 
>  
> Regards 
>  
> Martin Johnson 
> Governance Support Team 
> Aston University 
> Aston Triangle 
> Birmingham 
> B4 7ET 
>  
>  
>  
> From: Orr, Janis 
> Sent: 09 July 2015 16:40 
> To: University REC Enquiries 
> Subject: RE: Revised documentation for ethics applications 
>  
> Dear Martin, 
>  
> Attached are the documents containing the suggested amendments. 
>  
> Kind regards, 
>  
> Janis 
>  
>  
> Dr Janis B. Orr PhD BSc(Hons) MCOptom DipTp(IP) 
> Lecturer in Optometry 
> Aston University 
> Aston Triangle 
> Birmingham 
> B4 7ET 
>  
>  
> www.aston.ac.uk/lhs/research/centres-facilities/ophthalmic-research-
group/<http://www.aston.ac.uk/lhs/research/centres-facilities/ophthalmic-research-
group/> 
>  
> [Logo-for-Aston-University-001] 
>  
> [cid:image002.png@01D0D067.0BDC9A00] 
>  
> From: University REC Enquiries 
> Sent: 09 July 2015 14:05 
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> To: Orr, Janis 
> Subject: RE: Revised documentation for ethics applications 
>  
> Good afternoon Janis 
>  
> We have reviewed your resubmitted documents and request you address the 
following two points: 
>  
>  
> •         Project 833 - Please include some further detail to explain what a ‘bespoke 
aberrometer’ is and does. 
>  
>  
> •         Project 834 – Amend Consent Form to include a line asking participants if they 
are happy to take part in the second part of the study. 
>  
>  
> Thank you 
>  
> Regards 
>  
> Martin   
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MEMORANDUM 
DATE: 15 June 2015 
TO: Dr Janis Orr, 
 School of Life and Health Sciences 
FROM: Dr Nichola Seare, 
 Chair of the Aston University Research Ethics Committee 
SUBJECT: Ethics Application 834: ‘Factors Influencing Corneal Biomechanics’ 
 
Following a meeting of the Sub-Group of the University's Ethics Committee to consider 
the above project proposal, on behalf of the Committee. The Sub-Group asked the 
project team to address the following points and to submit appropriate revised 
documentation: 
 
Research Participant Information Sheet 
 
Members felt that you did not require the last two sentences under the heading ‘What will 
happen to me if I decide to take part?’. 
 
Members recommend that you have two separate Participant Information Sheets. One for 
people in the first part of the study and another for the small number of subjects who will be 
asked to return. 
 
Please add a line in the information sheet stating that you will talk to the participants about 
anything you see that could affect their health. 
 
Consent Form 
 
Please add a line on the consent form asking participants if they are happy to take part in the 
second part of the study. 
 
The revised documentation should be submitted to Martin Johnson 
(urec_queries@aston.ac.uk) who will then arrange asap for the Sub-Group to consider 
its approval on behalf of the Ethics Committee. 
 
Chair of the Ethics Committee 
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Appendix 7: Patient information sheets and consent forms (Chapter 5 and Chapter 
6) 
7.2 Short term corneal biomechanical changes in orthokeratology (Chapter 5) 
RESEARCH PARTICIPANT INFORMATION SHEET 
Short term corneal biomechanical changes in orthokeratology 
Invitation 
You are being invited to take part in a research project that will be conducted at Aston 
University. Before you decide it is important for you to understand why the research is 
being done and what it will involve. Please take time to read the following information 
carefully and discuss it with others if you wish. Ask us if there is anything that is not clear 
or if you would like more information. Take time to decide whether or not you wish to take 
part. Thank you for reading this. 
 
What is the purpose of the project? 
The purpose of this study is to find how an overnight application of specially designed 
lens, which provides a clear vision during the day without the need for additional 
spectacles or contact lenses (clinically referred to as orthokeratology), affects the 
biomechanical properties of the cornea (the transparent front surface of your eye) over 
the period of seven days. The results of this research project will inform the contact lens 
industry and practitioners of the biomechanical changes occurring during the first week 
of the lens wear, when most of the treatment effects take place. 
 
Why have I been chosen? 
You have been invited to take part because you are over 18, have healthy eyes and 
require corrective lenses for distance. 
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What will happen to me if I decide to take part? 
After the study has been explained to you and consent given, you will be asked about 
your ocular history (which will include the completion of a short questionnaire) and your 
eye health will be assessed and photographed using a clinical microscope. The shape of 
the front of your eye will be assessed using light reflected from the front surface and the 
biomechanics of your eye will be assessed with a puff of air (a clinical test used to 
evaluate the pressure in your eyes). Your refraction will be checked with clinical 
instrumentation and your vision will be measured over a range of distances. 
You will then be fitted with made-to-measure rigid contact lenses by a qualified 
optometrist to be worn overnight only. These lenses will make subtle, reversible changes 
to the shape of your cornea (the transparent layer at the front of your eye) which will allow 
you to have clear vision during the day without wearing spectacles or other contact 
lenses. You will be asked to return the morning after fitting for assessment using the same 
procedures and then 6 subsequent mornings. We will also ask you to fill out a 
questionnaire on how satisfied you are with the lens. The lenses will be worn in both eyes. 
If the initial lens does not give optimum vision, adjustments may need to be made the 
new lens type in order to achieve this.  
The duration of the tests will be approximately 20-25 minutes at a single appointment. By 
volunteering to participate you will be giving anybody in the research team consent to 
access your results and compare them to other participants involved in the project, as 
well as confirming your past refractive correction. 
What are the possible disadvantages and risks of taking part? 
You will need to attend the Aston University Eye Clinic on several occasions in order to 
be fitted for the lenses and for follow-up. The tests do not make contact with your eyes 
and have been tested to ensure they are safe. Your data will be anonymised before 
stORAge. 
It may take time to get used to wearing the lenses, particularly if you haven’t worn contact 
lenses before. It may also take some time for your vision to improve following the fitting 
of the lenses. If you decide to stop wearing the lenses, your eyes will go back to normal.  
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What are the possible benefits of taking part? 
You may be able to see well at all distances during waking hours without the need for 
glasses or contact lenses. This is the only non-surgical way to achieve this. The lenses 
will be provided to you free of charge. 
 
Do I have to take part? 
No, you do not have to participate if you do not wish to do so. This information sheet is 
yours to keep. If you would like to participate, you will be required to sign the enclosed 
consent form. You are free to withdraw at any time. No sanctions will be taken against 
any patient who refuses to participate in or withdraws from this project. A decision to 
withdraw at any time, or a decision not to take part, will not affect the standard of care 
you receive. 
 
What if new information becomes available?  
New information will be used to guide the study.  
 
What happens when the research study stops? 
When your participation in the study stops (you have worn the lenses in both eyes for 1 
week) you will be able to continue lens wear, if you wish to, and your care will be 
transferred to the Aston University Health Clinic.  
What if something goes wrong? 
You will be in the hands of fully qualified optometrists at Aston University Optometry 
Clinic. In the unlikely event that there are any complications, these will be managed in an 
appropriate, timely fashion. You will also be told what action to take should this happen 
out of hours. 
 
Will my taking part in this project be kept confidential? 
Yes. Your participation in this study will be strictly confidential. There will be no way to 
link any research data to any individual participant. 
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What will happen to the results of the research project and how will 
participant anonymity be protected? 
The results of the study will be available to the named investigators only and data files 
will be named in such a way that your identity is protected. We aim to publish the results 
of this project. However, there will be no reference to any individual’s performance in any 
publication. Details of any publication will be conveyed to participants on request.  
 
Who has reviewed the project? 
The research has been reviewed by Aston University’s Ethics Committee. 
 
Contacts for further information 
Dr Janis B. Orr (Principal Investigator)   
Ms Madara Zvirgzdina (Research Student)  
 
Who do I contact if I wish to make a complaint about the way in which the 
research is conducted.  
If you have any concerns about the way in which the study has been conducted, then you 
should contact Secretary of the University Research Ethics Committee: 
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Personal Identification Number for this study: ____________ 
CONSENT FORM 
 
Title of Project:   Short term biomechanical changes in orthokeratology 
Research Venue: Aston University Optometry Clinic 
Aston University Investigators:  Janis Orr PhD DipTp(IP) 
James Wolffsohn PhD PgDipAdvClinOptom PgCHE MBA  
Madara Zvirgzdina MSc BSc 
Please initial box 
 
I confirm that I have read and understand the information sheet dated ............................ 
    
for the above study and have had the opportunity to ask questions. 
 
I understand that my participation is voluntary; the study tests are not part of any  
medical treatment or negate the need for regular eye examination.   
 
I understand that I am free to withdraw at any time, without giving any reason, without  
my legal rights being affected.  
 
I agree to take part in the above study.    
________________________ ________________ __________________ 
Name of Research Participant  Date   Signature 
 
_________________________ ________________ __________________ 
Name of Person taking Consent  Date   Signature 
  
1 copy for research participant; 1 copy for Aston University  
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7.3 Factors influencing corneal biomechanics (Chapter 6) 
RESEARCH PARTICIPANT INFORMATION SHEET 
Factors Influencing Corneal Biomechanics 
Invitation 
You are being invited to take part in a research project that will be conducted at Aston 
University. Before you decide it is important for you to understand why the research is 
being done and what it will involve. Please take time to read the following information 
carefully and discuss it with others if you wish. Ask us if there is anything that is not clear 
or if you would like more information. Take time to decide whether or not you wish to take 
part. Thank you for reading this 
 
What is the purpose of the project? 
To find out which factors influence how rigid the cornea (the transparent part of the front 
of your eye) is. The results of this study will have important implications for several clinical 
situations including glaucoma diagnosis, refractive surgery and corneal reshaping 
therapy (also known as orthokeratology).  
 
Why have I been chosen? 
You have been chosen because you are over 18 and have healthy eyes. 
 
What will happen to me if I decide to take part? 
After the study has been explained to you and consent given, you will be asked about 
your ocular history and diet (including the completion of a short questionnaire) and your 
eye health will be assessed and photographed using a clinical microscope. Your height 
and weight may also be measured in order to investigate the influence of eye/body size 
on the rigidity of the cornea only. The shape of the front of your eye will be assessed 
using light reflected from the front surface and the biomechanics of your eye will be 
assessed with a puff of air (a clinical test used to evaluate the pressure in your eyes). 
The duration of the tests will be 45-60 minutes at a single appointment. 
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What are the possible disadvantages and risks of taking part? 
You will need to attend the Aston University Eye Clinic on one occasion in order to 
participate.  
 
What are the possible benefits of taking part? 
You will be providing us with important information on the cornea, a vital part of the eye, 
which has implications for many clinical areas. 
 
Do I have to take part? 
No, you do not have to participate if you do not wish to do so. This information sheet is 
yours to keep. If you would like to participate, you will be required to sign the enclosed 
consent form. You are free to withdraw at any time from the project. No sanctions will be 
taken against any patient who refuses to participate in or withdraws from this project. A 
decision to withdraw at any time, or a decision not to take part, will not affect the standard 
of care you receive. 
 
What if new information becomes available?  
New information will be used to guide the study.  
 
What if something goes wrong? 
It is extremely unlikely that anything will go wrong during your participation in this study. 
However if an adverse event occurs, you will be in the hands of fully qualified optometrists 
at Aston University Optometry Clinic. We are happy to discuss anything that could affect 
your health. 
 
Will my taking part in this project be kept confidential? 
Yes. Your participation in this study will be strictly confidential. There will be no way to 
link any research data to any individual participant. 
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What will happen to the results of the research project and how will 
participant anonymity be protected? 
The results of the study will be available to the named investigators only and data files 
will be named in such a way that your identity is protected. We aim to publish the results 
of this project. However, there will be no reference to any individual’s performance in any 
publication. Details of any publication will be conveyed to participants on request.  
 
Who has reviewed the project? 
The research has been reviewed by Aston University’s Ethics Committee. 
 
Contacts for further information 
Dr Janis B. Orr (Principal Investigator)   
Ms Madara Zvirgzdina (Research Student)  
 
Who do I contact if I wish to make a complaint about the way in which the 
research is conducted?  
If you have any concerns about the way in which the study has been conducted, then you 
should contact Secretary of the University Research Ethics Committee: 
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Personal Identification Number for this study: ____________ 
CONSENT FORM 
Title of Project:    Factors Influencing Corneal Biomechanics 
Research Venue:  Aston University Optometry Clinic 
Aston University Investigators:  Janis Orr PhD DipTp(IP) 
James Wolffsohn PhD PgDipAdvClinOptom PgCHE MBA,  
Madara Zvirgzdina MSc BSc 
               
Please initial box 
 
I confirm that I have read and understand the information sheet dated ............................ 
    
for the above study and have had the opportunity to ask questions. 
 
I understand that my participation is voluntary; the study tests are not part of any  
medical treatment or negate the need for regular eye examination.   
 
I understand that I am free to withdraw at any time, without giving any reason, without  
my legal rights being affected.  
 
I agree to take part in the above study. 
  
________________________ ________________                ____________________ 
Name of Research Participant  Date                                           Signature 
 
_________________________ ________________                 ___________________ 
Name of Person taking Consent  Date                                            Signature 
1 copy for research participant; 1 copy for Aston University 
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